title,url,time_published,summary,ticker,relevance_score,ticker_sentiment_score,ticker_sentiment_label
3 Top Dividend Kings to Buy for the Long Haul,https://www.fool.com/investing/2023/01/10/3-top-dividend-kings-to-buy-for-the-long-haul/,2023-01-10 10:52:00,It's the underlying businesses that fund their dividends that make these stocks especially attractive.,ABT,0.059341,0.086997,Neutral
Should Investors Worry About AbbVie's Dividend?,https://www.fool.com/investing/2023/01/10/should-investors-worry-about-abbvie-dividend/,2023-01-10 10:31:00,"The risks are real, but they're decreasing over time.",ABT,0.056674,0.134004,Neutral
Sight Sciences Announces Preliminary Unaudited Fourth Quarter and Full Year 2022 Financial Results - Sight Sciences  ( NASDAQ:SGHT ) ,https://www.benzinga.com/pressreleases/23/01/g30340924/sight-sciences-announces-preliminary-unaudited-fourth-quarter-and-full-year-2022-financial-results,2023-01-09 21:20:00,"MENLO PARK, Calif., Jan. 09, 2023 ( GLOBE NEWSWIRE ) -- Sight Sciences, Inc. SGHT ( ""Sight Sciences"" or the ""Company"" ) , an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients' lives, today announces several Company updates.",ABT,0.034233,-0.066145,Neutral
Abbott's  ( ABT )  New Launch to Boost Blood Donation Experience,https://www.zacks.com/stock/news/2036828/abbotts-abt-new-launch-to-boost-blood-donation-experience,2023-01-09 15:31:00,"Abbott's (ABT) mixed reality offers donors an innovative, immersive digital experience while giving blood.",ABT,0.105604,0.003282,Neutral
3 Reliable Dividend Stocks You Can Buy With $600,https://www.fool.com/investing/2023/01/09/3-reliable-dividend-stocks-you-can-buy-with-600/,2023-01-09 10:46:00,"With products and services that many of us can't live without, these businesses are poised to deliver steadily rising dividend payouts.",ABT,0.111747,0.078582,Neutral
"Imported baby formula is about to get expensive again, with tariffs back in place",https://www.marketwatch.com/story/imported-baby-formula-is-about-to-get-expensive-again-with-tariffs-back-in-place-11673102546,2023-01-07 14:42:00,Product recalls from Abbott Laboratories last February exacerbated an infant-formula shortage caused by supply-chain disruptions.,ABT,0.099683,-0.037102,Neutral
"Whey protein market size to grow by 5,012.28 million, Growth opportunities led by Abbott Laboratories and Agropur Dairy Cooperative - Technavio",https://www.prnewswire.com/news-releases/whey-protein-market-size-to-grow-by-5-012-28-million-growth-opportunities-led-by-abbott-laboratories-and-agropur-dairy-cooperative---technavio-301711856.html,2023-01-06 13:30:00,"Whey protein market size to grow by 5,012.28 million, Growth ... PR ...",ABT,0.038969,0.075192,Neutral
2 Best Healthcare Stocks to Buy Right Now,https://www.fool.com/investing/2023/01/05/2-best-healthcare-stocks-to-buy-right-now/,2023-01-05 13:00:00,Healthcare is a durable economic sector.,ABT,0.146469,0.10377,Neutral
"Alphabet And These 2 Healthcare Stocks Insiders Are Selling - Alphabet  ( NASDAQ:GOOG ) , Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/news/23/01/30272709/alphabet-and-these-2-healthcare-stocks-insiders-are-selling,2023-01-04 13:21:54,"The Nasdaq Composite dropped around 80 points on the first trading day of 2023. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it indicates their concern in the company's prospects or that they view the stock as being overpriced.",ABT,0.308246,-0.02016,Neutral
3 Outstanding Dividend Growth Stocks to Buy for 2023,https://www.fool.com/investing/2023/01/04/3-dividend-growth-stocks-to-buy-for-2023/,2023-01-04 10:11:00,Steadily growing dividend payments from these stocks could do wonders for your passive income portfolio down the road.,ABT,0.054483,-0.008,Neutral
Beat the Dow Jones With This Unstoppable Dividend Stock,https://www.fool.com/investing/2023/01/03/beat-the-dow-jones-with-this-unstoppable-dividend/,2023-01-03 15:23:00,This drugmaker is accustomed to outperforming the broader market.,ABT,0.109705,-0.001131,Neutral
Abbott faces criminal probe over baby formula - WSJ,https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-faces-criminal-probe-over-baby-formula-wsj-2023-01-20/,2023-01-20 23:36:00,Abbott faces criminal probe over baby formula ...,ABT,0.56415,0.06484,Neutral
Abbott facing criminal investigation over baby-formula plant operations,https://www.marketwatch.com/story/abbott-facing-criminal-investigation-over-baby-formula-plant-operations-11674257179,2023-01-20 23:26:00,"The Justice Department is investigating conduct at the Abbott Laboratories infant-formula plant in Sturgis, Mich., that led to its shutdown last year and worsened a nationwide formula shortage, people familiar with the matter said.",ABT,0.651499,0.154412,Somewhat-Bullish
News Exclusive | Abbott Under Criminal Investigation Over Baby Formula,https://www.wsj.com/articles/abbott-under-criminal-investigation-over-baby-formula-11674255871,2023-01-20 23:06:00,"Federal prosecutors are probing conduct at Abbott's baby-formula plant in Michigan, which the company temporarily shutdown last year after a potentially deadly bacteria was found ...",ABT,0.876064,0.138976,Neutral
"Drug Testing Market Value to Reach US$ 15.7 Billion by 2033: Transparency Market Research, Inc. Study",https://www.prnewswire.com/news-releases/drug-testing-market-value-to-reach-us-15-7-billion-by-2033-transparency-market-research-inc-study-301726896.html,2023-01-20 15:00:00,Drug Testing Market Value to Reach US$ 15.7 Billion by 2033 ... PR ...,ABT,0.047844,0.147756,Neutral
Fertility and Pregnancy Rapid Test Kits Market will surpass USD 808.1 million by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30503244/fertility-and-pregnancy-rapid-test-kits-market-will-surpass-usd-808-1-million-by-2030-greyviews,2023-01-20 15:00:00,"Pune India, Jan. 20, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa.",ABT,0.023861,0.04814,Neutral
3 Top Passive-Income Stocks to Own in 2023,https://www.fool.com/investing/2023/01/19/3-top-passive-income-stocks-to-own-in-2023/,2023-01-19 19:00:00,These stocks can add safety and growth to your portfolio.,ABT,0.1172,0.28086,Somewhat-Bullish
"The Zacks Analyst Blog Highlights Pfizer, Abbott Laboratories, Union Pacific Corporation, Citigroup and Intuitive Surgical.",https://www.zacks.com/stock/news/2041223/the-zacks-analyst-blog-highlights-pfizer-abbott-laboratories-union-pacific-corporation-citigroup-and-intuitive-surgical,2023-01-19 13:45:00,"Pfizer, Abbott Laboratories, Union Pacific Corporation, Citigroup and Intuitive Surgical are part of the Zacks top Analyst Blog.",ABT,0.724687,0.0,Neutral
Should You Invest in the iShares U.S. Medical Devices ETF  ( IHI ) ?,https://www.zacks.com/stock/news/2041105/should-you-invest-in-the-ishares-us-medical-devices-etf-ihi,2023-01-19 11:20:09,Sector ETF report for IHI ...,ABT,0.128822,0.069961,Neutral
"Top Analyst Reports for Pfizer, Abbott Laboratories & Union Pacific",https://www.zacks.com/research-daily/2040709/top-analyst-reports-for-pfizer-abbott-laboratories-union-pacific,2023-01-18 20:59:00,"Today's Research Daily features new research reports on 16 major stocks, including Pfizer Inc. (PFE), Abbott Laboratories (ABT) and Union Pacific Corporation (UNP).",ABT,0.254307,0.164282,Somewhat-Bullish
ABT: 3 Medical Device Stocks to Watch Right Now,https://stocknews.com/news/abt-mdt-utmd-3-medical-device-stocks-to-watch-right-now/,2023-01-18 18:13:04,The medical device industry produces various devices used in day-to-day healthcare. The industry gained significant investors' attention during the pandemic due to the rising sales of medical devices related to COVID-19 prevention and management.,ABT,0.28387,0.29625,Somewhat-Bullish
"Lung Cancer Screening Market Worth USD 4.13 Bn by 2029 Technological advancement, and key benchmarking of market players",https://www.benzinga.com/pressreleases/23/01/g30456038/lung-cancer-screening-market-worth-usd-4-13-bn-by-2029-technological-advancement-and-key-benchmark,2023-01-18 08:16:34,"Portland, Jan. 18, 2023 ( GLOBE NEWSWIRE ) -- According to the ""Lung Cancer Screening Market"" research published by Maximize Market Research, the market is expected to grow from USD 2.18 billion in 2021 to USD 4.13 billion in 2029, at a CAGR of 8.32 percent during the forecast period from 2022 ...",ABT,0.027603,0.164995,Somewhat-Bullish
FDA Approves Abbott's Next-Gen Navitor TAVI System For Aortic Stenosis,https://www.benzinga.com/news/large-cap/23/01/30447272/fda-approves-abbotts-next-gen-navitor-tavi-system-for-aortic-stenosis,2023-01-17 18:11:15,"The FDA has approved Abbott Laboratories ABT latest-generation transcatheter aortic valve implantation ( TAVI ) system, Navitor, to treat people with severe aortic stenosis who are at high or extreme risk for open-heart surgery.",ABT,0.48268,0.157683,Somewhat-Bullish
What's in Store for Abbott Laboratories  ( ABT )  in Q4 Earnings?,https://www.zacks.com/stock/news/2040079/whats-in-store-for-abbott-laboratories-abt-in-q4-earnings,2023-01-17 13:43:00,"Within Abbott's (ABT) Established Pharmaceuticals Division (EPD), new product launches across key markets have been majorly boosting business in recent months.",ABT,0.159834,0.0,Neutral
"With Competition on the Rise, Is AbbVie's Dividend Safe?",https://www.fool.com/investing/2023/01/17/with-competition-on-rise-is-abbvie-dividend-safe/,2023-01-17 12:45:00,This year isn't starting on the best of notes for the drugmaker.,ABT,0.061473,-0.061252,Neutral
5 Dividend Kings I Bought for My Portfolio,https://www.fool.com/investing/2023/01/16/5-dividend-kings-i-bought-for-my-portfolio/,2023-01-16 13:45:00,Rely upon income-generating stocks to see your portfolio through times of upheaval.,ABT,0.053509,0.128704,Neutral
"If You Invested $1000 in Agilent Technologies a Decade Ago, This is How Much It'd Be Worth Now",https://www.zacks.com/stock/news/2039539/if-you-invested-1000-in-agilent-technologies-a-decade-ago-this-is-how-much-itd-be-worth-now,2023-01-16 13:30:05,"Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",ABT,0.062761,0.046006,Neutral
Want to Get Richer? 3 Best Stocks to Buy Now and Hold Forever,https://www.fool.com/investing/2023/01/13/want-to-get-richer-3-best-stocks-to-buy-now-and-ho/,2023-01-13 14:45:00,Steady growth and dividends in an evergreen industry like healthcare can be a winning investment strategy.,ABT,0.060388,0.079,Neutral
"Zoetis, SL Green Realty, Abbott Laboratories And This Big Bank Reporting Earnings On Friday: CNBC's 'Final Trades' - Abbott Laboratories  ( NYSE:ABT ) , JPMorgan Chase  ( NYSE:JPM ) ",https://www.benzinga.com/news/23/01/30384546/zoetis-sl-green-realty-abbott-laboratories-and-this-big-bank-reporting-earnings-on-friday-cnbcs-fina,2023-01-12 14:25:13,"On CNBC's ""Halftime Report Final Trades,"" Brenda Vingiello of Sand Hill Global Advisors named Zoetis Inc. ZTS as her final trade. Jenny Harrington of Gilman Hill Asset Management said SL Green Realty Corp. SLG has a 9% dividend yield. Don't forget to check out our premarket coverage here",ABT,0.56415,0.0,Neutral
Should You Buy This Promising New Healthcare Stock?,https://www.fool.com/investing/2023/01/12/should-you-buy-this-promising-new-healthcare-stock/,2023-01-12 11:42:00,Shares of GE Healthcare began trading last week after the company completed its spinoff from General Electric.,ABT,0.074692,0.1151,Neutral
Global Cholesterol Test Market Is Expected to Generate $18.4 Billion by 2031: Allied Market Research,https://www.benzinga.com/pressreleases/23/01/g30384286/global-cholesterol-test-market-is-expected-to-generate-18-4-billion-by-2031-allied-market-research,2023-01-12 09:18:03,"Portland, OR, Jan. 12, 2023 ( GLOBE NEWSWIRE ) -- According to the report published by Allied Market Research, the global Cholesterol Test Market garnered $8.5 billion in 2021, and is estimated to generate $18.4 billion by 2031, manifesting a CAGR of 8.0% from 2022 to 2031.",ABT,0.033328,0.00191,Neutral
The Medical Bionic Implant/Artificial Organs Market Size Is Expected To Grow With The Rise In Number Of Road Accidents As Per The Business Research Company's Medical Bionic Implant/Artificial Organs Global Market Report 2023,https://www.benzinga.com/pressreleases/23/01/g30374907/the-medical-bionic-implantartificial-organs-market-size-is-expected-to-grow-with-the-rise-in-numbe,2023-01-11 16:30:00,"LONDON, Jan. 11, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the medical bionic implant/artificial organs market identifies the rise in road accidents and injuries to propel the growth of the medical bionic implant/artificial organs market going forward.",ABT,0.0362,-0.046791,Neutral
VDC: 3 ETFs to Stock up on in 2023,https://stocknews.com/news/vdc-sh-pwv-3-etfs-to-stock-up-on-in-2023/,2023-01-11 15:14:33,VDC: 3 ETFs to Stock up on in ...,ABT,0.085629,0.051249,Neutral
3 Supercharged Dividend Stocks to Buy If There's a Stock Market Sell-Off,https://www.fool.com/investing/2023/01/11/3-supercharged-dividend-stocks-to-buy-if-theres-a/,2023-01-11 12:50:00,"These three healthcare stocks all deliver dependable dividends, with yields of 3% or more.",ABT,0.051551,0.0289,Neutral
Hemato-Oncology Testing Market will value USD 8.56 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30614221/hemato-oncology-testing-market-will-value-usd-8-56-billion-by-2030-greyviews,2023-01-28 15:00:00,"Pune India, Jan. 28, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the hemato-oncology testing market is operating ...",ABT,0.022161,0.05174,Neutral
Is Abbott Laboratories a Good Dividend Stock to Buy Now?,https://www.fool.com/investing/2023/01/28/is-abbott-laboratories-a-good-dividend-stock-to-bu/,2023-01-28 10:24:00,At least four Wall Street banks recently raised their price targets for the healthcare giant.,ABT,0.311631,0.291258,Somewhat-Bullish
Structural Heart Devices Market will grow to USD 31.7 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30608665/structural-heart-devices-market-will-grow-to-usd-31-7-billion-by-2030-greyviews,2023-01-27 20:00:00,"Pune India, Jan. 27, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the structural heart devices market is operating ...",ABT,0.024077,0.147672,Neutral
Influenza Diagnostics Market will worth USD 2.58 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30606896/influenza-diagnostics-market-will-worth-usd-2-58-billion-by-2030-greyviews,2023-01-27 18:00:00,"Pune India, Jan. 27, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the influenza diagnostics market is operating and ...",ABT,0.026562,0.125674,Neutral
"Jim Cramer's top 8 things to watch in the market Friday: Intel sinks, Salesforce board shakeup",https://www.cnbc.com/2023/01/27/cramers-top-8-to-watch-friday-intel-sinks-salesforce-board-shakeup-.html,2023-01-27 14:28:05,Intel (INTC) catches multiple price target cuts on Wall Street after missing estimates with fourth-quarter earnings and revenue.,ABT,0.126784,0.21354,Somewhat-Bullish
"With 5.2% CAGR, Point of Care Diagnostics Market Size to Surpass USD 51.94 Billion by 2029 | Report by Fortune Business Insights",https://www.benzinga.com/pressreleases/23/01/g30598973/with-5-2-cagr-point-of-care-diagnostics-market-size-to-surpass-usd-51-94-billion-by-2029-report-by,2023-01-27 08:50:17,"Pune, India, Jan. 27, 2023 ( GLOBE NEWSWIRE ) -- The global Point of Care Diagnostics Market size was valued at USD 46.65 billion in 2021. It is estimated to rise from USD 36.37 billion in 2022 to USD 51.94 billion by 2029, at a 5.2% CAGR during the forecast period.",ABT,0.04111,0.0,Neutral
Laboratory information management system  ( LIMS )  market to grow by 10.89% Y-O-Y from 2022 to 2023: Adherence to compliance and government regulations will drive growth -Technavio,https://www.prnewswire.com/news-releases/laboratory-information-management-system-lims-market-to-grow-by-10-89-y-o-y-from-2022-to-2023-adherence-to-compliance-and-government-regulations-will-drive-growth--technavio-301730435.html,2023-01-27 08:00:00,Laboratory information management system ( LIMS ) market to grow ... PR ...,ABT,0.036983,0.100876,Neutral
"As Per The Home Healthcare Equipment Market Forecast, The Rise In The Ageing Population Will Drive Market Growth As Per The Business Research Company's Home Healthcare Equipment Global Market Report 2023",https://www.benzinga.com/pressreleases/23/01/g30589113/as-per-the-home-healthcare-equipment-market-forecast-the-rise-in-the-ageing-population-will-drive-,2023-01-26 16:30:00,"LONDON, Jan. 26, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the home healthcare equipment market forecasts the rise in the ageing population to propel the growth of the home healthcare equipment market going forward.",ABT,0.0428,-0.052565,Neutral
NIKE To Rally Over 23%? Here Are 10 Other Analyst Forecasts For Thursday,https://www.benzinga.com/news/23/01/30583092/nike-to-rally-over-23-here-are-10-other-analyst-forecasts-for-thursday,2023-01-26 12:48:11,"Keybanc raised the price target for D.R. Horton, Inc. DHI from $97 to $109. Keybanc analyst Kenneth Zener maintained an Overweight rating. D.R. Horton shares fell 1.6% to close at $95.48 on Wednesday. Raymond James boosted the price target for Intuitive Surgical, Inc. ISRG from $255 to $270.",ABT,0.191929,0.108698,Neutral
Why Abbott Laboratories Stock Got Whacked on Wednesday,https://www.fool.com/investing/2023/01/25/why-abbott-laboratories-stock-got-whacked-on-wedne/,2023-01-25 22:29:00,Double beats for its latest quarter couldn't keep the bears away from the company's shares on Hump Day.,ABT,0.316846,-0.250929,Somewhat-Bearish
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years,https://www.benzinga.com/news/earnings/23/01/30575277/heres-how-much-you-would-have-made-owning-abbott-laboratories-stock-in-the-last-10-years,2023-01-25 20:30:55,"Abbott Laboratories ABT has outperformed the market over the past 10 years by 2.47% on an annualized basis producing an average annual return of 12.73%. Currently, Abbott Laboratories has a market capitalization of $192.72 billion.",ABT,0.980595,0.386944,Bullish
What's Going On With Abbott Laboratories Stock Today?,https://www.benzinga.com/news/earnings/23/01/30572398/whats-going-on-with-abbott-laboratories-stock-today,2023-01-25 17:30:37,"Abbott Laboratories ABT shares are trading lower Wednesday in the wake of the company's quarterly results. What Happened: Abbott said fourth-quarter revenue decreased 12% year-over-year to $10.1 billion, which beat average analyst estimates of $9.64 billion, according to Benzinga Pro.",ABT,0.392948,-0.165528,Somewhat-Bearish
Why Aurora Cannabis Stock Is Fading Today,https://www.fool.com/investing/2023/01/25/why-aurora-cannabis-stock-is-fading-today/,2023-01-25 17:05:54,"With discretionary spending under pressure, investors are shying away from this Canadian cannabis stock today.",ABT,0.096671,-0.181802,Somewhat-Bearish
"Abbott's  ( ABT )  Q4 Earnings Beat Estimates, Margins Down",https://www.zacks.com/stock/news/2044215/abbotts-abt-q4-earnings-beat-estimates-margins-down,2023-01-25 16:31:00,"The downside can be attributed to a manufacturing disruption during 2022 of certain infant formula products at Abbott's (ABT) Sturgis, MI facility.",ABT,0.169975,0.070331,Neutral
Covid Testing Weighs On Sales And Abbott Labs Stock Skids,https://www.investors.com/news/technology/abt-stock-abbott-laboratories-q4-2022-earnings/,2023-01-25 13:48:00,ABT Stock Skids As Covid Testing Weighs On Sales Growth ... Investor's Business Daily ...,ABT,0.601928,0.187719,Somewhat-Bullish
Abbott Revenue Falls on Decline in Covid-Related Sales,https://www.barrons.com/articles/abbott-earnings-stock-price-51674651121,2023-01-25 13:12:00,Abbott Earnings: Revenue Falls on Decline in Covid-Related Sales ...,ABT,0.9545,-0.473943,Bearish
Abbott Revenue Falls on Decline in Covid-Related Sales,https://www.barrons.com/articles/abbott-earnings-covid-sales-51674651121,2023-01-25 12:55:00,"Abbott Laboratories reported fourth-quarter adjusted earnings that beat Wall Street estimates but sales fell 12% from a year earlier on what the company called an ""expected year-over-year decline in Covid-19 testing-related sales."" Abbott ( ticker: ABT ) shares were down 1.3% in premarket trading.",ABT,0.9545,-0.473943,Bearish
"Abbott beats profit estimate on diagnostics, diabetes devices boost",https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-beats-profit-estimate-diagnostics-diabetes-device-boost-2023-01-25/,2023-01-25 12:39:46,"Jan 25 ( Reuters ) - Abbott Laboratories ( ABT.N ) reported a better-than-expected quarterly profit on Wednesday, underpinned by strong demand for the U.S. healthcare company's diagnostics business and glucose monitoring device FreeStyle Libre.",ABT,0.263942,0.515777,Bullish
3 Reasons to Buy AbbVie and 2 Reasons Not to Buy,https://www.fool.com/investing/2023/01/25/3-reasons-to-buy-abbvie-and-2-reasons-not-to-buy/,2023-01-25 12:05:00,"The pharmaceutical specialist is facing a pivotal year in 2023, thanks to growing competition.",ABT,0.042196,0.06965,Neutral
Investor Optimism Declines Following Earnings Reports,https://www.benzinga.com/news/earnings/23/01/30562343/investor-optimism-declines-following-earnings-reports,2023-01-25 08:01:47,The CNN Money Fear and Greed index showed some decline in overall market sentiment among US investors. US stocks closed mixed on Tuesday as investors assessed the latest corporate earnings.,ABT,0.343279,0.0,Neutral
The Worldwide Hepatitis C Testing Industry is Projected to Reach $2.2 Billion by 2031 at a 5.3% CAGR,https://www.prnewswire.com/news-releases/the-worldwide-hepatitis-c-testing-industry-is-projected-to-reach-2-2-billion-by-2031-at-a-5-3-cagr-301729479.html,2023-01-24 18:50:00,The Worldwide Hepatitis C Testing Industry is Projected to Reach ... PR ...,ABT,0.03792,0.06715,Neutral
A Bullish Sign Appears On Abbott Laboratories's Chart,https://www.benzinga.com/markets/23/01/30548433/a-bullish-sign-appears-on-abbott-laboratoriess-chart,2023-01-24 14:48:15,"If history is any guide, there may be good fortune ahead for shares of Abbott Laboratories ABT. A so-called ""golden cross"" has formed on its chart and, not surprisingly, this could be bullish for the stock. What To Know: Many traders use moving average crossover systems to make their decisions.",ABT,0.558244,0.558056,Bullish
"Abbott Laboratories, QUALCOMM, GE HealthCare Technologies And This Subsidiary Of Diamondback Energy On CNBC's 'Final Trades'",https://www.benzinga.com/news/23/01/30539121/abbott-laboratories-qualcomm-ge-healthcare-technologies-and-this-subsidiary-of-diamondback-energy-on,2023-01-24 13:21:19,"On CNBC's ""Halftime Report Final Trades,"" Bryn Talkington of Requisite Capital Management named Viper Energy Partners LP VNOM, which is a subsidiary of Diamondback Energy, Inc, adding that she is going to stick with energy. Joseph Terranova of Virtus Investment Partners named Abbott Laboratories ...",ABT,0.552443,0.0,Neutral
"Syphilis Immunoassay Diagnostics Market worth USD 659.31 Million by 2029 Business Analysis, Market Dynamics Trends, Economical Environment, Competitive Landscape Regional Analysis",https://www.benzinga.com/pressreleases/23/01/g30539261/syphilis-immunoassay-diagnostics-market-worth-usd-659-31-million-by-2029-business-analysis-market-,2023-01-24 07:32:53,"Pune, Jan. 24, 2023 ( GLOBE NEWSWIRE ) -- Maximize Market Research is a leading market research company that has published a report on the ""Syphilis Immunoassay Diagnostics Market"".",ABT,0.030918,0.403161,Bullish
Abbott's baby formula crisis: A timeline of what led to a DOJ investigation,https://www.foxbusiness.com/lifestyle/abbotts-baby-formula-crisis-timeline,2023-01-23 21:38:30,"Abbott Laboratories, whose baby formula plant in Michigan was shut down last year due to contamination issues, is being investigated by the Justice Department. The probe comes nearly a year after the plant was first shut down, exacerbating the nationwide formula shortage that left parents and ...",ABT,0.050465,-0.056069,Neutral
Prosthetic Heart Valve Market will value USD 26.2 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30530546/prosthetic-heart-valve-market-will-value-usd-26-2-billion-by-2030-greyviews,2023-01-23 19:00:00,"Pune India, Jan. 23, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the prosthetic heart valve market is operating and ...",ABT,0.023885,0.240815,Somewhat-Bullish
"Global guidewires market: Driving factors, industry challenges, segmentation, key vendor analysis, leading countries, and market size and forecast 2023-2027 - Technavio",https://www.prnewswire.com/news-releases/global-guidewires-market-driving-factors-industry-challenges-segmentation-key-vendor-analysis-leading-countries-and-market-size-and-forecast-2023-2027---technavio-301726690.html,2023-01-23 17:30:00,"Global guidewires market: Driving factors, industry challenges ... PR ...",ABT,0.035983,-0.038843,Neutral
Abbott's  ( ABT )  New FDA Approval to Improve Patient Outcome,https://www.zacks.com/stock/news/2042746/abbotts-abt-new-fda-approval-to-improve-patient-outcome,2023-01-23 16:16:00,Abbott's (ABT) latest regulatory clearance is expected to improve the treatment of high-risk patients with aortic stenosis.,ABT,0.096866,0.116293,Neutral
ABT: 2 Medical Stocks to Buy Before January Ends and 1 to Sell,https://stocknews.com/news/abt-vrex-sdc-2-medical-stocks-to-buy-before-january-ends-and-1/,2023-01-23 13:58:58,"The healthcare industry, which prospered during the COVID-19 pandemic, is expected to stay buoyed in the foreseeable future amid increasing health awareness, an aging population, and advanced technological developments.",ABT,0.330876,0.157776,Somewhat-Bullish
"Top Stories Monday, Jan. 23",https://www.benzinga.com/news/large-cap/23/01/30521804/spotify-to-downsize-employee-count-activist-investor-elliott-invests-multibillion-dollars-in-sales,2023-01-23 13:25:07,"Juul Labs Inc, a unit of Altria Group MO, has reportedly secured preliminary court approval of a $255 million settlement resolving consumer claims for deceptive marketing. U.S.",ABT,0.090816,0.265364,Somewhat-Bullish
"Stocks making the biggest moves premarket: Wayfair, Salesforce, Paypal and more",https://www.cnbc.com/2023/01/23/stocks-making-the-biggest-moves-premarket-wayfair-salesforce-paypal-and-more.html,2023-01-23 12:55:59,These are the stocks posting the largest moves in the premarket.,ABT,0.085936,0.038864,Neutral
5 things to know before the stock market opens Monday,https://www.cnbc.com/2023/01/23/5-things-to-know-before-the-stock-market-opens-monday-january-23.html,2023-01-23 12:14:08,Here are the most important news items that investors need to start their trading day.,ABT,0.069094,-0.024167,Neutral
Want Safe and Growing Passive Income? Buy These 2 Dividend Kings In 2023,https://www.fool.com/investing/2023/01/23/safe-grow-passive-income-buy-dividend-jnj-abt/,2023-01-23 12:04:36,It doesn't get any safer for income investors than Dividend Kings.,ABT,0.120431,0.219363,Somewhat-Bullish
Abbott Under Federal Investigation Over Baby Formula-Here's How The Pharmaceutical Giant Got Here,https://www.forbes.com/sites/brianbushard/2023/01/21/abbott-under-federal-investigation-over-baby-formula-heres-how-the-pharmaceutical-giant-got-here/,2023-01-21 20:03:57,"The FDA found multiple unsanitary conditions at Abbott's plant in Michigan last year, following its recall of its baby formula, prompting a nationwide shortage.",ABT,0.231332,-0.090637,Neutral
Abbott Laboratories Under DOJ Investigation Following 2022 Baby Formula Plant Shutdown: Report,https://www.benzinga.com/news/23/01/30514454/abbott-laboratories-under-doj-investigation-following-2022-baby-formula-plant-shutdown-report,2023-01-21 19:46:03,"The Justice Department's consumer-protection branch is conducting an investigation into infant formula maker Abbott Laboratories ABT. The Wall Street Journal has reported that the Justice Department is investigating conduct at Abbott's plant in Sturgis, Michigan, citing people familiar with the ...",ABT,0.340915,0.438994,Bullish
Justice Department investigating Abbott baby formula plant,https://apnews.com/article/health-abbott-laboratories-sturgis-michigan-business-b511152befc37616c81933136b00aeb0,2023-01-21 17:08:23,"NEW YORK ( AP ) - The U.S. Justice Department is investigating the Abbott Laboratories infant formula plant in Michigan that was shut down for months last year due to contamination, the company confirmed.",ABT,0.133841,0.013718,Neutral
Low-Calorie Food Market is expected to grow from USD 12 billion in 2022 to USD 19.41 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/01/g30514198/low-calorie-food-market-is-expected-to-grow-from-usd-12-billion-in-2022-to-usd-19-41-billion-by-20,2023-01-21 16:00:00,"Pune India, Jan. 21, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the low-calorie food market is operating and is ...",ABT,0.02546,0.092583,Neutral
The benefits and risks of personal medical monitoring on the internet,https://www.cnbc.com/2023/01/21/the-benefits-and-risks-of-personal-medical-monitoring-on-the-internet.html,2023-01-21 14:46:43,"Personal medical devices for conditions such as diabetes and sleep apnea are connecting to the internet, introducing privacy, hacking and health risks.",ABT,0.029472,0.073099,Neutral
Abbott Labs under criminal investigation over baby formula shortage: Report,https://www.foxbusiness.com/industrials/abbott-labs-criminal-investigation-baby-formula-shortage,2023-01-21 00:14:06,"The Justice Department is investigating Abbott Laboratories' baby formula plant in Michigan, which was at the center of a nationwide formula shortage that plagued millions of families, the Wall Street Journal reports.",ABT,0.124164,0.048515,Neutral
"US Stocks Turn Lower; Dow Drops 50 Points - Blue Bird  ( NASDAQ:BLBD ) , AppHarvest  ( NASDAQ:APPH ) ",https://www.benzinga.com/news/earnings/23/02/30840790/us-stocks-turn-lower-dow-drops-50-points,2023-02-09 17:47:09,"U.S. stocks turned lower midway through trading, with the Dow Jones dropping around 50 points on Thursday. The Dow traded down 0.15% to 33,897.48 while the NASDAQ fell 0.12% to 11,896.28. The S&P 500 also fell, dropping, 0.17% to 4,110.99. Consumer discretionary shares rose by 0.6% on Wednesday.",ABT,0.085022,0.279672,Somewhat-Bullish
Why Cardiovascular Systems Stock Is Soaring Today,https://www.fool.com/investing/2023/02/09/why-cardiovascular-systems-stock-is-soaring-today/,2023-02-09 16:59:24,The medtech company has agreed to a buyout offer from Abbott Laboratories.,ABT,0.290607,0.413358,Bullish
"Top Analyst Reports for Abbott Laboratories, Boeing & Diageo",https://www.zacks.com/research-daily/2052341/top-analyst-reports-for-abbott-laboratories-boeing-diageo,2023-02-09 16:29:00,"Today's Research Daily features new research reports on 16 major stocks, including Abbott Laboratories (ABT), The Boeing Company (BA) and Diageo plc (DEO).",ABT,0.246582,0.154427,Somewhat-Bullish
"MGM Resorts, Madison Square Garden Entertainment, Cardiovascular Systems And Other Big Stocks Moving Higher On Thursday - AppLovin  ( NASDAQ:APP ) , Blue Bird  ( NASDAQ:BLBD ) ",https://www.benzinga.com/news/23/02/30837691/mgm-resorts-madison-square-garden-entertainment-cardiovascular-systems-and-other-big-stocks-moving-h,2023-02-09 16:18:03,"U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording losses in today's session. Cardiovascular Systems, Inc. CSII shares climbed 48.6% to $19.78 following Q2 results.",ABT,0.082677,0.286658,Somewhat-Bullish
"Dow Jumps 250 Points; US Jobless Claims Increase Last Week - AppLovin  ( NASDAQ:APP ) , AppHarvest  ( NASDAQ:APPH ) ",https://www.benzinga.com/news/earnings/23/02/30836364/dow-jumps-250-points-us-jobless-claims-increase-last-week,2023-02-09 15:42:14,"U.S. stocks traded higher this morning, with the Dow Jones jumping around 250 points on Thursday. The Dow traded up 0.75% to 34,204.99 while the NASDAQ rose 1.15% to 12,047.28. The S&P 500 also rose, gaining, 0.75% to 4,148.69. Health care shares rose by 0.2% on Thursday.",ABT,0.08687,0.280758,Somewhat-Bullish
Why Cardiovascular Systems  ( CSII )  Shares Are Trading Higher Premarket Today? - Cardiovascular Systems  ( NASDAQ:CSII ) ,https://www.benzinga.com/news/earnings/23/02/30828603/abbott-adds-complementary-technologies-to-its-vascular-offering-via-cardiovascular-systems-deal-for,2023-02-09 11:57:54,"Abbott Laboratories ABT agrees to acquire Cardiovascular Systems Inc CSII for $20/share for an equity value of approximately $890 million. CSI offers devices for atherectomy, a minimally invasive treatment for plaque build-up in arteries that can restrict blood flow.",ABT,0.338582,0.483689,Bullish
Nerve Repair and Regeneration Market Report Will Reach to USD 19.16 Billion by 2030 at a CAGR of 12.2% : GreyViews,https://www.benzinga.com/pressreleases/23/02/g30820533/nerve-repair-and-regeneration-market-report-will-reach-to-usd-19-16-billion-by-2030-at-a-cagr-of-1,2023-02-08 19:00:00,"Pune India, Feb. 08, 2023 ( GLOBE NEWSWIRE ) -- Nerve Repair and Regeneration Market Size by Product Type ( Biomaterials and Neurostimulation & Neuromodulation Devices ) , By Application ( Stem Cell Therapy, Neurorrhaphy, Neurostimulation, Nerve Grafting, Neuromodulation Surgeries, and Others ) ...",ABT,0.03443,0.106678,Neutral
"EF Hutton Announces Appointment of Keith Wellen, Managing Director, Institutional Healthcare Sales",https://www.globenewswire.com/news-release/2023/02/08/2604184/0/en/EF-Hutton-Announces-Appointment-of-Keith-Wellen-Managing-Director-Institutional-Healthcare-Sales.html,2023-02-08 15:36:00,"New York, NY, Feb. 08, 2023 ( GLOBE NEWSWIRE ) -- via NewMediaWire -- EF Hutton, division of Benchmark Investments, LLC ( ""EF Hutton"" ) , announced today Keith Wellen has joined the firm as Managing Director, Institutional Healthcare Sales. Mr. Wellen will be based in EF Hutton's Los Angeles ...",ABT,0.078099,0.096305,Neutral
3 Dividend Stocks That Will Hold Up No Matter the Market Conditions,https://www.fool.com/investing/2023/02/08/3-dividend-stocks-that-hold-up-in-any-market/,2023-02-08 10:30:00,These stocks could boost your portfolio in bear markets and bull markets.,ABT,0.107736,0.0,Neutral
Baby Formula Blues Hit Abbott Laboratories Stock Hard in 2022. Can It Rebound in 2023?,https://www.fool.com/investing/2023/02/07/baby-formula-blues-hit-abbott-laboratories-stock-h/,2023-02-07 16:05:00,The healthcare stock fell 22% last year.,ABT,0.102888,-0.078409,Neutral
Is This Dividend King a Buy for Income Investors?,https://www.fool.com/investing/2023/02/07/is-this-dividend-king-a-buy-for-income-investors/,2023-02-07 13:20:00,This healthcare company has one of the most established payouts in its sector.,ABT,0.139265,0.099652,Neutral
3 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income,https://www.fool.com/investing/2023/02/07/3-high-yield-healthcare-stocks-to-buy-now-for-a-li/,2023-02-07 10:41:00,These highly reliable healthcare stocks offer investors above-average dividend yields right now.,ABT,0.056275,0.095007,Neutral
Ensign Group  ( ENSG )  Shares Down 2% Since Q4 Earnings Release,https://www.zacks.com/stock/news/2050453/ensign-group-ensg-shares-down-2-since-q4-earnings-release,2023-02-06 16:17:00,"Ensign Group's (ENSG) fourth-quarter results indicate higher skilled services revenue and improved occupancies, partly offset by the increased cost of services.",ABT,0.190793,0.109024,Neutral
Global At-Home Testing Market Is Expected to Reach $45.58 Billion by 2031: Allied Market Research,https://www.benzinga.com/pressreleases/23/02/g30729498/global-at-home-testing-market-is-expected-to-reach-45-58-billion-by-2031-allied-market-research,2023-02-06 14:00:00,"Portland, OR, Feb. 06, 2023 ( GLOBE NEWSWIRE ) -- According to the report published by Allied Market Research, the global At-Home Testing Market generated $16.66 billion in 2021, and is estimated to reach $45.58 billion by 2031, witnessing a CAGR of 10.5% from 2022 to 2031.",ABT,0.035397,-0.017373,Neutral
2 Beaten-Down Stocks With Stable Dividends to Buy In 2023,https://www.fool.com/investing/2023/02/04/2-beaten-down-stocks-with-stable-dividends-to-buy/,2023-02-04 15:23:00,You can bet the farm on these companies' dividends.,ABT,0.194242,0.152545,Somewhat-Bullish
3 Unstoppable Dividend Stocks to Buy in February,https://www.fool.com/investing/2023/02/04/3-unstoppable-dividend-stocks-to-buy-in-february/,2023-02-04 12:45:00,All three belong to the elite group of stocks known as Dividend Kings.,ABT,0.177475,0.081889,Neutral
Organic Baby Food Market is expected to grow from USD 3.8 billion in 2022 to USD 7.4 billion by 2030 : GreyViews,https://www.benzinga.com/pressreleases/23/02/g30709165/organic-baby-food-market-is-expected-to-grow-from-usd-3-8-billion-in-2022-to-usd-7-4-billion-by-20,2023-02-03 16:00:00,"Pune India, Feb. 03, 2023 ( GLOBE NEWSWIRE ) -- The market has been studied for the below mentioned-segmentation and regional analysis for North America, Europe, Asia, South America, and the Middle East and Africa. These are the key regions where the organic baby food market is operating and is ...",ABT,0.023838,0.162111,Somewhat-Bullish
"If You Want Tons of Passive Income in the Future , Buy These 2 Stocks",https://www.fool.com/investing/2023/02/03/if-you-want-passive-income-buy-these-two-stocks/,2023-02-03 15:07:00,Good cash flows come to those who pick intelligently and wait.,ABT,0.062597,0.044051,Neutral
"As of 2027, the HPV Testing and Pap Test Market is expected to reach US$ 9.2 billion at a CAGR of 13.2% - Exclusive Report by MarketsandMarkets™",https://www.benzinga.com/pressreleases/23/02/g30687087/as-of-2027-the-hpv-testing-and-pap-test-market-is-expected-to-reach-us-9-2-billion-at-a-cagr-of-13,2023-02-02 13:20:00,"Chicago, Feb. 02, 2023 ( GLOBE NEWSWIRE ) -- According to the new market research report published by MarketsandMarkets, ""HPV Testing and Pap Test Market Size, Growth by Test Type ( HPV Testing ( Follow-Up HPV Testing, Co- Testing, Primary HPV Testing ) , PAP Test ) , End User ( Laboratories, ...",ABT,0.087185,0.146554,Neutral
Publicis Groupe : Full Year 2022 Results/Résultats annuels 2022,https://www.globenewswire.com/news-release/2023/02/02/2600150/0/en/Publicis-Groupe-Full-Year-2022-Results-R%C3%A9sultats-annuels-2022.html,2023-02-02 06:29:00,Full Year 2022 Results -Double-digit organic growth for the 2nd year in a rowConfident for ...,ABT,0.006084,0.229831,Somewhat-Bullish
Looking At Abbott Laboratories's Recent Unusual Options Activity,https://www.benzinga.com/markets/options/23/02/30673291/looking-at-abbott-laboratoriess-recent-unusual-options-activity,2023-02-01 18:18:48,"Someone with a lot of money to spend has taken a bearish stance on Abbott Laboratories ABT. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",ABT,0.832201,0.068912,Neutral
"Humana  ( HUM )  Q4 Earnings Beat Mark, '23 EPS View Upbeat",https://www.zacks.com/stock/news/2047820/humana-hum-q4-earnings-beat-mark-23-eps-view-upbeat,2023-02-01 16:41:00,Humana's (HUM) fourth-quarter results benefit from solid premiums from its individual Medicare Advantage business and the sound performance of the two newly formed segments.,ABT,0.090247,0.075105,Neutral
An Increase In Investments In The R&D Of Autoimmune Disease Drugs Is Expected To Drive The Autoimmune Treatment Market As Per The Business Research Company's Autoimmune Treatment Global Market Report 2023,https://www.benzinga.com/pressreleases/23/02/g30671480/an-increase-in-investments-in-the-r-d-of-autoimmune-disease-drugs-is-expected-to-drive-the-autoimm,2023-02-01 16:30:00,"LONDON, Feb. 01, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the ""Autoimmune Treatment Market"" forecasts the global autoimmune treatment market size to grow from $6 billion in 2022 to $6.8 billion in 2023 at a compound annual growth rate ( CAGR ) of more than 12%.",ABT,0.050572,-0.049564,Neutral
2 Top Dividend Growth Stocks to Buy in February,https://www.fool.com/investing/2023/02/01/top-dividend-growth-stocks-to-buy-in-february/,2023-02-01 10:26:00,"They don't offer the highest yields, but these strongly profitable businesses are poised to raise their payouts at a blistering pace.",ABT,0.113597,0.088526,Neutral
NATR: 5 No-Brainer Medical Stocks to Buy in 2023,https://stocknews.com/news/natr-abt-hum-moh-mck-5-no-brainer-medical-stocks-to-buy-in-2023/,2023-02-01 09:31:58,NATR: 5 No-Brainer Medical Stocks to Buy in ...,ABT,0.185917,0.083551,Neutral
"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSII, NUVA, ALR - AlerisLife  ( NASDAQ:ALR ) , Cardiovascular Systems  ( NASDAQ:CSII ) ",https://www.benzinga.com/pressreleases/23/02/g30973306/shareholder-investigation-halper-sadeh-llc-investigates-csii-nuva-alr,2023-02-19 13:34:25,"NEW YORK, Feb. 19, 2023 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cardiovascular Systems, Inc.",ABT,0.155451,0.104953,Neutral
"STOCKHOLDER ALERT: The M&A Class Action Firm Continues its Investigation of the Merger - SUMO, CSII, NUVA, FMIA",https://www.benzinga.com/pressreleases/23/02/g30970224/stockholder-alert-the-m-a-class-action-firm-continues-its-investigation-of-the-merger-sumo-csii-nu,2023-02-18 01:00:00,"NEW YORK, Feb. 17, 2023 ( GLOBE NEWSWIRE ) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC ( the ""M&A Class Action Firm"" ) , a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered ...",ABT,0.068502,0.119039,Neutral
Abbott Laboratories under SEC and FTC investigation over baby-formula business,https://www.marketwatch.com/story/abbott-laboratories-under-sec-and-ftc-investigation-over-baby-formula-business-1d473a28,2023-02-17 23:36:00,"The Securities and Exchange Commission and Federal Trade Commission are investigating Abbott Laboratories' baby-formula business, the company said.",ABT,0.622414,0.167071,Somewhat-Bullish
"Abbott Baby-Formula Business Is Under Investigation By SEC, FTC",https://www.wsj.com/articles/abbott-baby-formula-business-is-under-investigation-by-sec-ftc-9aa8484e,2023-02-17 23:24:00,"The SEC's enforcement division sent a subpoena to Abbott in December requesting information about its powder infant-formula business and related public disclosures, the company said Friday in a securities filing.",ABT,0.495015,0.359924,Bullish
Interview With David Rolfe of Wedgewood Partners,https://www.fool.com/investing/2023/02/17/interview-with-david-rolfe-of-wedgewood-partners/,2023-02-17 20:48:00,Motley Fool analyst John Rotonti recently seized the opportunity to interview David Rolfe.,ABT,0.014063,0.101238,Neutral
IVD Quality Control Market worth $1.6 Billion | MarketsandMarkets,https://www.prnewswire.com/news-releases/ivd-quality-control-market-worth-1-6-billion--marketsandmarkets-301749618.html,2023-02-17 18:30:00,"CHICAGO, Feb. 17, 2023 /PRNewswire/ -- The IVD quality control industry is expected to witness a significant growth in near future. This is due to the increasing demand for quality control in the health care sector and the development of new technologies and processes that can help improve ...",ABT,0.046907,0.079083,Neutral
Labcorp beats quarterly profit estimates,https://www.reuters.com/business/healthcare-pharmaceuticals/labcorp-beats-quarterly-profit-estimates-2023-02-16/,2023-02-16 12:07:00,"Feb 16 ( Reuters ) - Laboratory Corp of America Holdings ( LH.N ) on Thursday beat quarterly profit estimates, helped by strength in its diagnostics business and demand for its drug development services.",ABT,0.255641,-0.135199,Neutral
"Similac maker Abbott could face criminal penalties of up to $500,000 per offense in DOJ probe of factory conditions amid the baby formula shortage",https://www.businessinsider.com/similac-maker-abbott-could-face-criminal-penalties-over-formula-shortage-2023-2,2023-02-15 20:39:47,Similac Maker Could Face Criminal Penalties Over Formula Shortage - Business Insider ...,ABT,0.109956,0.064965,Neutral
Better Buy: Johnson & Johnson or AbbVie?,https://www.fool.com/investing/2023/02/14/better-buy-johnson-johnson-or-abbvie/,2023-02-14 13:26:00,The healthcare giants are favored by income-oriented investors but have a potentially disruptive year ahead.,ABT,0.050148,0.06742,Neutral
UNH: 3 Medical Stocks with Excellent Vital Signs and 1 to Avoid,https://stocknews.com/news/unh-abt-natr-sndl-3-medical-stocks-with-excellent-vital-signs-and-1-to/,2023-02-14 12:23:41,"The Fed's aggressive rate hikes to curb the stubbornly high inflation have plagued the economy for some time. But on the flip side, the medical industry, which thrived during the pandemic years, is envisioned to remain buoyed amid volatilities, thanks to rapid technological advancements, rising ...",ABT,0.226794,0.196392,Somewhat-Bullish
Candy? Flowers? These Top Stocks Offer You Something Even Sweeter,https://www.fool.com/investing/2023/02/14/candy-these-top-stocks-offer-you-something-sweeter/,2023-02-14 10:30:00,These stocks may reward you over time.,ABT,0.098862,0.125145,Neutral
Abbott-Cardiovascular Systems Acquisition Could Further Add Uncertainty Over Surmodics' Product: Analyst Downgrades Stock - Surmodics  ( NASDAQ:SRDX ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/02/30882334/abbott-cardiovascular-systems-acquisition-could-further-add-uncertainty-over-surmod,2023-02-13 17:57:51,"Needham has downgraded Surmodics Inc SRDX to Hold from Buy. In January, Surmodics received a letter from the FDA regarding its premarket approval ( PMA ) application for the SurVeil drug-coated balloon ( DCB ) .",ABT,0.380978,-0.236852,Somewhat-Bearish
Abbott  ( ABT )  to Expand Vascular Device Line With New Buyout,https://www.zacks.com/stock/news/2053484/abbott-abt-to-expand-vascular-device-line-with-new-buyout,2023-02-13 15:25:00,Abbott's (ABT) latest deal will help gain access to Cardiovascular System's leading atherectomy device to treat vascular disease.,ABT,0.116631,0.323205,Somewhat-Bullish
Abbott  ( ABT )  EPD Growth Continues Amid Macroeconomic Challenges,https://www.zacks.com/stock/news/2053387/abbott-abt-epd-growth-continues-amid-macroeconomic-challenges,2023-02-13 14:24:00,"At Abbott (ABT), Medical Device sales growth is led by strong performance in Electrophysiology, Structural Heart and Diabetes Care.",ABT,0.149966,0.123069,Neutral
"Global Outlook for Antacids Market | Growth rate at 4.5 percent during the forecast period, Regional Insights and Key Players",https://www.benzinga.com/pressreleases/23/02/g30872081/global-outlook-for-antacids-market-growth-rate-at-4-5-percent-during-the-forecast-period-regional-,2023-02-13 09:57:44,"NEW YORK, Feb. 13, 2023 ( GLOBE NEWSWIRE ) -- Maximize Market research, a global Healthcare market research firm, has published a competitive intelligence and market research report on the ""Antacids Market"".",ABT,0.03319,-0.009406,Neutral
"Sports Nutrition Market Size to Grow by 7.84%, Packaged Foods & Meats Market to be Parent Market -Technavio",https://www.prnewswire.com/news-releases/sports-nutrition-market-size-to-grow-by-7-84-packaged-foods--meats-market-to-be-parent-market--technavio-301744224.html,2023-02-13 02:15:00,"Sports Nutrition Market Size to Grow by 7.84%, Packaged Foods ... PR ...",ABT,0.085022,0.043194,Neutral
"Microbiology Testing Market to Grow by USD 3.01 Bn, Abbott Laboratories and Bio Rad Laboratories Inc. Among Key Vendors - Technavio",https://www.prnewswire.com/news-releases/microbiology-testing-market-to-grow-by-usd-3-01-bn-abbott-laboratories-and-bio-rad-laboratories-inc-among-key-vendors---technavio-301744250.html,2023-02-13 02:00:00,"Microbiology Testing Market to Grow by USD 3.01 Bn, Abbott ... PR ...",ABT,0.039944,0.111712,Neutral
"Lifshitz Law PLLC Announces Investigations of SUMO, GMED, NUVA, and CSII - Globus Medical  ( NYSE:GMED ) , Cardiovascular Systems  ( NASDAQ:CSII ) ",https://www.benzinga.com/pressreleases/23/02/g30868136/lifshitz-law-pllc-announces-investigations-of-sumo-gmed-nuva-and-csii,2023-02-12 01:11:00,"NEW YORK, Feb. 11, 2023 ( GLOBE NEWSWIRE ) -- Sumo Logic, Inc. SUMO Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the sale of SUMO to affiliates of Francisco Partners for $12.05 per share in cash.",ABT,0.107495,-0.031404,Neutral
"Cardiovascular Systems  ( CSII )  Q2 Earnings, Revenues Miss",https://www.zacks.com/stock/news/2052865/cardiovascular-systems-csii-q2-earnings-revenues-miss,2023-02-10 14:14:00,"With the announcement of the merger agreement with Abbott, Cardiovascular Systems (CSII) refrains from providing any update on the 2023 guidance.",ABT,0.063425,0.159164,Somewhat-Bullish
"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates OSH, ARGO, CSII - Argo Gr Intl Hldgs  ( NYSE:ARGO ) , Cardiovascular Systems  ( NASDAQ:CSII ) ",https://www.benzinga.com/pressreleases/23/02/g30851670/shareholder-investigation-halper-sadeh-llc-investigates-osh-argo-csii,2023-02-10 11:24:20,"NEW YORK, Feb. 10, 2023 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Oak Street Health, Inc.",ABT,0.159569,0.106704,Neutral
"The Zacks Analyst Blog Highlights Abbott Laboratories, Boeing, Diageo, Lam Research and Freeport-McMoRan",https://www.zacks.com/stock/news/2052691/the-zacks-analyst-blog-highlights-abbott-laboratories-boeing-diageo-lam-research-and-freeport-mcmoran,2023-02-10 09:31:00,"Abbott Laboratories, Boeing, Diageo, Lam Research and Freeport-McMoRan are included in this Analyst Blog.",ABT,0.733479,0.0,Neutral
Wall Street dips as Treasury yields rise after auction,https://www.moneycontrol.com/news/business/markets/wall-street-dips-as-treasury-yields-rise-after-auction-10046541.html,2023-02-10 00:33:45,"Yields on the U.S. 30-year note rose after the Treasury Department saw weak demand for a $21 billion sale, the final sale of $96 billion in coupon-bearing supply this week. In a note to clients, Jefferies said ""the buyside bid failed to come together."" ...",ABT,0.067727,-0.143476,Neutral
"ALERT: The M&A Class Action Firm Continues its Investigation of the Merger - TIG, NBTB, CSII, MPB",https://www.benzinga.com/pressreleases/23/03/g31141109/alert-the-m-a-class-action-firm-continues-its-investigation-of-the-merger-tig-nbtb-csii-mpb,2023-03-01 21:17:52,"NEW YORK, March 01, 2023 ( GLOBE NEWSWIRE ) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC ( the ""M&A Class Action Firm"" ) , a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and ...",ABT,0.067919,0.118957,Neutral
Get a Dividend Every Month With These 3 Healthcare Stocks,https://www.fool.com/investing/2023/03/01/get-a-dividend-every-month-with-these-3-healthcare/,2023-03-01 12:59:00,"With a little planning, you can receive a dependable dividend payout every month.",ABT,0.042953,0.14637,Neutral
Why Abbott Laboratories Stock Bumped Higher Today,https://www.fool.com/investing/2023/02/28/why-abbott-laboratories-stock-bumped-higher-today/,2023-02-28 23:30:55,The company's specialized heart care products appear to prove their value in clinical testing.,ABT,0.29234,0.249026,Somewhat-Bullish
How Is The Market Feeling About Abbott Laboratories? - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/short-sellers/23/02/31095194/how-is-the-market-feeling-about-abbott-laboratories,2023-02-28 16:30:40,"Abbott Laboratories's ABT short percent of float has risen 11.43% since its last report. The company recently reported that it has 13.19 million shares sold short, which is 0.78% of all regular shares that are available for trading.",ABT,0.221819,0.155473,Somewhat-Bullish
"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRMK, FOCS, CSII, TIG - Broadmark Realty Capital  ( NYSE:BRMK ) , Cardiovascular Systems  ( NASDAQ:CSII ) ",https://www.benzinga.com/pressreleases/23/02/g31091299/shareholder-investigation-halper-sadeh-llc-investigates-brmk-focs-csii-tig,2023-02-28 14:04:59,"NEW YORK, Feb. 28, 2023 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Broadmark Realty Capital Inc.",ABT,0.123526,0.092773,Neutral
"Henlius Swallows Bitter Pill In Watered-Down Licensing Deal - Abbott Laboratories  ( NYSE:ABT ) , Biogen  ( NASDAQ:BIIB ) ",https://www.benzinga.com/news/small-cap/23/02/31090323/henlius-swallows-bitter-pill-in-watered-down-licensing-deal,2023-02-28 13:41:25,"Henlius Biotech will receive up to $11 million less than originally agreed under a licensing agreement due to higher-than-expected R&D costs Such alterations aren't uncommon to licensing deals, but can still undermine investor confidence in a company and slow its overseas expansion",ABT,0.073659,0.038368,Neutral
Coagulation Analyzer Market Share  ( $5.91 Billion by 2028 )  Lead by Point-of-Care Testing Analyser  ( 7.20% CAGR )  - Growth Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/02/g31089808/coagulation-analyzer-market-share-5-91-billion-by-2028-lead-by-point-of-care-testing-analyser-7-20,2023-02-28 13:25:39,"New York, Feb. 28, 2023 ( GLOBE NEWSWIRE ) -- According to The Insight Partners, ""Coagulation Analyzer Market Size, Share, Growth, Trends and Global Forecast to 2028 - COVID-19 Impact and Global Analysis By Product ( Clinical Laboratory analyser and Point-of-Care Testing analyser ) , Test ( ...",ABT,0.019846,0.054707,Neutral
Should Abbott and DexCom Investors Be Worried About Apple's Latest News?,https://www.fool.com/investing/2023/02/28/abbott-dexcom-investors-worried-apple-news/,2023-02-28 10:52:00,The continuous glucose monitoring market could heat up.,ABT,0.110717,0.272767,Somewhat-Bullish
Dividend Stocks To Buy Now? 3 For Your Watchlist,https://stockmarket.com/featured/dividend-stocks-to-buy-now-3-for-your-watchlist-2023-02-27,2023-02-27 15:33:43,"Dividends refer to payments made by companies to their shareholders. This is typically in the form of cash or additional shares of stock. With that, companies generally pay dividends to their shareholders on a regular basis. This can be monthly, quarterly, or annually.",ABT,0.269776,0.082405,Neutral
Better Dividend Stock: Abbott Laboratories or Medtronic?,https://www.fool.com/investing/2023/02/27/better-dividend-stock-abbott-laboratories-or-medtr/,2023-02-27 15:30:00,One of these top dividend stocks is a far more compelling buy today.,ABT,0.124164,0.180979,Somewhat-Bullish
"Top 5 Health Care Stocks That May Rocket Higher In Q1 2023 - Abbott Laboratories  ( NYSE:ABT ) , Azenta  ( NASDAQ:AZTA ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/02/31065692/top-5-health-care-stocks-that-may-rocket-higher-in-q1-2023,2023-02-27 11:52:03,"The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.",ABT,0.419153,0.111406,Neutral
3 Stocks to Buy Right Now That Are Cash Cows,https://www.fool.com/investing/2023/02/25/3-stocks-to-buy-right-now-that-are-cash-cows/,2023-02-25 11:25:00,"If cash is king, these three stocks should wear crowns.",ABT,0.041181,0.06782,Neutral
Biomarkers Market worth $104.0 billion | MarketsandMarkets,https://www.prnewswire.com/news-releases/biomarkers-market-worth-104-0-billion--marketsandmarkets-301755245.html,2023-02-24 17:30:00,"CHICAGO, Feb. 24, 2023 /PRNewswire/ -- Biomarkers are a valuable tool for diagnostics, drug development, and personalised medicine. In the near future, we can expect to see an increase in the use of biomarkers in clinical practice, especially for personalised medicine.",ABT,0.030064,0.070487,Neutral
Better Buy: Abbott Laboratories or DexCom Stock?,https://www.fool.com/investing/2023/02/24/better-buy-abbott-laboratories-or-dexcom-stock/,2023-02-24 14:45:00,Both stocks should benefit from the growth in diabetes care.,ABT,0.141726,0.179337,Somewhat-Bullish
Apple's Secret Plans to Dominate  ( Another )  $16 Billion Market,https://www.fool.com/investing/2023/02/23/apples-secret-plans-to-dominate-a-16-billion-marke/,2023-02-23 14:48:24,A covert project dating back to the Steve Jobs era may soon come to fruition.,ABT,0.06623,0.00603,Neutral
Why Abbott Laboratories Stock Sank Today,https://www.fool.com/investing/2023/02/22/why-abbott-laboratories-stock-sank-today/,2023-02-22 23:07:29,The company's glucose monitoring business might come under some serious pressure.,ABT,0.29234,-0.067188,Neutral
"ALERT: The M&A Class Action Firm Continues its Investigation of the Merger - NBTB, MPB, CSII, NUVA",https://www.benzinga.com/pressreleases/23/02/g31018460/alert-the-m-a-class-action-firm-continues-its-investigation-of-the-merger-nbtb-mpb-csii-nuva,2023-02-22 22:16:56,"NEW YORK, Feb. 22, 2023 ( GLOBE NEWSWIRE ) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC ( the ""M&A Class Action Firm"" ) , a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and headquartered ...",ABT,0.068306,0.119011,Neutral
What Does Apple Have To Do With DexCom Stock Trading Lower? - DexCom  ( NASDAQ:DXCM ) ,https://www.benzinga.com/news/23/02/31013567/what-does-apple-have-to-do-with-dexcom-stock-trading-lower,2023-02-22 18:50:42,"DexCom shares DXCM are trading lower on Wednesday following a report that Apple Inc AAPL is making progress on no-prick glucose tracking for its Watch. According to a Bloomberg report, Apple is making progress on a project known as E5, which has been ongoing since the Steve Jobs era.",ABT,0.329551,-0.099073,Neutral
Performio Launches Business Intelligence and Advanced Reporting Capabilities with Analytics Studio,https://www.prnewswire.com/news-releases/performio-launches-business-intelligence-and-advanced-reporting-capabilities-with-analytics-studio-301752600.html,2023-02-22 11:05:00,Performio Launches Business Intelligence and Advanced Reporting ... PR ...,ABT,0.074926,0.210342,Somewhat-Bullish
United States Protein Supplements Market to Hit $16.41 Billion by 2029 | At a CAGR of 10.26%,https://www.benzinga.com/pressreleases/23/02/g30981186/united-states-protein-supplements-market-to-hit-16-41-billion-by-2029-at-a-cagr-of-10-26,2023-02-21 09:16:18,"Pune, India, Feb. 21, 2023 ( GLOBE NEWSWIRE ) -- The United States protein supplements market size was USD 7.70 billion in 2021. The market is projected to grow from USD 8.29 billion in 2022 to USD 16.41 billion by 2029, exhibiting a CAGR of 10.26% during the 2022-2029 period.",ABT,0.066506,0.0,Neutral
TMO: 3 Health Care Stocks That Have Just What the Doctor Ordered,https://stocknews.com/news/tmo-abt-cnc-3-health-care-stocks-that-have-just-what-the-doctor/,2023-02-20 16:43:24,"Thanks to strong drivers such as an aging population, increased spending on healthcare by developing nations, and technological advancements in medical devices and prescription drugs, healthcare stocks have outperformed the broader market.",ABT,0.167322,0.23992,Somewhat-Bullish
Here's Why You Should Retain Abbott  ( ABT )  Stock for Now,https://www.zacks.com/stock/news/2056436/heres-why-you-should-retain-abbott-abt-stock-for-now,2023-02-20 15:32:00,Investors are optimistic about Abbott (ABT) owing to continued growth in the Diabetes business.,ABT,0.100518,0.208519,Somewhat-Bullish
3 Top Dividend Kings to Buy for the Long Haul,https://www.fool.com/investing/2023/02/20/3-top-dividend-kings-to-buy-for-the-long-haul/,2023-02-20 12:25:00,These companies have more than 150 years of dividend growth between them.,ABT,0.084423,0.0,Neutral
2 Exceptional Growth Stocks Billionaires Keep Buying With Both Hands,https://www.fool.com/investing/2023/02/20/2-exceptional-growth-stocks-billionaires-keep-buyi/,2023-02-20 10:21:00,A poor performance from the broad market didn't stop these billionaire hedge fund managers from placing big bets on three supercharged growth stocks.,ABT,0.060388,0.046089,Neutral
The Worldwide Bionic Devices Industry is Expected to Reach $8.68 Billion by 2027,https://www.benzinga.com/pressreleases/23/02/g30975100/the-worldwide-bionic-devices-industry-is-expected-to-reach-8-68-billion-by-2027,2023-02-20 09:53:37,"Dublin, Feb. 20, 2023 ( GLOBE NEWSWIRE ) -- The ""Bionic Devices Market, Global Forecast 2023-2027, Industry Trends, Growth, Impact of Inflation, Opportunity Company Analysis"" report has been added to ResearchAndMarkets.com's offering.Global Bionic Devices Market will grow and reach US$ 8.68 ...",ABT,0.032602,0.128131,Neutral
"Stocks Tumble Amid SVB Collapse, 'Faster' Powell: Weekly Review",https://www.investors.com/news/stock-market-tumbles-amid-svb-financial-collapse-faster-powell/,2023-03-10 17:38:00,"Stock Market Tumbles Amid SVB Financial Collapse, 'Faster' Powell ... Investor's Business Daily ...",ABT,0.031949,-0.137858,Neutral
Intercept Tumbles On A New Obstacle For Its Experimental NASH Drug,https://www.investors.com/news/technology/icpt-stock-tumbles-on-new-obstacle-for-its-nash-drug/,2023-03-10 16:49:00,Intercept Tumbles On A New Obstacle For Its Experimental NASH ... Investor's Business Daily ...,ABT,0.07031,-0.167999,Somewhat-Bearish
"FDA Seeks 10% Increase In Biden's FY 2024 Budget, Proposes Enhancing Regulatory Authorities - Abbott Laboratories  ( NYSE:ABT ) , iShares Biotechnology ETF  ( NASDAQ:IBB ) ",https://www.benzinga.com/general/biotech/23/03/31296193/fda-seeks-10-increase-in-bidens-fy-2024-budget-proposes-enhancing-regulatory-authorities,2023-03-10 16:46:09,"The FDA has requested $7.2 billion as part of the president's fiscal year 2024 budget, $128.2 million of which the agency intends to invest in food safety and nutrition modernization, including food labeling and animal food safety oversight.",ABT,0.268294,0.031241,Neutral
Is Invesco Defensive Equity ETF  ( DEF )  a Strong ETF Right Now?,https://www.zacks.com/stock/news/2063943/is-invesco-defensive-equity-etf-def-a-strong-etf-right-now,2023-03-10 11:20:06,Smart Beta ETF report for DEF ...,ABT,0.120431,0.067868,Neutral
Eli Lilly's Decade-Long Effort In Alzheimer's Disease Just Failed,https://www.investors.com/news/technology/eli-lilly-stock-decade-long-effort-in-alzheimers-treatment-fails/,2023-03-09 14:37:00,Eli Lilly Stock: Decade-Long Effort In Alzheimer's Treatment Fails ... Investor's Business Daily ...,ABT,0.07446,-0.16879,Somewhat-Bearish
3 Surefire Stocks That Are Screaming Buys in March,https://www.fool.com/investing/2023/03/09/3-surefire-stocks-that-are-screaming-buys-in-march/,2023-03-09 11:07:00,"High-growth industries are risky, but they also have tremendous potential.",ABT,0.041828,0.18976,Somewhat-Bullish
3 High-Yield Dividend Stocks to Buy Before the Next Bull Rally,https://www.fool.com/investing/2023/03/09/3-high-yield-dividend-stocks-to-buy-before-the-nex/,2023-03-09 10:41:00,Here's why you'll want to hurry up and buy these stocks before the next big market rally pushes them out of reach.,ABT,0.055881,-0.075884,Neutral
2 Top Dividend Stocks You Can Buy and Hold Forever,https://www.fool.com/investing/2023/03/09/2-top-dividend-stocks-you-can-buy-and-hold-forever/,2023-03-09 10:17:00,These two companies have been growing their payouts for more than a century combined.,ABT,0.132004,0.130229,Neutral
Abbott  ( ABT )  Gets FDA Nod for Alinity I Laboratory Test,https://www.zacks.com/stock/news/2063078/abbott-abt-gets-fda-nod-for-alinity-i-laboratory-test,2023-03-08 16:41:00,Abbott's (ABT) Alinity i TBI lab test provides a new reliable result in 18 minutes to support clinicians in quickly assessing concussion and triaging patients.,ABT,0.106305,0.067399,Neutral
"Antifungal Drugs Market Worth  ( $13.99 Billion by 2028 )  at 3.3% CAGR - Global Analysis by Therapeutic Indication  ( Aspergillosis, Dermatophytosis, Candidiasis ) ",https://www.benzinga.com/pressreleases/23/03/g31257180/antifungal-drugs-market-worth-13-99-billion-by-2028-at-3-3-cagr-global-analysis-by-therapeutic-ind,2023-03-08 13:59:36,"New York, March 08, 2023 ( GLOBE NEWSWIRE ) -- Latest Research Report by The Insight Partners, ""Antifungal Drugs Market Size, Share, Growth, Value and Global Forecast to 2028 - Global Analysis by Infection Type ( Superficial Fungal Infection and Systemic Fungal Infection ) , Drug Type ( ...",ABT,0.033098,0.098384,Neutral
Abbott  ( ABT )  Reveals Favorable Data on Tricuspid Regurgitation,https://www.zacks.com/stock/news/2062874/abbott-abt-reveals-favorable-data-on-tricuspid-regurgitation,2023-03-08 13:34:00,"Abbott Laboratories (ABT) demonstrates the superiority of the TriClip device in treating patients with severe, symptomatic tricuspid regurgitation.",ABT,0.123315,0.028313,Neutral
"Zacks Investment Ideas feature highlights: Procter and Gamble, Johnson & Johnson and Abbott Labs",https://www.zacks.com/stock/news/2062753/zacks-investment-ideas-feature-highlights-procter-and-gamble-johnson-johnson-and-abbott-labs,2023-03-08 10:00:00,"Procter and Gamble, Johnson & Johnson and Abbott Labs have been highlighted in this Investment Ideas article.",ABT,0.222838,0.166332,Somewhat-Bullish
"Health Care ETFs Have Lost In The Last Month - These Top Pharma Stocks Are The Reason - SPDR Select Sector Fund - Health Care  ( ARCA:XLV ) , iShares Biotechnology ETF  ( NASDAQ:IBB ) ",https://www.benzinga.com/general/biotech/23/03/31223747/health-care-etfs-have-lost-in-the-last-month-these-top-pharma-stocks-are-the-reason,2023-03-08 00:34:06,"The Health Care Select Sector SPDR Fund XLV, heavily tilted towards mega-caps, lost around 5.25% over the last month, with substantial companies reporting annual earnings. Shares of Health Care Select Sector SPDR Fund opened at $129.26 on Monday, with a twelve-month low of $118.75 and a ...",ABT,0.28387,0.10837,Neutral
3 Value Stocks on Sale Now,https://www.zacks.com/commentary/2062658/3-value-stocks-on-sale-now,2023-03-07 20:02:00,"Growth stocks have clearly led the market thus far in 2023, but will that continue?",ABT,0.228717,0.147462,Neutral
Merck Nears Breakout On A New $10 Billion Sales Potential,https://www.investors.com/news/technology/merck-stock-keytruda-who-analysts-eye-two-heart-drugs/,2023-03-07 15:14:00,Merck Stock: Keytruda Who? Analysts Eye $10 Billion From Two ... Investor's Business Daily ...,ABT,0.06179,-0.167086,Somewhat-Bearish
U.S. FDA clears Abbott's blood test for concussions,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-clears-abbotts-blood-test-evaluate-concussion-2023-03-07/,2023-03-07 14:09:00,U.S. FDA clears Abbott's blood test to evaluate concussion ...,ABT,0.250386,-0.118627,Neutral
Abbott's  ( ABT )  MitraClip Device Shows Favorable Outcome,https://www.zacks.com/stock/news/2062470/abbotts-abt-mitraclip-device-shows-favorable-outcome,2023-03-07 13:03:00,Abbott's (ABT) landmark COAPT trial demonstrated that MitraClip is safe and effective and can reduce the hospitalization rate.,ABT,0.104455,0.037918,Neutral
ABT: 3 Health Care Stocks to Buy in a Heartbeat,https://stocknews.com/news/abt-mck-cnc-3-health-care-stocks-to-buy-in-a-heartbeat/,2023-03-07 08:57:06,"The introduction of advanced technologies has unlocked fresh opportunities for the healthcare industry. Moreover, healthcare stocks tend to perform relatively well despite economic headwinds, thanks to inelastic demand for their products and services.",ABT,0.294682,0.085748,Neutral
Osteoarthritis therapeutics market to grow at a CAGR of 8.97% from 2022 to 2027: Growth opportunities led by Abbott Laboratories and Alvogen Iceland ehf among others- Technavio,https://www.prnewswire.com/news-releases/osteoarthritis-therapeutics-market-to-grow-at-a-cagr-of-8-97-from-2022-to-2027-growth-opportunities-led-by-abbott-laboratories-and-alvogen-iceland-ehf-among-others--technavio-301761982.html,2023-03-06 19:30:00,Osteoarthritis therapeutics market to grow at a CAGR of 8.97% from ... PR ...,ABT,0.03878,-0.080555,Neutral
Dexcom Pummeled After Abbott Gains A Key FDA Clearance,https://www.investors.com/news/technology/dexcom-stock-pummeled-as-rival-abbott-steps-up-in-diabetes/,2023-03-06 17:18:00,Dexcom Stock Pummeled As Rival Abbott Steps Up In Diabetes ... Investor's Business Daily ...,ABT,0.174587,0.086664,Neutral
"Krystal Biotech Appoints Catherine Mazzacco to Board of Directors - Krystal Biotech  ( NASDAQ:KRYS ) , Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/pressreleases/23/03/g31213747/krystal-biotech-appoints-catherine-mazzacco-to-board-of-directors,2023-03-06 12:00:00,"PITTSBURGH, March 06, 2023 ( GLOBE NEWSWIRE ) -- Krystal Biotech, Inc. ( the ""Company"" ) KRYS a biotechnology company focused on developing and commercializing genetic medicines for patients with rare diseases, today announced the appointment of Catherine Mazzacco to its Board of Directors.",ABT,0.19117,-0.058878,Neutral
Should Invesco Defensive Equity ETF  ( DEF )  Be on Your Investing Radar?,https://www.zacks.com/stock/news/2061910/should-invesco-defensive-equity-etf-def-be-on-your-investing-radar,2023-03-06 11:20:08,Style Box ETF report for DEF ...,ABT,0.122894,0.068464,Neutral
Data Shows Abbott's TriClip System Superior To Other Medical Therapy In Heart Valve Disorder - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/large-cap/23/03/31212475/data-shows-abbotts-triclip-system-superior-to-other-medical-therapy-in-heart-valve-disorder,2023-03-06 10:39:59,"Abbott Laboratories ABT announced late-breaking data for the TriClip transcatheter edge-to-edge repair ( TEER ) system, a minimally invasive device designed specifically for tricuspid heart valve repair.",ABT,0.421485,0.235687,Somewhat-Bullish
"This Stock Could Soar By as Much as 106%, According to Wall Street",https://www.fool.com/investing/2023/03/05/this-stock-could-soar-by-as-much-as-106-according/,2023-03-05 15:00:00,"Some of Wall Street's predictions seem a bit aggressive, but investors should still consider this company.",ABT,0.047654,0.170695,Somewhat-Bullish
2 Top Dividend Kings to Buy for the Long Haul,https://www.fool.com/investing/2023/03/04/2-top-dividend-kings-to-buy-for-the-long-haul/,2023-03-04 14:53:00,"These aren't just dividend plays, either.",ABT,0.31282,0.291406,Somewhat-Bullish
2 High-Yield Dividend Stocks to Buy in March,https://www.fool.com/investing/2023/03/04/2-high-yield-dividend-stocks-to-buy-in-march/,2023-03-04 11:27:00,Putting some shares of these stocks in your portfolio now could lead to heaps of passive income in your retirement years.,ABT,0.057215,0.073943,Neutral
Investing Action Plan: Feeling March Momentum,https://www.investors.com/research/investing-action-plan/stock-market-investing-action-plan-from-powell-to-payrolls-a-busy-week/,2023-03-03 23:23:00,"Stock Market Investing Action Plan: From Powell To Payrolls, A Busy ... Investor's Business Daily ...",ABT,0.059785,0.079999,Neutral
"1 High-Flying Growth Stock With 19% Upside, According to Wall Street",https://www.fool.com/investing/2023/03/03/1-high-flying-growth-stock-with-18-upside-accordin/,2023-03-03 13:20:00,"This company could keep going up, but beware of the risks.",ABT,0.092927,0.052422,Neutral
Diabetes Giant Nears Breakout On A Surprise CMS Decision,https://www.investors.com/news/technology/dexcom-stock-pops-on-massive-expansion-for-cgms/,2023-03-02 19:04:00,Dexcom Stock Pops On Massive Medicare Expansion For CGMs ... Investor's Business Daily ...,ABT,0.27432,0.329807,Somewhat-Bullish
Build Your Wealth by Buying and Holding These 2 Dividend Stocks for at Least 20 Years,https://www.fool.com/investing/2023/03/02/build-your-wealth-by-buying-these-2-dividend/,2023-03-02 15:15:00,"The road to wealth is long, but it'll be a bit shorter with the right investments.",ABT,0.114137,0.19049,Somewhat-Bullish
WORLD BUSINESS CHICAGO HONORS COMPANIES DRIVING GROWTH AND INNOVATION IN GREATER CHICAGOLAND REGION AT ANNUAL AWARDS CEREMONY,https://www.prnewswire.com/news-releases/world-business-chicago-honors-companies-driving-growth-and-innovation-in-greater-chicagoland-region-at-annual-awards-ceremony-301760904.html,2023-03-02 13:44:00,WORLD BUSINESS CHICAGO HONORS COMPANIES DRIVING ... PR ...,ABT,0.045482,0.282314,Somewhat-Bullish
Could Apple Be the Next Big Tech Company to Make a Move in Healthcare?,https://www.fool.com/investing/2023/03/02/could-apple-be-the-next-big-tech-company-to-make-a/,2023-03-02 11:00:00,Healthcare is an industry that has been on Apple's radar for a while.,ABT,0.071145,0.031128,Neutral
"Republicans Seek Documents, Schedule Hearing Related To FDA's Response To Baby-Formula Shortage - Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/government/23/03/31443656/republicans-seek-documents-schedule-hearing-related-to-fdas-response-to-baby-formula-shortage,2023-03-21 19:37:56,"House Republicans are reportedly speeding up their scrutiny of the FDA and the White House's handling of the baby formula shortage last year. The supply crunch hit the U.S. market when Abbott Laboratories ABT, a significant supplier, closed its Sturgis, Michigan, plant due to bacterial infection.",ABT,0.249106,-0.09264,Neutral
Should You Invest in the iShares U.S. Medical Devices ETF  ( IHI ) ?,https://www.zacks.com/stock/news/2068308/should-you-invest-in-the-ishares-us-medical-devices-etf-ihi,2023-03-21 10:20:08,Sector ETF report for IHI ...,ABT,0.130571,0.07042,Neutral
"PHARMACEUTICS INTERNATIONAL ONBOARDS NEW LEADERSHIP TEAM TO DRIVE QUALITY, OPERATIONAL IMPROVEMENTS, AND GROWTH",https://www.benzinga.com/pressreleases/23/03/g31424142/pharmaceutics-international-onboards-new-leadership-team-to-drive-quality-operational-improvements,2023-03-20 16:24:14,"Hunt Valley, MD, March 20, 2023 ( GLOBE NEWSWIRE ) -- HUNT VALLEY, MD., March 20, 2023",ABT,0.033515,0.047639,Neutral
JNJ: 3 Stocks That Could Deliver Healthy Returns in 2023,https://stocknews.com/news/jnj-abt-hum-abmd-csii-3-stocks-that-could-deliver-healthy-returns-in-2023/,2023-03-17 18:07:29,JNJ: 3 Stocks That Could Deliver Healthy Returns in ...,ABT,0.220408,0.182852,Somewhat-Bullish
Abbott  ( ABT )  Diabetes Arm Growth Robust Amid Macroeconomic Woes,https://www.zacks.com/stock/news/2067328/abbott-abt-diabetes-arm-growth-robust-amid-macroeconomic-woes,2023-03-17 14:15:00,"Abbott (ABT) currently forecasts total organic sales growth, excluding the impact of COVID testing-related sales, to be in the high-single digits in 2023.",ABT,0.142847,0.119653,Neutral
Meet 100 Women Who Are Leading Finance Into the Future,https://www.barrons.com/articles/most-influential-women-in-finance-ca839b71,2023-03-17 13:00:00,Barron's 100 Most Influential Women in U.S. Finance ...,ABT,0.47672,0.430348,Bullish
Peering Into Abbott Laboratories's Recent Short Interest - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/short-sellers/23/03/31384557/peering-into-abbott-laboratoriess-recent-short-interest,2023-03-16 16:45:31,"Abbott Laboratories's ABT short percent of float has risen 5.13% since its last report. The company recently reported that it has 13.93 million shares sold short, which is 0.82% of all regular shares that are available for trading.",ABT,0.221819,0.155473,Somewhat-Bullish
Biosensors Development and Demand Market To Expand at a CAGR of 11.8% To Reach Valuation of USD 29.6 Billion By 2030,https://www.benzinga.com/pressreleases/23/03/g31376301/biosensors-development-and-demand-market-to-expand-at-a-cagr-of-11-8-to-reach-valuation-of-usd-29-,2023-03-16 11:00:00,"New York, US, March 16, 2023 ( GLOBE NEWSWIRE ) -- According to a comprehensive research report by Market Research Future ( MRFR ) , ""Biosensors Development and Demand market Research Report: By Application, By Type, By Design Methods, and Region - Forecast till 2030, the market is anticipated ...",ABT,0.034882,-0.101047,Neutral
Angiography Devices Market Size to Cross USD 22 Bn by 2031 Due to the Rise in Prevalence of Cardiovascular Diseases | TMR Study,https://www.benzinga.com/pressreleases/23/03/g31375788/angiography-devices-market-size-to-cross-usd-22-bn-by-2031-due-to-the-rise-in-prevalence-of-cardio,2023-03-16 10:30:00,"Wilmington, Delaware, United States, March 16, 2023 ( GLOBE NEWSWIRE ) -- According to the latest study by Transparency Market Research, ""The global angiography devices market was valued at US$ 12.4 Bn in 2022 and is estimated to grow at a CAGR of 6.7% for the forecast period between 2023 and ...",ABT,0.038906,-0.011758,Neutral
"SHAREHOLDER ALERT: The M&A Class Action Firm Continues its Investigation of the Merger - AGFS, NUVA, CSII, ANGN",https://www.benzinga.com/pressreleases/23/03/g31371084/shareholder-alert-the-m-a-class-action-firm-continues-its-investigation-of-the-merger-agfs-nuva-cs,2023-03-15 21:14:22,"NEW YORK, March 15, 2023 ( GLOBE NEWSWIRE ) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC ( the ""M&A Class Action Firm"" ) , a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and ...",ABT,0.067919,0.118957,Neutral
Could GE HealthCare Stock Help You Retire a Millionaire?,https://www.fool.com/investing/2023/03/15/could-ge-healthcare-stock-help-retire-millionaire/,2023-03-15 12:44:45,"The healthcare specialist's fundamentals look sound, but it's the growth potential that is the big question mark for investors.",ABT,0.059636,0.125048,Neutral
2 Market-Beating ETFs to Buy Before the Bull Run,https://www.fool.com/investing/2023/03/15/2-market-beating-etfs-to-buy-before-the-bull-run/,2023-03-15 11:30:00,These can be ideal buy-and-forget investments to add to your portfolio right now.,ABT,0.064623,0.159253,Somewhat-Bullish
"Top Research Reports for AbbVie, NextEra Energy & ConocoPhillips",https://www.zacks.com/research-daily/2064755/top-research-reports-for-abbvie-nextera-energy-conocophillips,2023-03-13 17:10:00,"Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), NextEra Energy, Inc. (NEE) and ConocoPhillips (COP).",ABT,0.124164,0.072817,Neutral
Abbott  ( ABT )  to Pair CGM Sensors & AID System on FDA Clearance,https://www.zacks.com/stock/news/2064906/abbott-abt-to-pair-cgm-sensors-aid-system-on-fda-clearance,2023-03-13 16:41:00,Abbott Laboratories (ABT) receives FDA clearance for the integration of its iCGM system sensors with automated insulin delivery (AID) systems.,ABT,0.187827,0.010733,Neutral
Abbott's  ( ABT )  Epic Max Tissue Valve Receives FDA Approval,https://www.zacks.com/stock/news/2073266/abbotts-abt-epic-max-tissue-valve-receives-fda-approval,2023-03-31 16:48:00,Abbott's (ABT) Epic Max design optimizes patient blood flow and has a low profile that makes future cardiac interventions simpler.,ABT,0.113062,0.225606,Somewhat-Bullish
The Top Healthcare Stocks to Buy With $100,https://www.fool.com/investing/2023/03/31/the-top-healthcare-stocks-to-buy-with-100/,2023-03-31 14:00:00,"With the right stocks, even a small investment can yield huge returns.",ABT,0.055621,0.247987,Somewhat-Bullish
Biomarkers Market is Expected to Reach $104.0 billion | MarketsandMarkets.,https://www.benzinga.com/pressreleases/23/03/g31608818/biomarkers-market-is-expected-to-reach-104-0-billion-marketsandmarkets,2023-03-31 13:30:00,"Chicago, March 31, 2023 ( GLOBE NEWSWIRE ) -- The future of biomarkers is expected to be a very promising one. As new technologies and techniques continue to emerge, the use of biomarkers will become increasingly more commonplace.",ABT,0.037387,0.032368,Neutral
2 High-Yielding Dividend Investments to Buy for the Long Haul,https://www.fool.com/investing/2023/03/30/2-high-yielding-dividend-investments-for-long-haul/,2023-03-30 11:45:00,"Both of these stocks are Dividend Kings, and their payouts are likely to continue rising in the future.",ABT,0.071145,0.0,Neutral
"ALERT: The M&A Class Action Firm Continues its Investigation of the Merger - ANGN, CSII, AGFS, NUVA",https://www.benzinga.com/pressreleases/23/03/g31561689/alert-the-m-a-class-action-firm-continues-its-investigation-of-the-merger-angn-csii-agfs-nuva,2023-03-29 20:35:20,"NEW YORK, March 29, 2023 ( GLOBE NEWSWIRE ) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC ( the ""M&A Class Action Firm"" ) , a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and ...",ABT,0.067919,0.118957,Neutral
"Grant Weinstein joins Performio as Head of Sales, APAC -- Performio Strengthens Global Sales Leadership Team",https://www.prnewswire.com/apac/news-releases/grant-weinstein-joins-performio-as-head-of-sales-apac--performio-strengthens-global-sales-leadership-team-301784328.html,2023-03-29 18:00:00,"Grant Weinstein joins Performio as Head of Sales, APAC ... PR ...",ABT,0.071784,0.218563,Somewhat-Bullish
"Grant Weinstein joins Performio as Head of Sales, APAC -- Performio Strengthens Global Sales Leadership Team",https://www.prnewswire.com/news-releases/grant-weinstein-joins-performio-as-head-of-sales-apac--performio-strengthens-global-sales-leadership-team-301784161.html,2023-03-29 18:00:00,"Grant Weinstein joins Performio as Head of Sales, APAC ... PR ...",ABT,0.071784,0.218563,Somewhat-Bullish
2 Dividend Stocks Down 11% to 22% to Buy and Hold Forever,https://www.fool.com/investing/2023/03/28/2-dividend-stocks-down-11-to-22-to-buy-and-hold/,2023-03-28 13:53:00,Investors should buy the dips on these healthcare giants.,ABT,0.286082,0.257147,Somewhat-Bullish
Tencent's Cash Dividend Weighs On Meituan,https://www.forbes.com/sites/brendanahern/2023/03/27/tencents-cash-dividend-weighs-on-meituan/,2023-03-27 14:36:16,Asian equity markets were mixed overnight on light volumes as investors worried about financial contagion.,ABT,0.057767,0.050009,Neutral
EG 427 Appoints New Members To Board of Directors and Scientific Advisory Board,https://www.benzinga.com/pressreleases/23/03/g31508778/eg-427-appoints-new-members-to-board-of-directors-and-scientific-advisory-board,2023-03-27 12:00:13,"PARIS, March 27, 2023 ( GLOBE NEWSWIRE ) -- EG 427, a biotechnology company leading the development of pinpoint DNA medicine solutions based on its unique non-replicative HSV-1 vector platform, announced today the appointment of Sundar Kodiyalam to the Board of Directors and Gregory A.",ABT,0.053271,0.01698,Neutral
Abbott's  ( ABT )  CardioMEMS Favors Heart Failure Management,https://www.zacks.com/stock/news/2070646/abbotts-abt-cardiomems-favors-heart-failure-management,2023-03-27 11:37:00,"Abbott (ABT) announces key findings from meta-analysis, which shows remote pressure monitoring to be a life-extending option among heart failure patients.",ABT,0.261117,0.072712,Neutral
Pneumonia testing market size is set to grow by USD 709 million from 2022 to 2027; The rising number of M and A and new product launches are a key trend - Technavio,https://www.prnewswire.com/news-releases/pneumonia-testing-market-size-is-set-to-grow-by-usd-709-million-from-2022-to-2027-the-rising-number-of-m-and-a-and-new-product-launches-are-a-key-trend---technavio-301781432.html,2023-03-27 10:56:00,Pneumonia testing market size is set to grow by USD 709 million ... PR ...,ABT,0.029728,0.003889,Neutral
"Baby formula 'getting harder' to find as supply dwindles, pharmacy owner warns",https://www.foxbusiness.com/lifestyle/baby-formula-getting-harder-to-find-again-pharmacy-owner-warns,2023-03-25 11:11:12,"One year later, the baby formula shortage continues to plague families nationwide - and relief from the Biden administration is seemingly nowhere in sight. BABY FORMULA STILL HARD TO FIND NEARLY A YEAR AFTER SHORTAGE BEGAN",ABT,0.204072,0.133309,Neutral
Nasdaq Bear Market: 2 Growth Stocks to Buy That Keep Bucking the Trend,https://www.fool.com/investing/2023/03/25/nasdaq-bear-market-2-growth-stocks-to-buy-that-kee/,2023-03-25 09:41:00,These red-hot stocks keep climbing despite the bear market.,ABT,0.06211,0.219221,Somewhat-Bullish
"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates ANGN, CSII, MPB, TIG - Angion Biomedica  ( NASDAQ:ANGN ) , Cardiovascular Systems  ( NASDAQ:CSII ) ",https://www.benzinga.com/pressreleases/23/03/g31490689/shareholder-investigation-halper-sadeh-llc-investigates-angn-csii-mpb-tig,2023-03-24 13:02:32,"NEW YORK, March 24, 2023 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Angion Biomedica Corp.",ABT,0.113062,0.08948,Neutral
Endovascular Abdominal Aortic Aneurysm Repair Devices Market to Reach USD 3.7 Bn by 2031 | TMR,https://www.benzinga.com/pressreleases/23/03/g31477467/endovascular-abdominal-aortic-aneurysm-repair-devices-market-to-reach-usd-3-7-bn-by-2031-tmr,2023-03-23 15:30:00,"Wilmington, Delaware, United States, March 23, 2023 ( GLOBE NEWSWIRE ) -- According to Transparency Market Research, ""The endovascular abdominal aortic aneurysm repair devices market was valued at USD 2.3 Bn in 2022 and it is expected to reach a USD 3.7 Bn by 2031 with CAGR of 5.0%.""",ABT,0.042122,0.172932,Somewhat-Bullish
2 High-Yield Dividend Stocks You Won't Regret Buying Right Now,https://www.fool.com/investing/2023/03/23/2-high-yield-dividend-stocks-you-wont-regret-buyin/,2023-03-23 14:00:00,These two blue-chip dividend stocks offer investors a reliable income stream in a volatile market.,ABT,0.058188,0.025023,Neutral
Players In The Sports Nutrition Market Are Focusing On Developing Products That Are Vegan-Based And Use Clean Label Ingredients - By The Business Research Company,https://www.prnewswire.com/news-releases/players-in-the-sports-nutrition-market-are-focusing-on-developing-products-that-are-vegan-based-and-use-clean-label-ingredients--by-the-business-research-company-301779713.html,2023-03-23 10:59:00,Players In The Sports Nutrition Market Are Focusing On Developing ... PR ...,ABT,0.060236,0.010016,Neutral
"STOCKHOLDER ALERT: The M&A Class Action Firm Continues its Investigation of the Merger - NUVA, ANGN, AGFS, CSII",https://www.benzinga.com/pressreleases/23/03/g31463746/stockholder-alert-the-m-a-class-action-firm-continues-its-investigation-of-the-merger-nuva-angn-ag,2023-03-22 19:50:50,"NEW YORK, March 22, 2023 ( GLOBE NEWSWIRE ) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC ( the ""M&A Class Action Firm"" ) , a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and ...",ABT,0.067919,0.118957,Neutral
Here's Why You Should Retain Abbott  ( ABT )  Stock for Now,https://www.zacks.com/stock/news/2069241/heres-why-you-should-retain-abbott-abt-stock-for-now,2023-03-22 17:07:00,Investors are optimistic about Abbott (ABT) on continued growth in the core Diagnostics arm.,ABT,0.097655,0.264324,Somewhat-Bullish
GSK ADR Trying To Close In On Key Technical Measure,https://www.investors.com/ibd-data-stories/gsk-adr-trying-to-close-in-on-key-technical-measure/,2023-04-10 07:00:00,"GSK ADR ( GSK ) had its Relative Strength ( RS ) Rating upgraded from 63 to 72 Monday -- a welcome improvement, but still below the 80 or higher score you look for. When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",ABT,0.306963,0.0,Neutral
"AnaptysBio Announces Appointment of Rita Jain, M.D., to Board of Directors",https://www.globenewswire.com/news-release/2023/04/06/2642996/0/en/AnaptysBio-Announces-Appointment-of-Rita-Jain-M-D-to-Board-of-Directors.html,2023-04-06 20:15:00,"SAN DIEGO, April 06, 2023 ( GLOBE NEWSWIRE ) -- AnaptysBio, Inc. ( Nasdaq: ANAB ) , a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced the appointment of Rita Jain, M.D., to the company's Board of Directors, effective immediately.",ABT,0.040484,-0.085299,Neutral
"AnaptysBio Announces Appointment of Rita Jain, M.D., to Board of Directors - AnaptysBio  ( NASDAQ:ANAB ) ",https://www.benzinga.com/pressreleases/23/04/g31705743/anaptysbio-announces-appointment-of-rita-jain-m-d-to-board-of-directors,2023-04-06 20:15:00,"SAN DIEGO, April 06, 2023 ( GLOBE NEWSWIRE ) -- AnaptysBio, Inc. ANAB, a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced the appointment of Rita Jain, M.D., to the company's Board of Directors, effective immediately.",ABT,0.039353,-0.085043,Neutral
3 No-Brainer Medical Device Stocks to Buy Right Now,https://www.fool.com/investing/2023/04/06/3-no-brainer-medical-device-stocks-to-buy-now/,2023-04-06 11:45:00,These companies have consistently delivered revenue and EPS gains.,ABT,0.157141,0.108558,Neutral
Cardiovascular Systems  ( CSII )  Finishes ECLIPSE Trial Enrollment,https://www.zacks.com/stock/news/2074814/cardiovascular-systems-csii-finishes-eclipse-trial-enrollment,2023-04-05 13:11:00,Cardiovascular Systems' (CSII) ECLIPSE clinical trial data is likely to help physicians form an optimal treatment plan for patients with severely calcified coronary arteries.,ABT,0.066047,0.322536,Somewhat-Bullish
Better Dividend Stock: AbbVie vs. Johnson & Johnson,https://www.fool.com/investing/2023/04/05/better-dividend-stock-abbvie-vs-johnson-johnson/,2023-04-05 12:55:00,Both companies have a lot to offer income-seekers.,ABT,0.048621,0.092464,Neutral
"The Zacks Analyst Blog Highlights T-Mobile US, Abbott Laboratories, Advanced Micro Devices, Intuit and Cintas",https://www.zacks.com/stock/news/2074640/the-zacks-analyst-blog-highlights-t-mobile-us-abbott-laboratories-advanced-micro-devices-intuit-and-cintas,2023-04-05 09:46:00,"T-Mobile US, Abbott Laboratories, Advanced Micro Devices, Intuit and Cintas are included in this Analyst Blog.",ABT,0.716023,0.0,Neutral
"Top Stock Reports for T-Mobile US, Abbott Laboratories & AMD",https://www.zacks.com/research-daily/2074337/top-stock-reports-for-t-mobile-us-abbott-laboratories-amd,2023-04-04 18:01:00,"Today's Research Daily features new research reports on 16 major stock, including T-Mobile US, Inc. (TMUS), Abbott Laboratories (ABT) and Advanced Micro Devices, Inc. (AMD).",ABT,0.241684,0.155073,Somewhat-Bullish
"IoT In Healthcare Market Size Growing at 19.20 % CAGR, Set to Reach USD 388.18 Billion by 2027 says Brandessence Market Research",https://www.prnewswire.com/news-releases/iot-in-healthcare-market-size-growing-at-19-20--cagr-set-to-reach-usd-388-18-billion-by-2027-says-brandessence-market-research-301789350.html,2023-04-04 08:46:00,"IoT In Healthcare Market Size Growing at 19.20 % CAGR, Set to ... PR ...",ABT,0.029256,0.139885,Neutral
3 Dividend-Growth Stocks to Buy in April That Can Crush Inflation,https://www.fool.com/investing/2023/04/02/3-dividend-growth-stocks-that-can-crush-inflation/,2023-04-02 10:37:00,No need to worry about keeping up with inflation with these rapidly growing payouts.,ABT,0.109455,0.215256,Somewhat-Bullish
Could This Drug News Lift AbbVie's Stock?,https://www.fool.com/investing/2023/04/01/could-this-drug-news-lift-abbvies-stock/,2023-04-01 13:15:00,"Alongside Skyrizi, the immunology medicine is part of AbbVie's bright post-Humira future.",ABT,0.055751,0.147908,Neutral
"Lam Research, D.R. Horton, Las Vegas Sands And Other Big Stocks Moving Higher On Thursday",https://markets.businessinsider.com/news/stocks/lam-research-d-r-horton-las-vegas-sands-and-other-big-stocks-moving-higher-on-thursday-1032247495,2023-04-20 15:11:16,"Lam Research, D.R. Horton, Las Vegas Sands And Other Big Stocks ... - Markets Insider ...",ABT,0.122894,0.0,Neutral
Home Medical Equipment Market in United States Is Expected to Reach $20.39 Billion by 2031: Allied Market Research,https://www.benzinga.com/pressreleases/23/04/g31917234/home-medical-equipment-market-in-united-states-is-expected-to-reach-20-39-billion-by-2031-allied-m,2023-04-20 15:01:40,"Portland, OR, April 20, 2023 ( GLOBE NEWSWIRE ) -- According to the report published by Allied Market Research, the U.S. home medical equipment market generated $12.38 billion in 2021, and is estimated to reach $20.39 billion by 2031, witnessing a CAGR of 5.1% from 2022 to 2031.",ABT,0.041039,-0.016685,Neutral
"Abbott Laboratories To Rally 17%? Here Are 10 Other Analyst Forecasts For Thursday - Abbott Laboratories  ( NYSE:ABT ) , Airbnb  ( NASDAQ:ABNB ) ",https://www.benzinga.com/news/23/04/31915203/abbott-laboratories-to-rally-17-here-are-10-other-analyst-forecasts-for-thursday,2023-04-20 13:56:29,"Morgan Stanley cut the price target for Charter Communications, Inc. CHTR from $460 to $420. Morgan Stanley analyst Benjamin Swinburne maintained an Equal-Weight rating. Charter Communications shares fell 1.6% to $338.33 on Thursday. BMO Capital cut the price target for Morgan Stanley MS from ...",ABT,0.198221,-0.045192,Neutral
"CBOE Volatility Index Drops To Lowest Level Since November 2021; S&P 500 Ends Almost Flat - Netflix  ( NASDAQ:NFLX ) , Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/news/earnings/23/04/31908290/cboe-volatility-index-drops-to-lowest-level-since-november-2021-s-p-500-ends-almost-flat,2023-04-20 09:50:42,"The S&P 500 closed almost flat on Wednesday following the release of corporate earnings. Abbott Laboratories ABT shares gained 7.8% on Wednesday after the company reported better-than-expected Q1 results and issued guidance. Netflix, Inc. NFLX shares dropped after the company reported mixed Q1 ...",ABT,0.366061,0.722373,Bullish
Stock market today: Asian shares trading mostly lower,https://apnews.com/article/stock-market-banks-rates-earnings-7578df8f439bfe027890f8268514836c,2023-04-20 07:02:58,"A currency trader walks by the screen showing the Korea Composite Stock Price Index ( KOSPI ) at a foreign exchange dealing room in Seoul, South Korea, Thursday, April 20, 2023.",ABT,0.052112,0.223659,Somewhat-Bullish
"Tesla, Rivian, IBM, Zions, Lam Research: Why These Five Stocks Are Drawing Investors' Attention Today - Netflix  ( NASDAQ:NFLX ) , Abbott Laboratories  ( NYSE:ABT ) , Tesla  ( NASDAQ:TSLA ) , Western Alliance  ( NYSE:WAL ) , Zions Bancorp  ( NASDAQ:ZION ) , IBM  ( NYSE:IBM ) , Lam Research  ( NASDAQ:LRCX ) , Rivian Automotive  ( NASDAQ:RIVN ) ",https://www.benzinga.com/markets/equities/23/04/31906137/tesla-rivian-ibm-zions-lam-research-why-these-five-stocks-are-drawing-investors-attention-today,2023-04-20 01:28:08,"U.S. markets ended in the flat zone on Wednesday after investors and traders weighed-in a mixed set of corporate earnings. While shares of Western Alliance Bancorporation WAL and Abbott Laboratories ABT rose following their results, Netflix Inc NFLX stock fell due to a downbeat forecast.",ABT,0.250386,-0.119183,Neutral
"Dow dips, S&P 500 ends flat amid rising fears of economic downturn",https://www.moneycontrol.com/news/business/markets/dow-dips-sp-500-ends-flat-amid-rising-fears-of-economic-downturn-10443331.html,2023-04-20 00:40:13,"Investors are looking for signs in corporate results that inflation may be driving up costs or hurting consumer spending, amid fears the economy may be on the cusp of a downturn ...",ABT,0.067727,0.110966,Neutral
"Business Highlights: Nazi-linked accounts, Tesla's earnings",https://apnews.com/article/business-highlights-73eed916a176448e5029e2514ec1de2b,2023-04-19 21:02:33,GENEVA ( AP ) - U.S. lawmakers have accused the embattled Swiss bank Credit Suisse of limiting the scope of an internal investigation into Nazi clients and Nazi-linked accounts.,ABT,0.036091,0.024705,Neutral
How major US stock indexes fared Wednesday 4/19/2023,https://apnews.com/article/netflix-inc-abbott-laboratories-financial-markets-business-66d2b1a37b0778b207043ef699673de2,2023-04-19 20:19:34,"Stocks are closing mostly flat on Wall Street Wednesday following mixed earnings reports from big U.S. companies. The S&P 500 was virtually unchanged, the Dow slipped and the Nasdaq gained less than 0.1%. Netflix dropped after reporting weaker revenue than expected.",ABT,0.220809,0.13644,Neutral
"Nasdaq Edges Higher; Abbott Laboratories Reports Upbeat Results - Abbott Laboratories  ( NYSE:ABT ) , Agrify  ( NASDAQ:AGFY ) ",https://www.benzinga.com/news/earnings/23/04/31899245/nasdaq-edges-higher-abbott-laboratories-reports-upbeat-results,2023-04-19 18:33:37,"U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite turning higher on Wednesday. The Dow traded down 0.23% to 33,899.20 while the NASDAQ rose 0.16% to 12,172.92. The S&P 500, also rose, gaining, 0.04% to 4,156.70. Utilities shares rose by 0.6% on Wednesday.",ABT,0.166551,0.144796,Neutral
"Abbott Labs shares pop as revenue, earnings defy steep drop in Covid test sales",https://www.cnbc.com/2023/04/19/abbott-labs-shares-pop-as-revenue-earnings-defy-drop-in-covid-sales.html,2023-04-19 17:57:22,Abbott Laboratories said Covid-related headwinds may actually be easing.,ABT,0.099476,0.089075,Neutral
"Stocks making the biggest moves midday: Rivian, Western Alliance, Peloton and more",https://www.cnbc.com/2023/04/19/stocks-making-the-biggest-moves-midday-rivn-wal-pton-and-more.html,2023-04-19 17:09:41,"Regional bank stocks gained on Wednesday. Western Alliance led the pack, with its shares jumping 18% after it said deposits have been rebounding in April.",ABT,0.044551,0.110112,Neutral
"Abbott Labs stock soars 8% as medical tests, procedures rebound from COVID lull",https://www.marketwatch.com/story/abbott-labs-stock-up-2-premarket-after-earnings-beat-despite-declining-covid-testing-sales-8cb12c61,2023-04-19 16:42:00,Abbott's stock is the second biggest gainer on the S&P 500 index after company tops consensus estimates for the first quarter.,ABT,0.173333,0.139318,Neutral
Check Out What Whales Are Doing With ABT - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/markets/options/23/04/31895073/check-out-what-whales-are-doing-with-abt,2023-04-19 15:46:01,A whale with a lot of money to spend has taken a noticeably bearish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories ABT we detected 15 strange trades.,ABT,0.860547,0.171395,Somewhat-Bullish
"Abbott's  ( ABT )  Q1 Earnings Beat Estimates, Margins Down",https://www.zacks.com/stock/news/2081409/abbotts-abt-q1-earnings-beat-estimates-margins-down,2023-04-19 14:03:00,"Double-digit organic growth in Diabetes Care, Structural Heart, Heart Failure and Neuromodulation contributed to Abbott's (ABT) Q1 revenues.",ABT,0.166169,0.070741,Neutral
"Top Stories Wednesday, Apr. 19: Meta Prepares For Further Job Cuts, Google To Allow Developers To Use Alternative Payment Options, Intel Ditches Production Of Bitcoin Mining Chip - Apple  ( NASDAQ:AAPL ) ",https://www.benzinga.com/news/earnings/23/04/31891070/meta-prepares-for-further-job-cuts-google-to-allow-developers-to-use-alternative-payment-options-in,2023-04-19 13:34:37,"Meta Platforms Inc META notified managers to prepare to announce job cuts on Wednesday under a cost-cutting push likely to pare 10,000 positions at the company. The downsizing will impact Facebook, WhatsApp, Instagram, and Reality Labs, which houses the firm's virtual reality efforts and Quest ...",ABT,0.096477,0.14663,Neutral
"Abbott Reports Lower, But Better Than Expected Q1 Earnings, Reaffirms Annual Guidance - Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/news/earnings/23/04/31888957/why-abbott-laboratories-shares-are-trading-higher-today,2023-04-19 13:09:37,"Abbott Laboratories ABT has reported Q1 FY23 adjusted EPS of $1.03, down 40.5% Y/Y, better than the consensus of $0.99. Q1 sales of $9.75 billion decreased 18.1% on a reported basis and 14.5% on an organic basis, beating the consensus of $9.64 billion. Organic growth, excluding COVID-19 tests, ...",ABT,0.40348,0.331864,Somewhat-Bullish
Medical Giant Defies Covid Slowdown To Beat Expectations,https://www.investors.com/news/technology/abt-stock-abbott-earnings-q1-2023/,2023-04-19 12:52:00,ABT Stock: Abbott Shakes Off Covid Declines To Beat Expectations ... Investor's Business Daily ...,ABT,0.744196,0.502651,Bullish
"Stocks making the biggest moves premarket: United Airlines, Netflix, Morgan Stanley and more",https://www.cnbc.com/2023/04/19/stocks-making-the-biggest-moves-premarket-united-airlines-netflix-morgan-stanley-and-more.html,2023-04-19 12:27:03,These are the stocks posting the largest moves in premarket trading.,ABT,0.036255,0.084454,Neutral
2 Stocks That Could Help Make You a Millionaire by Retirement,https://www.fool.com/investing/2023/04/19/2-stocks-that-could-help-make-you-a-millionaire-by/,2023-04-19 12:25:00,These companies are accustomed to delivering excellent returns.,ABT,0.318897,0.390282,Bullish
"Abbott Labs' Sales, Earnings Defy Slowdown in Covid-19 Tests. Stock Rises.",https://www.barrons.com/articles/abbott-laboratories-sales-earnings-covid-tests-stock-1ed637df,2023-04-19 11:31:00,"Abbott Laboratories Sales, Earnings Defy Covid-19 Tests Slowdown. Stock Rises. ...",ABT,0.876064,0.26774,Somewhat-Bullish
Abbott beats profit estimates on strong medical device sales,https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-beats-profit-estimates-strong-medical-device-sales-2023-04-19/,2023-04-19 11:20:00,"April 19 ( Reuters ) - Abbott Laboratories ( ABT.N ) on Wednesday reported quarterly profit above expectations, driven by sales of its diabetes care devices and an improved demand for other devices due to a resumption in non-urgent medical procedures.",ABT,0.279015,0.371273,Bullish
"Morgan Stanley, Tesla And 3 Stocks To Watch Heading Into Wednesday - Abbott Laboratories  ( NYSE:ABT ) , Morgan Stanley  ( NYSE:MS ) ",https://www.benzinga.com/news/earnings/23/04/31883314/morgan-stanley-tesla-and-3-stocks-to-watch-heading-into-wednesday,2023-04-19 08:19:46,"With US futures trading lower this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects Morgan Stanley MS to post quarterly earnings at $1.62 per share on revenue of $13.92 billion before the opening bell.",ABT,0.366061,0.482057,Bullish
"Investor Optimism Declines Following Earnings Reports - Abbott Laboratories  ( NYSE:ABT ) , Bank of America  ( NYSE:BAC ) ",https://www.benzinga.com/news/earnings/23/04/31882672/investor-optimism-declines-following-earnings-reports,2023-04-19 07:40:53,The CNN Money Fear and Greed index showed some decline in overall sentiment among U.S. investors on Tuesday. U.S stocks closed mostly flat on Tuesday as investors digested the recent batch of earnings reports.,ABT,0.355588,0.0,Neutral
"Abbott Laboratories, National Retail Properties, UnitedHealth Group And A Big Bank Reporting Upbeat Earnings: CNBC's 'Final Trades' - Abbott Laboratories  ( NYSE:ABT ) , JPMorgan Chase  ( NYSE:JPM ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/04/31846485/abbott-laboratories-national-retail-properties-unitedhealth-group-and-a-big-bank-reporti,2023-04-18 12:21:22,"On CNBC's ""Halftime Report Final Trades,"" Brenda Vingiello of Sand Hill Global Advisors named Abbott Laboratories ABT as her final trade. On Monday, Raymond James maintained Abbott Laboratories with an Outperform and lowered the price target from $123 to $116, while BTIG maintained the stock with ...",ABT,0.744196,0.120337,Neutral
Diabetes Devices Market to Reach Over USD 90.2 Bn by 2031 with 6.0% of CAGR | TMR Study,https://www.benzinga.com/pressreleases/23/04/g31843569/diabetes-devices-market-to-reach-over-usd-90-2-bn-by-2031-with-6-0-of-cagr-tmr-study,2023-04-17 21:30:00,"Wilmington, Delaware, United States, April 18, 2023 ( GLOBE NEWSWIRE ) -- The global diabetes devices market was valued at USD 50.5 Bn in 2021 and is anticipated to reach USD 90.2 Bn by 2031. Increase in prevalence of diabetes has led to rise in demand for diabetes care devices and diabetes ...",ABT,0.038468,0.062437,Neutral
Cormedix Inc. Announces Appointment of Robert A. Stewart to Its Board of Directors,https://www.globenewswire.com/news-release/2023/04/17/2647934/0/en/Cormedix-Inc-Announces-Appointment-of-Robert-A-Stewart-to-Its-Board-of-Directors.html,2023-04-17 12:30:00,"BERKELEY HEIGHTS, N.J., April 17, 2023 ( GLOBE NEWSWIRE ) -- CorMedix Inc. ( Nasdaq: CRMD ) , a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases, today announced the appointment ...",ABT,0.039289,0.061652,Neutral
Abbott  ( ABT )  Gets FDA Clearance for FreeStyle Libre 3 Reader,https://www.zacks.com/stock/news/2079480/abbott-abt-gets-fda-clearance-for-freestyle-libre-3-reader,2023-04-17 12:05:00,Abbott (ABT) receives the FDA clearance for a standalone reader to be used for the FreeStyle Libre 3 iCGM system.,ABT,0.230235,0.15403,Somewhat-Bullish
Amarin Names Aaron Berg Interim President & Chief Executive Officer and Adds Oliver O'Connor to Company's Board of Directors - Amarin Corp  ( NASDAQ:AMRN ) ,https://www.benzinga.com/pressreleases/23/04/g31825227/amarin-names-aaron-berg-interim-president-chief-executive-officer-and-adds-oliver-oconnor-to-compa,2023-04-17 11:00:00,"DUBLIN, Ireland and BRIDGEWATER, N.J., April 17, 2023 ( GLOBE NEWSWIRE ) -- Amarin Corporation plc AMRN today announced that the Company's Board of Directors has appointed Aaron Berg, currently Amarin's Executive Vice President and President of the U.S.",ABT,0.040212,0.013842,Neutral
3 Stocks You Can Keep Forever,https://www.fool.com/investing/2023/04/16/3-stocks-you-can-keep-forever/,2023-04-16 14:15:00,Three solid profitable companies that are growing their businesses and their dividends.,ABT,0.04076,0.063845,Neutral
"Protein Bar Market size to grow at a CAGR of 8.1% from 2022 to 2027, Driven by the rising product innovations in protein bars - Technavio",https://www.prnewswire.com/news-releases/protein-bar-market-size-to-grow-at-a-cagr-of--8-1-from-2022-to-2027--driven-by-the-rising-product-innovations-in-protein-bars---technavio-301796771.html,2023-04-14 21:15:00,Protein Bar Market size to grow at a CAGR of 8.1% from 2022 to ... PR ...,ABT,0.087095,0.076144,Neutral
DexCom Stock Sets Up; Can It Catch Up To Company's Torrid Growth?,https://www.investors.com/stock-lists/ibd-big-cap-20/dexcom-stock-sets-up-can-it-catch-up-to-companys-torrid-growth/,2023-04-13 20:28:00,DexCom Stock Sets Up. Can It Catch Up To Company's Torrid ... Investor's Business Daily ...,ABT,0.138066,0.036016,Neutral
"SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CSII, NUVA, OSH, SUMO - NuVasive  ( NASDAQ:NUVA ) , Cardiovascular Systems  ( NASDAQ:CSII ) ",https://www.benzinga.com/pressreleases/23/04/g31793243/shareholder-investigation-halper-sadeh-llc-investigates-csii-nuva-osh-sumo,2023-04-13 16:49:13,"NEW YORK, April 13, 2023 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cardiovascular Systems, Inc.",ABT,0.137671,0.097824,Neutral
Conquering Venous Diseases: Global Treatment Market Set to Reach USD10 Billion by 2030,https://www.benzinga.com/pressreleases/23/04/g31781195/conquering-venous-diseases-global-treatment-market-set-to-reach-usd10-billion-by-2030,2023-04-13 03:00:00,"Houston, Texas, April 13, 2023 ( GLOBE NEWSWIRE ) -- Market Overview A series of diseases in which there is an issue with blood flow in the veins in the legs are collectively referred to as a venous disease, sometimes known as venous insufficiency.",ABT,0.027011,0.067157,Neutral
"SHAREHOLDER ALERT: The M&A Class Action Firm Continues its Investigation of the Merger - ANGN, FOCS, UNVR, CSII",https://www.benzinga.com/pressreleases/23/04/g31778839/shareholder-alert-the-m-a-class-action-firm-continues-its-investigation-of-the-merger-angn-focs-un,2023-04-12 21:20:48,"NEW YORK, April 12, 2023 ( GLOBE NEWSWIRE ) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC ( the ""M&A Class Action Firm"" ) , a national securities firm rated Top 50 in the 2018-2021 ISS Securities Class Action Services Report and ...",ABT,0.067919,0.118957,Neutral
What's in Store for Abbott Laboratories  ( ABT )  in Q1 Earnings?,https://www.zacks.com/stock/news/2077603/whats-in-store-for-abbott-laboratories-abt-in-q1-earnings,2023-04-12 14:46:00,Abbott Laboratories' (ABT) Established Pharmaceuticals Division (EPD) and Diabetes arm are boosting business in recent months.,ABT,0.23907,0.23541,Somewhat-Bullish
Why 2023 Could Be a Tough Year for AbbVie Stock,https://www.fool.com/investing/2023/04/12/why-2023-could-be-a-tough-year-for-abbvie-stock/,2023-04-12 09:15:00,Should you buy the stock despite its headwinds?,ABT,0.067919,-0.037365,Neutral
"Gynesonics Names Industry Veteran Skip Baldino President and CEO, Announces $25M Financing to Expand Worldwide Commercialization",https://www.benzinga.com/pressreleases/23/04/g31749678/gynesonics-names-industry-veteran-skip-baldino-president-and-ceo-announces-25m-financing-to-expand,2023-04-11 16:00:00,"REDWOOD CITY, Calif., April 11, 2023 ( GLOBE NEWSWIRE ) -- Gynesonics®, Inc. a women's healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, announced that Skip Baldino was appointed in early March to the role of President and Chief ...",ABT,0.044222,0.175686,Somewhat-Bullish
Looking At Abbott Laboratories's Recent Unusual Options Activity - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/markets/options/23/04/32092495/looking-at-abbott-laboratoriess-recent-unusual-options-activity,2023-04-28 19:33:48,"Someone with a lot of money to spend has taken a bearish stance on Abbott Laboratories ABT. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",ABT,0.83383,0.117358,Neutral
"Got $1,000? 2 Top Dividend Stocks to Buy Now",https://moneymorning.com/investing/got-1000-2-top-dividend-stocks-to-buy-now/,2023-04-28 18:00:00,"If you're looking to grow your $1,000, you can do that by investing in stocks that probably will deliver share performance. But you can boost your opportunities for gains if you invest in stocks that also pay you just for investing in them: dividend stocks.",ABT,0.156461,0.136767,Neutral
"Got $1,000? 2 Top Dividend Stocks to Buy Now",https://www.fool.com/investing/2023/04/28/got-1000-2-top-dividend-stocks-to-buy-now/,2023-04-28 18:00:00,Passive income can add to your stock market winnings.,ABT,0.130926,0.123771,Neutral
"If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today - Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/news/earnings/23/04/32051553/if-you-invested-100-in-this-stock-10-years-ago-you-would-have-300-today,2023-04-27 16:00:32,"Abbott Laboratories ABT has outperformed the market over the past 10 years by 1.37% on an annualized basis producing an average annual return of 11.32%. Currently, Abbott Laboratories has a market capitalization of $187.30 billion.",ABT,0.980595,0.386944,Bullish
Quest Diagnostics beats profit estimates as routine testing demand returns,https://www.reuters.com/markets/us/quest-diagnostics-beats-profit-estimates-routine-testing-demand-returns-2023-04-27/,2023-04-27 13:31:00,Quest Diagnostics beats profit estimates as routine testing demand ... ...,ABT,0.120431,-0.170852,Somewhat-Bearish
Why Abbott Laboratories Stock Looks Ridiculously Overpriced,https://moneymorning.com/investing/why-abbott-laboratories-stock-looks-ridiculously-overpriced/,2023-04-27 12:45:00,"Abbott Laboratories ( NYSE: ABT ) has had a volatile couple of years. It benefited from COVID-related tests boosting its sales, but last year it ran into manufacturing issues that affected its baby formula production and hurt sales in its nutritional segment.",ABT,0.252987,-0.004045,Neutral
Why Abbott Laboratories Stock Looks Ridiculously Overpriced,https://www.fool.com/investing/2023/04/27/why-abbott-stock-looks-ridiculously-overpriced/,2023-04-27 12:45:00,"Abbott's stock is trading at a huge premium, and it isn't a justifiable one for investors.",ABT,0.229872,-0.003753,Neutral
Boston Scientific lifts annual profit forecast on heart devices strength,https://www.reuters.com/business/healthcare-pharmaceuticals/boston-scientific-lifts-annual-profit-forecast-heart-devices-strength-2023-04-26/,2023-04-26 12:23:00,"April 26 ( Reuters ) - Boston Scientific Corp ( BSX.N ) raised its full-year profit forecast on Wednesday, after strong sales in its cardiovascular devices unit helped the company beat first-quarter estimates.",ABT,0.12165,0.119638,Neutral
The Fed Predicts a Recession: Should You Still Buy Stocks Now?,https://www.fool.com/investing/2023/04/25/the-fed-predicts-recession-should-you-invest/,2023-04-25 18:00:00,"The Fed expects a ""mild"" downturn.",ABT,0.12165,0.033083,Neutral
"Centene  ( CNC )  Q1 Earnings Miss Estimates, '23 EPS View Raised",https://www.zacks.com/stock/news/2084488/centene-cnc-q1-earnings-miss-estimates-23-eps-view-raised,2023-04-25 16:49:00,"Centene's (CNC) first-quarter 2023 results grapple with higher operating expenses, partly offset by an expanding customer base. Management presently expects adjusted EPS to be at least $6.40 in 2023.",ABT,0.154951,0.120775,Neutral
Sleep Easy With These 2 Rock-Solid Dividend Stocks,https://www.fool.com/investing/2023/04/25/sleep-easy-with-these-2-rock-solid-dividend-stocks/,2023-04-25 13:53:00,They aren't in any danger of crimping their dividends.,ABT,0.1172,0.304612,Somewhat-Bullish
This Supercharged Dividend King Stock Might Soon Run Out of Steam,https://www.fool.com/investing/2023/04/25/this-supercharged-dividend-king-stock-may-soon-run/,2023-04-25 13:45:00,"Emerging competitive threats in immunology, oncology, and medical aesthetics, along with a highly leveraged balance sheet, might dampen the drugmaker's growth trajectory post-2025.",ABT,0.076358,0.13366,Neutral
Is Abbott Laboratories Stock a Buy for Dividend Investors?,https://www.fool.com/investing/2023/04/25/is-abbott-laboratories-stock-a-buy-for-dividend-in/,2023-04-25 12:15:00,This healthcare company stands out among its peers as a Dividend King.,ABT,0.193207,0.268608,Somewhat-Bullish
"This Company's Non-Invasive Tech Looks To Be Unique In the Market And Can Help People Take Ownership Over Monitoring Their Health - Abbott Laboratories  ( NYSE:ABT ) , DexCom  ( NASDAQ:DXCM ) ",https://www.benzinga.com/general/healthcare/23/04/31985359/this-companys-non-invasive-tech-looks-to-be-unique-in-the-market-and-can-help-people,2023-04-25 11:48:43,"The need for noninvasive healthcare technology that allows people to take ownership and gather more insight into their health became acute when COVID revealed the fragility of the hospital system. This health-driven interest is reflected in the burgeoning healthtech market, currently valued at ...",ABT,0.136499,0.116736,Neutral
Point-of-Care Diagnostics Market Worth USD 66.0 Bn by 2028: Says Transparency Market Research,https://www.benzinga.com/pressreleases/23/04/g31972595/point-of-care-diagnostics-market-worth-usd-66-0-bn-by-2028-says-transparency-market-research,2023-04-24 21:30:00,"Wilmington, Delaware, United States, April 25, 2023 ( GLOBE NEWSWIRE ) -- According to the recent study published by Transparency Market Research, the global point-of-care diagnostics market stood at USD 34.1 billion in 2020 and the global market is projected to reach USD 66.0 billion by 2028.",ABT,0.038101,-0.018606,Neutral
Mitral Valve Disease Market Is Expected to Generate $5.7 Billion by 2031: Allied Market Research,https://www.benzinga.com/pressreleases/23/04/g31959989/mitral-valve-disease-market-is-expected-to-generate-5-7-billion-by-2031-allied-market-research,2023-04-24 15:24:46,"Portland, OR, April 24, 2023 ( GLOBE NEWSWIRE ) -- According to the report published by allied Market Research, the global mitral valve disease market garnered $2.5 billion in 2021, and is estimated to generate $5.7 billion by 2031, manifesting a CAGR of 8.8% from 2022 to 2031.",ABT,0.040145,-0.170133,Somewhat-Bearish
Is Abbott Laboratories Still a Good Dividend Stock to Buy?,https://www.fool.com/investing/2023/04/23/is-abbott-laboratories-still-a-good-dividend-stock/,2023-04-23 09:12:00,A better-than-expected first-quarter report already pushed it much higher.,ABT,0.176717,0.039031,Neutral
3 Top Dividend Kings to Buy for the Long Haul,https://www.fool.com/investing/2023/04/22/3-top-dividend-kings-to-buy-for-the-long-haul/,2023-04-22 11:20:00,These healthcare stocks all have above-average dividends.,ABT,0.030408,0.158953,Somewhat-Bullish
Abbott Laboratories Unusual Options Activity - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/markets/options/23/04/31939453/abbott-laboratories-unusual-options-activity,2023-04-21 16:46:05,"Someone with a lot of money to spend has taken a bearish stance on Abbott Laboratories ABT. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",ABT,0.816694,0.171383,Somewhat-Bullish
"HCA Healthcare  ( HCA )  Beats on Q1 Earnings, Ups '23 EPS View",https://www.zacks.com/stock/news/2082948/hca-healthcare-hca-beats-on-q1-earnings-ups-23-eps-view,2023-04-21 15:48:00,"HCA Healthcare's (HCA) first-quarter results gain from increased patient admissions. Management expects EPS within the $17.25-$18.55 band this year, higher than the previous view of $16.40-$17.60.",ABT,0.175539,0.132673,Neutral
Market Rally Drifts Lower; Tesla Dives On Margins: Weekly Review,https://www.investors.com/news/stock-market-rally-drifts-lower-tesla-dives-on-margins-isrg-dhi-lvs-are-winners/,2023-04-21 15:16:00,Market Rally Drifts Lower. Tesla Dives On Margins: Weekly Review Investor's Business Daily ...,ABT,0.041538,-0.047931,Neutral
P/E Ratio Insights for Abbott Laboratories - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/23/04/31935027/pe-ratio-insights-for-abbott-laboratories,2023-04-21 13:32:58,"Looking into the current session, Abbott Laboratories Inc. ABT shares are trading at $110.39, after a 0.04% increase. Moreover, over the past month, the stock spiked by 12.96%, but in the past year, decreased by 7.71%.",ABT,0.414559,0.120293,Neutral
Abbott Laboratories Unusual Options Activity For May 10 - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/markets/options/23/05/32322639/abbott-laboratories-unusual-options-activity-for-may-10,2023-05-10 17:16:27,"Someone with a lot of money to spend has taken a bearish stance on Abbott Laboratories ABT. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",ABT,0.835459,0.203288,Somewhat-Bullish
"NPPA to cap medicine prices to boost affordability, curb profiteering",https://www.business-standard.com/industry/news/nppa-to-cap-medicine-prices-to-boost-affordability-curb-profiteering-123051000328_1.html,2023-05-10 05:39:05,"The National Pharmaceutical Pricing Authority ( NPPA ) is planning to use its powers to further public interest. NPPA is planning to impose price caps under para 19 of the Drugs Prices Control Order ( DPCO ) , 2013. It can do so for an indefinite period to make essential medicines more affordable ...",ABT,0.12546,0.035553,Neutral
Here's Why You Should Retain Abbott  ( ABT )  Stock For Now,https://www.zacks.com/stock/news/2092431/heres-why-you-should-retain-abbott-abt-stock-for-now,2023-05-09 13:37:00,Investors are optimistic about Abbott (ABT) on continued growth in the core Diagnostics arm.,ABT,0.098456,0.155885,Somewhat-Bullish
"Why Cramer Says Important Not To Miss The Trees For The Forest - KB Home  ( NYSE:KBH ) , Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , Abbott Laboratories  ( NYSE:ABT ) , Campbell Soup  ( NYSE:CPB ) , Lennar  ( NYSE:LEN ) , PepsiCo  ( NASDAQ:PEP ) , Medtronic  ( NYSE:MDT ) , SPDR S&P 500  ( ARCA:SPY ) , General Electric  ( NYSE:GE ) ",https://www.benzinga.com/markets/equities/23/05/32280247/cramer-asks-investors-to-focus-on-individual-stocks-over-macro-strategies-says-dont-miss-the-tre,2023-05-09 07:03:34,Market commentator Jim Cramer reportedly said that investors should focus on deep research on individual stocks rather than depend on macro strategies for deciding investments.,ABT,0.24289,0.358433,Bullish
"Abbott  ( ABT )  EPD Business Grows Strong, Macro Issues Stay",https://www.zacks.com/stock/news/2091614/abbott-abt-epd-business-grows-strong-macro-issues-stay,2023-05-08 14:45:00,"Abbott (ABT) continues to make good progress, increasing manufacturing production and recovering market share in the Nutrition business.",ABT,0.213988,0.154654,Somewhat-Bullish
Global Sports Nutrition Market to 2032: Growing Adoption of Supplements by Gym-goers Fuels the Sector,https://www.prnewswire.com/news-releases/global-sports-nutrition-market-to-2032-growing-adoption-of-supplements-by-gym-goers-fuels-the-sector-301818055.html,2023-05-08 10:00:00,Global Sports Nutrition Market to 2032: Growing Adoption of ... PR ...,ABT,0.03178,0.02553,Neutral
"Looking for Steady, Passive Income? Buy AbbVie Stock",https://www.fool.com/investing/2023/05/06/looking-for-steady-passive-income-buy-abbvie-stock/,2023-05-06 13:00:00,The drugmaker looks poised to rebound from its Humira loss of exclusivity.,ABT,0.073546,0.210197,Somewhat-Bullish
3 Great Income Stocks That Retirees Should Love,https://www.fool.com/investing/2023/05/06/3-great-income-stocks-that-retirees-should-love/,2023-05-06 10:14:00,"If you're looking for additional retirement income, these three stocks should be right up your alley.",ABT,0.042122,0.139137,Neutral
3 Dividend Stock Warning Signs That Could Portend Trouble,https://www.fool.com/investing/2023/05/06/3-dividend-stock-warning-signs-that-could-portend/,2023-05-06 09:30:00,Recognizing these red flags will help you avoid investing in weaker businesses.,ABT,0.097062,0.025202,Neutral
Heart valve repair and replacement devices market size to grow by USD 3.01 billion from 2021 to 2026; Innovations in heart valve repair and replacement devices to improve market growth - Technavio,https://www.prnewswire.com/news-releases/heart-valve-repair-and-replacement-devices-market-size-to-grow-by-usd-3-01-billion-from-2021-to-2026-innovations-in-heart-valve-repair-and-replacement-devices-to-improve-market-growth---technavio-301816248.html,2023-05-05 20:15:00,Heart valve repair and replacement devices market size to grow by ... PR ...,ABT,0.032871,0.0,Neutral
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/earnings/23/05/32247214/heres-how-much-you-would-have-made-owning-abbott-laboratories-stock-in-the-last-10-years,2023-05-05 19:30:31,"Abbott Laboratories ABT has outperformed the market over the past 10 years by 2.16% on an annualized basis producing an average annual return of 11.92%. Currently, Abbott Laboratories has a market capitalization of $193.88 billion.",ABT,0.980595,0.386944,Bullish
"Cigna  ( CI )  Q1 Earnings Surpass Estimates, Ups '23 EPS View",https://www.zacks.com/stock/news/2091110/cigna-ci-q1-earnings-surpass-estimates-ups-23-eps-view,2023-05-05 16:28:00,Cigna's (CI) first-quarter 2023 results indicate a strong contribution to revenues from Evernorth Health Services and Cigna Healthcare businesses. Management currently expects adjusted EPS to be a minimum of $24.70 in 2023.,ABT,0.134027,0.111096,Neutral
Epilepsy Drugs Market Is Expected to Reach $9.8 Billion by 2032: Allied Market Research,https://www.benzinga.com/pressreleases/23/05/g32241720/epilepsy-drugs-market-is-expected-to-reach-9-8-billion-by-2032-allied-market-research,2023-05-05 15:16:17,"Portland, OR, May 05, 2023 ( GLOBE NEWSWIRE ) -- According to the report published by Allied Market Research, the global epilepsy drugs market generated $7 billion in 2022, and is estimated to reach $9.8 billion by 2032, witnessing a CAGR of 3.5% from 2023 to 2032.",ABT,0.036756,0.063953,Neutral
Dexcom to build its first European factory in Ireland,https://www.reuters.com/business/healthcare-pharmaceuticals/dexcom-build-its-first-european-factory-ireland-2023-05-05/,2023-05-05 08:37:05,"DUBLIN, May 5 ( Reuters ) - U.S. medical device company Dexcom ( DXCM.O ) plans to invest 300 million euros ( $330.8 million ) over the next five years to build a manufacturing site in Ireland, creating up to 1,000 jobs, it said on Friday.",ABT,0.188193,0.006301,Neutral
"Microelectronic Medical Implants Market Size, Share And Growth Analysis For 2023-2032 As Per The Business Research Company's Microelectronic Medical Implants Global Market Report 2023",https://www.benzinga.com/pressreleases/23/05/g32217716/microelectronic-medical-implants-market-size-share-and-growth-analysis-for-2023-2032-as-per-the-bu,2023-05-04 15:30:00,"LONDON, May 04, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the microelectronic medical implants market forecasts the global microelectronic medical implants market to grow at a CAGR of more than 9%, increasing from $37.6 billion in 2022 to $41.2 billion in 2023.",ABT,0.060236,0.093,Neutral
The Global Rapid Microbiology Testing Kits Market Is Projected To Grow At A 5% Rate Through The Forecast Period As Per The Business Research Company's Rapid Microbiology Testing Kits Global Market Report 2023,https://www.benzinga.com/pressreleases/23/05/g32217712/the-global-rapid-microbiology-testing-kits-market-is-projected-to-grow-at-a-5-rate-through-the-for,2023-05-04 15:30:00,"LONDON, May 04, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the rapid microbiology testing kits market forecasts the market to grow from $4.3 billion in 2022 to $4.6 billion in 2023, at a CAGR of more than 5%.",ABT,0.113866,0.031759,Neutral
Becton Dickinson raises 2023 profit forecast as demand rebounds,https://www.reuters.com/business/healthcare-pharmaceuticals/becton-dickinson-raises-2023-profit-forecast-demand-rebounds-2023-05-04/,2023-05-04 12:20:00,May 4 ( Reuters ) - Becton Dickinson and Co ( BDX.N ) on Thursday raised its full-year profit forecast and beat estimates for the second-quarter results on strong demand for its drug delivery devices and surgical equipment.,ABT,0.146025,0.104686,Neutral
"The Zacks Analyst Blog Highlights Berkshire Hathaway, Tesla, JPMorgan Chase, Abbott Laboratories and Comcast",https://www.zacks.com/stock/news/2089682/the-zacks-analyst-blog-highlights-berkshire-hathaway-tesla-jpmorgan-chase-abbott-laboratories-and-comcast,2023-05-04 09:16:00,"Berkshire Hathaway, Tesla, JPMorgan Chase, Abbott Laboratories and Comcast are included in this Analyst Blog.",ABT,0.724687,0.0,Neutral
"Top Research Reports for Berkshire Hathaway, Tesla & JPMorgan Chase",https://www.zacks.com/research-daily/2089148/top-research-reports-for-berkshire-hathaway-tesla-jpmorgan-chase,2023-05-03 15:55:00,"Today's Research Daily features new research reports on 16 major stocks, including Berkshire Hathaway Inc. (BRK.B), Tesla, Inc. (TSLA) and JPMorgan Chase & Co. (JPM).",ABT,0.129168,0.120127,Neutral
"Remote Patient Monitoring Market Set to Grow at 26.7% CAGR, Reaching USD 53.6 Billion in 2022, Driven by Rising Prevalence of Chronic Diseases and Technological Advances.",https://markets.businessinsider.com/news/stocks/remote-patient-monitoring-market-set-to-grow-at-26-7-cagr-reaching-usd-53-6-billion-in-2022-driven-by-rising-prevalence-of-chronic-diseases-and-technological-advances-1032286872,2023-05-03 14:26:00,"Remote Patient Monitoring ( RPM ) Devices Market, By Product Type ( Stationary Devices, Wearable Devices, and Others ) , By End-use, and By Region Forecast to 2032 The Remote Patient Monitoring ( RPM ) market has witnessed significant growth in recent years, with a size of USD 53.6 billion in ...",ABT,0.100308,0.299819,Somewhat-Bullish
Acadia Healthcare  ( ACHC )  Q1 Earnings Beat on Higher Patient Volumes,https://www.zacks.com/stock/news/2088470/acadia-healthcare-achc-q1-earnings-beat-on-higher-patient-volumes,2023-05-02 18:57:00,"Acadia Healthcare's (ACHC) Q1 results reflect higher revenue per patient day, partly offset by an elevated cost level. Management reaffirms its 2023 business guidance.",ABT,0.167612,0.127122,Neutral
"Blood Screening Market Size, Share, Revenue, Trends And Drivers For 2023-2032 As Per The Business Research Company's Blood Screening Global Market Report 2023",https://www.benzinga.com/pressreleases/23/05/g32164622/blood-screening-market-size-share-revenue-trends-and-drivers-for-2023-2032-as-per-the-business-res,2023-05-02 15:30:00,"LONDON, May 02, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the blood screening market forecasts the size of the worldwide blood screening market to increase from $2.6 billion in 2022 to $2.9 billion in 2023, with a compound annual growth rate ( CAGR ) of more than 10%.",ABT,0.063763,0.100068,Neutral
"Diabetic Neuropathy Market Size, Share And Growth Analysis For 2023-2032 As Per The Business Research Company's Diabetic Neuropathy Global Market Report 2023",https://www.benzinga.com/pressreleases/23/05/g32164624/diabetic-neuropathy-market-size-share-and-growth-analysis-for-2023-2032-as-per-the-business-resear,2023-05-02 15:30:00,"LONDON, May 02, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the diabetic neuropathy market identifies that the growth of the diabetic neuropathy market share is being fueled by the increasing prevalence of diabetes.",ABT,0.061159,0.100008,Neutral
"Hemoglobin A1c Testing Devices Market Size, Share, Revenue, Trends And Drivers For 2023-2032 As Per The Business Research Company's Hemoglobin A1c Testing Devices Global Market Report 2023",https://www.benzinga.com/pressreleases/23/05/g32164620/hemoglobin-a1c-testing-devices-market-size-share-revenue-trends-and-drivers-for-2023-2032-as-per-t,2023-05-02 15:30:00,"LONDON, May 02, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the hemoglobin A1c testing devices market predicts the market size of hemoglobin A1c testing devices to increase from $1.5 billion in 2022 to $1.7 billion in 2023, with a compound annual growth rate ( CAGR ) ...",ABT,0.058759,0.065984,Neutral
Antacids Market Is Expected to Reach $9.1 Billion by 2032: Allied Market Research,https://www.benzinga.com/pressreleases/23/05/g32161276/antacids-market-is-expected-to-reach-9-1-billion-by-2032-allied-market-research,2023-05-02 13:55:08,"Portland, OR, May 02, 2023 ( GLOBE NEWSWIRE ) -- According to the report published by Allied Market Research, the global antacids market generated $6.7 billion in 2022 and is estimated to reach $9.1 billion by 2032, witnessing a CAGR of 3.1% from 2023 to 2032.",ABT,0.038345,0.109189,Neutral
3 of the Best High-Yielding Dividend Stocks to Buy in May,https://www.fool.com/investing/2023/05/02/3-of-the-best-high-yielding-dividend-stocks-to-buy/,2023-05-02 13:39:48,"These dividend stocks are trading at cheap prices, and long-term investors should consider buying them right now.",ABT,0.049526,0.045503,Neutral
Zimmer Biomet raises annual forecasts on knees and hips unit strength,https://www.reuters.com/markets/us/zimmer-biomet-raises-annual-forecasts-knees-hips-unit-strength-2023-05-02/,2023-05-02 12:23:00,Zimmer Biomet raises annual forecasts on knees and hips unit ... ...,ABT,0.12546,0.113786,Neutral
Is Dexcom a Good Stock to Buy Now?,https://www.fool.com/investing/2023/05/02/is-dexcom-still-a-good-stock-to-buy/,2023-05-02 09:14:00,A poorly received first-quarter earnings report has investors wondering if this stock's best days are behind it.,ABT,0.128822,0.218277,Somewhat-Bullish
Where Will AbbVie Be in 5 Years?,https://www.fool.com/investing/2023/05/01/where-will-abbvie-be-in-5-years/,2023-05-01 13:30:00,"AbbVie has been a strong performer since its split from Abbott Labs, and it's trying hard to keep the momentum going.",ABT,0.053153,-0.109929,Neutral
3 Relatively Safe Stocks to Buy if a Recession Is on the Way,https://www.fool.com/investing/2023/05/20/3-relatively-safe-stocks-to-buy-if-a-recession-is/,2023-05-20 10:14:00,"If the economy falters, these stocks should hold up better than most.",ABT,0.043499,-0.012978,Neutral
"Diabetes Management Devices Market size to grow by USD 10.9 billion from 2022 to 2027, Growing focus on the artificial pancreas to be a major trend - Technavio",https://www.prnewswire.com/news-releases/diabetes-management-devices-market-size-to-grow-by-usd-10-9-billion-from-2022-to-2027--growing-focus-on-the-artificial-pancreas-to-be-a-major-trend---technavio-301828790.html,2023-05-19 19:45:00,Diabetes Management Devices Market size to grow by USD 10.9 ... PR ...,ABT,0.039033,0.045032,Neutral
"Stereotaxis, Abbott Ink Pact To Combine Mapping & Robotic Tech: FDA Approves Abbott's Next-Gen Abalation Catheter - Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/news/large-cap/23/05/32489673/stereotaxis-abbott-ink-pact-to-combine-mapping-robotic-tech-fda-approves-abbotts-next-gen-abalatio,2023-05-19 17:23:03,Stereotaxis Inc STXS shares are gaining after the company announced a global collaboration with Abbott Laboratories ABT to integrate Abbott's EnSite X EP System with Stereotaxis' Robotic Magnetic Navigation systems.,ABT,0.414559,0.433501,Bullish
Abbott's  ( ABT )  Assert-IQ Cardiac Monitor Receives FDA Approval,https://www.zacks.com/stock/news/2097566/abbotts-abt-assert-iq-cardiac-monitor-receives-fda-approval,2023-05-19 15:39:00,Abbott's (ABT) latest approval adds to its line-up of remote patient management and treatment tools that can support doctors more effectively.,ABT,0.099271,0.224191,Somewhat-Bullish
Abbott's India arm posts 9.5% rise in fourth-quarter profit | The Financial Express,https://www.financialexpress.com/industry/abbotts-india-arm-posts-9-5-rise-in-fourth-quarter-profit/3094502/,2023-05-19 13:09:19,Abbott's India arm posts 9.5% rise in fourth-quarter profit The Financial Express ...,ABT,0.229149,0.301333,Somewhat-Bullish
Meal Replacement Market Growth Size is Anticipated to Reach $15.5 billion by 2026,https://www.benzinga.com/pressreleases/23/05/g32484236/meal-replacement-market-growth-size-is-anticipated-to-reach-15-5-billion-by-2026,2023-05-19 12:45:00,"Chicago, May 19, 2023 ( GLOBE NEWSWIRE ) -- The meal replacement market was valued at USD 11.9 billion in 2021. The market is estimated to expand USD 15.5 billion by 2026, exhibiting a CAGR of 5.4% over the projected period.",ABT,0.069798,0.0,Neutral
Abbott's India arm posts 9.5% rise in fourth-quarter profit,https://www.reuters.com/business/healthcare-pharmaceuticals/abbotts-india-arm-posts-95-rise-fourth-quarter-profit-2023-05-19/,2023-05-19 11:32:00,"BENGALURU, May 19 ( Reuters ) - Abbott India Ltd ( ABOT.NS ) reported a 9.5% jump in fourth-quarter profit on Friday, helped by strong sales in its mainstay pharmaceuticals segment.",ABT,0.165031,0.202137,Somewhat-Bullish
Volta Medical Announces FDA Clearance of Volta AF-Xplorer™ Software to Simplify Complex Atrial Fibrillation Procedures,https://www.benzinga.com/pressreleases/23/05/g32477046/volta-medical-announces-fda-clearance-of-volta-af-xplorer-software-to-simplify-complex-atrial-fibr,2023-05-18 21:00:00,"• Live demonstration of new software at Heart Rhythm Society ( HRS ) 2023, May 19-21",ABT,0.044801,0.150939,Somewhat-Bullish
Want to Invest in Pharmaceutical Stocks but Don't Know How? Try This ETF.,https://www.fool.com/investing/2023/05/18/invest-in-pharmaceutical-stocks-with-invesco-etf/,2023-05-18 13:21:00,Simplify your exposure to an ever-changing prescription drug market with this rules-based fund.,ABT,0.05654,0.166964,Somewhat-Bullish
"Enteral Nutrition Market  ( Form, Nutrient Composition )  - Reach $16.18Bn by 2027 at 7.4% CAGR with Liquid Segment Driving Growth During 2019-2027 | The Insight Partners",https://www.benzinga.com/pressreleases/23/05/g32461610/enteral-nutrition-market-form-nutrient-composition-reach-16-18bn-by-2027-at-7-4-cagr-with-liquid-s,2023-05-18 10:46:25,"Pune, India., May 18, 2023 ( GLOBE NEWSWIRE ) -- The Insight Partners published latest research report on ""Enteral Nutrition Market Share Report, Trends, Growth and Revenue Forecasts to 2027 - Global Analysis and Forecasts by Form.",ABT,0.0362,0.122045,Neutral
We're starting a new position in one of the Big 3 global medical imaging and diagnostics companies,https://www.cnbc.com/2023/05/17/were-starting-a-new-position-in-a-medical-imaging-and-diagnostics-leader.html,2023-05-17 17:30:53,This company operates in an $84 billion total addressable market that the company sees growing to around $100 billion by 2024.,ABT,0.073209,0.110168,Neutral
"Back Off, Chronic Pain! FDA Nods for Abbott's Spinal Cord Stimulation Devices - Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/news/large-cap/23/05/32427647/back-off-chronic-pain-fda-nods-for-abbotts-spinal-cord-stimulation-devices,2023-05-16 18:22:49,"The FDA approved Abbott Laboratories ABT spinal cord stimulation ( SCS ) devices for chronic back pain in people who have not had or are not eligible to receive back surgery, known as non-surgical back pain. Abbott's DISTINCT study enrolled 270 participants who suffered pain for an average of ...",ABT,0.514619,-0.201931,Somewhat-Bearish
 ( ABT )  - Analyzing Abbott Laboratories's Short Interest - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/short-sellers/23/05/32424438/abt-analyzing-abbott-laboratoriess-short-interest,2023-05-16 14:45:54,"Abbott Laboratories's ABT short percent of float has fallen 9.88% since its last report. The company recently reported that it has 12.60 million shares sold short, which is 0.73% of all regular shares that are available for trading.",ABT,0.221819,0.083071,Neutral
Claims of PediaSure Boosting Children's Height Challenged in Lawsuit Against Abbott Laboratories - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/large-cap/23/05/32419502/claims-of-pediasure-boosting-childrens-height-challenged-in-lawsuit-against-abbott-laboratories,2023-05-16 13:44:12,"A New York City woman has reportedly sued Abbott Laboratories ABT, accusing them of misleading consumers into believing its PediaSure nutrition drinks were ""clinically proven"" to increase children's height.",ABT,0.578355,0.007197,Neutral
Abbott's  ( ABT )  New Pact to Advance Clinical Trials Diversity,https://www.zacks.com/stock/news/2095454/abbotts-abt-new-pact-to-advance-clinical-trials-diversity,2023-05-15 17:10:00,"Abbott's (ABT) latest additions to Diversity in Clinical Trials effort expand upon the alliances, awards and the emphasis on diverse participation in its own clinical trials.",ABT,0.142284,0.178906,Somewhat-Bullish
A Look Into Abbott Laboratories Inc's Price Over Earnings - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/23/05/32392578/a-look-into-abbott-laboratories-incs-price-over-earnings,2023-05-15 13:03:24,"In the current market session, Abbott Laboratories Inc. ABT share price is at $110.46, after a 0.03% decrease. Over the past month, the stock increased by 6.63%, but over the past year, it actually decreased by 3.30%.",ABT,0.333257,0.074789,Neutral
Don't blame China for monopolies that threaten economic security,https://www.scmp.com/comment/opinion/article/3220496/dont-blame-china-monopolies-threaten-economic-security,2023-05-14 19:30:16,"While some concerns about the state of the world's supply chains are driven by paranoia, others are legitimate and must be addressed. Rather than blame China, countries in the West should examine the deregulation and weak enforcement of antitrust laws which allowed monopolies to emerge.",ABT,0.04028,-0.01766,Neutral
ABT: Best Medical Stock Investors Should Buy in a Recession,https://stocknews.com/news/abt-snn-utmd-zbh-best-medical-stock-investors-should-buy-in-a-recession/,2023-05-12 18:23:47,"Inflation remains way above the Fed's 2% target despite cooling down. Moreover, although the central bank has indicated a rate hike pause, a cut is not in sight. Amid this, the stable demand for healthcare products should help fundamentally sound medical stock Abbott Laboratories ( ABT ) perform ...",ABT,0.666827,0.370074,Bullish
"NeuroBo Pharmaceuticals, Inc. Appoints Pharmaceutical Industry Executive, Mark A. Glickman, to its Board of Directors",https://www.prnewswire.com/news-releases/neurobo-pharmaceuticals-inc-appoints-pharmaceutical-industry-executive-mark-a-glickman-to-its-board-of-directors-301823219.html,2023-05-12 12:00:00,"NeuroBo Pharmaceuticals, Inc. Appoints Pharmaceutical Industry ... PR ...",ABT,0.040212,-0.016555,Neutral
"GOP law cut Big Pharma tax rates by 40%, Senate report says",https://www.cnbc.com/2023/05/11/gop-law-cut-big-pharma-tax-rates-by-40percent-senate-report-says.html,2023-05-11 17:07:41,Senate Finance Committee Democrats said the Republican bill resulted in billion of dollars in tax savings for pharmaceutical companies.,ABT,0.078354,0.0,Neutral
Abbott  ( ABT )  Reports Upbeat Cardiomems Sensor Study Result,https://www.zacks.com/stock/news/2101442/abbott-abt-reports-upbeat-cardiomems-sensor-study-result,2023-05-30 13:39:00,"Abbott's (ABT) MONITOR-HF is the third randomized, controlled trial that will provide significant health benefits to indicated heart failure patients.",ABT,0.094576,0.113359,Neutral
Lancets Market worth $3.6 billion | MarketsandMarkets,https://www.prnewswire.com/news-releases/lancets-market-worth-3-6-billion--marketsandmarkets-301836379.html,2023-05-29 17:00:00,"CHICAGO, May 29, 2023 /PRNewswire/ -- The lancets industry is poised for significant growth and innovation in the near future. Lancets, which are small, pricking devices used for blood sampling, play a crucial role in various healthcare settings, including home-based testing, diagnostics, and ...",ABT,0.021504,-0.078844,Neutral
"Blood Glucose Monitoring Devices Market to grow by USD 7,488.81 million during 2023-2027; The rising global burden of diabetes to drive the market growth - Technavio",https://www.prnewswire.com/news-releases/blood-glucose-monitoring-devices-market-to-grow-by-usd-7-488-81-million-during-2023-2027-the-rising-global-burden-of-diabetes-to-drive-the-market-growth---technavio-301835790.html,2023-05-29 16:45:00,"Blood Glucose Monitoring Devices Market to grow by USD 7,488.81 ... PR ...",ABT,0.036926,0.047631,Neutral
Pain Relief Therapeutics Market to Grow Significantly by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/pain-relief-therapeutics-market-to-grow-significantly-by-2029--brandessence-market-research-301836608.html,2023-05-29 15:15:00,Pain Relief Therapeutics Market to Grow Significantly by 2029 ... PR ...,ABT,0.023487,0.099264,Neutral
Should You Invest in the iShares U.S. Medical Devices ETF  ( IHI ) ?,https://www.zacks.com/stock/news/2100033/should-you-invest-in-the-ishares-us-medical-devices-etf-ihi,2023-05-26 10:20:04,Sector ETF report for IHI ...,ABT,0.132733,0.070997,Neutral
Abed Abdo Joins Organic Valley as Chief Financial Officer,https://www.prnewswire.com/news-releases/abed-abdo-joins-organic-valley-as-chief-financial-officer-301833986.html,2023-05-25 19:23:00,"Abdo brings two-decade financial leadership tenure and passion for sustainable agriculture and mission-driven organizations to the farmer-owned cooperative. LA FARGE, Wis., May 25, 2023 /PRNewswire/ -- Organic Valley proudly welcomes Abed Abdo as the farmer-owned cooperative's new Chief Financial ...",ABT,0.085324,0.108693,Neutral
2 Dividend Kings on Sale That Are Yielding More Than 4%,https://www.fool.com/investing/2023/05/25/2-dividend-kingsthat-are-yielding-more-than-4/,2023-05-25 13:37:00,"Before you rush out to buy these stocks, you should consider the risks that come with them.",ABT,0.059935,0.038996,Neutral
2 Top Dividend Kings to Buy for the Long Haul,https://www.fool.com/investing/2023/05/25/2-top-dividend-kings-to-buy-for-the-long-haul/,2023-05-25 13:00:00,Dividend stocks are an easy way to earn passive income.,ABT,0.051441,0.096477,Neutral
"Spring 2023 Layoff Tracker: Meta, First Citizens Bank Axe Hundreds Of Jobs",https://www.forbes.com/sites/brianbushard/2023/05/24/spring-2023-layoff-tracker-meta-first-citizens-bank-axe-hundreds-of-jobs/,2023-05-24 16:51:39,"More than 136,000 employees were laid off by major U.S. companies in the first quarter of 2023.",ABT,0.163909,-0.349865,Somewhat-Bearish
Hemostasis Diagnostics Market to Grow Significantly by 2029- Brandessence Market Research,https://www.prnewswire.com/news-releases/hemostasis-diagnostics-market-to-grow-significantly-by-2029--brandessence-market-research-301833482.html,2023-05-24 14:20:00,Hemostasis Diagnostics Market to Grow Significantly by 2029 ... PR ...,ABT,0.019474,0.085922,Neutral
"Top Stories Wednesday, May 24: Nvidia Chief Flags Dangers To US Chips Act, Disney, Shell, Gucci Allegedly Used Worthless Carbon Credits, Microsoft's Daring Attempt to Outshine Google In Search Game - Alibaba Group Holding  ( NYSE:BABA ) , Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/news/earnings/23/05/32551791/nvidia-chief-flags-dangers-to-us-chips-act-disney-shell-gucci-allegedly-used-worthless-carbon-credi,2023-05-24 13:37:02,"David Antonioli, the CEO of Verra, a Washington-based non-profit, the world's largest carbon credit certifier, has resigned following allegations that the organization approved millions of worthless offsets used by major companies, impacting the climate.",ABT,0.065416,-0.05385,Neutral
Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/large-cap/23/05/32549547/is-there-collusion-in-the-baby-formula-industry-ftc-scrutinizes-state-contracts-bidding-process,2023-05-24 12:39:45,The Federal Trade Commission's ( FTC ) investigation concerns potential collusion among baby-formula manufacturers as it examines whether companies like Abbott Laboratories ABT and other formula manufacturers have engaged in collusion or coordination while bidding for state contracts.,ABT,0.445569,-0.139861,Neutral
FTC probing baby-formula makers for collusion: report,https://www.foxbusiness.com/markets/ftc-probing-baby-formula-makers-collusion-report,2023-05-24 07:28:20,The Federal Trade Commission is looking into whether baby-formula makers colluded on bids for lucrative state contracts.,ABT,0.097457,-0.007534,Neutral
"Abbott, other formula makers face FTC investigation for collusion - WSJ",https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-other-formula-makers-face-ftc-investigation-collusion-wsj-2023-05-24/,2023-05-24 04:37:00,"Abbott, other formula makers face FTC investigation for collusion ... ...",ABT,0.421485,-0.020028,Neutral
"Abbott's Baby Formula Brouhaha: Judge Says No Harm, No Foul in Contamination Controversy - Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/news/large-cap/23/05/32530497/abbotts-baby-formula-brouhaha-judge-says-no-harm-no-foul-in-contamination-controversy,2023-05-23 16:36:58,"U.S. District Judge Matthew Kennelly in Chicago dismissed claims by parents pursuing only ""economic loss"" claims related to Abbott Laboratories ABT Similac and other formulas that they said had a ""substantial risk"" of bacteria contamination.",ABT,0.454174,-0.192127,Somewhat-Bearish
Looking At Abbott Laboratories's Recent Unusual Options Activity - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/markets/options/23/05/32535055/looking-at-abbott-laboratoriess-recent-unusual-options-activity,2023-05-23 16:16:39,A whale with a lot of money to spend has taken a noticeably bullish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories ABT we detected 12 strange trades.,ABT,0.802374,0.416791,Bullish
Sight Sciences Announces Addition of New Director Catherine Mazzacco - Sight Sciences  ( NASDAQ:SGHT ) ,https://www.benzinga.com/pressreleases/23/06/g32802632/sight-sciences-announces-addition-of-new-director-catherine-mazzacco,2023-06-09 20:05:00,"MENLO PARK, Calif., June 09, 2023 ( GLOBE NEWSWIRE ) -- Sight Sciences, Inc.",ABT,0.056275,-0.010994,Neutral
Sight Sciences Announces Addition of New Director Catherine Mazzacco,https://www.globenewswire.com/news-release/2023/06/09/2685798/0/en/Sight-Sciences-Announces-Addition-of-New-Director-Catherine-Mazzacco.html,2023-06-09 20:05:00,"MENLO PARK, Calif., June 09, 2023 ( GLOBE NEWSWIRE ) -- Sight Sciences, Inc. ( Nasdaq: SGHT ) ( ""Sight Sciences"" or the ""Company"" ) , an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients' lives, today announces that Catherine ...",ABT,0.035608,-0.010481,Neutral
"Global Contact Lenses Marketplace 2023-2028: Soft Contact Lenses Continue to Dominate, Silicone Hydrogel  ( SiHy )  Lenses Projected to Increase in Popularity",https://www.prnewswire.com/news-releases/global-contact-lenses-marketplace-2023-2028-soft-contact-lenses-continue-to-dominate-silicone-hydrogel-sihy-lenses-projected-to-increase-in-popularity-301847074.html,2023-06-09 18:45:00,Global Contact Lenses Marketplace 2023-2028: Soft Contact ... PR ...,ABT,0.04912,0.159491,Somewhat-Bullish
"Top Stock Reports for Procter & Gamble, Bank of America & Abbott Laboratories",https://www.zacks.com/research-daily/2105794/top-stock-reports-for-procter-gamble-bank-of-america-abbott-laboratories,2023-06-08 15:49:00,"Today's Research Daily features new research reports on 16 major stocks, including The Procter & Gamble Company (PG), Bank of America Corporation (BAC) and Abbott Laboratories (ABT).",ABT,0.261117,0.206582,Somewhat-Bullish
"Lateral Flow Assays Market Growth Report - Reach $12.18 Billion, Globally, by 2028 with 6.7% CAGR Lead by Multiplex Detection Assays Segment During 2023-2028 | The Insight Partners",https://www.benzinga.com/pressreleases/23/06/g32779525/lateral-flow-assays-market-growth-report-reach-12-18-billion-globally-by-2028-with-6-7-cagr-lead-b,2023-06-08 14:08:35,"Pune, India, June 08, 2023 ( GLOBE NEWSWIRE ) -- The Insight Partners published latest research study on ""Lateral Flow Assays Market Growth Report, Size, Share, Revenue, Strategy, Industry Trends and Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type, Application, Technology, ...",ABT,0.029149,0.110904,Neutral
"Cancer Diagnostics Market Size is projected to reach USD 323.97 billion by 2030, growing at a CAGR of 7%: Straits Research",https://www.benzinga.com/pressreleases/23/06/g32761380/cancer-diagnostics-market-size-is-projected-to-reach-usd-323-97-billion-by-2030-growing-at-a-cagr-,2023-06-07 15:20:00,"New York, United States, June 07, 2023 ( GLOBE NEWSWIRE ) -- Cancer diagnostics is the process of identifying biomarkers, proteins, and other indicators that assist in identifying a cancerous tumor.",ABT,0.029363,-0.067011,Neutral
"Family Control Takes Bite Out Of Modern Dental Group - Abbott Laboratories  ( NYSE:ABT ) , Medtronic  ( NYSE:MDT ) ",https://www.benzinga.com/23/06/32758370/family-control-takes-bite-out-of-modern-dental-group,2023-06-07 13:39:23,"Modern Dental Group's revenue rose to HK$788.2 million in the first three months of the year, led by strong growth in Europe and China Revenue for the global provider of high-tech dental products and services rose 30% in Europe and 24% in Greater China",ABT,0.064973,-0.018126,Neutral
Looking At Abbott Laboratories's Recent Unusual Options Activity - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/markets/options/23/06/32748024/looking-at-abbott-laboratoriess-recent-unusual-options-activity,2023-06-06 20:46:40,A whale with a lot of money to spend has taken a noticeably bearish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories ABT we detected 11 strange trades.,ABT,0.718897,0.057628,Neutral
2 Dividend Kings Down 12% and 14% You'll Regret Not Buying on The Dip,https://www.fool.com/investing/2023/06/04/2-dividend-kings-down-youll-regret-not-buying/,2023-06-04 14:15:00,Recent troubles won't stop these companies' long-term trajectories.,ABT,0.208914,0.162308,Somewhat-Bullish
Mark Cuban Helping Lower Cost Of Bestselling Humira With Cost Plus Drug Company: 'The Game Just Changed',https://markets.businessinsider.com/news/stocks/mark-cuban-helping-lower-cost-of-bestselling-humira-with-cost-plus-drug-company-the-game-just-changed-1032365572,2023-06-01 18:13:51,"One of the bestselling medical drugs of all time has come off patent. The result could mean lower costs for those who need the drug as a treatment option. Enter Mark Cuban and his Cost Plus Drug Company, which announced a new initiative Thursday.",ABT,0.053271,0.135681,Neutral
"Drugs of Abuse  ( DOA )  Testing Market Size, Share And Growth Analysis For 2023-2032 As Per The Business Research Company's Drugs Of Abuse  ( DOA )  Testing Global Market Report 2023",https://www.benzinga.com/pressreleases/23/06/g32913436/drugs-of-abuse-doa-testing-market-size-share-and-growth-analysis-for-2023-2032-as-per-the-business,2023-06-19 15:40:00,"LONDON, June 19, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's drugs of abuse ( DOA ) testing Market Report 2023, the market will grow from $6 billion in 2022 to $6.6 billion in 2023, at a compound annual growth rate ( CAGR ) of more than 10%.",ABT,0.05654,-0.288008,Somewhat-Bearish
2 Healthcare Stocks That Could Help Set You Up for Life,https://www.fool.com/investing/2023/06/19/healthcare-stocks-could-help-set-you-up-for-life/,2023-06-19 11:30:00,Healthcare is a critically important economic sector.,ABT,0.067919,0.098273,Neutral
Here's How Much $1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth Today - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/earnings/23/06/32901609/heres-how-much-1000-invested-in-abbott-laboratories-10-years-ago-would-be-worth-today,2023-06-16 21:01:01,"Abbott Laboratories ABT has outperformed the market over the past 10 years by 1.01% on an annualized basis producing an average annual return of 11.69%. Currently, Abbott Laboratories has a market capitalization of $184.68 billion.",ABT,0.980595,0.386944,Bullish
Dietary Supplements Market size to grow by USD 61.4 billion from 2023 to 2027: Increasing adoption of healthy eating habits to Boost the market growth - Technavio,https://www.prnewswire.com/news-releases/dietary-supplements-market-size-to-grow-by-usd-61-4-billion-from-2023-to-2027-increasing-adoption-of-healthy-eating-habits-to-boost-the-market-growth---technavio-301852668.html,2023-06-16 14:30:00,Dietary Supplements Market size to grow by USD 61.4 billion from 2023 to 2027: Increasing adoption of healthy eating ... PR ...,ABT,0.025761,0.00673,Neutral
Second Time May Be a Charm: Analyst Is Bullish As Surmodics Resubmits SurVeil DCB Application - Surmodics  ( NASDAQ:SRDX ) ,https://www.benzinga.com/news/23/06/32841319/second-time-may-be-a-charm-analyst-is-bullish-as-surmodics-resubmits-surveil-dcb-application,2023-06-13 18:40:12,"In an investor presentation, Surmodics Inc SRDX said it submitted its amended SurVeil drug-coated balloon premarket approval ( PMA ) application in May - with no new testing required.",ABT,0.31282,0.156665,Somewhat-Bullish
Why Shares of Surmodics Soared on Tuesday,https://www.fool.com/investing/2023/06/13/why-shares-of-surmodics-soared-on-tuesday/,2023-06-13 17:11:25,An analyst upgrade gave the stock a boost.,ABT,0.143415,0.256618,Somewhat-Bullish
"Abbott  ( ABT )  EPD Sales Gain Traction, Margin Pressure Lingers",https://www.zacks.com/stock/news/2107112/abbott-abt-epd-sales-gain-traction-margin-pressure-lingers,2023-06-12 15:25:00,"Abbott (ABT) continues to make good progress in Nutrition, increasing manufacturing production and recovering market share in this business.",ABT,0.152499,0.121741,Neutral
Better Long-Term Buy: AbbVie or Novo Nordisk?,https://www.fool.com/investing/2023/06/10/better-long-term-buy-abbvie-or-novo-nordisk/,2023-06-10 12:05:00,It's important to factor in a pharmaceutical company's pipeline depth.,ABT,0.049526,0.029831,Neutral
3 Dividend Kings Yielding Royal Sums,https://www.zacks.com/commentary/2114999/3-dividend-kings-yielding-royal-sums,2023-06-29 21:15:00,Dividend Kings are stocks that have raised their dividends for at least 50 consecutive years ...,ABT,0.050572,0.039631,Neutral
"Cardiac Biomarkers Testing Market Analysis 2023-2027: Estimated Market Size, Lucrative Segments And Key Trends As Per The Business Research Company's Cardiac Biomarkers Testing Global Market Report 2023",https://www.benzinga.com/pressreleases/23/06/g33062156/cardiac-biomarkers-testing-market-analysis-2023-2027-estimated-market-size-lucrative-segments-and-,2023-06-29 15:30:00,"LONDON, June 29, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's research on the cardiac biomarkers testing market forecasts the global cardiac biomarkers testing market size to grow from $10.8 billion in 2022 to $12.1 billion in 2023 at a compound annual growth rate ( CAGR ) of more ...",ABT,0.053509,0.0,Neutral
"Artificial Organ Market Overview 2023-2027: Market Size, Key Trends, And Top Segments As Per The Business Research Company's Artificial Organ Global Market Report 2023",https://www.benzinga.com/pressreleases/23/06/g33062157/artificial-organ-market-overview-2023-2027-market-size-key-trends-and-top-segments-as-per-the-busi,2023-06-29 15:30:00,"LONDON, June 29, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's report on the artificial organ market forecasts the global artificial organ market size is expected to grow from $20.3 billion in 2022 to $22.2 billion in 2023 at a compound annual growth rate ( CAGR ) of more than 9%.",ABT,0.053035,0.275868,Somewhat-Bullish
5 High-Yielding Dividend Stocks That Are Bargain Buys,https://www.fool.com/investing/2023/06/29/5-high-yielding-dividend-stocks-that-are-bargain/,2023-06-29 14:00:00,This is a good time for investors to load up on healthcare companies.,ABT,0.042496,0.104615,Neutral
GE HealthCare's Solid Demand And Sensible Margin Targets: Morgan Stanley Sees Potential Upside Despite Street's High Expectations - GE HealthCare Techs  ( NASDAQ:GEHC ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/06/33030575/ge-healthcares-solid-demand-and-sensible-margin-targets-morgan-stanley-sees-potenti,2023-06-27 18:25:15,Morgan Stanley analyst Patrick Wood initiated coverage on GE HealthCare Technologies Inc GEHC with an Equal-Weight rating and a price target of $76.,ABT,0.245339,0.113125,Neutral
Abbott  ( ABT )  EPD Sales Aid Growth Amid Currency Headwind,https://www.zacks.com/stock/news/2113772/abbott-abt-epd-sales-aid-growth-amid-currency-headwind,2023-06-27 16:28:00,"Abbott (ABT) continues to make good progress, increasing manufacturing production and recovering market share in the Nutrition business.",ABT,0.139265,0.113098,Neutral
"Prenatal Vitamin Supplements Market 2023-2027|CAGR accelerating at 8.12% by 2027|Segmentation by Distribution channel, Form factor and Geography|Technavio",https://www.prnewswire.com/news-releases/prenatal-vitamin-supplements-market-2023-2027cagr-accelerating-at-8-12-by-2027segmentation-by-distribution-channel-form-factor-and-geographytechnavio-301864129.html,2023-06-27 15:00:00,Prenatal Vitamin Supplements Market 2023-2027|CAGR accelerating at 8.12% by 2027|Segmentation by Distribution ... PR ...,ABT,0.04028,0.089483,Neutral
Here's Why Investors Should Retain Abbott  ( ABT )  Stock Now,https://www.zacks.com/stock/news/2113211/heres-why-investors-should-retain-abbott-abt-stock-now,2023-06-26 16:30:00,Investors are optimistic about Abbott (ABT) on continued growth in Diabetes business and upbeat guidance.,ABT,0.100941,0.163658,Somewhat-Bullish
uniQure Announces Leadership Addition to Support Advancement of Clinical Programs - uniQure  ( NASDAQ:QURE ) ,https://www.benzinga.com/pressreleases/23/06/g33002867/uniqure-announces-leadership-addition-to-support-advancement-of-clinical-programs,2023-06-26 11:11:42,"LEXINGTON, Mass. and AMSTERDAM, June 26, 2023 ( GLOBE NEWSWIRE ) -- uniQure N.V. QURE, a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the appointment of Walid Abi-Saab, M.D., as Chief Medical Officer, effective immediately.",ABT,0.036091,0.024952,Neutral
uniQure Announces Leadership Addition to Support Advancement of Clinical Programs,https://www.globenewswire.com/news-release/2023/06/26/2694317/0/en/uniQure-Announces-Leadership-Addition-to-Support-Advancement-of-Clinical-Programs.html,2023-06-26 11:11:00,"~ Walid Abi-Saab, M.D., appointed Chief Medical Officer, will bring extensive track record in leading drug development and execution ~ ~ Walid Abi-Saab, M.D., appointed Chief Medical Officer, will bring extensive track record in leading drug development and execution ...",ABT,0.036532,0.025962,Neutral
Our early-adopters index examines how corporate America is deploying AI,https://www.economist.com/business/2023/06/25/our-early-adopters-index-examines-how-corporate-america-is-deploying-ai,2023-06-25 18:49:27,"T are having a bumper year. Despite a recent wobble, the share price of the Big Five-Alphabet, Amazon, Apple, Meta and Microsoft-has jumped by 60% since January, when measured in an equally weighted basket ( see chart 1 ) . The price of shares in one big chipmaker, Nvidia, has tripled and in ...",ABT,0.022347,0.068325,Neutral
Top 2% Dexcom Bolsters 2025 Outlook On 'Rapidly' Expanding Market,https://www.investors.com/news/technology/dexcom-stock-the-bullish-2025-call-that-could-send-shares-soaring/,2023-06-24 00:15:00,Dexcom Stock: The Bullish 2025 Call That Could Send Shares ... Investor's Business Daily ...,ABT,0.120733,0.150139,Somewhat-Bullish
$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/earnings/23/06/32994108/100-invested-in-abbott-laboratories-10-years-ago-would-be-worth-this-much-today,2023-06-23 21:32:17,"Abbott Laboratories ABT has outperformed the market over the past 10 years by 1.42% on an annualized basis producing an average annual return of 11.82%. Currently, Abbott Laboratories has a market capitalization of $187.89 billion.",ABT,0.980595,0.386944,Bullish
Best Healthcare Stocks To Beat Inflation,https://www.forbes.com/sites/investor-hub/article/best-healthcare-stocks-to-beat-inflation/,2023-06-23 19:50:02,"When your investment portfolio faces inflation, one of the approaches you can take to minimize the impact is to have companies whose value can stand up. Here are 9 healthcare stocks to consider adding to your portfolio.",ABT,0.045786,0.066746,Neutral
Abbott  ( ABT )  FreeStyle Libre 2 Gets Reimbursement in France,https://www.zacks.com/stock/news/2112562/abbott-abt-freestyle-libre-2-gets-reimbursement-in-france,2023-06-23 16:28:00,Abbott's (ABT) FreeStyle Libre increased reimbursement makes it possible for more people in France with diabetes to use the recent CGM technology.,ABT,0.096091,0.046723,Neutral
Why Shares of Surmodics Jumped This Week,https://www.fool.com/investing/2023/06/23/why-shares-of-surmodics-jumped-this-week/,2023-06-23 14:27:12,The company gained FDA marketing approval for a drug-coated balloon that will help clear blocked arteries.,ABT,0.13459,-0.014489,Neutral
The Sports Nutrition Market size is to grow at a CAGR of 7.84% from 2022 to 2027; The rising number of health clubs and fitness centers to boost the market growth - Technavio,https://www.prnewswire.com/news-releases/the-sports-nutrition-market-size-is-to-grow-at-a-cagr-of-7-84-from-2022-to-2027-the-rising-number-of-health-clubs-and-fitness-centers-to-boost-the-market-growth---technavio-301858304.html,2023-06-23 04:15:00,The Sports Nutrition Market size is to grow at a CAGR of 7.84% from 2022 to 2027. The rising number of health clubs ... PR ...,ABT,0.06171,0.109108,Neutral
2 AI Stocks to Buy Before They Skyrocket,https://www.fool.com/investing/2023/06/21/2-ai-stocks-to-buy-before-they-skyrocket/,2023-06-21 11:15:00,Intuitive Surgical and Lemonade stand to benefit dramatically from breakthroughs in AI technologies.,ABT,0.044469,0.046696,Neutral
Surmodics  ( SRDX )  Rallies on FDA Approval for SurVeil DCB,https://www.zacks.com/stock/news/2111023/surmodics-srdx-rallies-on-fda-approval-for-surveil-dcb,2023-06-21 10:10:00,"Surmodics' (SRDX) SurVeil DCB is indicated to treat percutaneous transluminal angioplasty in peripheral artery disease patients. Abbott will initiate commercialization of SurVeil DCB, per a deal with Surmodics.",ABT,0.123951,0.185478,Somewhat-Bullish
Looking At Abbott Laboratories's Recent Unusual Options Activity - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/markets/options/23/06/32934872/looking-at-abbott-laboratoriess-recent-unusual-options-activity,2023-06-20 20:16:27,A whale with a lot of money to spend has taken a noticeably bearish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories ABT we detected 13 strange trades.,ABT,0.716023,0.057527,Neutral
"After FDA Rejection, Surmodics' SurVeil Drug-Coated Balloon Scores FDA Approval - Surmodics  ( NASDAQ:SRDX ) ",https://www.benzinga.com/news/23/06/32923892/after-fda-rejection-surmodics-surveil-drug-coated-balloon-scores-fda-approval,2023-06-20 13:54:53,"The FDA has approved Surmodics Inc's SRDX SurVeil drug-coated balloon ( DCB ) , a next-generation device for peripheral artery disease.",ABT,0.345674,0.393719,Bullish
3 Passive Income Stocks to Hold for the Next 20 Years,https://www.fool.com/investing/2023/06/20/3-passive-income-stocks-to-hold-for-the-next-20/,2023-06-20 13:53:00,These three stocks are likely to keep increasing their dividends over years or even decades.,ABT,0.085629,0.069682,Neutral
"Wall St Week Ahead As earnings loom, investors weigh recession resilience",https://www.reuters.com/markets/us/wall-st-week-ahead-earnings-loom-investors-weigh-recession-resilience-2023-07-07/,2023-07-07 18:33:00,"NEW YORK, July 7 ( Reuters ) - As second-quarter earnings approach, investors are looking at beaten-down sectors which might gain ground regardless of whether the U.S. economy falls into recession this year.",ABT,0.051999,0.061989,Neutral
Global 2000 List 2023: The Top 200,https://www.forbes.com/sites/forbesstaff/2023/07/07/forbes-global-2000-list-2023-the-top-200/,2023-07-07 15:45:31,"Two years after the start of the pandemic, Covid casualties like airlines and oil producers have reclaimed top spots among the largest companies in the world.",ABT,0.010247,0.171113,Somewhat-Bullish
Why Dividend Stocks Should Be a Key Part of Your Retirement Plan,https://www.fool.com/investing/2023/07/07/dividend-stocks-should-be-part-of-your-retirement/,2023-07-07 11:15:00,You can collect the dividend income while keeping your original investment intact.,ABT,0.056808,-0.041938,Neutral
"Global Lactose Intolerance Treatment Market Forecast 2023-2032 - Market Size, Drivers, Trends, And Competitors As Per The Business Research Company's Lactose Intolerance Treatment Global Market Report 2023",https://www.benzinga.com/pressreleases/23/07/g33135424/global-lactose-intolerance-treatment-market-forecast-2023-2032-market-size-drivers-trends-and-comp,2023-07-06 15:30:00,"LONDON, July 06, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Lactose Intolerance Treatment Global Market Report 2023, the market will grow from $28.3 billion in 2022 to $30.3 billion in 2023, with a compound annual growth rate ( CAGR ) of more than 7%.",ABT,0.051221,-0.053597,Neutral
"France $3.39 Bn Diabetes Markets to 2028: Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis",https://www.prnewswire.com/news-releases/france-3-39-bn-diabetes-markets-to-2028-insulin-pump-cgm-self-monitoring-blood-device-and-company-analysis-301870998.html,2023-07-06 15:30:00,"DUBLIN, July 6, 2023 /PRNewswire/ -- The ""France Diabetes Market, Size, Forecast 2023-2028, By Insulin Pump, CGM, Self-Monitoring Blood Device and Company Analysis"" report has been added to ResearchAndMarkets.com's offering.",ABT,0.038969,-0.078115,Neutral
2 Best Biotech Stocks to Buy in July,https://www.fool.com/investing/2023/07/06/2-best-biotech-stocks-to-buy-in-july/,2023-07-06 14:00:00,These are two of the largest pharmaceutical companies on the planet.,ABT,0.132004,0.222046,Somewhat-Bullish
"Abbott Scores FDA Nod For First Dual-Chamber Leadless Pacemaker To Treat Abnormal, Slow Heart Rhythms - Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/news/large-cap/23/07/33115992/abbott-scores-fda-nod-for-first-dual-chamber-leadless-pacemaker-to-treat-abnormal-slow-heart-rhyth,2023-07-05 16:34:58,"The FDA has approved Abbott Laboratories' ABT AVEIR dual chamber ( DR ) leadless pacemaker system, the world's first dual chamber leadless pacing system to treat abnormal or slow heart rhythms.",ABT,0.362505,0.320842,Somewhat-Bullish
Abbott's Minimally Invasive Dual Chamber Leadless Pacemaker System Gets FDA Approval,https://markets.businessinsider.com/news/stocks/abbott-s-minimally-invasive-dual-chamber-leadless-pacemaker-system-gets-fda-approval-1032427658,2023-07-05 13:46:15,"( RTTNews ) - Abbott Laboratories ( ABT ) a biopharmaceutical major, announced on Wednesday that it has received FDA approval for its dual chamber ( DR ) leadless pacemaker system dubbed AVEIR.",ABT,0.363388,0.278749,Somewhat-Bullish
Pericardial Patches Market Size to Cross USD 604 million by 2031 growing at a 6.8%: TMR Report,https://www.benzinga.com/pressreleases/23/07/g33108898/pericardial-patches-market-size-to-cross-usd-604-million-by-2031-growing-at-a-6-8-tmr-report,2023-07-04 16:30:00,"Wilmington, Delaware, United States, July 04, 2023 ( GLOBE NEWSWIRE ) -- The global pericardial patches market is anticipated to grow at a 6.8% CAGR from 2023 to 2031. A market valuation of US$ 604 million is expected by the end of the forecast period.",ABT,0.040212,0.029616,Neutral
 ( ABT )  - Analyzing Abbott Laboratories's Short Interest - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/short-sellers/23/07/33100156/abt-analyzing-abbott-laboratoriess-short-interest,2023-07-03 17:46:10,"Abbott Laboratories's ABT short percent of float has fallen 12.82% since its last report. The company recently reported that it has 11.82 million shares sold short, which is 0.68% of all regular shares that are available for trading.",ABT,0.221819,0.083071,Neutral
Molecular Diagnostics Market worth $28.6 billion | MarketsandMarkets,https://www.prnewswire.com/news-releases/molecular-diagnostics-market-worth-28-6-billion--marketsandmarkets-301868746.html,2023-07-03 15:15:00,"CHICAGO, July 3, 2023 /PRNewswire/ -- The molecular diagnostics industry is poised to undergo significant advancements in the near future, fueled by rapid technological innovation and increasing demand for personalized healthcare.",ABT,0.040246,-0.045329,Neutral
"Merck and AbbVie Are Facing Big Patent Cliffs, But Here's Why Both Are Still Buys",https://www.fool.com/investing/2023/07/03/merck-and-abbvie-are-facing-big-patent-cliffs-but/,2023-07-03 13:15:00,"Both companies are facing significant patent cliffs, but they've been preparing for this moment.",ABT,0.04882,0.156967,Somewhat-Bullish
5 Big Cap Earnings Charts to Watch This Week,https://www.zacks.com/stock/news/2123852/5-big-cap-earnings-charts-to-watch-this-week,2023-07-19 14:50:00,We are going to get a good look at the global economy.,ABT,0.48028,0.203573,Somewhat-Bullish
3 Ignored Dividends Growing 66%+  ( With Upside Ahead ) ,https://www.forbes.com/sites/brettowens/2023/07/19/3-ignored-dividends-growing-66-with-upside-ahead/,2023-07-19 14:35:00,A recession or more rate hikes in late 2023? We contrarian dividend investors don't care!,ABT,0.130041,-0.081212,Neutral
2 Medical Stocks to Buy as Earnings Approach,https://www.zacks.com/commentary/2123222/2-medical-stocks-to-buy-as-earnings-approach,2023-07-18 21:54:00,"Among the broader healthcare space, Abbott Laboratories (ABT) and Intuitive Surgical (ISRG) are two medical stocks that will highlight this week's earnings lineup.",ABT,0.591019,0.397412,Bullish
Here's Why You Should Add BD  ( BDX )  Stock in Your Portfolio,https://www.zacks.com/stock/news/2123156/heres-why-you-should-add-bd-bdx-stock-in-your-portfolio,2023-07-18 16:20:00,BD's (BDX) slew of product launches raises optimism about the stock.,ABT,0.109705,0.0,Neutral
Why Abbott  ( ABT )  Might Surprise This Earnings Season,https://www.zacks.com/stock/news/2122843/why-abbott-abt-might-surprise-this-earnings-season,2023-07-18 13:45:00,Abbott (ABT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.,ABT,0.817578,0.576767,Bullish
"In-vitro Diagnostics Market to grow at a CAGR of 6.89% from 2021 to 2026| Abbott Laboratories, Agilent Technologies Inc., ARKRAY Inc. and more to emerge as key players - Technavio",https://www.prnewswire.com/news-releases/in-vitro-diagnostics-market-to-grow-at-a-cagr-of-6-89--from-2021-to-2026-abbott-laboratories-agilent-technologies-inc-arkray-inc-and-more-to-emerge-as-key-players---technavio-301877804.html,2023-07-17 07:30:00,"In-vitro Diagnostics Market to grow at a CAGR of 6.89% from 2021 to 2026| Abbott Laboratories, Agilent Technologies ... PR ...",ABT,0.067441,0.065132,Neutral
They Lost Their Legs. Doctors and Health Care Giants Profited.,https://www.nytimes.com/2023/07/15/health/atherectomy-peripheral-artery-disease.html,2023-07-15 09:00:50,Medical device makers have bankrolled a cottage industry of doctors and clinics that perform artery-clearing procedures that can lead to amputations.,ABT,0.010517,0.103787,Neutral
"Weight Loss Supplement Market to grow by USD 2,066.13 million from 2022 to 2027 | Abbott Laboratories, Ajinomoto Co. Inc., Amway Corp., and more to emerge as key players- Technavio",https://www.prnewswire.com/news-releases/weight-loss-supplement-market-to-grow-by-usd-2-066-13-million-from-2022-to-2027--abbott-laboratories-ajinomoto-co-inc-amway-corp-and-more-to-emerge-as-key-players--technavio-301876882.html,2023-07-14 23:45:00,"Weight Loss Supplement Market to grow by USD 2,066.13 million from 2022 to 2027 | Abbott Laboratories, Ajinomoto ... PR ...",ABT,0.054175,0.104854,Neutral
"Investing Action Plan: Tesla, Netflix And Airlines Fly Into The Q2 Season",https://www.investors.com/research/investing-action-plan/stock-market-action-plan-tesla-netflix-and-airlines-fly-into-the-q2-earnings-season/,2023-07-14 21:54:00,"After a rousing week of stock market gains, earnings season is upon us. Analysts and companies have lowered their expectations for second-quarter earnings. Early rounds of reports, however, have shown investors briskly rewarding performances that top those low targets.",ABT,0.036615,-0.073412,Neutral
"S&P Makes Weekly Advance As Inflation Reaches Lowest Level Since March 2021; Amazon, Microsoft, Alphabet And Major Banks Lead Market Optimism - Netflix  ( NASDAQ:NFLX ) , Alphabet  ( NASDAQ:GOOG ) , Alphabet  ( NASDAQ:GOOGL ) , Interactive Brokers Gr  ( NASDAQ:IBKR ) , Citigroup  ( NYSE:C ) , SAP  ( NYSE:SAP ) , Bank of America  ( NYSE:BAC ) , JPMorgan Chase  ( NYSE:JPM ) , Morgan Stanley  ( NYSE:MS ) , Novartis  ( NYSE:NVS ) , Goldman Sachs Gr  ( NYSE:GS ) , ASML Holding  ( NASDAQ:ASML ) , Taiwan Semiconductor  ( NYSE:TSM ) , Microsoft  ( NASDAQ:MSFT ) , Lockheed Martin  ( NYSE:LMT ) , Tesla  ( NASDAQ:TSLA ) , IBM  ( NYSE:IBM ) , Wells Fargo  ( NYSE:WFC ) , Activision Blizzard  ( NASDAQ:ATVI ) , American Express  ( NYSE:AXP ) , Charles Schwab  ( NYSE:SCHW ) , Amazon.com  ( NASDAQ:AMZN ) ",https://www.benzinga.com/markets/equities/23/07/33235717/s-p-makes-weekly-advance-as-inflation-reaches-lowest-level-since-march-2021-amazon-microsoft-alp,2023-07-14 19:50:57,"The S&P 500 is closing the week in the green in light of positive inflation data. The index was 2.48% higher on the week ahead of the market close Friday. Other major market indexes also showed an upward trajectory, with the Dow Jones rising 2.36% on the week.",ABT,0.05234,0.0,Neutral
"Vaccine research market to grow at a CAGR of 9.88% from 2022 to 2027 | Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players- Technavio",https://www.prnewswire.com/news-releases/vaccine-research-market-to-grow-at-a-cagr-of-9-88-from-2022-to-2027--abbott-laboratories-astellas-pharma-inc-astrazeneca-plc-more-to-emerge-as-key-players--technavio-301876877.html,2023-07-14 11:01:00,"Vaccine research market to grow at a CAGR of 9.88% from 2022 to 2027 | Abbott Laboratories, Astellas Pharma Inc ... PR ...",ABT,0.068112,0.088244,Neutral
In Vitro Diagnostics Market to Grow Rapidly at a CAGR of 4.2% by 2030 | DataM Intelligence,https://www.benzinga.com/pressreleases/23/07/g33227633/in-vitro-diagnostics-market-to-grow-rapidly-at-a-cagr-of-4-2-by-2030-datam-intelligence,2023-07-14 09:00:00,"USA, New York, July 14, 2023 ( GLOBE NEWSWIRE ) -- The Global In Vitro Diagnostics Market reached USD 101.1 billion in 2022 and is expected to reach USD 139.7 billion by 2030 and is expected to grow with a CAGR of 4.2% during the forecast period 2023-2030.",ABT,0.053992,0.0,Neutral
"Point of Care Diagnostics Market to Grow by 10.65% from 2022 to 2027|Abbott Laboratories, altona Diagnostics GmbH, and more to emerge as key players -Technavio",https://www.prnewswire.com/news-releases/point-of-care-diagnostics-market-to-grow-by-10-65-from-2022-to-2027abbott-laboratories-altona-diagnostics-gmbh-and-more-to-emerge-as-key-players--technavio-301875838.html,2023-07-13 23:00:00,"Point of Care Diagnostics Market to Grow by 10.65% from 2022 to 2027|Abbott Laboratories, altona Diagnostics GmbH ... PR ...",ABT,0.063425,0.076032,Neutral
5 Stocks to Buy Ahead of Q2 Earnings Next Week,https://www.zacks.com/stock/news/2120358/5-stocks-to-buy-ahead-of-q2-earnings-next-week,2023-07-13 09:43:00,"We have narrowed our search to five companies that are set to declare second-quarter earnings results next week. These are: GPC, ABT, AN, SNA, PPG.",ABT,0.174272,0.348337,Somewhat-Bullish
What's in Store for Abbott Laboratories  ( ABT )  in Q2 Earnings?,https://www.zacks.com/stock/news/2120152/whats-in-store-for-abbott-laboratories-abt-in-q2-earnings,2023-07-12 16:07:00,The recent FDA approvals and growing customer demand for core therapeutic lines is likely to have driven Abbott's (ABT) Q2 performance.,ABT,0.142355,0.0,Neutral
Worried About U.S.-China Relations? Buy These 2 ETFs.,https://www.fool.com/investing/2023/07/12/worried-about-us-china-relations-buy-these-2-etfs/,2023-07-12 13:31:00,These funds focus on U.S.-based companies in relatively stable industries.,ABT,0.066047,0.032031,Neutral
AngioDynamics  ( ANGO )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2119339/angiodynamics-ango-to-report-q4-earnings-whats-in-the-cards,2023-07-11 15:52:00,AngioDynamics' (ANGO) fiscal fourth quarter's top line is likely to have been driven by strong demand for its products.,ABT,0.142005,0.076051,Neutral
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/earnings/23/07/33172399/heres-how-much-you-would-have-made-owning-abbott-laboratories-stock-in-the-last-10-years,2023-07-10 19:30:22,"Abbott Laboratories ABT has outperformed the market over the past 10 years by 1.48% on an annualized basis producing an average annual return of 11.59%. Currently, Abbott Laboratories has a market capitalization of $185.94 billion.",ABT,0.980595,0.386944,Bullish
Fractional Flow Reserve Devices Market to grow at a CAGR of 15.56% from 2022 to 2027|Increasing prevalence of CVDs is one of the key factors boosting the market growth- Technavio,https://www.prnewswire.com/news-releases/fractional-flow-reserve-devices-market-to-grow-at-a-cagr-of-15-56-from-2022-to-2027increasing-prevalence-of-cvds-is-one-of-the-key-factors-boosting-the-market-growth--technavio-301872020.html,2023-07-10 15:45:00,Fractional Flow Reserve Devices Market to grow at a CAGR of 15.56% from 2022 to 2027|Increasing prevalence of ... PR ...,ABT,0.03468,-0.120076,Neutral
"Immunodiagnostics Market size to grow by USD 22,669.75 million from 2022 to 2027|Increased demand for biomarker ... - PR Newswire",https://www.prnewswire.com/news-releases/immunodiagnostics-market-size-to-grow-by-usd-22-669-75-million-from-2022-to-2027increased-demand-for-biomarker-based-tests-boost-the-market---technavio-301887598.html,2023-07-28 23:00:00,"Immunodiagnostics Market size to grow by USD 22,669.75 million from 2022 to 2027|Increased demand for biomarker ... PR ...",ABT,0.067823,-0.036206,Neutral
"Integer Holdings  ( ITGR )  Q2 Earnings Top Estimates, FY23 View Up",https://www.zacks.com/stock/news/2129651/integer-holdings-itgr-q2-earnings-top-estimates-fy23-view-up,2023-07-28 17:39:00,"Integer Holdings' (ITGR) second-quarter results reflect robust Medical and Non-Medical Sales, besides strength in all the product lines.",ABT,0.074115,0.0,Neutral
"Amedisys  ( AMED )  Q2 Earnings Beat Estimates, Margins Dip",https://www.zacks.com/stock/news/2129610/amedisys-amed-q2-earnings-beat-estimates-margins-dip,2023-07-28 15:47:00,Strength in Hugh Acuity Care segment and Hospice division drive Amedisys (AMED) Q2 performance.,ABT,0.096866,0.0,Neutral
"Integra's  ( IART )  Q2 Earnings Top Estimates, 2023 View Cut",https://www.zacks.com/stock/news/2129597/integras-iart-q2-earnings-top-estimates-2023-view-cut,2023-07-28 15:12:00,"In CSS, Integra (IART) registers strong growth owing to high single-digit growth in Advanced Energy and mid-single-digit growth in CSF management during Q2.",ABT,0.082111,0.0,Neutral
"DexCom  ( DXCM )  Q2 Earnings Beat Estimates, Volumes Remain Strong",https://www.zacks.com/stock/news/2129448/dexcom-dxcm-q2-earnings-beat-estimates-volumes-remain-strong,2023-07-28 12:52:00,DexCom's (DXCM) second-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.,ABT,0.092748,0.0,Neutral
"Neogen  ( NEOG )  Q4 Earnings Beat Estimates, Gross Margin Up",https://www.zacks.com/stock/news/2129319/neogen-neog-q4-earnings-beat-estimates-gross-margin-up,2023-07-28 12:14:00,Neogen (NEOG) Q4 fiscal 2023 results reflect core growth in both operating segments despite softening market conditions.,ABT,0.081276,0.0,Neutral
Dietary supplements market to grow by 61.4 billion from 2022 to 2027 |The growing number of healthy eating habits to ... - PR Newswire,https://www.prnewswire.com/news-releases/dietary-supplements-market-to-grow-by-61-4-billion-from-2022-to-2027-the-growing-number-of-healthy-eating-habits-to-boost-the-market-growth---technavio-301886583.html,2023-07-28 04:15:00,Dietary supplements market to grow by 61.4 billion from 2022 to 2027 |The growing number of healthy eating habits to ... PR ...,ABT,0.051441,0.096806,Neutral
"Dexcom Earnings Tops Estimates, Medical Device Maker Hikes Outlook",https://www.investors.com/news/technology/dexcom-stock-dexcom-earnings-dexcom-stock-q22023/,2023-07-27 20:24:00,Dexcom ( DXCM ) reported June-quarter earnings and revenue that topped Wall Street targets. Shares of Dexcom stock rose as the company raised its outlook for the year. Dexcom said second-quarter profit doubled to 34 cents a share. Revenue climbed 25% to $871.3 million.,ABT,0.28387,0.161261,Somewhat-Bullish
"LabCorp  ( LH )  Q2 Earnings Miss Estimates, Margins Decline",https://www.zacks.com/stock/news/2128991/labcorp-lh-q2-earnings-miss-estimates-margins-decline,2023-07-27 17:00:00,"A rise in organic revenues, acquisitions, net of divestitures and foreign currency translation drive LabCorp's (LH) Q2 revenues.",ABT,0.083541,0.0,Neutral
"Edwards Lifesciences  ( EW )  Q2 Earnings Top Estimates, View Up",https://www.zacks.com/stock/news/2128980/edwards-lifesciences-ew-q2-earnings-top-estimates-view-up,2023-07-27 16:33:00,The growing adoption of the PASCAL Precision system in Europe and the United States and Edwards' premium products across all regions have driven Edwards Lifesciences' (EW) Q2 revenues.,ABT,0.077719,0.0,Neutral
"Boston Scientific  ( BSX )  Q2 Earnings Beat, Margins Improve",https://www.zacks.com/stock/news/2128921/boston-scientific-bsx-q2-earnings-beat-margins-improve,2023-07-27 15:53:00,Boston Scientific's (BSX) organic and operational revenues at its respective core business segments and geographies rise in the second quarter.,ABT,0.07423,0.0,Neutral
"CONMED  ( CNMD )  Beats on Q2 Earnings, Ups '23 EPS View",https://www.zacks.com/stock/news/2128899/conmed-cnmd-beats-on-q2-earnings-ups-23-eps-view,2023-07-27 14:33:00,CONMED's (CNMD) adjusted second-quarter earnings and sales recover from the disruption in the last two quarters due to implementation of a new warehouse management system.,ABT,0.090134,0.0,Neutral
"Baxter  ( BAX )  Beats on Q2 Earnings, Revises 2023 EPS Guidance",https://www.zacks.com/stock/news/2128871/baxter-bax-beats-on-q2-earnings-revises-2023-eps-guidance,2023-07-27 14:13:00,Baxter's (BAX) second-quarter 2023 results reflect sustained demand for its medically essential products amid a stabilizing macroeconomic climate and healthcare marketplace.,ABT,0.066414,0.0,Neutral
"West Pharmaceutical  ( WST )  Q2 Earnings Beat, HVP Drives Sales",https://www.zacks.com/stock/news/2128868/west-pharmaceutical-wst-q2-earnings-beat-hvp-drives-sales,2023-07-27 14:08:00,West Pharmaceutical's (WST) second-quarter results reflect a sustained recovery in non-COVID-19 demand amid dismal overall performance.,ABT,0.080458,0.0,Neutral
Johnson & Johnson's Inflection Point: What It Means For Investors - Johnson & Johnson  ( NYSE:JNJ ) ,https://www.benzinga.com/news/earnings/23/07/33408984/johnson-johnsons-inflection-point-what-it-means-for-investors,2023-07-27 13:15:59,"After three years of waiting, Johnson & Johnson JNJ shares have returned to trend, a monumental event for the market which presents a potential buying opportunity for income investors.",ABT,0.383905,0.3258,Somewhat-Bullish
"Chemed  ( CHE )  Q2 Earnings Miss Estimates, '23 EPS View Down",https://www.zacks.com/stock/news/2128627/chemed-che-q2-earnings-miss-estimates-23-eps-view-down,2023-07-27 12:23:00,"Chemed's (CHE) second-quarter 2023 performance reflects strength in the VITAS segment, while expenses weigh on margins.",ABT,0.083251,0.0,Neutral
"Chronic Pain Specialist Speaks At Panel On Stem Cell-Based Therapies And The Need For Spinal Care Reform - Insights From The Discussion - Abbott Laboratories  ( NYSE:ABT ) , BioRestorative Therapies  ( NASDAQ:BRTX ) ",https://www.benzinga.com/general/biotech/23/07/33417469/chronic-pain-specialist-speaks-at-panel-on-stem-cell-based-therapies-and-the-need-for-spinal-care,2023-07-27 12:05:32,"Chronic back pain is a significant issue in the United States, affecting millions of individuals annually. According to the National Institute of Neurological Disorders and Stroke, approximately 80% of adults will experience back pain at some point. BioRestorative Therapies Inc.",ABT,0.142565,-0.322125,Somewhat-Bearish
"Align Technology  ( ALGN )  Q2 Earnings Beat, Gross Margin Up",https://www.zacks.com/stock/news/2128589/align-technology-algn-q2-earnings-beat-gross-margin-up,2023-07-27 11:58:00,Align Technology (ALGN) delivers impressive earnings in the second quarter of 2023.,ABT,0.076236,0.0,Neutral
Boston Scientific lifts annual profit forecast on heart devices strength,https://www.reuters.com/business/healthcare-pharmaceuticals/boston-scientific-lifts-annual-profit-forecast-heart-devices-strength-2023-07-27/,2023-07-27 11:55:00,"July 27 ( Reuters ) - Boston Scientific ( BSX.N ) raised its annual profit forecast for a second straight quarter on Thursday, banking on resilient demand for its cardiovascular devices as surgical procedure volumes pick up pace.",ABT,0.140896,-0.034586,Neutral
The worst investment advice I know,https://www.marketwatch.com/story/the-worst-investment-advice-i-know-24e92700,2023-07-27 10:20:00,"This scenario works great for Wall Street, but turns out poorly for most investors ...",ABT,0.067727,0.194805,Somewhat-Bullish
Abbott Recalls Amplatzer Steerable Delivery Sheath On Risk Of Air Embolism - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/large-cap/23/07/33398033/abbott-recalls-amplatzer-steerable-delivery-sheath-on-risk-of-air-embolism,2023-07-26 18:20:45,Abbott Laboratories ABT is recalling the Amplatzer Steerable Delivery Sheath due to an increased risk for air bubbles ( air emboli ) to be introduced into patients who have procedures with this device.,ABT,0.433523,0.126751,Neutral
Merit Medical  ( MMSI )  Q2 Earnings & Revenues Beat Estimates,https://www.zacks.com/stock/news/2128089/merit-medical-mmsi-q2-earnings-revenues-beat-estimates,2023-07-26 16:07:00,Merit Medical (MMSI) benefits from revenue growth in both segments and all product categories within its Cardiovascular unit in the second quarter.,ABT,0.067252,0.0,Neutral
"Universal Health  ( UHS )  Q2 Earnings Beat, Boosts '23 EPS View",https://www.zacks.com/stock/news/2128140/universal-health-uhs-q2-earnings-beat-boosts-23-eps-view,2023-07-26 15:32:00,Universal Health's (UHS) Q2 results indicate improved patient admissions and solid segmental performance. Management currently expects adjusted EPS within $9.85-$10.50 for 2023.,ABT,0.152983,0.096074,Neutral
"Thermo Fisher  ( TMO )  Q2 Earnings Miss Estimates, Margins Down",https://www.zacks.com/stock/news/2128091/thermo-fisher-tmo-q2-earnings-miss-estimates-margins-down,2023-07-26 15:05:00,Challenging macroeconomic conditions and slowdown in activities in China impede Thermo Fisher's (TMO) Q2 revenues.,ABT,0.100518,0.0,Neutral
"Quest Diagnostics  ( DGX )  Q2 Earnings Beat Estimates, FY View Up",https://www.zacks.com/stock/news/2127978/quest-diagnostics-dgx-q2-earnings-beat-estimates-fy-view-up,2023-07-26 14:10:00,Quest Diagnostics (DGX) delivers better-than-expected earnings and revenues in the second quarter of 2023.,ABT,0.098862,0.0,Neutral
Should You Invest in the iShares U.S. Medical Devices ETF  ( IHI ) ?,https://www.zacks.com/stock/news/2127500/should-you-invest-in-the-ishares-us-medical-devices-etf-ihi,2023-07-26 10:20:07,Sector ETF report for IHI ...,ABT,0.129168,0.070052,Neutral
"NextGen  ( NXGN )  Q1 Earnings Top Estimates, Revenues Surge Y/Y",https://www.zacks.com/stock/news/2127174/nextgen-nxgn-q1-earnings-top-estimates-revenues-surge-yy,2023-07-25 16:02:00,NextGen's (NXGN) first-quarter fiscal 2024 results reflect strength in its revenue sources.,ABT,0.090989,0.0,Neutral
Looking Into Abbott Laboratories's Recent Short Interest - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/short-sellers/23/07/33372049/looking-into-abbott-laboratoriess-recent-short-interest,2023-07-25 15:15:26,"Abbott Laboratories's ABT short percent of float has risen 11.76% since its last report. The company recently reported that it has 13.22 million shares sold short, which is 0.76% of all regular shares that are available for trading.",ABT,0.221819,0.155473,Somewhat-Bullish
GE HealthCare says Alzheimer's drug approval to drive imaging equipment sales,https://www.reuters.com/business/healthcare-pharmaceuticals/ge-healthcare-raises-2023-profit-forecast-supply-chain-woes-ease-2023-07-25/,2023-07-25 15:04:00,July 25 ( Reuters ) - GE HealthCare Technologies Inc ( GEHC.O ) said on Tuesday that the commercial launch of Alzheimer's treatment and related testing for patients would help drive demand for its imaging equipment at hospitals and medical centers next year. The U.S.,ABT,0.113597,0.146717,Neutral
2 Top Dividend Stocks to Buy and Hold Forever,https://www.fool.com/investing/2023/07/25/2-top-dividend-stocks-to-buy-and-hold-forever/,2023-07-25 14:07:00,They have been paying dividends for a long time.,ABT,0.364529,0.322342,Somewhat-Bullish
"Russia Is Seizing European Company Assets - What US Businesses Are Still At Risk? - Deere  ( NYSE:DE ) , United Airlines Holdings  ( NASDAQ:UAL ) , Ford Motor  ( NYSE:F ) , Danone  ( OTC:DANOY ) , Johnson & Johnson  ( NYSE:JNJ ) , Merck & Co  ( NYSE:MRK ) , HP  ( NYSE:HPQ ) , Kellogg  ( NYSE:K ) , Pfizer  ( NYSE:PFE ) , Abbott Laboratories  ( NYSE:ABT ) , Starbucks  ( NASDAQ:SBUX ) , IBM  ( NYSE:IBM ) , Qualcomm  ( NASDAQ:QCOM ) , Carlsberg  ( OTC:CABGY ) , Eli Lilly  ( NYSE:LLY ) , United Parcel Service  ( NYSE:UPS ) , FedEx  ( NYSE:FDX ) , Uber Technologies  ( NYSE:UBER ) , Dell Technologies  ( NYSE:DELL ) , General Electric  ( NYSE:GE ) , Netflix  ( NASDAQ:NFLX ) , Whirlpool  ( NYSE:WHR ) , Kimberly-Clark  ( NYSE:KMB ) , NVIDIA  ( NASDAQ:NVDA ) , Coca-Cola  ( NYSE:KO ) , Micron Technology  ( NASDAQ:MU ) , Colgate-Palmolive  ( NYSE:CL ) , Nike  ( NYSE:NKE ) , Delta Air Lines  ( NYSE:DAL ) , Tupperware Brands  ( NYSE:TUP ) , McDonald's  ( NYSE:MCD ) , Restaurant Brands Intl  ( NYSE:QSR ) , Intel  ( NASDAQ:INTC ) , Procter & Gamble  ( NYSE:PG ) , PepsiCo  ( NASDAQ:PEP ) , Cloudflare  ( NYSE:NET ) , Philip Morris Intl  ( NYSE:PM ) ",https://www.benzinga.com/markets/asia/23/07/33354641/russia-is-seizing-european-company-assets-what-us-businesses-are-still-at-risk,2023-07-24 20:45:18,"In recent months, Russia began seizing assets from companies based in Western countries. The most recent development came last week, when the Russian government seized the local operations of two of the world's largest consumer packaged goods manufacturers.",ABT,0.09186,-0.187684,Somewhat-Bearish
3 Ultrareliable Dividend Stocks to Buy and Hold for Decades,https://www.fool.com/investing/2023/07/24/3-ultra-reliable-dividend-stocks-buy-and-hold-for/,2023-07-24 14:37:16,"These stocks have decades of annual dividend raises under their belts, and rising healthcare costs mean there could be plenty more to come.",ABT,0.167322,-0.010216,Neutral
"Apple To Rally Over 17%? Here Are 10 Other Analyst Forecasts For Monday - Apple  ( NASDAQ:AAPL ) , Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/news/23/07/33342531/apple-to-rally-over-17-here-are-10-other-analyst-forecasts-for-monday,2023-07-24 11:44:59,Citigroup raised the price target for Cintas Corporation CTAS from $540 to $550. Citigroup analyst Leo Carrington downgraded the stock from Buy to Neutral. Cintas shares fell 0.8% to $503.43 in pre-market trading. Stifel raised Lam Research Corporation LRCX price target from $505 to $725.,ABT,0.193465,-0.014157,Neutral
Significant Influence of Healthy Diet Talks Boosts Low-calorie Food Market: TMR Study,https://www.benzinga.com/pressreleases/23/07/g33342175/significant-influence-of-healthy-diet-talks-boosts-low-calorie-food-market-tmr-study,2023-07-24 11:30:00,"Wilmington, Delaware, United States, July 24, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global low-calorie food market was valued at more than US$ 10 Bn in 2019. Rise in awareness about the importance of good heath is fueling the low-calorie food market.",ABT,0.037155,0.136191,Neutral
Dermatology Diagnostic Devices Market to grow at a CAGR of 10.12% from 2022 to 2027|Increasing demand for ... - PR Newswire,https://www.prnewswire.com/news-releases/dermatology-diagnostic-devices-market-to-grow-at-a-cagr-of-10-12-from-2022-to-2027increasing-demand-for-advanced-dermatology-diagnostic-services-to-drive-the-market-growth--technavio-301882435.html,2023-07-22 01:00:00,Dermatology Diagnostic Devices Market to grow at a CAGR of 10.12% from 2022 to 2027|Increasing demand for ... PR ...,ABT,0.04872,0.0,Neutral
Protein Supplements Market to grow by USD 10.9 billion from 2022 to 2027|Growing interest in sports and fitness ... - PR Newswire,https://www.prnewswire.com/news-releases/protein-supplements-market-to-grow-by-usd-10-9-billion-from-2022-to-2027growing-interest-in-sports-and-fitness-activities-to-boost-market-growth---technavio-301882391.html,2023-07-21 23:00:00,Protein Supplements Market to grow by USD 10.9 billion from 2022 to 2027|Growing interest in sports and fitness ... PR ...,ABT,0.04872,0.036786,Neutral
Abbott's Higher Than Expected Q2 Earnings: Analyst Foresees Strong Performance In 2024 - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/analyst-ratings/analyst-color/23/07/33326022/abbotts-higher-than-expected-q2-earnings-analyst-foresees-strong-performance-in-202,2023-07-21 17:18:18,"Thursday, Abbott Laboratories ABT reported better-than-expected Q2 earnings. Organic sales growth for the underlying base business was 11.5%, led by Medical Devices, Established Pharmaceuticals, and Nutrition. It reaffirmed FY23 adjusted EPS of $4.30 - $4.50 vs. consensus of $4.40",ABT,0.535653,0.433916,Bullish
"Dow Leads As Tesla, Netflix, Taiwan Semi Hit Growth: Weekly Review",https://www.investors.com/news/dow-jones-leads-market-advance-as-tesla-netflix-taiwan-semiconductor-hit-growth-weekly-review/,2023-07-21 14:03:00,"The stock market rally saw the Dow Jones join the S&P 500 and Nasdaq composite in hitting 52-week highs, but then the Nasdaq sold off hard Thursday, wiping out weekly gains, amid earnings-related sell-offs from Tesla ( TSLA ) , Netflix ( NFLX ) and Taiwan Semiconductor ( TSM ) .",ABT,0.038937,0.064974,Neutral
"Company News for Jul 21, 2023",https://www.zacks.com/stock/news/2125314/company-news-for-jul-21-2023,2023-07-21 13:31:00,"Companies In The News Are: KMI, UAL, ABT, IBM.",ABT,0.576289,0.654568,Bullish
"Intuitive Surgical beats profit, revenue estimates",https://www.reuters.com/business/healthcare-pharmaceuticals/intuitive-surgical-beats-profit-revenue-estimates-2023-07-20/,2023-07-20 21:00:23,"July 20 ( Reuters ) - Intuitive Surgical Inc ( ISRG.O ) beat Wall Street estimates for quarterly sales and profit on Thursday, boosted by a rise in total procedures volume of its surgical robot da Vinci. Shares of the company, however, fell about 6% to $328, after the bell, due to higher ...",ABT,0.130926,0.099404,Neutral
Looking At Abbott Laboratories's Recent Unusual Options Activity - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/markets/options/23/07/33310925/looking-at-abbott-laboratoriess-recent-unusual-options-activity,2023-07-20 19:46:06,A whale with a lot of money to spend has taken a noticeably bearish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories ABT we detected 22 strange trades.,ABT,0.71032,0.057325,Neutral
IBD Stock Of The Day: Weight-Loss Kingpin Retakes 50-Day Line,https://www.investors.com/research/ibd-stock-of-the-day/novo-nordisk-stock-bounds-above-50-day-line-weight-loss-drugs-drive-enthusiasm/,2023-07-20 17:10:00,Novo Nordisk Stock Stock Bounds Above 50-Day Line. Weight-Loss Drugs Drive Enthusiasm Investor's Business Daily ...,ABT,0.121037,0.154758,Somewhat-Bullish
"Stocks making the biggest moves midday: Netflix, American Airlines, Johnson & Johnson and more",https://www.cnbc.com/2023/07/20/stocks-making-the-biggest-moves-midday-netflix-american-airlines-johnson-johnson-and-more.html,2023-07-20 15:44:36,These are the stocks posting the largest moves in midday trading.,ABT,0.058759,0.149,Neutral
"Abbott  ( ABT )  Q2 Earnings & Revenues Beat Estimates, Down Y/Y",https://www.zacks.com/stock/news/2124781/abbott-abt-q2-earnings-revenues-beat-estimates-down-yy,2023-07-20 14:54:00,Abbott (ABT) delivers better-than-expected earnings and revenues in the second quarter of ...,ABT,0.140076,0.03016,Neutral
"Top Stories Thursday, July 20: Tesla Recalls Over 17K EVs Over Camera & Seat Belt Issues, University Research Uncovers Unexpected Fluctuations In ChatGPT Capabilities, Juul Seeks FDA Nod For Next-Generation Vaporizer - Abbott Laboratories  ( NYSE:ABT ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/news/23/07/33304679/tesla-recalls-over-17k-evs-over-camera-seat-belt-issues-university-research-uncovers-unexpected-fluc,2023-07-20 14:09:21,"Tesla Inc TSLA has issued a recall for over 1,300 Model S, X, and Y vehicles made in 2023, citing an issue with the forward-facing front camera, and over 15,000 Model S and X vehicles for problems related to front-row seat belts.",ABT,0.069094,-0.171841,Somewhat-Bearish
"Abbott Laboratories Clocks Strong Q2 Growth In Underlying Base Business, Reaffirms FY23 Outlook - Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/news/earnings/23/07/33302273/abbott-laboratories-clocks-strong-q2-growth-in-underlying-base-business-reaffirms-fy23-outlook,2023-07-20 13:15:23,"Abbott Laboratories ABT has reported Q2 FY23 adjusted EPS of $1.08, down 25% Y/Y, beating the consensus of $1.05. Q2 sales of $9.97 billion decreased 11.4%, beating the consensus of $9.70 billion. Organic sales growth for the underlying base business was 11.5%, led by Medical Devices, Established ...",ABT,0.401331,-0.190078,Somewhat-Bearish
Med Stock Creeps Up As Earnings Decline But Still Top Forecasts,https://www.investors.com/news/technology/abbott-stock-abbott-earnings-q2-2023/,2023-07-20 12:59:00,"Abbott Stock Edges Higher As Earnings Decline, But Less Than Expected Investor's Business Daily ...",ABT,0.350564,0.236972,Somewhat-Bullish
Abbott beats profit estimates on recovery in demand for medical devices,https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-beats-quarterly-profit-estimates-demand-medical-devices-2023-07-20/,2023-07-20 12:32:00,"July 20 ( Reuters ) - Abbott Laboratories ( ABT.N ) on Thursday reported second-quarter profit above expectations, due to recovery in surgical procedure volumes and demand for its diabetes care devices.",ABT,0.115232,0.239804,Somewhat-Bullish
"Morning Bid: Tesla, Netflix underwhelm",https://www.reuters.com/markets/us/global-markets-view-usa-2023-07-20/,2023-07-20 10:02:00,"Morning Bid: Tesla, ...",ABT,0.067347,0.0,Neutral
"Johnson & Johnson, Tesla And 3 Stocks To Watch Heading Into Thursday - Abbott Laboratories  ( NYSE:ABT ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/news/earnings/23/07/33297635/johnson-johnson-tesla-and-3-stocks-to-watch-heading-into-thursday,2023-07-20 08:17:03,Wall Street expects Johnson & Johnson JNJ to post quarterly earnings at $2.62 per share on revenue of $24.66 billion before the opening bell. Johnson & Johnson shares gained 0.2% to $159.09 in after-hours trading.,ABT,0.401331,0.352496,Bullish
"Markets Remain Bullish After Dow Rises For Eighth Consecutive Session - Abbott Laboratories  ( NYSE:ABT ) , American Airlines Group  ( NASDAQ:AAL ) ",https://www.benzinga.com/news/earnings/23/07/33296853/markets-remain-bullish-after-dow-rises-for-eighth-consecutive-session,2023-07-20 06:23:57,"The CNN Money Fear and Greed index remained in the ""Extreme Greed"" zone on Wednesday. The Dow Jones gained recorded gains for the eighth straight session on Wednesday, its longest winning streak since Sept. 2019. The Goldman Sachs Group, Inc.",ABT,0.275867,0.0,Neutral
Is AbbVie Still a Good Dividend Stock to Buy?,https://www.fool.com/investing/2023/08/08/is-abbvie-still-a-good-dividend-stock-to-buy/,2023-08-08 09:37:00,Find out if AbbVie can overcome sinking sales of its top-selling product.,ABT,0.067347,0.118317,Neutral
"Vigil Neuroscience Appoints Christopher J. Silber, M.D. as Chief Medical Officer - Vigil Neuroscience  ( NASDAQ:VIGL ) ",https://www.benzinga.com/pressreleases/23/08/g33608302/vigil-neuroscience-appoints-christopher-j-silber-m-d-as-chief-medical-officer,2023-08-07 20:05:00,"WATERTOWN, Mass., Aug. 07, 2023 ( GLOBE NEWSWIRE ) -- Vigil Neuroscience, Inc. VIGL, a clinical-stage biotechnology company committed to harnessing the power of microglia for the treatment of neurodegenerative diseases, today announced the appointment of Christopher J. Silber, M.D. as Chief ...",ABT,0.041323,-0.006947,Neutral
"Henry Schein  ( HSIC )  Q2 Earnings Top, Operating Margin Dips",https://www.zacks.com/stock/news/2133149/henry-schein-hsic-q2-earnings-top-operating-margin-dips,2023-08-07 14:25:00,Henry Schein's (HSIC) second quarter 2023 performance demonstrates strength in the North American dental business.,ABT,0.075635,0.0,Neutral
2 Top Stocks to Buy in August and Hold Forever,https://www.fool.com/investing/2023/08/06/2-top-stocks-to-buy-in-august-and-hold-forever/,2023-08-06 13:00:00,These companies won't disappoint long-term investors.,ABT,0.187827,0.363151,Bullish
This Is What Whales Are Betting On Abbott Laboratories - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/markets/options/23/08/33581014/this-is-what-whales-are-betting-on-abbott-laboratories,2023-08-04 19:01:19,"Someone with a lot of money to spend has taken a bearish stance on Abbott Laboratories ABT. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",ABT,0.77688,0.283971,Somewhat-Bullish
"Globus Medical  ( GMED )  Q2 Earnings Beat Estimates, Margins Dip",https://www.zacks.com/stock/news/2132825/globus-medical-gmed-q2-earnings-beat-estimates-margins-dip,2023-08-04 16:26:00,"According to Globus Medical (GMED), the increase in R&D expenses is largely focused on Spine and Enabling Technologies.",ABT,0.082111,0.0,Neutral
"ResMed's  ( RMD )  Q4 Earnings Miss, Revenues Beat Estimates",https://www.zacks.com/stock/news/2132820/resmeds-rmd-q4-earnings-miss-revenues-beat-estimates,2023-08-04 16:20:00,ResMed (RMD) records a robust sales performance in fiscal Q4 backed by the ongoing combined availability of cloud-connected AirSense 10 and AirSense 11 sleep devices.,ABT,0.082393,0.0,Neutral
"Tandem Diabetes  ( TNDM )  Reports Narrower Q2 Loss, Trims '23 View",https://www.zacks.com/stock/news/2132706/tandem-diabetes-tndm-reports-narrower-q2-loss-trims-23-view,2023-08-04 13:49:00,Tandem Diabetes' (TNDM) second-quarter 2023 performance reflects new technology innovations and operational improvements throughout its business.,ABT,0.086556,0.0,Neutral
"Stryker  ( SYK )  Q2 Earnings Beat Estimates, Volume Improves",https://www.zacks.com/stock/news/2132719/stryker-syk-q2-earnings-beat-estimates-volume-improves,2023-08-04 13:01:00,"Stryker's (SYK) second-quarter earnings reflect strong performance across its segments. However, unfavorable currency movement hurts sales growth and rising costs affect margins.",ABT,0.102888,0.0,Neutral
Does Abbott Laboratories' Dividend Make It a Buy?,https://www.fool.com/investing/2023/08/04/does-abbott-laboratories-dividend-make-it-a-buy/,2023-08-04 13:00:00,There's a lot to like about this business when it comes to dividends.,ABT,0.121343,0.246966,Somewhat-Bullish
"Inari Medical  ( NARI )  Q2 Earnings Top, Revenues Rise Y/Y",https://www.zacks.com/stock/news/2132712/inari-medical-nari-q2-earnings-top-revenues-rise-yy,2023-08-04 12:59:00,Inari Medical's (NARI) second-quarter results benefit from significant progress made across all its growth drivers.,ABT,0.113597,0.0,Neutral
Is AbbVie Stock a Buy for Income Investors?,https://www.fool.com/investing/2023/08/04/is-abbvie-stock-a-buy-for-income-investors/,2023-08-04 12:19:37,The pharmaceutical giant is forecasting a return to growth starting in 2024.,ABT,0.057079,0.146122,Neutral
Stryker lifts annual profit forecast as demand for its devices picks up,https://www.reuters.com/business/healthcare-pharmaceuticals/stryker-lifts-annual-profit-forecast-demand-its-devices-picks-up-2023-08-03/,2023-08-03 20:59:00,"Aug 3 ( Reuters ) - Stryker ( SYK.N ) raised its annual profit forecast on Thursday as the medtech company sees strong demand for its medical and surgical devices, aided by a post-pandemic pickup in surgical procedure volumes at hospitals.",ABT,0.16171,0.107801,Neutral
Cigna  ( CI )  Q2 Earnings Beat on Strong U.S. Commercial Unit,https://www.zacks.com/stock/news/2132224/cigna-ci-q2-earnings-beat-on-strong-us-commercial-unit,2023-08-03 18:02:00,Cigna's (CI) Q2 results reflect solid premium rate hikes and a growing membership base across its U.S. Commercial and Medicare Advantage businesses.,ABT,0.138066,0.090502,Neutral
"PacBio  ( PACB )  Tops on Q2 Earnings, Raises FY23 Revenue View",https://www.zacks.com/stock/news/2132189/pacbio-pacb-tops-on-q2-earnings-raises-fy23-revenue-view,2023-08-03 17:16:00,"PacBio (PACB) witnesses strong revenue growth in the second quarter, partly aided by customers' product transition to the Revio system.",ABT,0.088472,0.0,Neutral
"Surmodics  ( SRDX )  Q3 Earnings Top Estimates, FY23 View Up",https://www.zacks.com/stock/news/2132180/surmodics-srdx-q3-earnings-top-estimates-fy23-view-up,2023-08-03 17:03:00,Surmodics (SRDX) reports a solid fiscal third quarter top line on the back of robust Medical Device revenues.,ABT,0.077218,0.0,Neutral
"BD  ( BDX )  Q3 Earnings Surpass Estimates, Margins Contract",https://www.zacks.com/stock/news/2132172/bd-bdx-q3-earnings-surpass-estimates-margins-contract,2023-08-03 16:57:00,BD's (BDX) overall top line benefits from revenue growth in the majority of its segments and both geographic regions in the fiscal third quarter.,ABT,0.063425,0.0,Neutral
"Envista  ( NVST )  Q2 Earnings Top Estimates, Margins Expands",https://www.zacks.com/stock/news/2132147/envista-nvst-q2-earnings-top-estimates-margins-expands,2023-08-03 15:22:00,Consistent growth in the Specialty Products & Technologies segment and a return to growth in the Equipment & Consumables segment drive Envista's (NVST) Q2 revenues.,ABT,0.105141,0.0,Neutral
"Glaukos  ( GKOS )  Q2 Earnings Beat Estimates, Revenues Rise Y/Y",https://www.zacks.com/stock/news/2132137/glaukos-gkos-q2-earnings-beat-estimates-revenues-rise-yy,2023-08-03 15:16:00,"Glaukos' (GKOS) second-quarter revenues beat estimates but fall year over year. Sales and gross margin improve, while higher operating expenses lead to a wider operating loss.",ABT,0.114137,0.0,Neutral
"STERIS  ( STE )  Q1 Earnings Beat Estimates, Gross Margin Falls",https://www.zacks.com/stock/news/2132049/steris-ste-q1-earnings-beat-estimates-gross-margin-falls,2023-08-03 15:12:00,"Barring Life Sciences and Dental, rest of STERIS (STE) operating segments report organic revenue growth in fiscal Q1.",ABT,0.085629,0.0,Neutral
"Genetic Testing Market size to grow by USD 7,103.8 million from 2022 to 2027|The growing adoption of direct-to ... - PR Newswire",https://www.prnewswire.com/news-releases/genetic-testing-market-size-to-grow-by-usd-7-103-8-million-from-2022-to-2027the-growing-adoption-of-direct-to-consumer-genetic-tests-in-early-disease-diagnosis-is-a-major-trend--technavio-301891403.html,2023-08-03 15:10:00,"Genetic Testing Market size to grow by USD 7,103.8 million from 2022 to 2027|The growing adoption of direct-to ... PR ...",ABT,0.088964,0.012455,Neutral
"McKesson  ( MCK )  Q1 Earnings Beat Estimates, U.S. Sales Strong",https://www.zacks.com/stock/news/2132121/mckesson-mck-q1-earnings-beat-estimates-us-sales-strong,2023-08-03 15:00:00,McKesson's (MCK) fiscal first-quarter 2024 results benefit from growth in the United States. Divestment hurts the International segment.,ABT,0.091335,0.0,Neutral
Fresenius Medical  ( FMS )  Q2 Earnings and Revenues Beat Estimates,https://www.zacks.com/stock/news/2132095/fresenius-medical-fms-q2-earnings-and-revenues-beat-estimates,2023-08-03 14:55:00,"Fresenius Medical's (FMS) second-quarter revenues benefit from strong performance across all segments. Inflationary pressure continues to improve, benefiting operating income.",ABT,0.105836,0.0,Neutral
"DENTSPLY SIRONA  ( XRAY )  Beats on Q2 Earnings, Ups '23 EPS View",https://www.zacks.com/stock/news/2132093/dentsply-sirona-xray-beats-on-q2-earnings-ups-23-eps-view,2023-08-03 14:53:00,"DENTSPLY SIRONA's (XRAY) Q2 revenues are driven by a rise in demand across key markets, especially in China. Improved pricing and restructuring initiatives boost earnings.",ABT,0.064449,0.0,Neutral
"NuVasive  ( NUVA )  Q2 Earnings Meet Estimates, Margins Down",https://www.zacks.com/stock/news/2132002/nuvasive-nuva-q2-earnings-meet-estimates-margins-down,2023-08-03 14:14:00,NuVasive's (NUVA) second-quarter 2023 results reflect the robust performance of the U.S. Cervical business.,ABT,0.082963,0.0,Neutral
"Got $5,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond",https://www.fool.com/investing/2023/08/03/got-5000-these-2-stocks-could-be-bargain-buys-for/,2023-08-03 13:45:00,There's lots of upside potential for these drugmakers.,ABT,0.050465,0.110316,Neutral
3 High-Yielding Dividend Stocks to Buy and Hold for Decades,https://www.fool.com/investing/2023/08/03/3-high-yielding-dividend-stocks-to-hold-for/,2023-08-03 11:00:00,These are all solid businesses that could continue raising their dividend payments in the years ahead.,ABT,0.065327,0.038029,Neutral
Mobile health solutions market to grow at a CAGR of 27.09% from 2022 to 2027 | Increasing smartphone penetration will drive growth - Technavio,https://www.benzinga.com/pressreleases/23/08/n33534424/mobile-health-solutions-market-to-grow-at-a-cagr-of-27-09-from-2022-to-2027-increasing-smartphone-,2023-08-02 21:15:00,"NEW YORK, Aug. 2, 2023 /PRNewswire/ -- The mobile health solutions market size is estimated to grow by USD 256.69 billion from 2022 to 2027, at a CAGR of 27.09% according to Technavio. Download a Sample Report! Coverage: Parent market analysis. key drivers, major trends, and challenges.",ABT,0.01441,0.091708,Neutral
"CVS Health  ( CVS )  Q2 Earnings Surpass Estimates, Margins Up",https://www.zacks.com/stock/news/2131295/cvs-health-cvs-q2-earnings-surpass-estimates-margins-up,2023-08-02 16:28:00,"Pharmacy drug mix, growth in specialty pharmacy, brand inflation and the acquisitions of Oak Street Health and Signify Health drive CVS Health's (CVS) Q2 revenues.",ABT,0.091684,0.0,Neutral
"Penumbra  ( PEN )  Q2 Earnings Top Estimates, Sales View Raised",https://www.zacks.com/stock/news/2131234/penumbra-pen-q2-earnings-top-estimates-sales-view-raised,2023-08-02 15:51:00,"Penumbra's (PEN) U.S. thrombectomy records 50% year-over-year growth, while the international Vascular business sees relatively flat sales in the second quarter.",ABT,0.102231,0.0,Neutral
"Nevro  ( NVRO )  Q2 Earnings Lag Estimates, FY23 View Cut",https://www.zacks.com/stock/news/2131208/nevro-nvro-q2-earnings-lag-estimates-fy23-view-cut,2023-08-02 15:28:00,Nevro's (NVRO) worldwide revenues improve on a year-over-year basis in the second quarter owing to robust domestic and international performances.,ABT,0.079261,0.0,Neutral
Inspire Medical  ( INSP )  Q2 Earnings & Revenues Top Estimates,https://www.zacks.com/stock/news/2131206/inspire-medical-insp-q2-earnings-revenues-top-estimates,2023-08-02 15:25:00,Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the second quarter.,ABT,0.083107,0.0,Neutral
"Exact Sciences  ( EXAS )  Beats on Q2 Earnings, Ups '23 Sales View",https://www.zacks.com/stock/news/2131232/exact-sciences-exas-beats-on-q2-earnings-ups-23-sales-view,2023-08-02 14:44:00,Strength in Screening revenues and Precision Oncology drive Exact Sciences (EXAS) Q2 performance.,ABT,0.105604,0.0,Neutral
"AmerisourceBergen  ( ABC )  Beats on Q3 Earnings, Ups '23 EPS View",https://www.zacks.com/stock/news/2131183/amerisourcebergen-abc-beats-on-q3-earnings-ups-23-eps-view,2023-08-02 13:53:00,AmerisourceBergen's (ABC) fiscal third-quarter 2023 results benefit from segmental growth. Inflation and unfavorable currency rates hurt operating margin.,ABT,0.081138,0.0,Neutral
"Revvity  ( RVTY )  Beats on Q2 Earnings, Lowers '23 EPS View",https://www.zacks.com/stock/news/2131116/revvity-rvty-beats-on-q2-earnings-lowers-23-eps-view,2023-08-02 13:00:00,Revvity's (RVTY) second-quarter results reflect the impact of lower COVID-related sales. Both earnings and sales outpace their respective consensus estimate.,ABT,0.100518,0.0,Neutral
"Omnicell  ( OMCL )  Q2 Earnings and Revenues Top, '23 View Raised",https://www.zacks.com/stock/news/2130995/omnicell-omcl-q2-earnings-and-revenues-top-23-view-raised,2023-08-02 12:48:00,Omnicell's (OMCL) second-quarter 2023 performance reflects strength in advanced services and technical services as well as continued strong execution.,ABT,0.089462,0.0,Neutral
Zimmer Biomet's downbeat 2024 view hits shares after forecast raise,https://www.reuters.com/business/healthcare-pharmaceuticals/medical-device-maker-zimmer-biomet-lifts-profit-forecast-surgeries-rebound-2023-08-01/,2023-08-01 17:22:00,"An employee takes a glowing piece of metal from a furnace at the forge of medical implants maker Zimmer Biomet in Winterthur, Switzerland, January 23, 2017. REUTERS/Arnd Wiegmann/File Photo",ABT,0.143415,0.182568,Somewhat-Bullish
Tenet Healthcare  ( THC )  Q2 Earnings Beat on Solid Hospital Unit,https://www.zacks.com/stock/news/2130616/tenet-healthcare-thc-q2-earnings-beat-on-solid-hospital-unit,2023-08-01 16:15:00,Tenet Healthcare's (THC) Q2 results gain on improved adjusted admissions and higher pricing yield. Management expects adjusted EPS of $5.18-$6.03 for this year.,ABT,0.119532,0.064923,Neutral
"Ecolab  ( ECL )  Q2 Earnings Surpass Estimates, Margins Rise",https://www.zacks.com/stock/news/2130585/ecolab-ecl-q2-earnings-surpass-estimates-margins-rise,2023-08-01 16:12:00,"Ecolab's (ECL) robust performance across all segments drives its Q2 sales, despite business challenges.",ABT,0.085629,0.0,Neutral
Chronic Kidney Disease Nutritional Supplement Market to Exceed USD 5.0 Bn by 2031 with CAGR of 4.3%: TMR Study,https://www.benzinga.com/pressreleases/23/08/g33498289/chronic-kidney-disease-nutritional-supplement-market-to-exceed-usd-5-0-bn-by-2031-with-cagr-of-4-3,2023-08-01 15:30:00,"Wilmington, Delaware, United States, Aug. 01, 2023 ( GLOBE NEWSWIRE ) -- The global chronic kidney disease nutritional supplement market was valued at US$ 3.3 Bn in 2021, and it is projected to expand at a CAGR of 4.3% from 2022 to 2031.",ABT,0.039811,-0.102032,Neutral
"Hologic's  ( HOLX )  Q3 Earnings Beat Estimates, 2023 View Up",https://www.zacks.com/stock/news/2130597/hologics-holx-q3-earnings-beat-estimates-2023-view-up,2023-08-01 15:27:00,Strength in Breast Health and GYN Surgical drives Hologic's (HOLX) Q3 performance.,ABT,0.077468,0.0,Neutral
"IDEXX  ( IDXX )  Q2 Earnings and Revenues Beat Estimates, View Up",https://www.zacks.com/stock/news/2130520/idexx-idxx-q2-earnings-and-revenues-beat-estimates-view-up,2023-08-01 15:02:00,"IDEXX (IDXX) delivers better-than-expected earnings and revenues in the second quarter of 2023, backed by CAG Diagnostics' recurring revenue growth.",ABT,0.085022,0.0,Neutral
"Zimmer Biomet  ( ZBH )  Q2 Earnings Match Estimates, View Raised",https://www.zacks.com/stock/news/2130501/zimmer-biomet-zbh-q2-earnings-match-estimates-view-raised,2023-08-01 14:44:00,"Barring S.E.T., Zimmer Biomet (ZBH) records strong growth across each of its business segments in the second quarter.",ABT,0.098862,0.0,Neutral
"Zacks Industry Outlook Highlights Abbott Laboratories, Stryker, Zimmer Biomet and Haemonetics",https://www.zacks.com/stock/news/2130297/zacks-industry-outlook-highlights-abbott-laboratories-stryker-zimmer-biomet-and-haemonetics,2023-08-01 11:29:00,"Abbott Laboratories, Stryker, Zimmer Biomet and Haemonetics are part of the Zacks Industry Outlook article.",ABT,0.08197,0.093828,Neutral
uniQure Announces Second Quarter 2023 Financial Results and Highlights Recent Company Progress,https://www.globenewswire.com/news-release/2023/08/01/2715661/0/en/uniQure-Announces-Second-Quarter-2023-Financial-Results-and-Highlights-Recent-Company-Progress.html,2023-08-01 11:05:00,~ Announced encouraging interim analysis data from ongoing Phase I/II clinical trial of AMT-130 in Huntington's disease showing preservation of function compared to baseline and clinical benefits relative to natural history. both dose cohorts of AMT-130 continue to be generally ...,ABT,0.016304,0.049953,Neutral
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/earnings/23/07/33478046/heres-how-much-you-would-have-made-owning-abbott-laboratories-stock-in-the-last-10-years,2023-07-31 19:30:30,"Abbott Laboratories ABT has outperformed the market over the past 10 years by 1.5% on an annualized basis producing an average annual return of 11.9%. Currently, Abbott Laboratories has a market capitalization of $193.20 billion.",ABT,0.980595,0.386944,Bullish
"Avantor  ( AVTR )  Q2 Earnings Lag Estimates, FY23 View Revised",https://www.zacks.com/stock/news/2130026/avantor-avtr-q2-earnings-lag-estimates-fy23-view-revised,2023-07-31 16:50:00,"Despite Avantor's (AVTR) strength in end markets, it reports an overall soft second-quarter performance.",ABT,0.073209,0.0,Neutral
4 Medical Product Stocks to Buy Amid Recovering Prospects,https://www.zacks.com/commentary/2129849/4-medical-product-stocks-to-buy-amid-recovering-prospects,2023-07-31 12:46:00,"Despite the ongoing macro headwinds, recovering demand for medical procedures and cost-cutting initiatives should lend support to the Zacks Medical-Products industry. ABT, SYK, ZBH and HAE are well poised to gain from the favorable factors.",ABT,0.063313,0.00101,Neutral
"Image guided therapy system market to grow by USD 1,594.18 million between 2022 to 2027|Growth opportunities led ... - PR Newswire",https://www.prnewswire.com/news-releases/image-guided-therapy-system-market-to-grow-by-usd-1-594-18-million-between-2022-to-2027growth-opportunities-led-by-brainlab-ag-and-c-rad-ab---technavio-301888277.html,2023-07-31 06:30:00,"Image guided therapy system market to grow by USD 1,594.18 million between 2022 to 2027|Growth opportunities led ... PR ...",ABT,0.043658,0.099737,Neutral
The Drug Screening Market size to grow by USD 6.6599 billion from 2022 to 2027; Advancements in Drug Screening ... - PR Newswire,https://www.prnewswire.com/news-releases/the-drug-screening-market-size-to-grow-by-usd-6-6599-billion-from-2022-to-2027-advancements-in-drug-screening-technologies-to-influence-market-growth---technavio-301903528.html,2023-08-18 02:30:00,The Drug Screening Market size to grow by USD 6.6599 billion from 2022 to 2027. Advancements in Drug Screening ... PR ...,ABT,0.038592,0.062178,Neutral
Dietary Supplements Market to grow by USD 61.4 billion from 2022 to 2027; Growing popularity of healthy eating habits ... - PR Newswire,https://www.prnewswire.com/news-releases/dietary-supplements-market-to-grow-by-usd-61-4-billion-from-2022-to-2027-growing-popularity-of-healthy-eating-habits-boosts-the-market---technavio-301903490.html,2023-08-17 22:15:00,Dietary Supplements Market to grow by USD 61.4 billion from 2022 to 2027. Growing popularity of healthy eating habits ... PR ...,ABT,0.035138,0.0,Neutral
Nerve Repair and Regeneration Global Market is Expected to Showcase a Significant Growth at a CAGR of ~9% by 2028 | DelveInsight,https://www.prnewswire.com/news-releases/nerve-repair-and-regeneration-global-market-is-expected-to-showcase-a-significant-growth-at-a-cagr-of-9-by-2028--delveinsight-301903232.html,2023-08-17 21:01:00,Nerve Repair and Regeneration Global Market is Expected to Showcase a Significant Growth at a CAGR of ~9% by ... PR ...,ABT,0.071713,0.026117,Neutral
"Alcon  ( ALC )  Q2 Earnings Surpass Estimates, Margins Increase",https://www.zacks.com/stock/news/2137512/alcon-alc-q2-earnings-surpass-estimates-margins-increase,2023-08-17 13:41:00,Alcon (ALC) delivers better-than-expected earnings and revenues in the second quarter of 2023.,ABT,0.077845,0.0,Neutral
1 High-Yield Dividend Stock That Looks Like a Screaming Buy,https://www.fool.com/investing/2023/08/17/1-high-yield-dividend-stock-that-looks-like-a/,2023-08-17 12:45:00,Look beyond the company's near-term headwinds.,ABT,0.053992,-0.0692,Neutral
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/earnings/23/08/33879468/heres-how-much-you-would-have-made-owning-abbott-laboratories-stock-in-the-last-10-years,2023-08-16 17:00:47,"Abbott Laboratories ABT has outperformed the market over the past 10 years by 1.38% on an annualized basis producing an average annual return of 11.71%. Currently, Abbott Laboratories has a market capitalization of $182.22 billion.",ABT,0.980595,0.386944,Bullish
Boston Scientific's  ( BSX )  POLARx System Gets FDA Approval,https://www.zacks.com/stock/news/2136460/boston-scientifics-bsx-polarx-system-gets-fda-approval,2023-08-15 13:38:00,Boston Scientific's (BSX) POLARx enables doctors to expand and modify the new POLARx catheter to match a patient's unique anatomy during an ablation treatment.,ABT,0.106305,0.148603,Neutral
2 Blue Chip Dividend Stocks That Are Top Buys in August,https://www.fool.com/investing/2023/08/14/2-blue-chip-dividend-stocks-that-are-top-buys-in-a/,2023-08-14 18:36:00,These two dividend-paying healthcare stocks stand out as top buys right now.,ABT,0.193723,0.179553,Somewhat-Bullish
"Hero Digital Joins Forces with Avionos, a Leader in Salesforce and Adobe B2B Commerce",https://www.prnewswire.com/news-releases/hero-digital-joins-forces-with-avionos-a-leader-in-salesforce-and-adobe-b2b-commerce-301899925.html,2023-08-14 16:01:00,The combined company will operate as Hero Digital and move its headquarters to Chicago,ABT,0.116631,0.29501,Somewhat-Bullish
"Abbott  ( ABT )  EPD Arm Grows, Low Testing Sales Play Spoilsport",https://www.zacks.com/stock/news/2136258/abbott-abt-epd-arm-grows-low-testing-sales-play-spoilsport,2023-08-14 15:44:00,"Banking on the successful execution of Abbott's (ABT) branded generic operating model, EPD is well positioned for sustained growth in many of the growing pharmaceutical markets.",ABT,0.162073,0.123826,Neutral
Here's Why Investors Should Retain Abbott  ( ABT )  Stock Now,https://www.zacks.com/stock/news/2136306/heres-why-investors-should-retain-abbott-abt-stock-now,2023-08-14 15:31:00,Investors are optimistic about Abbott (ABT) on its strategic expansion in the global market and recovery within the Nutrition segment.,ABT,0.096477,0.16047,Somewhat-Bullish
2 Best Healthcare Stocks to Buy Right Now,https://www.fool.com/investing/2023/08/14/2-best-healthcare-stocks-to-buy-right-now/,2023-08-14 13:01:01,The healthcare sector has plenty of growth tailwinds.,ABT,0.127795,0.086045,Neutral
"Lyme Disease Diagnostics Market Size Worth USD 2.1 Billion in 2031, to Expand at a 3.8% CAGR Says, Transparency Market Research",https://www.benzinga.com/pressreleases/23/08/g33824735/lyme-disease-diagnostics-market-size-worth-usd-2-1-billion-in-2031-to-expand-at-a-3-8-cagr-says-tr,2023-08-14 10:30:00,"Wilmington, Delaware, United States, Aug. 14, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global Lyme disease diagnostics market is expected to total US$ 1.56 billion in 2023 and is expected to expand at a CAGR of 3.8% until 2031.",ABT,0.077972,0.094254,Neutral
3 Unstoppable Dividend Stocks to Buy Right Now,https://www.fool.com/investing/2023/08/12/3-unstoppable-dividend-stocks-to-buy-right-now/,2023-08-12 10:15:00,These stocks' dividends are more dependable than most.,ABT,0.044634,0.107159,Neutral
"Asensus Surgical  ( ASXC )  Q2 Loss Widens, Revenues In Line",https://www.zacks.com/stock/news/2135749/asensus-surgical-asxc-q2-loss-widens-revenues-in-line,2023-08-11 14:20:00,Asensus Surgical (ASXC) reports a significant increase in total surgical procedures completed utilizing the Senhance System.,ABT,0.112269,0.0,Neutral
"National Vision  ( EYE )  Q2 Earnings Top Estimates, Margins Down",https://www.zacks.com/stock/news/2135553/national-vision-eye-q2-earnings-top-estimates-margins-down,2023-08-11 12:48:00,"National Vision's (EYE) second-quarter 2023 performance highlights positive comparable store sales growth, retention and recruitment trends.",ABT,0.088147,0.0,Neutral
"The Zacks Analyst Blog Highlights JPMorgan Chase, Salesforce, Abbott Laboratories, HCA Healthcare and General Motors",https://www.zacks.com/stock/news/2135473/the-zacks-analyst-blog-highlights-jpmorgan-chase-salesforce-abbott-laboratories-hca-healthcare-and-general-motors,2023-08-11 09:14:00,"JPMorgan Chase, Salesforce, Abbott Laboratories, HCA Healthcare and General Motors are included in this Analyst Blog.",ABT,0.267559,-0.058692,Neutral
"Top Stock Reports for JPMorgan Chase, Salesforce & Abbott Laboratories",https://www.zacks.com/research-daily/2135006/top-stock-reports-for-jpmorgan-chase-salesforce-abbott-laboratories,2023-08-10 17:24:00,"Today's Research Daily features new research reports on 16 major stocks, including JPMorgan Chase & Co. (JPM), Salesforce, Inc. (CRM) and Abbott Laboratories (ABT).",ABT,0.092569,-0.15821,Somewhat-Bearish
How Is The Market Feeling About Abbott Laboratories? - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/short-sellers/23/08/33714463/how-is-the-market-feeling-about-abbott-laboratories,2023-08-10 16:00:20,"Abbott Laboratories's ABT short percent of float has risen 9.38% since its last report. The company recently reported that it has 12.05 million shares sold short, which is 0.7% of all regular shares that are available for trading.",ABT,0.221819,0.155473,Somewhat-Bullish
Is Abbott Laboratories Stock a Buy Now?,https://www.fool.com/investing/2023/08/10/is-abbott-laboratories-stock-a-buy-now/,2023-08-10 14:00:00,The healthcare company recently boosted its guidance.,ABT,0.172097,0.237394,Somewhat-Bullish
"Charles River  ( CRL )  Q2 Earnings Top, 2023 View Narrowed",https://www.zacks.com/stock/news/2134393/charles-river-crl-q2-earnings-top-2023-view-narrowed,2023-08-09 15:12:00,"Charles River (CRL) registers robust growth in small research models, research model services and the Safety Assessment business.",ABT,0.09186,0.0,Neutral
"Insulet  ( PODD )  Q2 Earnings Beat, Sales Growth View Raised",https://www.zacks.com/stock/news/2134385/insulet-podd-q2-earnings-beat-sales-growth-view-raised,2023-08-09 15:03:00,"Insulet's (PODD) Omnipod 5 gains market share in the second quarter within the diabetes technology market as the only FDA-approved fully disposable, pod-based automated insulin delivery system.",ABT,0.097259,0.0,Neutral
"Investing $1,000 in These 2 Top Stocks Would Be a Brilliant Move",https://www.fool.com/investing/2023/08/09/investing-1000-in-these-2-top-stocks-would-be-a/,2023-08-09 13:00:00,"Even after crushing the market in the past year, these stocks are worth investing in.",ABT,0.048523,0.080759,Neutral
"QIAGEN  ( QGEN )  Q2 Earnings and Revenues Top, '23 View Slashed",https://www.zacks.com/stock/news/2134203/qiagen-qgen-q2-earnings-and-revenues-top-23-view-slashed,2023-08-09 12:21:00,QIAGEN (QGEN) surpasses the earnings and revenue outlook in the second quarter of 2023 amid a challenging macro environment.,ABT,0.065775,0.0,Neutral
"SmileDirectClub  ( SDC )  Q2 Earnings Miss Estimates, '23 View Up",https://www.zacks.com/stock/news/2134193/smiledirectclub-sdc-q2-earnings-miss-estimates-23-view-up,2023-08-09 12:17:00,SmileDirectClub (SDC) reports a higher-than-expected loss in the second quarter of 2023.,ABT,0.100941,0.0,Neutral
Is This MedTech Giant a Buy for Dividend Investors?,https://www.fool.com/investing/2023/08/09/is-this-medtech-giant-a-buy-for-dividend-investors/,2023-08-09 09:30:00,The company stands out as a titan of the medical devices industry.,ABT,0.06623,0.151365,Somewhat-Bullish
The Spinal Implants and Surgical Devices Market size to grow at a CAGR of 5.3% from 2022 to 2027; Technological ... - PR Newswire,https://www.prnewswire.com/news-releases/the-spinal-implants-and-surgical-devices-market-size-to-grow-at-a-cagr-of-5-3-from-2022-to-2027-technological-advancements-are-a-major-trend---technavio-301895596.html,2023-08-09 07:00:00,The Spinal Implants and Surgical Devices Market size to grow at a CAGR of 5.3% from 2022 to 2027. Technological ... PR ...,ABT,0.042346,0.103516,Neutral
1 Stock-Split Stock Billionaires Are Buying Hand Over Fist and 1 Unexpected Stock-Split Stock They're Selling,https://www.fool.com/investing/2023/08/28/1-stock-split-stock-billionaires-are-buying-hand-o/,2023-08-28 10:53:00,Some of the world's most successful investors are focusing on stocks.,ABT,0.050679,0.000998,Neutral
"30 dividend-paying stocks in solid sectors with upside outside the AI hype, according to a 30-year fund manager",https://www.businessinsider.com/30-dividend-paying-stocks-held-by-30-year-fund-manager-2023-8,2023-08-27 16:51:00,30 Dividend-Paying Stocks With Upside Held by 30-Year Fund Manager - Business Insider ...,ABT,0.08183,0.0,Neutral
Wall Street Week Ahead-Historically stormy month of September may test US stock rally,https://www.financialexpress.com/market/wall-street-week-ahead-historically-stormy-month-of-september-may-test-us-stock-rally-3224334/,2023-08-27 13:23:11,"U.S. stock investors are bracing for a potentially volatile September as the market faces key economic data reports, a Federal Reserve meeting and worries over a possible government shutdown during a month of historically muted equity performance.In Septembers since 1945, the S&P 500 has ...",ABT,0.064276,-0.004018,Neutral
Wall St Week Ahead Historically stormy month of September may test US stock rally,https://www.reuters.com/markets/us/wall-st-week-ahead-historically-stormy-month-september-may-test-us-stock-rally-2023-08-25/,2023-08-25 21:42:00,"The Wall Street entrance to the New York Stock Exchange ( NYSE ) is seen in New York City, U.S., November 15, 2022. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",ABT,0.059194,-0.047008,Neutral
Enanta Pharmaceuticals  ( NASDAQ:ENTA )  Rating Increased to Hold at StockNews.com,https://www.defenseworld.net/2023/08/24/enanta-pharmaceuticals-nasdaqenta-rating-increased-to-hold-at-stocknews-com.html,2023-08-24 05:18:44,Enanta Pharmaceuticals ( NASDAQ:ENTA ) Rating Increased to Hold ... Defense World ...,ABT,0.060848,-0.039371,Neutral
US FDA taps EPA veteran James Jones to oversee food division after formula crisis,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-taps-epa-veteran-james-jones-oversee-food-division-after-formula-crisis-2023-08-23/,2023-08-23 17:39:16,"Signage is seen outside of the Food and Drug Administration ( FDA ) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights Aug 23 ( Reuters ) - The U.S.",ABT,0.12546,-0.437035,Bearish
Want Growing Passive Income? This Dividend King Could Be a Smart Buy,https://www.fool.com/investing/2023/08/23/want-growing-passive-income-this-dividend-king-abt/,2023-08-23 13:30:00,The company boasts one of the longest dividend growth streaks in the healthcare sector.,ABT,0.111488,0.045578,Neutral
Medtronic raises forecast as demand for heart devices powers upbeat results,https://www.reuters.com/business/healthcare-pharmaceuticals/medtronic-raises-annual-forecast-demand-medical-procedures-picks-up-2023-08-22/,2023-08-22 11:53:00,"Medtronic Plc logo is seen displayed in this illustration taken, April 10, 2023. REUTERS/Dado Ruvic/Illustration/File Photo Acquire Licensing Rights",ABT,0.132368,0.0,Neutral
This Is What Whales Are Betting On Abbott Laboratories - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/markets/options/23/08/33971657/this-is-what-whales-are-betting-on-abbott-laboratories,2023-08-21 20:16:01,"Someone with a lot of money to spend has taken a bearish stance on Abbott Laboratories ABT. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",ABT,0.812186,0.206387,Somewhat-Bullish
2 Healthcare Stocks You Can Buy and Hold for the Next Decade,https://www.fool.com/investing/2023/08/19/2-healthcare-stocks-you-can-buy-and-hold-for-the/,2023-08-19 12:23:00,Investors can expect steady returns from these two longtime market-beaters.,ABT,0.254042,0.209765,Somewhat-Bullish
"Down 4% to 17%, These Monster Dividend Stocks Could Be Picking Up Steam",https://www.fool.com/investing/2023/08/19/down-4-to-17-these-monster-dividend-stocks-could-b/,2023-08-19 10:05:00,These companies have shown they can increase their lucrative dividends regardless of company struggles in recent times.,ABT,0.214937,0.141485,Neutral
Pain Management Devices Market size to grow by USD 2.70 billion from 2022 to 2027 | Technological advances in ... - PR Newswire,https://www.prnewswire.com/news-releases/pain-management-devices-market-size-to-grow-by-usd-2-70-billion-from-2022-to-2027--technological-advances-in-ablation-devices-are-major-trends---technavio-301904152.html,2023-08-19 04:15:00,Pain Management Devices Market size to grow by USD 2.70 billion from 2022 to 2027 | Technological advances in ... PR ...,ABT,0.048425,-0.103848,Neutral
"Ferid Murad, Nobelist Who Saw How a Gas Can Aid the Heart, Dies at 86",https://www.nytimes.com/2023/09/06/science/ferid-murad-nobelist-dead.html,2023-09-06 19:08:04,"Ferid Murad, a pharmacologist whose research into the effects of nitric oxide on the heart and blood vessels enabled widespread advancements in the treatment of cardiovascular disease, hypertension and erectile dysfunction, and which earned him a share in a Nobel Prize in 1998, died on Monday at ...",ABT,0.046633,0.039842,Neutral
Looking At Abbott Laboratories's Recent Unusual Options Activity - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/markets/options/23/09/34290407/looking-at-abbott-laboratoriess-recent-unusual-options-activity,2023-09-06 18:32:00,"Someone with a lot of money to spend has taken a bearish stance on Abbott Laboratories ABT. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga. Whether this is an institution or just a wealthy individual, we don't know.",ABT,0.720958,0.166616,Somewhat-Bullish
Abbott  ( ABT )  to Advance Diabetes Care With New Acquisition,https://www.zacks.com/stock/news/2145513/abbott-abt-to-advance-diabetes-care-with-new-acquisition,2023-09-06 14:27:00,Abbott's (ABT) recent deal will enable it to create more interconnected solutions to improve the personalization and accuracy of diabetes control.,ABT,0.116914,0.237581,Somewhat-Bullish
"Down 10.3%, Is Abbott Laboratories Stock a Buy on the Dip?",https://www.fool.com/investing/2023/09/05/down-103-is-abbott-laboratories-stock-a-buy-on-the/,2023-09-05 16:00:41,Its latest pullback could be an opportunity to buy a legendary dividend stock before it begins a long upward climb.,ABT,0.25168,0.24504,Somewhat-Bullish
Abbott's  ( ABT )  New Positive Data Favors OCT in Stent Implantation,https://www.zacks.com/stock/news/2144476/abbotts-abt-new-positive-data-favors-oct-in-stent-implantation,2023-09-04 16:18:00,Abbott's (ABT) latest late-breaking data reflects OCT's potential to improve clinical practice related to stent placement.,ABT,0.099271,0.057134,Neutral
"Decoding the Global Vasectomy Market 2023: Trends, Strategies, and Regulatory Insights",https://www.prnewswire.com/news-releases/decoding-the-global-vasectomy-market-2023-trends-strategies-and-regulatory-insights-301916835.html,2023-09-04 16:00:00,"DUBLIN, Sept. 4, 2023 /PRNewswire/ -- The ""Global Vasectomy Market ( 2023-2028 ) by Drug, Type, Patients, End Users, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis"" report has been added to ResearchAndMarkets.com's offering.",ABT,0.088147,0.211476,Somewhat-Bullish
Healthcare IT market in Saudi Arabia is set to grow by USD 1.6032 billion from 2022 to 2027 | A remarkable increase in ... - PR Newswire,https://www.prnewswire.com/news-releases/healthcare-it-market-in-saudi-arabia-is-set-to-grow-by-usd-1-6032-billion-from-2022-to-2027--a-remarkable-increase-in-the-detection-of-chronic-diseases-drives-growth---technavio-301915537.html,2023-09-03 05:00:00,Healthcare IT market in Saudi Arabia is set to grow by USD 1.6032 billion from 2022 to 2027 | A remarkable increase in ... PR ...,ABT,0.061949,0.0,Neutral
2 Incredible Stocks to Buy on the Dip,https://www.fool.com/investing/2023/09/02/2-incredible-stocks-to-buy-on-the-dip/,2023-09-02 10:00:00,Today's bargain may pay off big down the road.,ABT,0.120733,0.042502,Neutral
Enanta Pharmaceuticals  ( NASDAQ:ENTA )  Lowered to Sell at StockNews.com,https://www.defenseworld.net/2023/09/02/enanta-pharmaceuticals-nasdaqenta-lowered-to-sell-at-stocknews-com.html,2023-09-02 08:38:44,Enanta Pharmaceuticals ( NASDAQ:ENTA ) Lowered to Sell at ... Defense World ...,ABT,0.059935,-0.03323,Neutral
"The Zacks Analyst Blog Highlights Oracle, Abbott Laboratories, Sanofi, Realty Income and Hilton Worldwide Holdings",https://www.zacks.com/stock/news/2143655/the-zacks-analyst-blog-highlights-oracle-abbott-laboratories-sanofi-realty-income-and-hilton-worldwide-holdings,2023-09-01 13:09:00,"Oracle, Abbott Laboratories, Sanofi, Realty Income and Hilton Worldwide Holdings are part of the Zacks top Analyst Blog.",ABT,0.213674,0.051951,Neutral
Virax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth Momentum,https://www.prnewswire.com/news-releases/virax-biolabs-group-appoints-dr-nigel-mccracken-as-chief-operating-officer-to-oversee-growth-momentum-301915423.html,2023-09-01 11:30:00,"LONDON, Sept. 1, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ( ""Virax"" or the ""Company"" ) ( Nasdaq: VRAX ) , an innovative diagnostics company focused on the detection of immune responses and diagnosis of viral diseases, announced today the appointment of Dr. Nigel McCracken as the ...",ABT,0.041901,0.178822,Somewhat-Bullish
Peering Into Abbott Laboratories's Recent Short Interest - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/short-sellers/23/08/34152263/peering-into-abbott-laboratoriess-recent-short-interest,2023-08-31 17:00:40,"Abbott Laboratories's ABT short percent of float has risen 5.71% since its last report. The company recently reported that it has 12.77 million shares sold short, which is 0.74% of all regular shares that are available for trading.",ABT,0.221819,0.155473,Somewhat-Bullish
Abbott's  ( ABT )  Libre Gains Momentum Amid Low Testing Sales,https://www.zacks.com/stock/news/2143055/abbotts-abt-libre-gains-momentum-amid-low-testing-sales,2023-08-31 14:36:00,"Banking on the successful execution of Abbott's (ABT) branded generic operating model, EPD is well positioned for sustained growth in many of the growing pharmaceutical markets.",ABT,0.182967,0.140379,Neutral
2 Unstoppable Growth Stocks to Buy in 2023 and Beyond,https://www.fool.com/investing/2023/08/31/2-unstoppable-growth-stocks-to-buy-in-2023-and-bey/,2023-08-31 12:30:00,These reliable dividend payers are a fantastic opportunity for investors to generate passive income.,ABT,0.104911,0.195899,Somewhat-Bullish
US FDA warns 3 baby formula makers to correct manufacturing process controls,https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-issues-warning-letters-three-baby-formula-manufacturers-2023-08-30/,2023-08-30 21:33:00,"Signage is seen outside of the Food and Drug Administration ( FDA ) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo Acquire Licensing Rights Aug 30 ( Reuters ) - The U.S.",ABT,0.130926,0.023295,Neutral
FDA warns three baby-formula makers about production violations,https://www.marketwatch.com/story/fda-warns-three-baby-formula-makers-about-production-violations-b83192e9,2023-08-30 21:15:00,The FDA Wednesday sent warning letters to three baby-formula makers as part of what the agency called enhanced oversight of a product plagued by recalls and shortages.,ABT,0.259727,-0.087374,Neutral
"Top Dividend Stocks: In Biotech Space, AbbVie Entices With 4% Yield",https://www.investors.com/research/the-income-investor/dividend-stock-in-biotech-space-abbvie-entices-with-four-percent-yield/,2023-08-30 18:26:00,"For investors looking for yield in the biotech sector, AbbVie ( ABBV ) is a strong candidate for investment and is in IBD's Dividend Leaders screen. It's a top dividend stock to buy and watch. Headquartered in Chicago, AbbVie is a large-cap pharmaceutical company formed from a 2013 spinoff from ...",ABT,0.205807,0.0,Neutral
How Lawmakers Want To Stop Cronobacter Outbreaks That Spurred Baby Formula Shortage Last Year - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/large-cap/23/08/34094361/how-lawmakers-want-to-stop-cronobacter-outbreaks-that-spurred-baby-formula-shortage-last-year,2023-08-29 17:20:04,"Under bipartisan Congressional legislation, baby formula manufacturers must notify the U.S. Food and Drug Administration ( FDA ) within 24 hours about product contamination in various circumstances to prevent and quickly halt any future outbreaks of cronobacter bacteria that resulted in severe ...",ABT,0.492659,-0.365836,Bearish
Nearing Retirement? These Stocks Will Pay You For Life,https://www.fool.com/investing/2023/08/29/nearing-retirement-these-stocks-will-pay-you-for/,2023-08-29 13:45:00,These companies are passive income machines.,ABT,0.051999,0.069013,Neutral
Apple Taps Seasoned Executive To Head 'Secret' Team Developing Glucose Monitoring Device - Stocks To Watch - Apple  ( NASDAQ:AAPL ) ,https://www.benzinga.com/news/large-cap/23/09/34623127/apple-taps-seasoned-executive-to-head-secret-team-developing-glucose-monitoring-device-stocks-to-w,2023-09-15 17:46:53,"Apple Inc AAPL has appointed Tim Millet, a seasoned executive with a background in iPhone and Mac chip technology, to oversee its secretive team dedicated to developing a noninvasive blood sugar monitor, signaling a significant move in the company's health technology endeavors.",ABT,0.228073,0.176207,Somewhat-Bullish
2 Dividend Kings to Buy on the Dip and Hold Forever,https://www.fool.com/investing/2023/09/15/2-dividend-kings-buy-on-the-dip-and-hold-forever/,2023-09-15 13:15:00,Don't ignore these stocks just because the rest of the market is.,ABT,0.282234,0.065262,Neutral
Why Jim Cramer Warns Investors To Avoid This Stock Up Over 90% This Year - Roku  ( NASDAQ:ROKU ) ,https://www.benzinga.com/trading-ideas/long-ideas/23/09/34601046/why-jim-cramer-warns-investors-to-avoid-this-stock-up-over-90-this-year,2023-09-15 12:40:00,"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said UiPath Inc. PATH is a ""decent"" stock. Cramer said the company is not making money, and he doesn't recommend stocks that don't make money. ""If they start making money, we will rethink,"" he added. When asked about Kenvue Inc.",ABT,0.320974,0.217466,Somewhat-Bullish
Could Abbott Laboratories Stock Help You Become a Millionaire?,https://www.fool.com/investing/2023/09/15/abbott-laboratories-stock-help-become-millionaire/,2023-09-15 09:20:00,"One promising area of its business is diabetes care, which experienced significant growth this year.",ABT,0.524949,0.273815,Somewhat-Bullish
Apple Inc taps new leader for 'secret' team developing glucose tracker,https://www.business-standard.com/technology/tech-news/apple-inc-taps-new-leader-for-secret-team-developing-glucose-tracker-123091500147_1.html,2023-09-15 03:16:18,"Apple Inc. has named a new leader for its secret group working on a noninvasive blood sugar monitor, putting a veteran iPhone and Mac chip executive in charge of one of the company's most ambitious forays into health technology.",ABT,0.076847,-0.028784,Neutral
"If You Invested $100 In This Stock 10 Years Ago, You Would Have $300 Today - Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/news/earnings/23/09/34594079/if-you-invested-100-in-this-stock-10-years-ago-you-would-have-300-today,2023-09-14 20:30:37,"Abbott Laboratories ABT has outperformed the market over the past 10 years by 1.12% on an annualized basis producing an average annual return of 11.16%. Currently, Abbott Laboratories has a market capitalization of $178.13 billion.",ABT,0.980595,0.386944,Bullish
Goa state warns Abbott India on antacid Digene license suspension,https://www.business-standard.com/companies/news/goa-state-warns-abbott-india-on-antacid-digene-license-suspension-123091400842_1.html,2023-09-14 12:07:53,"India's Goa state has warned the local unit of Abbott Laboratories it plans to suspend the manufacturing license of its popular antacid medicine after inspectors flagged contamination risks and sanitization issues at its factory, government documents show.",ABT,0.079656,-0.244966,Somewhat-Bearish
Goa state warns Abbott India on antacid license suspension,https://www.reuters.com/business/healthcare-pharmaceuticals/goa-state-warns-abbott-india-antacid-license-suspension-2023-09-14/,2023-09-14 11:14:00,"An Abbott company logo is pictured at the reception of its office in Mumbai, India, September 8, 2015. REUTERS/Shailesh Andrade/File Photo Acquire Licensing Rights",ABT,0.117486,-0.24155,Somewhat-Bearish
Coronary Stents Market worth $13.87 Billion by 2025 - Exclusive Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/09/g34536532/coronary-stents-market-worth-13-87-billion-by-2025-exclusive-report-by-the-insight-partners,2023-09-13 13:23:47,"Pune, India, Sept. 13, 2023 ( GLOBE NEWSWIRE ) -- Coronary stents are a kind of little mesh metal tubes that are developed for providing support to the weakened arteries within the heart.",ABT,0.035502,-0.015663,Neutral
"COVID-19 Diagnostics Market Revenue to Cross USD 45.8 billion by 2031, Registering a Negative 7.9% CAGR Says, Transparency Market Research",https://www.benzinga.com/pressreleases/23/09/g34527619/covid-19-diagnostics-market-revenue-to-cross-usd-45-8-billion-by-2031-registering-a-negative-7-9-c,2023-09-13 10:20:24,"Wilmington, Delaware, United States, Sept. 13, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The COVID-19 diagnostics market was estimated to have acquired US$ 79.8 billion in 2021. It is anticipated to register a -7.9% CAGR from 2022 to 2031 and by 2031 the market is likely to ...",ABT,0.040622,0.109967,Neutral
Is Abbott Laboratories a Buy?,https://www.fool.com/investing/2023/09/12/is-abbott-laboratories-a-buy/,2023-09-12 13:45:00,"If you're willing to invest with the right mindset, it could be a great option.",ABT,0.243498,0.156142,Somewhat-Bullish
Enanta Pharmaceuticals  ( NASDAQ:ENTA )  Upgraded to Hold at StockNews.com,https://www.defenseworld.net/2023/09/12/enanta-pharmaceuticals-nasdaqenta-upgraded-to-hold-at-stocknews-com.html,2023-09-12 07:46:45,Enanta Pharmaceuticals ( NASDAQ:ENTA ) Upgraded to Hold at ... Defense World ...,ABT,0.056808,0.043135,Neutral
Smart Healthcare Market to grow by USD 115.39 billion from 2022-2027; North America to account for 43% of market ... - PR Newswire,https://www.prnewswire.com/news-releases/smart-healthcare-market-to-grow-by-usd-115-39-billion-from-2022-2027-north-america-to-account-for-43-of-market-growth---technavio-301922137.html,2023-09-11 07:15:00,Smart Healthcare Market to grow by USD 115.39 billion from 2022-2027. North America to account for 43% of market ... PR ...,ABT,0.05234,0.0,Neutral
3 No-Brainer Dividend Stocks to Buy No Matter What the Market Is Doing,https://www.fool.com/investing/2023/09/09/3-no-brainer-dividend-stocks-to-buy-no-matter-what/,2023-09-09 09:00:00,You'll want to hold on to these players for the long term.,ABT,0.107978,0.177943,Somewhat-Bullish
"Blood Market to grow by USD 2,195.69 million from 2022 to 2027, North America to account for 40% of market growth ... - PR Newswire",https://www.prnewswire.com/news-releases/blood-market-to-grow-by-usd-2-195-69-million-from-2022-to-2027--north-america-to-account-for-40-of-market-growth---technavio-301921622.html,2023-09-08 23:35:00,"Blood Market to grow by USD 2,195.69 million from 2022 to 2027, North America to account for 40% of market growth ... PR ...",ABT,0.045139,0.118202,Neutral
"Cataract Surgery Devices And Equipment Market Analysis 2023-2027: Projected Market Size, Key Drivers, And Major Segments As Per The Business Research Company's Cataract Surgery Devices And Equipment Global Market Report 2023",https://www.benzinga.com/pressreleases/23/09/g34915104/cataract-surgery-devices-and-equipment-market-analysis-2023-2027-projected-market-size-key-drivers,2023-09-26 15:30:00,"LONDON, Sept. 26, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Cataract Surgery Devices And Equipment Global Market Report 2023, the global cataract surgery devices and equipment market is on a remarkable growth trajectory, with a projected market size of $7.11 billion in ...",ABT,0.118064,0.122673,Neutral
Prestige Consumer  ( PBH )  Stock Rallies 20% in a Year: Here's Why,https://www.zacks.com/stock/news/2155487/prestige-consumer-pbh-stock-rallies-20-in-a-year-heres-why,2023-09-26 13:56:00,Prestige Consumer (PBH) benefits from a robust healthcare brand portfolio and solid demand.,ABT,0.269033,-0.036184,Neutral
Here's Why Investors Should Invest in Abbott  ( ABT )  Stock Now,https://www.zacks.com/stock/news/2155467/heres-why-investors-should-invest-in-abbott-abt-stock-now,2023-09-26 12:48:00,Investors are optimistic about Abbott (ABT) on strong growth in the Diagnostics business and upbeat guidance.,ABT,0.101367,0.072794,Neutral
5 Dividend Aristocrats to Buy as Things Look Dicey for Wall Street,https://www.zacks.com/stock/news/2155371/5-dividend-aristocrats-to-buy-as-things-look-dicey-for-wall-street,2023-09-26 12:03:00,"As stocks are subjected to bouts of volatility, place bets on dividend aristocrats like Caterpillar (CAT), Abbott Laboratories (ABT), McDonald's (MCD), Aflac (AFL) and Automatic Data Processing (ADP) for steady income.",ABT,0.223248,0.063275,Neutral
Cardiovascular Information System (CVIS) Market size to grow by USD 582.77 million from 2022-2027| Abbott ... - PR Newswire,https://www.prnewswire.com/news-releases/cardiovascular-information-system-cvis-market-size-to-grow-by-usd-582-77-million-from-2022-2027-abbott-laboratories-fujifilm-corp-and-general-electric-co-are-some-of-the-emerging-companies-in-the-market---technavio-301936347.html,2023-09-25 23:15:00,Cardiovascular Information System ( CVIS ) Market size to grow by USD 582.77 million from 2022-2027| Abbott ... PR ...,ABT,0.107016,0.110671,Neutral
"Electrophysiology Catheters Market size to grow by USD 2.24 billion from 2022-2027| Abbott Laboratories, Acutus ... - PR Newswire",https://www.prnewswire.com/news-releases/electrophysiology-catheters-market-size-to-grow-by-usd-2-24-billion-from-2022-2027-abbott-laboratories-acutus-medical-inc-and-johnson-and-johnson-are-some-of-the-major-companies-in-the-market---technavio-301936344.html,2023-09-25 21:15:00,"Electrophysiology Catheters Market size to grow by USD 2.24 billion from 2022-2027| Abbott Laboratories, Acutus ... PR ...",ABT,0.127456,0.074271,Neutral
Looking At Abbott Laboratories's Recent Unusual Options Activity - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/markets/options/23/09/34878163/looking-at-abbott-laboratoriess-recent-unusual-options-activity,2023-09-25 19:16:01,A whale with a lot of money to spend has taken a noticeably bearish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories ABT we detected 11 strange trades.,ABT,0.718897,0.057628,Neutral
"Leading Companies Like Medtronic, Abbott Laboratories, and Boston Scientific Corp. Spearhead Innovation in the Neuroprosthetics Market Amid Technological Advancements and Regulatory Support",https://www.prnewswire.com/news-releases/leading-companies-like-medtronic-abbott-laboratories-and-boston-scientific-corp-spearhead-innovation-in-the-neuroprosthetics-market-amid-technological-advancements-and-regulatory-support-301937588.html,2023-09-25 16:30:00,"Leading Companies Like Medtronic, Abbott Laboratories, and Boston Scientific Corp. Spearhead Innovation in the ... PR ...",ABT,0.071145,0.13405,Neutral
Abbott  ( ABT )  Closes Acquisition Deal of Bigfoot Biomedical,https://www.zacks.com/stock/news/2154825/abbott-abt-closes-acquisition-deal-of-bigfoot-biomedical,2023-09-25 12:35:00,Abbott's (ABT) footprint in the diabetes care market is increased by the Bigfoot Biomedical acquisition.,ABT,0.113062,0.08948,Neutral
Should You Invest in the iShares U.S. Medical Devices ETF  ( IHI ) ?,https://www.zacks.com/stock/news/2154632/should-you-invest-in-the-ishares-us-medical-devices-etf-ihi,2023-09-25 10:20:07,Sector ETF report for IHI ...,ABT,0.128135,0.069783,Neutral
Baby Food Market size to hit USD 122.81 Bn by 2029 at a CAGR 6.2 percent - says Maximize Market Research,https://www.benzinga.com/pressreleases/23/09/g34850149/baby-food-market-size-to-hit-usd-122-81-bn-by-2029-at-a-cagr-6-2-percent-says-maximize-market-rese,2023-09-25 07:14:56,"Pune, Sept. 25, 2023 ( GLOBE NEWSWIRE ) -- As per the report published by Maximize Market Research, the global Baby Food Market was USD 80.60 Bn in 2022 and is expected to reach USD 122.81 Bn with a CAGR of 6.2 percent by the end of 2029.",ABT,0.030102,0.0,Neutral
The Thyroid Gland Disorder Treatment Market to grow by USD 868.87 million from 2022 to 2027 | Abbott Laboratories ... - PR Newswire,https://www.prnewswire.com/news-releases/the-thyroid-gland-disorder-treatment-market-to-grow-by-usd-868-87-million-from-2022-to-2027--abbott-laboratories-abbvie-inc-alvogen-iceland-ehf-and-more-among-key-companies--technavio-301936306.html,2023-09-25 02:15:00,The Thyroid Gland Disorder Treatment Market to grow by USD 868.87 million from 2022 to 2027 | Abbott Laboratories ... PR ...,ABT,0.077845,0.027652,Neutral
"Consumer Healthcare Market to grow by USD 189.13 billion from 2022 to 2027, North America to account for 33% of ... - PR Newswire",https://www.prnewswire.com/news-releases/consumer-healthcare-market-to-grow-by-usd-189-13-billion-from-2022-to-2027--north-america-to-account-for-33-of-market-growth--technavio-301935802.html,2023-09-24 20:35:00,"Consumer Healthcare Market to grow by USD 189.13 billion from 2022 to 2027, North America to account for 33% of ... PR ...",ABT,0.052918,0.0,Neutral
3 Best Stocks to Buy in September and Hold Forever,https://www.fool.com/investing/2023/09/24/3-best-stocks-to-buy-in-september-and-hold-forever/,2023-09-24 11:41:00,Healthcare blue chip stocks with proven track records can be excellent long-term investments.,ABT,0.110209,0.0,Neutral
"POC HIV Testing Market to grow by USD 290.77 million from 2022-2027, Asia to account for 33% of market growth ... - PR Newswire",https://www.prnewswire.com/news-releases/poc-hiv-testing-market-to-grow-by-usd-290-77-million-from-2022-2027--asia-to-account-for-33-of-market-growth---technavio-301935792.html,2023-09-24 10:15:00,"POC HIV Testing Market to grow by USD 290.77 million from 2022-2027, Asia to account for 33% of market growth ... PR ...",ABT,0.098659,0.0581,Neutral
Abbott Stock: Bear vs. Bull,https://www.fool.com/investing/2023/09/23/abbott-stock-bear-vs-bull/,2023-09-23 13:15:00,"Abbott is a favorite of income-oriented investors, but is the price right?",ABT,0.111747,0.252498,Somewhat-Bullish
Smarter Science: How Laboratory Automation Is Shaping the Future of Research and Diagnostics,https://www.prnewswire.com/news-releases/smarter-science-how-laboratory-automation-is-shaping-the-future-of-research-and-diagnostics-301936087.html,2023-09-22 22:15:00,"DUBLIN, Sept. 22, 2023 /PRNewswire/ -- The ""Laboratory Automation Market - A Global Market and Regional Analysis: Focus on Product, Application, End User, and Region - Analysis and Forecast, 2023-2033"" report has been added to ResearchAndMarkets.com's offering.",ABT,0.050359,0.118287,Neutral
Abbott India warns of potential laxative syrup shortages amid production halt,https://www.foxbusiness.com/fox-news-world/abbott-india-warns-potential-laxative-syrup-shortages-amid-production-halt,2023-09-22 20:49:41,"Abbott Laboratories' Indian unit has warned of potential supply shortages of two popular laxative syrups after production was prohibited in India's Goa state, where drug inspectors have found lapses at a company factory, a letter shows.",ABT,0.096671,-0.024845,Neutral
"Global COVID-19 Testing Strategic Business Report 2023: Market to Reach $5.8 Billion by 2030, Declining by 16.3% - US and Europe Dominate, Asia-Pacific to Witness Fastest Growth",https://www.prnewswire.com/news-releases/global-covid-19-testing-strategic-business-report-2023-market-to-reach-5-8-billion-by-2030--declining-by-16-3---us-and-europe-dominate-asia-pacific-to-witness-fastest-growth-301936075.html,2023-09-22 18:45:00,"Global COVID-19 Testing Strategic Business Report 2023: Market to Reach $5.8 Billion by 2030, Declining by 16.3 ... PR ...",ABT,0.048919,0.121643,Neutral
P/E Ratio Insights for Abbott Laboratories - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/23/09/34829275/pe-ratio-insights-for-abbott-laboratories,2023-09-22 17:15:23,"In the current session, Abbott Laboratories Inc. ABT is trading at $98.52, after a 0.42% drop. Over the past month, the stock decreased by 5.46%, and in the past year, by 1.33%. With performance like this, long-term shareholders are more likely to start looking into the company's ...",ABT,0.371523,-0.036439,Neutral
2 Healthcare Stocks That Could Make You Richer,https://www.fool.com/investing/2023/09/22/2-healthcare-stocks-that-could-make-you-richer/,2023-09-22 14:07:00,They've beaten the market before.,ABT,0.058759,0.141,Neutral
Abbott India warns of laxatives shortage in tussle with Goa regulator,https://www.business-standard.com/companies/news/abbott-india-warns-of-laxatives-shortage-in-tussle-with-goa-regulator-123092201055_1.html,2023-09-22 13:51:39,"Abbott Laboratories' Indian unit has warned of potential supply shortages of two popular laxative syrups after production was prohibited in India's Goa state, where drug inspectors have found lapses at a company factory, a letter shows.",ABT,0.101582,-0.025239,Neutral
Abbott India warns of laxatives shortage in tussle with Goa regulator,https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-india-warns-laxatives-shortage-tussle-with-goa-regulator-2023-09-22/,2023-09-22 13:18:00,"A worker waters plants next to an advertisement billboard of Abbott in Mumbai, India, November 12, 2015. To match Special Report INDIA-MEDICINE/ABBOTT REUTERS/Danish Siddiqui/File Photo Acquire Licensing Rights",ABT,0.09186,-0.022281,Neutral
Biopsy Market to grow at a CAGR of 11.14% during the forecast period reaching USD 61.03 Bn. by 2029 - says Maximize Market Research,https://www.benzinga.com/pressreleases/23/09/g34788934/biopsy-market-to-grow-at-a-cagr-of-11-14-during-the-forecast-period-reaching-usd-61-03-bn-by-2029-,2023-09-21 11:41:19,"Pune, Sept. 21, 2023 ( GLOBE NEWSWIRE ) -- A global healthcare business-consulting firm, Maximize Market Research, has published a market intelligence and competitive landscape report on the ""Biopsy Market"".",ABT,0.029618,0.028382,Neutral
This Is What Whales Are Betting On Abbott Laboratories - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/markets/options/23/09/34772110/this-is-what-whales-are-betting-on-abbott-laboratories,2023-09-20 19:33:50,A whale with a lot of money to spend has taken a noticeably bearish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories ABT we detected 10 strange trades.,ABT,0.802374,0.228994,Somewhat-Bullish
Abbott  ( ABT )  Broadens Electrophysiology Footprint With TactiFlex,https://www.zacks.com/stock/news/2153168/abbott-abt-broadens-electrophysiology-footprint-with-tactiflex,2023-09-20 15:07:00,"The successful deployment of Abbott's (ABT) TactiFlex Ablation Catheter, Sensor Enabled in Canada broadens the company's global footprint in the electrophysiology space.",ABT,0.157141,0.056753,Neutral
Abbott  ( ABT )  Unveils Connected Diabetes App With New Pact,https://www.zacks.com/stock/news/2153183/abbott-abt-unveils-connected-diabetes-app-with-new-pact,2023-09-20 14:18:00,"Abbott's (ABT) FreeStyle Libre portfolio is the world's top sensor-based CGM system, changing the lives of over 5 million people.",ABT,0.231332,0.056689,Neutral
 ( ABT )  - Analyzing Abbott Laboratories's Short Interest - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/short-sellers/23/09/34762496/abt-analyzing-abbott-laboratoriess-short-interest,2023-09-20 13:30:19,"Abbott Laboratories's ABT short percent of float has fallen 10.81% since its last report. The company recently reported that it has 11.47 million shares sold short, which is 0.66% of all regular shares that are available for trading.",ABT,0.221819,0.083071,Neutral
Neurological Biomarkers Market to grow by USD 6.92 billion from 2022 to 2027 | North America to account for 43% of ... - PR Newswire,https://www.prnewswire.com/news-releases/neurological-biomarkers-market-to-grow-by-usd-6-92-billion-from-2022-to-2027--north-america-to-account-for-43-of-market-growth--technavio-301929311.html,2023-09-18 05:35:00,Neurological Biomarkers Market to grow by USD 6.92 billion from 2022 to 2027 | North America to account for 43% of ... PR ...,ABT,0.056808,0.044936,Neutral
Should You Load Up On This 1 Dividend Stock?,https://www.fool.com/investing/2023/10/06/should-you-load-up-on-this-dividend-stock/,2023-10-06 14:15:00,It's not that hard a call.,ABT,0.06211,0.042032,Neutral
Looking Into Abbott Laboratories's Recent Short Interest - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/short-sellers/23/10/35126614/looking-into-abbott-laboratoriess-recent-short-interest,2023-10-06 14:00:40,"Abbott Laboratories's ABT short percent of float has fallen 7.58% since its last report. The company recently reported that it has 10.61 million shares sold short, which is 0.61% of all regular shares that are available for trading.",ABT,0.221819,0.083071,Neutral
"These diabetes stocks, pummeled by the Ozempic craze, now look like bargains, analysts say",https://www.marketwatch.com/story/these-diabetes-stocks-pummeled-by-the-ozempic-craze-now-look-like-bargains-analysts-say-30906b51,2023-10-05 13:31:00,"DexCom could be the first stock to break out of 'GLP jail,' analysts say, as market continues to punish device makers ...",ABT,0.105836,0.023242,Neutral
India Baby Care Products Market size to grow by USD 15.69 billion from 2022 to 2027 | Market is fragmented due to the ... - PR Newswire,https://www.prnewswire.com/news-releases/india-baby-care-products-market-size-to-grow-by-usd-15-69-billion-from-2022-to-2027--market-is-fragmented-due-to-the-presence-of-prominent-companies-like-abbott-laboratories-artsana-spa-bio-veda-action-research-co-and-many-mo-301944281.html,2023-10-04 23:00:00,India Baby Care Products Market size to grow by USD 15.69 billion from 2022 to 2027 | Market is fragmented due to the ... PR ...,ABT,0.07446,0.089055,Neutral
Medical-Device Stocks Dip on Kaiser Strike,https://www.barrons.com/articles/kaiser-strike-medical-devices-d8bf2422,2023-10-04 18:09:00,"The brief strike launched Wednesday by more than 75,000 workers in the sprawling Kaiser Permanente healthcare system won't badly hurt other companies right now, but points to potential trouble later this year if the two sides can't cut a deal.",ABT,0.148731,-0.036967,Neutral
3 High-Yielding Dividend Growth Stocks That Have Increased Their Payouts by 50% in 5 Years,https://www.fool.com/investing/2023/10/04/3-high-yielding-dividend-growth-stocks-that-have/,2023-10-04 13:53:00,These are relatively safe income investments that you can hold on to for the long haul.,ABT,0.056143,0.041917,Neutral
"Molecular Diagnostic for Infectious Diseases Market Size Worth $17.61 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/10/g35063825/molecular-diagnostic-for-infectious-diseases-market-size-worth-17-61-billion-globally-by-2030-excl,2023-10-03 13:29:52,"Pune, India, Oct. 03, 2023 ( GLOBE NEWSWIRE ) -- Molecular diagnostics is referred to as the detection of genomic variants, aiming to facilitate detection, diagnosis, subclassification, prognosis, and monitoring response to therapy.",ABT,0.022643,0.082167,Neutral
"The Zacks Analyst Blog Highlights Abbott Laboratories, Koninklijke Philips and Smith & Nephew",https://www.zacks.com/stock/news/2158989/the-zacks-analyst-blog-highlights-abbott-laboratories-koninklijke-philips-and-smith-nephew,2023-10-03 09:02:00,"Abbott Laboratories, Koninklijke Philips and Smith & Nephew are included in this Analyst Blog.",ABT,0.337044,0.311457,Somewhat-Bullish
Sports And Energy Drinks Market size is to grow by USD 68.29 billion from 2022 to 2027 | the market is fragmented due ... - PR Newswire,https://www.prnewswire.com/news-releases/sports-and-energy-drinks-market-size-is-to-grow-by-usd-68-29-billion-from-2022-to-2027--the-market-is-fragmented-due-to-the-presence-of-prominent-companies-like-abbott-laboratories-britvic-plc-and-biosteel-nordics-and-many-more-301943967.html,2023-10-03 01:30:00,Sports And Energy Drinks Market size is to grow by USD 68.29 billion from 2022 to 2027 | the market is fragmented due ... PR ...,ABT,0.096283,0.11068,Neutral
3 Medical Product Stocks With Solid Dividend Yield: ABT & Others,https://www.zacks.com/stock/news/2158634/3-medical-product-stocks-with-solid-dividend-yield-abt-others,2023-10-02 13:15:00,"Here we pick three stocks, Abbott Laboratories (ABT), Koninklijke Philips (PHG) and Smith & Nephew SNATS (SNN) from the Medical - Products industry, with a solid five-year dividend growth history.",ABT,0.308504,0.349187,Somewhat-Bullish
3 Revolutionary Stocks I'd Buy Right Now Without Hesitation,https://www.fool.com/investing/2023/10/01/3-revolutionary-stocks-id-buy-right-now-without-he/,2023-10-02 02:07:00,These companies are helping change medicine. they could make boatloads of money along the way.,ABT,0.228287,0.373606,Bullish
Enanta Pharmaceuticals  ( NASDAQ:ENTA )  Rating Lowered to Sell at StockNews.com,https://www.defenseworld.net/2023/10/01/enanta-pharmaceuticals-nasdaqenta-rating-lowered-to-sell-at-stocknews-com.html,2023-10-01 06:32:48,Enanta Pharmaceuticals ( NASDAQ:ENTA ) Rating Lowered to Sell at ... Defense World ...,ABT,0.056143,0.015067,Neutral
Enanta Pharmaceuticals Downgraded to Sell Rating by StockNews.com,https://www.claytoncountyregister.com/news2/enanta-pharmaceuticals-nasdaqenta-cut-to-sell-at-stocknews-com/519025/,2023-10-01 02:26:11,Enanta Pharmaceuticals Downgraded to Sell Rating by StockNews ... Clayton County Register ...,ABT,0.114682,-0.220725,Somewhat-Bearish
Healthcare at Your Fingertips: Global Mobile Medical Apps Market Skyrockets,https://www.prnewswire.com/news-releases/healthcare-at-your-fingertips-global-mobile-medical-apps-market-skyrockets-301942828.html,2023-09-29 15:45:00,"DUBLIN, Sept. 29, 2023 /PRNewswire/ -- The ""Mobile Medical Apps - Global Strategic Business Report"" has been added to ResearchAndMarkets.com's offering. In an ever-evolving digital health landscape, the global Mobile Medical Apps market stands to play an indispensable role.",ABT,0.105604,0.047939,Neutral
"Abbott Laboratories And More On CNBC's 'Final Trades' - Abbott Laboratories  ( NYSE:ABT ) , Innovator U.S. Equity Power Buffer ETF - October  ( BATS:POCT ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/09/34995204/abbott-laboratories-and-more-on-cnbcs-final-trades,2023-09-29 12:53:58,"On CNBC's ""Halftime Report Final Trades,"" Bryn Talkington of Requisite Capital Management named Innovator U.S. Equity Power Buffer ETF October POCT as her final trade. Stephen Weiss of Short Hills Capital Partners picked U.S. 10 Year Treasury Note . Don't forget to check out our premarket ...",ABT,0.56217,0.368045,Bullish
"Want $500 in Passive Income? Invest $3,500 Into These 3 Dividend Stocks and Wait 4 Years",https://www.fool.com/investing/2023/09/29/want-passive-income-invest-top-3-dividend-stocks/,2023-09-29 10:15:00,"A basket of passive income opportunities in oil and gas, renewable energy, and healthcare.",ABT,0.091509,0.138996,Neutral
Abbott Laboratories Unusual Options Activity - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/markets/options/23/09/34985123/abbott-laboratories-unusual-options-activity,2023-09-28 18:48:12,"Benzinga's options scanner just detected over 11 options trades for Abbott Laboratories ABT summing a total amount of $2,738,150. At the same time, our algo caught 2 for a total amount of 196,174.",ABT,0.685927,0.257478,Somewhat-Bullish
Why Abbott Says It Won't Be A Casualty Of The Weight-Loss Battle,https://www.investors.com/news/technology/abbott-stock-surges-after-spelling-out-bull-case-in-battle-with-weight-loss-drugs/,2023-09-28 16:22:00,Abbott Stock Surges After Spelling Our Bull Case In Battle With ... Investor's Business Daily ...,ABT,0.163909,0.052129,Neutral
"The Zacks Analyst Blog Highlights Alphabet, Exxon Mobil, Merck, Abbott Laboratories and NextEra Energy",https://www.zacks.com/stock/news/2156942/the-zacks-analyst-blog-highlights-alphabet-exxon-mobil-merck-abbott-laboratories-and-nextera-energy,2023-09-28 11:37:00,"Alphabet, Exxon Mobil, Merck, Abbott Laboratories and NextEra Energy are part of the Zacks top Analyst Blog.",ABT,0.133841,0.035561,Neutral
"Personalized Nutrition Market size to increase by USD 6.47 billion between 2022 to 2027. Abbott Laboratories, Amway ... - PR Newswire",https://www.prnewswire.com/news-releases/personalized-nutrition-market-size-to-increase-by-usd-6-47-billion-between-2022-to-2027--abbott-laboratories-amway-corp-archer-daniels-midland-co-and-more-among-key-companies---technavio-301940716.html,2023-09-28 03:35:00,"Personalized Nutrition Market size to increase by USD 6.47 billion between 2022 to 2027. Abbott Laboratories, Amway ... PR ...",ABT,0.072876,0.149816,Neutral
ABT: Abbott Laboratories  ( ABT )  Earnings Insights: Will the Medical Stock Build Investor Confidence?,https://stocknews.com/news/abt-mahly-fonr-elmd-abbott-laboratories-abt-earnings-insights-will-the-medical-stock-build/,2023-10-17 16:52:32,ABT: Abbott Laboratories ( ABT ) Earnings Insights: Will the Medical ... ...,ABT,0.664996,0.401531,Bullish
3 Supercharged Dividend Stocks to Buy if There's a Stock Market Sell-Off,https://www.fool.com/investing/2023/10/17/supercharged-dividend-stocks-buy-market-sell-off/,2023-10-17 15:32:27,These three top-notch stocks would make great additions to any dividend portfolio.,ABT,0.053271,0.125935,Neutral
Intuitive Surgical  ( ISRG )  to Post Q3 Earnings: What's in Store?,https://www.zacks.com/stock/news/2167270/intuitive-surgical-isrg-to-post-q3-earnings-whats-in-store,2023-10-17 13:07:00,"Intuitive Surgical's (ISRG) third-quarter results are likely to reflect solid performance in the Instruments & Accessories segment. However, rising costs might have hurt margins.",ABT,0.142005,-0.00628,Neutral
A Look Into Abbott Laboratories Inc's Price Over Earnings - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/23/10/35271735/a-look-into-abbott-laboratories-incs-price-over-earnings,2023-10-16 16:30:14,"In the current market session, Abbott Laboratories Inc. ABT price is at $92.73, after a 2.05% spike. However, over the past month, the stock decreased by 7.89%, and in the past year, by 11.67%.",ABT,0.428632,0.097214,Neutral
Should You Buy Abbott  ( ABT )  Ahead of Earnings?,https://www.zacks.com/stock/news/2166375/should-you-buy-abbott-abt-ahead-of-earnings,2023-10-16 12:58:00,Abbott (ABT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.,ABT,0.820009,0.582681,Bullish
Tired of Waiting for Student Debt Relief? These 20 Companies Help Employees Pay Off Their Student Loans,https://www.fool.com/student-loans/2023/10/14/student-debt-relief-these-companies-help-repayment/,2023-10-14 12:07:00,"Lots of companies pay employees with student loans $100, $200, or more per month toward repayments -- totaling up to $10,000 or more.",ABT,0.048523,-0.036866,Neutral
"Israel-Hamas War Shakes Middle East, Inflation Reawakens, Oil Surges: The Week In The Markets - United Airlines Holdings  ( NASDAQ:UAL ) , Johnson & Johnson  ( NYSE:JNJ ) , SLB  ( NYSE:SLB ) , Bank of New York Mellon  ( NYSE:BK ) ",https://www.benzinga.com/markets/equities/23/10/35248880/israel-hamas-war-shakes-middle-east-inflation-reawakens-oil-surges-the-week-in-the-markets,2023-10-13 20:33:31,"Global geopolitical developments and domestic economic data shaped investor sentiment throughout the week, sparking fresh concerns regarding the outlook for growth and inflation. The week commenced with the eruption of conflict in the Middle East involving Israel and the Palestinian militant ...",ABT,0.095517,0.0,Neutral
Abbott Laboratories Unusual Options Activity For October 12 - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/markets/options/23/10/35226852/abbott-laboratories-unusual-options-activity-for-october-12,2023-10-12 18:03:29,A whale with a lot of money to spend has taken a noticeably bullish stance on Abbott Laboratories. Looking at options history for Abbott Laboratories ABT we detected 10 strange trades.,ABT,0.718897,0.306771,Somewhat-Bullish
"The Global In Vitro Toxicology Testing Market is Poised for Exponential Growth and is Expected to Reach USD 64,094.9 Million by 2030 | Infinium Global Research",https://www.prnewswire.com/news-releases/the-global-in-vitro-toxicology-testing-market-is-poised-for-exponential-growth-and-is-expected-to-reach-usd-64-094-9-million-by-2030--infinium-global-research-301954579.html,2023-10-12 10:15:00,The Global In Vitro Toxicology Testing Market is Poised for Exponential Growth and is Expected to Reach USD ... PR ...,ABT,0.042647,0.0,Neutral
Mankind Pharma's Founders Map Growth Plan After Pulling Off Major IPO,https://www.forbes.com/sites/anuraghunathan/2023/10/11/mankind-pharmas-founders-map-growth-plan-after-pulling-off-major-ipo/,2023-10-11 21:04:53,Juneja brothers eye a spot among India's top three sales leaders by expanding into bigger cities and selling more expensive medications.,ABT,0.017955,0.008828,Neutral
Abbott Laboratories Explores Consumer Wearables Market As COVID Testing Sales Dwindle: CEO - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/23/10/35188793/abbott-laboratories-explores-consumer-wearables-market-as-covid-testing-sales-dwindle-ceo,2023-10-11 13:29:21,"Abbott Laboratories ABT CEO Robert Ford, while speaking at the HLTH conference in Las Vegas, outlined the company's strategic move into the consumer wearables market.",ABT,0.364275,0.126805,Neutral
3 Reasons to Buy Abbott Laboratories Stock,https://www.fool.com/investing/2023/10/11/3-reasons-to-buy-abbott-laboratories-stock/,2023-10-11 13:15:00,Don't just focus on the recent past.,ABT,0.20279,0.116099,Neutral
"Jim Cramer Is 'A Seller' Of This Company Because 'Elon Musk Said That He Doesn't Like That Business' - Abbott Laboratories  ( NYSE:ABT ) , Albemarle  ( NYSE:ALB ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/10/35184085/jim-carmer-is-a-seller-of-this-company-because-elon-musk-said-that-he-doesnt-like-that-b,2023-10-11 12:51:18,"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said Abbott Laboratories ABT is a ""very good company and will be up to the-let's say-up to the challenge. I think that's fair. You're getting a premium company at a very low multiple that is doing a lot right."" When asked about Herbalife Ltd.",ABT,0.299478,0.0501,Neutral
"As Covid testing business drops, Abbott searches for new line of business with consumer wearables",https://www.cnbc.com/2023/10/10/abbott-ceo-robert-ford-at-hlth-pushing-into-wearables-as-covid-fades.html,2023-10-10 16:50:26,Abbott is working to bring a new glucose-tracking wearable called Lingo to U.S. consumers next year ...,ABT,0.048621,0.0,Neutral
What's in Store for Abbott Laboratories  ( ABT )  in Q3 Earnings?,https://www.zacks.com/stock/news/2163489/whats-in-store-for-abbott-laboratories-abt-in-q3-earnings,2023-10-10 14:09:00,Abbott Laboratories' (ABT) third-quarter 2023 results are likely to reflect solid underlying base business organic sales growth.,ABT,0.124809,0.0,Neutral
2 Magnificent Dividend Stocks to Buy Hand Over Fist in October,https://www.fool.com/investing/2023/10/09/2-magnificent-dividend-stocks-to-buy-hand-over-fis/,2023-10-09 14:15:00,These two healthcare stocks are reliable passive income vehicles.,ABT,0.055621,0.202953,Somewhat-Bullish
"High Protein-Based Food Market to increase by USD 40.67 billion from 2022 to 2027, The market share growth of the ... - PR Newswire",https://www.prnewswire.com/news-releases/high-protein-based-food-market-to-increase-by-usd-40-67-billion-from-2022-to-2027--the-market-share-growth-of-the-protein-rich-drinks-segment-will-be-significant-during-the-forecast-period---technavio-301969656.html,2023-10-27 20:15:00,"High Protein-Based Food Market to increase by USD 40.67 billion from 2022 to 2027, The market share growth of the ... PR ...",ABT,0.073321,0.018224,Neutral
"MedTech Giant DexCom Spotlight Is On G7 US Launch, Analyst Forecasts 22% Revenue Gain In 2024 - DexCom  ( NASDAQ:DXCM ) ",https://www.benzinga.com/analyst-ratings/analyst-color/23/10/35468867/medtech-giant-dexcom-spotlight-is-on-g7-us-launch-analyst-forecasts-22-revenue-gain,2023-10-27 18:15:50,"Oppenheimer analyst Steven Lichtman reiterated the Outperform rating on DexCom, Inc. DXCM, with a reduced price target of $122 from $150. With an underpenetrated patient population and robust pipeline, Lichtman forecasts strong sales growth over the next several years for DexCom.",ABT,0.262522,0.063564,Neutral
"Integer Holdings  ( ITGR )  Q3 Earnings Top Estimates, FY23 View Up",https://www.zacks.com/stock/news/2173867/integer-holdings-itgr-q3-earnings-top-estimates-fy23-view-up,2023-10-27 15:35:00,"Integer Holdings' (ITGR) third-quarter results reflect robust Medical Sales, along with strength in the majority of the product lines.",ABT,0.073098,0.0,Neutral
"Merit Medical  ( MMSI )  Q3 Earnings Top Estimates, FY23 View Revised",https://www.zacks.com/stock/news/2173855/merit-medical-mmsi-q3-earnings-top-estimates-fy23-view-revised,2023-10-27 15:16:00,Merit Medical (MMSI) benefits from revenue growth in both segments and all product categories within its Cardiovascular unit in the third quarter.,ABT,0.069294,0.0,Neutral
"DexCom  ( DXCM )  Beats on Q3 Earnings, Raises Sales Outlook",https://www.zacks.com/stock/news/2173560/dexcom-dxcm-beats-on-q3-earnings-raises-sales-outlook,2023-10-27 11:30:00,DexCom's (DXCM) third-quarter 2023 results reflect strong domestic and international revenue growth on the back of its real-time Continuous Glucose Monitoring system.,ABT,0.091684,0.0,Neutral
Biotechnology reagents market size to increase by USD 36.01 billion | the high usage of biotechnology reagents in ... - PR Newswire,https://www.prnewswire.com/news-releases/biotechnology-reagents-market-size-to-increase-by-usd-36-01-billion--the-high-usage-of-biotechnology-reagents-in-diagnostic-and-therapeutic-applications-drives-market-growth--technavio-301969558.html,2023-10-27 07:15:00,Biotechnology reagents market size to increase by USD 36.01 billion | the high usage of biotechnology reagents in ... PR ...,ABT,0.062597,0.0,Neutral
"FDA warns about giving probiotics to preterm babies after infant death, other injuries",https://apnews.com/article/probiotics-infants-fda-abbott-infinant-d7c461459ff2d4c26a73a862cab8f6fb,2023-10-26 19:26:00,The U.S. Food and Drug Administration is and the public about injuries and at least one death in premature infants who were given probiotic products in the hospital.,ABT,0.107495,-0.06028,Neutral
Abbott to cease sale of infant probiotic products after FDA warning,https://www.reuters.com/business/healthcare-pharmaceuticals/fda-issues-warning-letter-abbott-probiotic-products-infants-2023-10-26/,2023-10-26 16:01:00,"Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange ( NYSE ) in New York City, U.S., October 18, 2021. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",ABT,0.252987,-0.128449,Neutral
Boston Scientific lifts earnings forecast on solid demand for heart devices,https://www.reuters.com/business/healthcare-pharmaceuticals/boston-scientific-beats-quarterly-profit-estimates-strength-heart-devices-unit-2023-10-26/,2023-10-26 15:13:00,"Oct 26 ( Reuters ) - Boston Scientific ( BSX.N ) raised its annual profit forecast on Thursday, banking on strong demand for heart devices including its stroke prevention product, Watchman, and a recovery in demand for elective surgeries.",ABT,0.124164,0.345723,Somewhat-Bullish
"CONMED  ( CNMD )  Beats on Q3 Earnings, Ups '23 EPS View",https://www.zacks.com/stock/news/2172960/conmed-cnmd-beats-on-q3-earnings-ups-23-eps-view,2023-10-26 14:08:00,CONMED's (CNMD) adjusted third-quarter earnings and sales beat estimates on the back of strong growth in the U.S and international markets. Gross margin improves.,ABT,0.098862,0.0,Neutral
"West Pharmaceutical  ( WST )  Beats on Q3 Earnings, HVP Drives Sales",https://www.zacks.com/stock/news/2172954/west-pharmaceutical-wst-beats-on-q3-earnings-hvp-drives-sales,2023-10-26 14:06:00,"West Pharmaceutical's (WST) third-quarter results reflect a strong demand for non-COVID-19 demand, especially HVP devices.",ABT,0.080323,0.0,Neutral
"Got $1,000? These 2 Stocks Could Be Bargain Buys for 2023 and Beyond",https://www.fool.com/investing/2023/10/26/got-1000-these-2-stocks-could-be-bargain-buys-for/,2023-10-26 11:50:00,"The market has punished them, but don't overlook these stocks.",ABT,0.05234,0.182615,Somewhat-Bullish
Teladoc Health  ( TDOC )  Q3 Loss Narrows on Integrated Care Strength,https://www.zacks.com/stock/news/2171950/teladoc-health-tdoc-q3-loss-narrows-on-integrated-care-strength,2023-10-25 15:42:00,Teladoc Health's (TDOC) Q3 results were aided by membership growth in the Integrated Care unit as well as strong BetterHelp revenues. Management presently expects 2023 net loss per share to be within $1.50-$1.40.,ABT,0.126119,0.068811,Neutral
5 Stocks to Watch on Solid Revenues in Last Reported Quarter,https://www.zacks.com/stock/news/2171446/5-stocks-to-watch-on-solid-revenues-in-last-reported-quarter,2023-10-25 12:28:00,"We have narrowed our search to five U.S. corporate behemoths. These are: JPM, UNH, PG, ABT, FCX.",ABT,0.215319,0.082873,Neutral
Stocks to own ahead of a rally that this $15 billion fund house says is coming soon,https://www.marketwatch.com/story/stocks-to-own-ahead-of-a-rally-that-this-15-billion-fund-house-says-is-coming-soon-adffe026,2023-10-25 12:07:00,"Sit Investment Associates, Roger Sit, says a short sharp recession is coming, along with a stock rally and lots of opportunities to own names across the board.",ABT,0.071784,0.136927,Neutral
"Rapid Influenza Diagnostic Tests Market Worth Nearly $2 Billion, Globally, by 2030 - Exclusive Report by The Insight Partners",https://www.benzinga.com/pressreleases/23/10/g35410282/rapid-influenza-diagnostic-tests-market-worth-nearly-2-billion-globally-by-2030-exclusive-report-b,2023-10-25 09:06:59,"Pune, India, Oct. 25, 2023 ( GLOBE NEWSWIRE ) -- According to our new research study on ""Rapid Influenza Diagnostic Tests Market covers analysis By Test Type ( Influenza A Tests, Influenza B Test, and Influenza A+B Test ). Sample Type ( Nasal Swab, Throat Swab, Nasopharyngeal Swab, and Others ).",ABT,0.040348,0.10201,Neutral
"Air Conditioning Market size to grow by USD 19.65 billion from 2022 to 2027, AB Electrolux, Blue Star Ltd., Daikin ... - PR Newswire",https://www.prnewswire.com/news-releases/air-conditioning-market-size-to-grow-by-usd-19-65-billion-from-2022-to-2027--ab-electrolux-blue-star-ltd-daikin-industries-ltd-delonghi-appliances-srl-and-more-among-the-key-companies-in-the-market--technavio-301966564.html,2023-10-25 06:15:00,"Air Conditioning Market size to grow by USD 19.65 billion from 2022 to 2027, AB Electrolux, Blue Star Ltd., Daikin ... PR ...",ABT,0.050148,0.0,Neutral
"Dietary supplements market size to grow by USD 61.4 billion from 2022 to 2027 | Abbott Laboratories, Amway Corp ... - PR Newswire",https://www.prnewswire.com/news-releases/dietary-supplements-market-size-to-grow-by-usd-61-4-billion-from-2022-to-2027--abbott-laboratories-amway-corp-archer-daniels-midland-co-arkopharma-laboratories-and-more-among-the-key-companies-in-the-market---technavio-301966560.html,2023-10-25 03:00:00,"Dietary supplements market size to grow by USD 61.4 billion from 2022 to 2027 | Abbott Laboratories, Amway Corp ... PR ...",ABT,0.076602,0.0,Neutral
HCA Healthcare's  ( HCA )  Q3 Earnings Miss on High Expense Level,https://www.zacks.com/stock/news/2170994/hca-healthcares-hca-q3-earnings-miss-on-high-expense-level,2023-10-24 16:11:00,"HCA Healthcare's (HCA) Q3 results were hurt by an increase in salaries and benefits expenses. Management presently estimates 2023 EPS to be within $17.80-$18.50, compared with the prior-view of $17.70-$18.90 per share.",ABT,0.159569,0.078563,Neutral
Abbott Laboratories May Soon Launch a Game-Changing New Device in the U.S.,https://www.fool.com/investing/2023/10/24/abbott-laboratories-may-soon-launch-new-device/,2023-10-24 14:01:04,Abbott Laboratories is getting into the consumer wearables market.,ABT,0.451494,0.484577,Bullish
Shockwave Medical  ( SWAV )  Announces IVL Studies' Positive Results,https://www.zacks.com/stock/news/2170737/shockwave-medical-swav-announces-ivl-studies-positive-results,2023-10-24 13:15:00,Shockwave Medical's (SWAV) latest announcement of two new publications validates the utility of IVL in complex nodular and eccentric calcium.,ABT,0.169676,0.248436,Somewhat-Bullish
"As Ozempic and Wegovy take off, this tech startup just raised $20 million to tackle weight loss with data",https://www.cnbc.com/2023/10/24/signos-raised-20-million-to-tackle-weight-loss-with-cgms-and-data.html,2023-10-24 10:00:01,"Signos, a Silicon Valley startup that's trying to help consumers lose weight, raised $20 million in a funding round led by Cheyenne Ventures and GV.",ABT,0.039944,0.135374,Neutral
 ( ABT )  - Analyzing Abbott Laboratories's Short Interest - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/short-sellers/23/10/35378344/abt-analyzing-abbott-laboratoriess-short-interest,2023-10-23 16:15:20,"Abbott Laboratories's ABT short percent of float has fallen 7.58% since its last report. The company recently reported that it has 10.61 million shares sold short, which is 0.61% of all regular shares that are available for trading.",ABT,0.221819,0.083071,Neutral
DNA Sequencing Market On A Consistent Growth Trajectory With 15.6% CAGR: Driven By The Battle Against Cancer As Per The Business Research Company's DNA Sequencing Global Market Report 2023,https://www.benzinga.com/pressreleases/23/10/g35377394/dna-sequencing-market-on-a-consistent-growth-trajectory-with-15-6-cagr-driven-by-the-battle-agains,2023-10-23 15:35:00,"LONDON, Oct. 23, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's DNA Sequencing Global Market Report 2023, the global DNA sequencing market is poised for remarkable expansion, with projected growth from $10.24 billion in 2022 to $11.84 billion in 2023, reflecting an impressive ...",ABT,0.056275,0.059908,Neutral
Flow cytometer market size to grow at a CAGR of 13.12% by 2027 | The reagents and consumables segment will ... - PR Newswire,https://www.prnewswire.com/news-releases/flow-cytometer-market-size-to-grow-at-a-cagr-of-13-12-by-2027--the-reagents-and-consumables-segment-will-significantly-contribute-to-the-market-share--technavio-301963453.html,2023-10-23 02:35:00,Flow cytometer market size to grow at a CAGR of 13.12% by 2027 | The reagents and consumables segment will ... PR ...,ABT,0.048036,0.0,Neutral
Next-Gen Technology Spurs Vascular Grafts Market as 3D Printed Grafts Gain Traction,https://www.prnewswire.com/news-releases/next-gen-technology-spurs-vascular-grafts-market-as-3d-printed-grafts-gain-traction-301963365.html,2023-10-21 01:00:00,"DUBLIN, Oct. 20, 2023 /PRNewswire/ -- The ""Vascular Grafts Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028"" report has been added to ResearchAndMarkets.com's offering.",ABT,0.056011,-0.030992,Neutral
Transcatheter Aortic Valve Replacement Market size to grow by USD 2.34 billion from 2022-2027| 4C Medical ... - PR Newswire,https://www.prnewswire.com/news-releases/transcatheter-aortic-valve-replacement-market-size-to-grow-by-usd-2-34-billion-from-2022-2027-4c-medical-technologies-inc-abbott-laboratories-anteris-technologies-ltd-are-among-the-major-companies-in-the-market---technavio-301962355.html,2023-10-20 21:15:00,Transcatheter Aortic Valve Replacement Market size to grow by USD 2.34 billion from 2022-2027| 4C Medical ... PR ...,ABT,0.063091,0.063017,Neutral
Stocks Struggle As Yields Soar; Tesla Tumbles: Weekly Review,https://www.investors.com/news/stock-market-struggles-as-treasury-yields-soar-tesla-nvidia-among-notable-losers/,2023-10-20 15:49:00,"Stock Market Struggles As Treasury Yields Soar. Tesla, Nvidia ... Investor's Business Daily ...",ABT,0.044469,-0.064247,Neutral
These Analysts Cut Their Forecasts On Abbott After Q3 Results - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/earnings/23/10/35337192/these-analysts-cut-their-forecasts-on-abbott-after-q3-results,2023-10-19 18:28:19,"Abbott Laboratories ABT reported better-than-expected third-quarter results. Abbott reported quarterly adjusted EPS of $1.14, compared to $1.15 a year ago, beating the consensus of $1.04. Sales of $10.1 billion decreased 2.6%, beating the consensus of $9.32 billion.",ABT,0.42503,0.860871,Bullish
"Company News for Oct 19, 2023",https://www.zacks.com/stock/news/2168645/company-news-for-oct-19-2023,2023-10-19 12:40:00,"Companies In The News Are: PG, ABT, STT, USB.",ABT,0.595343,0.451143,Bullish
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer,https://www.globenewswire.com/news-release/2023/10/19/2763152/13009/en/Catalyst-Pharmaceuticals-Appoints-Richard-J-Daly-as-Chief-Executive-Officer.html,2023-10-19 12:03:00,Patrick J. McEnany to Retire as CEO and will Continue to Serve as Catalyst's Chairman Patrick J. McEnany to Retire as CEO and will Continue to Serve as Catalyst's Chairman ...,ABT,0.042647,-0.00597,Neutral
Catalyst Pharmaceuticals Appoints Richard J. Daly as Chief Executive Officer - Catalyst Pharmaceuticals  ( NASDAQ:CPRX ) ,https://www.benzinga.com/pressreleases/23/10/g35327003/catalyst-pharmaceuticals-appoints-richard-j-daly-as-chief-executive-officer,2023-10-19 12:03:00,"CORAL GABLES, Fla., Oct. 19, 2023 ( GLOBE NEWSWIRE ) -- Catalyst Pharmaceuticals, Inc. ( ""Catalyst"" or ""Company"" ) CPRX, a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare diseases, today announced ...",ABT,0.042048,-0.005965,Neutral
Corporate America weighs risks of the Ozempic effect,https://www.reuters.com/business/healthcare-pharmaceuticals/corporate-america-weighs-risks-ozempic-effect-2023-10-19/,2023-10-19 11:28:00,"Boxes of Ozempic, a semaglutide injection drug used for treating type 2 diabetes made by Novo Nordisk, is seen at a Rock Canyon Pharmacy in Provo, Utah, U.S. March 29, 2023. REUTERS/George Frey/File Photo Acquire Licensing Rights",ABT,0.07913,0.182216,Somewhat-Bullish
"Abbott Laboratories, Nasdaq, Spirit AeroSystems And Other Big Stocks Moving Higher On Wednesday - Abbott Laboratories  ( NYSE:ABT ) , Ardelyx  ( NASDAQ:ARDX ) ",https://www.benzinga.com/news/23/10/35310235/abbott-laboratories-nasdaq-spirit-aerosystems-and-other-big-stocks-moving-higher-on-wednesday,2023-10-18 15:04:05,"U.S. stocks traded lower, with the Dow Jones falling around 50 points on Wednesday. Here are some big stocks recording gains in today's session. Spirit AeroSystems Holdings, Inc. SPR jumped 24.6% to $21.42 after the company announced it reached an agreement with Boeing to support production ...",ABT,0.327366,0.529605,Bullish
Geopolitical Conflicts in Middle-East in Focus,https://www.zacks.com/stock/news/2168147/geopolitical-conflicts-in-middle-east-in-focus,2023-10-18 14:55:00,"U.S. stock futures are trading lower as the geopolitical conflicts between Israel and Palestine-based terrorist group Hamas heightened. President Joe Biden has reached Israel. However, his planned meeting with Arab leaders has been canceled by Jordan following the allegation that Israel bombed a ...",ABT,0.308891,0.065935,Neutral
"Abbott  ( ABT )  Q3 Earnings and Revenues Surpass, Margins Dip",https://www.zacks.com/stock/news/2168143/abbott-abt-q3-earnings-and-revenues-surpass-margins-dip,2023-10-18 14:50:00,Abbott (ABT) reports solid underlying base business performance in the third quarter of 2023.,ABT,0.14069,0.030236,Neutral
"Pre-Markets in Red on Mid-East Concerns, Q3 Earnings in Focus",https://www.zacks.com/stock/news/2168129/pre-markets-in-red-on-mid-east-concerns-q3-earnings-in-focus,2023-10-18 14:39:00,U.S. stock futures are trading lower as the geopolitical conflicts between Israel and Palestine-based terrorist group Hamas heightened.,ABT,0.308891,0.065935,Neutral
Abbott profit beats on strong sales of glucose monitoring system,https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-beats-profit-estimates-strong-sales-devices-diagnostics-2023-10-18/,2023-10-18 13:26:00,"Abbott Laboratories logo is displayed on a screen at the New York Stock Exchange ( NYSE ) in New York City, U.S., October 18, 2021. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",ABT,0.244109,0.143903,Neutral
"Abbott Stock Gains On Q3 Performance, 10% Organic Diagnostics Revenue Growth, Raised Annual Outlook - Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/general/biotech/23/10/35308511/abbott-stock-gains-on-q3-performance-10-organic-diagnostics-revenue-growth-raised-annual-outlook,2023-10-18 13:25:58,"Abbott Laboratories ABT has reported Q3 FY23 adjusted EPS of $1.14, almost similar to $1.15 a year ago, beating the consensus of $1.04. Q3 sales of $10.1 billion decreased 2.6%, beating the consensus of $9.32 billion.",ABT,0.514619,-0.20697,Somewhat-Bearish
How One Device's 'Whopping' Growth Helped Abbott Beat And Raise,https://www.investors.com/news/technology/abbott-stock-abbott-earnings-q3-2023/,2023-10-18 13:09:00,"Abbott Raises Outlook, Boosted By 'Whopping' Growth Of Diabetes ... Investor's Business Daily ...",ABT,0.366061,0.268395,Somewhat-Bullish
The top 10 things to watch in the stock market Wednesday,https://www.cnbc.com/2023/10/18/the-investing-clubs-top-10-things-to-watch-in-the-market-wednesday.html,2023-10-18 13:06:29,"U.S. stock are under pressure in premarket trading Wednesday, while Club names Procter & Gamble and Morgan Stanley deliver quarterly beats.",ABT,0.117486,0.162044,Somewhat-Bullish
Abbott Labs' stock rises as third-quarter results beat estimates despite plunging COVID sales,https://www.marketwatch.com/story/abbott-labs-shares-rise-as-company-beats-earnings-estimates-raises-full-year-guidance-cb5dad2f,2023-10-18 13:05:00,Strong medical device sales boost results even as investors fear obesity drugs' impact.,ABT,0.270773,0.165273,Somewhat-Bullish
Glucose Monitoring Devices Market Worth $39.53 Billion by 2030 - Exclusive Report by The Insight Partners,https://www.benzinga.com/pressreleases/23/10/g35306553/glucose-monitoring-devices-market-worth-39-53-billion-by-2030-exclusive-report-by-the-insight-part,2023-10-18 12:09:27,"Pune, India, Oct. 18, 2023 ( GLOBE NEWSWIRE ) -- Monitoring blood sugar is a vital part of diabetes management. A glucometer or blood sugar meter is commonly used for blood glucose monitoring. It involves taking a small drop of blood, usually by pricking the fingertip and placing it on the test ...",ABT,0.034185,0.134784,Neutral
"S&P 500, Nasdaq To Open Weaker Ahead Of Tesla Earnings: What's Dragging Futures? - Alcoa  ( NYSE:AA ) , Netflix  ( NASDAQ:NFLX ) , United Airlines Holdings  ( NASDAQ:UAL ) , U.S. Bancorp  ( NYSE:USB ) ",https://www.benzinga.com/news/earnings/23/10/35305691/us-stocks-set-for-weak-open-ahead-of-tesla-q3-print-why-this-analyst-is-skeptical-of-s-p-500-recove,2023-10-18 11:40:03,U.S. stocks faced another setback on Wednesday due to uncertainty surrounding interest rates and inflation. Bond yields eased slightly but remained above recent levels. Traders are closely monitoring statements from multiple Federal Reserve speakers today.,ABT,0.092036,0.0,Neutral
Futures down on Middle East worries as earnings get into full swing,https://www.reuters.com/markets/us/futures-slip-middle-east-worries-earnings-gets-into-full-swing-2023-10-18/,2023-10-18 11:18:00,"Traders work on the floor of the New York Stock Exchange ( NYSE ) in New York City, U.S., September 26, 2023. REUTERS/Brendan McDermid/File Photo Acquire Licensing Rights",ABT,0.067919,0.0,Neutral
Morning Bid: US growth topping China as megacaps report,https://www.reuters.com/markets/global-markets-view-usa-2023-10-18/,2023-10-18 10:10:00,"A street sign for Wall Street hangs in front of the New York Stock Exchange May 8, 2013. REUTERS/Lucas Jackson/File Photo Acquire Licensing Rights A look at the day ahead in U.S. and global markets from Mike Dolan",ABT,0.052226,0.0,Neutral
"Insulet  ( PODD )  Q3 Earnings Beat, 2023 Sales Growth View Up",https://www.zacks.com/stock/news/2179256/insulet-podd-q3-earnings-beat-2023-sales-growth-view-up,2023-11-06 14:56:00,Insulet's (PODD) third-quarter 2023 revenues increase year over year as a result of continued high demand for Omnipod 5.,ABT,0.096866,0.0,Neutral
3 Spectacular High-Yield Dividend Stocks to Buy in November,https://www.fool.com/investing/2023/11/05/3-spectacular-high-yield-dividend-stocks-to-buy-in/,2023-11-05 15:00:00,Income investors should find plenty to like with these stocks.,ABT,0.041755,0.137027,Neutral
Looking for a Lifetime of Passive Income? 2 Top Dividend Stocks to Buy and Hold Forever,https://www.fool.com/investing/2023/11/04/want-passive-income-top-dividend-stocks-to-buy/,2023-11-04 09:30:00,Dividend stocks can cushion your portfolio in times of market trouble.,ABT,0.054483,0.047997,Neutral
Inari Medical  ( NARI )  Q3 Earnings and Revenues Beat Estimates,https://www.zacks.com/stock/news/2178311/inari-medical-nari-q3-earnings-and-revenues-beat-estimates,2023-11-03 16:27:00,Inari Medical's (NARI) third-quarter results benefit from strong product adoption and geographical performances.,ABT,0.097062,0.0,Neutral
AMN Healthcare  ( AMN )  Q3 Earnings and Revenues Beat Estimates,https://www.zacks.com/stock/news/2178304/amn-healthcare-amn-q3-earnings-and-revenues-beat-estimates,2023-11-03 16:22:00,AMN Healthcare's (AMN) dismal results in all its segments led to a soft overall third-quarter performance.,ABT,0.07887,0.0,Neutral
"Cardinal Health  ( CAH )  Beats on Q1 Earnings, Ups '24 EPS View",https://www.zacks.com/stock/news/2178192/cardinal-health-cah-beats-on-q1-earnings-ups-24-eps-view,2023-11-03 13:35:00,Cardinal Health's (CAH) first-quarter fiscal 2024 results benefit from the Pharmaceutical segment's solid performance.,ABT,0.113329,0.0,Neutral
"Fresenius Medical  ( FMS )  Q3 Earnings Miss, Operating Margin Up",https://www.zacks.com/stock/news/2178191/fresenius-medical-fms-q3-earnings-miss-operating-margin-up,2023-11-03 13:34:00,"Fresenius Medical's (FMS) third-quarter revenues suffer due to unfavorable currency movement. However, the company's transformational plans continue to benefit its operating income.",ABT,0.083541,0.0,Neutral
Stryker  ( SYK )  Q3 Earnings Beat on Strong Segmental Result,https://www.zacks.com/stock/news/2178190/stryker-syk-q3-earnings-beat-on-strong-segmental-result,2023-11-03 13:34:00,"Stryker's (SYK) third-quarter earnings reflect strong performance across its segments and geographies. However, unfavorable currency movement hurts sales growth, and rising costs affect margins.",ABT,0.104683,0.0,Neutral
"Penumbra  ( PEN )  Q3 Earnings Top Estimates, Margins Increase",https://www.zacks.com/stock/news/2177952/penumbra-pen-q3-earnings-top-estimates-margins-increase,2023-11-03 12:59:00,Penumbra's (PEN) vascular and neuro product categories continue to show encouraging growth trends.,ABT,0.105604,0.0,Neutral
"Global Blood Glucose Monitoring Device Market Poised for Remarkable Growth, Set to Reach USD 26.44 Billion by 2030, Reports Infinium Global Research",https://www.prnewswire.com/news-releases/global-blood-glucose-monitoring-device-market-poised-for-remarkable-growth-set-to-reach-usd-26-44-billion-by-2030--reports-infinium-global-research-301976947.html,2023-11-03 09:30:00,"Global Blood Glucose Monitoring Device Market Poised for Remarkable Growth, Set to Reach USD 26.44 Billion by ... PR ...",ABT,0.02695,0.152236,Somewhat-Bullish
"Avanos  ( AVNS )  Q3 Earnings Top Estimates, Margins Contract",https://www.zacks.com/stock/news/2177569/avanos-avns-q3-earnings-top-estimates-margins-contract,2023-11-02 16:25:00,"Despite strength in Avanos' (AVNS) Digestive Health segment, its overall third-quarter results reflect soft performances.",ABT,0.081691,0.0,Neutral
"QuidelOrtho  ( QDEL )  Q3 Earnings Top Estimates, Margins Down",https://www.zacks.com/stock/news/2177567/quidelortho-qdel-q3-earnings-top-estimates-margins-down,2023-11-02 16:22:00,"Despite solid performances by the Labs and TM segments and China and Other regions, QuidelOrtho (QDEL) reports soft overall top-line results in third-quarter 2023.",ABT,0.072217,0.0,Neutral
"Nevro  ( NVRO )  Q3 Earnings Top Estimates, FY23 Revenue View Up",https://www.zacks.com/stock/news/2177558/nevro-nvro-q3-earnings-top-estimates-fy23-revenue-view-up,2023-11-02 16:16:00,"Nevro's (NVRO) worldwide revenues improve on a year-over-year basis in the third quarter, owing to robust domestic performance.",ABT,0.085476,0.0,Neutral
"Cencora  ( COR )  Q4 Earnings Top, GLP-1 Drugs Boost Sales",https://www.zacks.com/stock/news/2177583/cencora-cor-q4-earnings-top-glp-1-drugs-boost-sales,2023-11-02 15:43:00,"Cencora's (COR) fourth-quarter fiscal 2023 results benefit from overall market growth, including rising demand for GLP-1 drugs approved for diabetes and weight loss. Inflationary pressure remains.",ABT,0.088147,0.0,Neutral
"Exact Sciences  ( EXAS )  Q3 Earnings Beat, Gross Margin Rises",https://www.zacks.com/stock/news/2177442/exact-sciences-exas-q3-earnings-beat-gross-margin-rises,2023-11-02 15:03:00,Exact Sciences' (EXAS) Screening revenue upside is primarily attributable to broad-based momentum in Cologuard adoption.,ABT,0.105372,0.0,Neutral
"Baxter  ( BAX )  Beats on Q3 Earnings, Divests BioPharma Business",https://www.zacks.com/stock/news/2177513/baxter-bax-beats-on-q3-earnings-divests-biopharma-business,2023-11-02 14:56:00,Baxter (BAX) reports better-than-expected third-quarter earnings and sales. The company completes the divestment of its BioPharma Solution business. It starts reporting under a new operating model.,ABT,0.068404,0.0,Neutral
"DENTSPLY SIRONA  ( XRAY )  Beats on Q3 Earnings, Lowers '23 Guidance",https://www.zacks.com/stock/news/2177511/dentsply-sirona-xray-beats-on-q3-earnings-lowers-23-guidance,2023-11-02 14:54:00,DENTSPLY SIRONA's (XRAY) Q3 revenues are driven by a rise in demand for aligners and CAD/CAM in the United States and a recovery in demand in China. Challenging macro headwinds linger.,ABT,0.073209,0.0,Neutral
"Glaukos  ( GKOS )  Q3 Earnings Beat Estimates, Revenues Rise Y/Y",https://www.zacks.com/stock/news/2177492/glaukos-gkos-q3-earnings-beat-estimates-revenues-rise-yy,2023-11-02 14:34:00,"Glaukos' (GKOS) third-quarter revenues beat estimates but fall year over year. Sales and gross margin improve, while higher operating expenses lead to a wider operating loss.",ABT,0.114137,0.0,Neutral
"McKesson  ( MCK )  Beats on Q2 Earnings, Raises '23 EPS View",https://www.zacks.com/stock/news/2177488/mckesson-mck-beats-on-q2-earnings-raises-23-eps-view,2023-11-02 14:32:00,McKesson's (MCK) second-quarter fiscal 2024 results benefit from growth in the United States. Divestment hurts the International segment.,ABT,0.090645,0.0,Neutral
1 Stock Down 15% This Year to Buy and Hold Forever,https://www.fool.com/investing/2023/11/02/1-stock-down-15-this-year-to-buy-and-hold-forever/,2023-11-02 14:15:00,This stock has been delivering solid performances for a long time.,ABT,0.330286,0.256242,Somewhat-Bullish
"CVS Health  ( CVS )  Q3 Earnings Surpass Estimates, Margins Up",https://www.zacks.com/stock/news/2176592/cvs-health-cvs-q3-earnings-surpass-estimates-margins-up,2023-11-01 15:07:00,Robust sales growth across all three operating segments drove CVS Health's (CVS) third-quarter results.,ABT,0.086556,0.0,Neutral
"Global In-Vitro Diagnostics Market Size is Projected to Reach USD 116.32 Billion by 2030, with a CAGR of 5.2%: Straits Research",https://www.benzinga.com/pressreleases/23/10/g35522768/global-in-vitro-diagnostics-market-size-is-projected-to-reach-usd-116-32-billion-by-2030-with-a-ca,2023-10-31 18:50:00,"New York, United States, Oct. 31, 2023 ( GLOBE NEWSWIRE ) -- In-vitro diagnostics, or IVD, are medical devices and reagents used to examine body fluids and tissues to diagnose diseases, conditions, and infections. In-vitro diagnostics use PCR, microarrays, sequencing, and mass spectrometry.",ABT,0.041538,0.0,Neutral
"PacBio  ( PACB )  Tops on Q3 Earnings, Raises FY23 Revenue View",https://www.zacks.com/stock/news/2175683/pacbio-pacb-tops-on-q3-earnings-raises-fy23-revenue-view,2023-10-31 15:35:00,"PacBio (PACB) witnesses strong revenue growth in the third quarter, partly aided by customers' continued product transition to the Revio system.",ABT,0.081552,0.0,Neutral
"Ecolab  ( ECL )  Q3 Earnings Surpass Estimates, Margins Rise",https://www.zacks.com/stock/news/2175651/ecolab-ecl-q3-earnings-surpass-estimates-margins-rise,2023-10-31 15:07:00,Ecolab's (ECL) robust performance across all segments drives its third-quarter sales despite business challenges.,ABT,0.08687,0.0,Neutral
"SLB, Abbott And 2 Other Stocks Insiders Are Selling - Abbott Laboratories  ( NYSE:ABT ) , Bentley Systems  ( NASDAQ:BSY ) ",https://www.benzinga.com/news/23/10/35511249/slb-abbott-and-2-other-stocks-insiders-are-selling,2023-10-31 12:06:59,"The Nasdaq 100 closed higher by over 1% on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company's prospects or that they view the stock as being overpriced.",ABT,0.265859,0.299305,Somewhat-Bullish
GE HealthCare beats quarterly profit estimates on imaging device demand,https://www.reuters.com/business/healthcare-pharmaceuticals/ge-healthcare-beats-quarterly-profit-estimates-imaging-device-demand-2023-10-31/,2023-10-31 11:41:00,"A logo is displayed on a GE digital anesthesia carestation as U.S. Vice President Mike Pence ( not pictured ) visits a GE Healthcare manufacturing facility during the global coronavirus disease ( COVID-19 ) outbreak in Madison, Wisconsin, U.S. April 21, 2020.",ABT,0.107495,0.320608,Somewhat-Bullish
"Avantor  ( AVTR )  Q3 Earnings In-Line With Estimates, Revenues Top",https://www.zacks.com/stock/news/2174744/avantor-avtr-q3-earnings-in-line-with-estimates-revenues-top,2023-10-30 16:24:00,"Despite Avantor's (AVTR) continued stability in end markets, it reports an overall soft third-quarter performance.",ABT,0.077719,0.0,Neutral
"Revvity  ( RVTY )  Misses on Q3 Earnings, Lowers '23 EPS View",https://www.zacks.com/stock/news/2174778/revvity-rvty-misses-on-q3-earnings-lowers-23-eps-view,2023-10-30 15:55:00,Revvity's (RVTY) third-quarter results reflect the impact of increased market uncertainty. The company's earnings and sales miss their respective estimates.,ABT,0.127119,0.0,Neutral
2 No-Brainer Dividend Stocks to Buy This Week,https://www.fool.com/investing/2023/10/30/2-no-brainer-dividend-stocks-to-buy-this-week/,2023-10-30 13:15:00,These two top-income stocks are too cheap to ignore.,ABT,0.065866,0.262979,Somewhat-Bullish
"After infant's death, FDA sends new warning about probiotics for premature babies in the hospital",https://www.cnn.com/2023/10/27/health/fda-probiotics-preterm-infants-warning/index.html,2023-10-28 04:15:00,"The US Food and Drug Administration is sharing a new warning about the risks of probiotics for hospitalized preterm infants. The products have been linked with over two dozen reported adverse events since 2018 and one death in 2023, the agency said.",ABT,0.040899,-0.077624,Neutral
"After infant's death, FDA sends new warning about probiotics for premature babies",https://www.cnn.com/2023/10/27/health/after-infants-death-fda-sends-new-warning-about-probiotics-for-premature-babies/index.html,2023-10-28 00:18:00,"The US Food and Drug Administration is sharing a new warning about the risks of probiotics for hospitalized preterm infants. The products have been linked with over two dozen reported adverse events since 2018 and one death in 2023, the agency said.",ABT,0.042876,-0.093006,Neutral
"After infant's death, FDA sends new warning about probiotics for premature babies in the hospital",https://www.cnn.com/2023/10/27/health/fda-probiotics-preterm-infants-warning,2023-10-28 00:18:00,"After infant's death, FDA sends new warning about probiotics for premature babies ...",ABT,0.040899,-0.077624,Neutral
"Unraveling the Shifting Rare Eye Diseases Market Landscape: Analysis of Retinoblastoma Market, Retinitis Pigmentosa Market, Limbal Stem Cell Deficiency Market, Leber Hereditary Optic Neuropathy Market, and Stargardt Disease Market | DelveInsight",https://www.prnewswire.com/news-releases/unraveling-the-shifting-rare-eye-diseases-market-landscape-analysis-of-retinoblastoma-market-retinitis-pigmentosa-market-limbal-stem-cell-deficiency-market-leber-hereditary-optic-neuropathy-market-and-stargardt-disease-market-301991311.html,2023-11-16 22:01:00,"Unraveling the Shifting Rare Eye Diseases Market Landscape: Analysis of Retinoblastoma Market, Retinitis ... PR ...",ABT,0.01645,0.006093,Neutral
QIAGEN  ( QGEN )  Expands Sample Technologies Line With New Launch,https://www.zacks.com/stock/news/2185396/qiagen-qgen-expands-sample-technologies-line-with-new-launch,2023-11-16 14:58:00,"QIAGEN's (QGEN) latest launches will better address the special needs of researchers working with challenging samples, allowing them to work more efficiently.",ABT,0.097259,0.0,Neutral
"Alcon  ( ALC )  Q3 Earnings Miss Estimates, Margins Increase",https://www.zacks.com/stock/news/2184719/alcon-alc-q3-earnings-miss-estimates-margins-increase,2023-11-15 16:07:00,"Alcon (ALC) Q3 revenues increase year over year, driven by strength in Surgical and Vision Care segments.",ABT,0.085173,0.0,Neutral
NeuroOne® Appoints Medtech Executive Christopher R. Volker as Chief Operating Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ,https://www.globenewswire.com/news-release/2023/11/14/2780611/0/en/NeuroOne-Appoints-Medtech-Executive-Christopher-R-Volker-as-Chief-Operating-Officer-and-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html,2023-11-14 22:15:00,"Volker strengthens existing management team in areas of commercialization, business development, and reimbursement ...",ABT,0.03319,0.067416,Neutral
"Medical Component Manufacturing Market Analysis 2023-2027: Estimated Market Size, Key Drivers And Lucrative Segments As Per The Business Research Company's Medical Component Manufacturing Global Market Report 2023",https://www.benzinga.com/pressreleases/23/11/g35781916/medical-component-manufacturing-market-analysis-2023-2027-estimated-market-size-key-drivers-and-lu,2023-11-14 16:30:00,"LONDON, Nov. 14, 2023 ( GLOBE NEWSWIRE ) -- The Business Research Company's Medical Component Manufacturing Global Market Report 2023 unveils a robust trajectory, forecasting growth from $12.44 billion in 2022 to $13.29 billion in 2023, reflecting a commendable compound annual growth rate ( CAGR ...",ABT,0.054359,0.211882,Somewhat-Bullish
Here's Why You Should Retain Penumbra  ( PEN )  Stock for Now,https://www.zacks.com/stock/news/2184063/heres-why-you-should-retain-penumbra-pen-stock-for-now,2023-11-14 15:19:00,Investors are optimistic about Penumbra (PEN) on strong vascular and neuro businesses growth and upbeat guidance.,ABT,0.096477,0.0,Neutral
"Bio-Rad  ( BIO )  Hurt by Macroeconomic Woes, Margin Pressure",https://www.zacks.com/stock/news/2183916/bio-rad-bio-hurt-by-macroeconomic-woes-margin-pressure,2023-11-14 14:15:00,"Bio-Rad's (BIO) margin performance is affected by the inflationary trend of elevated raw material costs, increased logistics costs and higher employee-related expenses.",ABT,0.086245,0.0,Neutral
Charles River  ( CRL )  to Advance AI Drug Discovery With New Pact,https://www.zacks.com/stock/news/2183914/charles-river-crl-to-advance-ai-drug-discovery-with-new-pact,2023-11-14 14:12:00,Charles River's (CRL) recent partnership will enable the optimization of the discovery and early development of multiple therapeutic programs for neurodegenerative disease and oncology.,ABT,0.095517,0.0,Neutral
2 High-Yield Dividend Stocks You Can Buy Now and Hold for a Decade,https://www.fool.com/investing/2023/11/14/2-high-yield-dividend-stocks-you-can-buy-now-and-h/,2023-11-14 10:36:00,These stocks could be great investments to bump up your passive income stream.,ABT,0.057628,-0.048151,Neutral
3 Dividend Giants to Grow Wealth no Matter What the Market Is Doing,https://www.fool.com/investing/2023/11/14/3-dividend-giants-to-grow-wealth-in-any-market/,2023-11-14 10:30:00,You'll be happy to own these top companies in any market environment.,ABT,0.061631,0.080007,Neutral
"Novo, Lilly Skid - But These Weight-Loss Results Are 'Hard To Ignore'",https://www.investors.com/news/technology/novo-nordisk-stock-can-weight-loss-drugs-prevent-diabetes/,2023-11-13 16:25:00,Novo Nordisk Stock: Can Weight-Loss Drugs Prevent Diabetes? Investor's Business Daily ...,ABT,0.120733,0.171906,Somewhat-Bullish
Here's Why You Should Retain CVS Health  ( CVS )  Stock for Now,https://www.zacks.com/stock/news/2183413/heres-why-you-should-retain-cvs-health-cvs-stock-for-now,2023-11-13 15:41:00,Investors are optimistic about CVS Health's (CVS) strength in Health Care Benefits business arm and stable solvency position.,ABT,0.090816,0.0,Neutral
Quest Diagnostics  ( DGX )  Introduces Mobile Phlebotomy Service,https://www.zacks.com/stock/news/2183411/quest-diagnostics-dgx-introduces-mobile-phlebotomy-service,2023-11-13 15:34:00,Quest Diagnostics (DGX) can offer patients and physicians a seamless connection to Quest Diagnostic's laboratory testing with the launch of Quest Mobile.,ABT,0.101582,0.0,Neutral
Medical device makers rise on relief after Wegovy obesity trial data,https://www.reuters.com/business/healthcare-pharmaceuticals/medical-device-makers-rise-relief-after-wegovy-obesity-trial-data-2023-11-13/,2023-11-13 15:21:00,"A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights",ABT,0.147818,0.317247,Somewhat-Bullish
"Abbott India trades lower after Q2 results, CLSA downgrades stock to outperform",https://www.moneycontrol.com/news/business/stocks/abbott-india-trades-lower-after-q2-results-clsa-downgrades-stock-to-outperform-11732041.html,2023-11-13 06:03:56,"Analysts at CLSA have downgraded the stock to outperform from Buy and have raised the target price to Rs 27,500 per share.",ABT,0.200688,0.18278,Somewhat-Bullish
Peripheral Vascular Diagnostic Systems Market to grow by USD 178.07 million from 2023-2028; North America to ... - PR Newswire,https://www.prnewswire.com/news-releases/peripheral-vascular-diagnostic-systems-market-to-grow-by-usd-178-07-million-from-2023-2028-north-america-to-account-for-39-of-market-growth---technavio-301984286.html,2023-11-10 23:35:00,Peripheral Vascular Diagnostic Systems Market to grow by USD 178.07 million from 2023-2028. North America to ... PR ...,ABT,0.116631,0.037884,Neutral
"Who's afraid of Ozempic? From restaurants to package makers, companies work to calm investors' GLP-1 jitters.",https://www.marketwatch.com/story/whos-afraid-of-ozempic-from-restaurants-to-package-makers-companies-work-to-calm-investors-glp-1-jitters-0599dba5,2023-11-10 16:13:00,"With Eli Lilly's Zepbound set to enter the fray, companies are flooded with weight-loss drug questions ...",ABT,0.077677,0.07861,Neutral
"Hologic's  ( HOLX )  Q4 Earnings Beat Estimates, Gross Margin Down",https://www.zacks.com/stock/news/2182249/hologics-holx-q4-earnings-beat-estimates-gross-margin-down,2023-11-10 14:02:00,Solid year-over-year growth in the Breast Health segment drives Hologic's (HOLX) Q4 performance.,ABT,0.077719,0.0,Neutral
AbbVie's $21 Billion Drug Humira Is on the Decline. Should You Still Buy This Dividend Stock?,https://www.fool.com/investing/2023/11/10/abbvie-after-humira-should-you-buy/,2023-11-10 10:00:00,"AbbVie is committed to rewarding shareholders, even during tough times.",ABT,0.051999,0.056649,Neutral
"The Influenza Diagnostics Market size to grow at a CAGR of 6.95% from 2022 to 2027|Abbott Laboratories, Becton ... - PR Newswire",https://www.prnewswire.com/news-releases/the-influenza-diagnostics-market-size-to-grow-at-a-cagr-of-6-95-from-2022-to-2027abbott-laboratories-becton-dickinson-and-co-bico-group-ab-and-more-among-the-key-companies-in-the-market--technavio-301983746.html,2023-11-10 02:30:00,"The Influenza Diagnostics Market size to grow at a CAGR of 6.95% from 2022 to 2027|Abbott Laboratories, Becton ... PR ...",ABT,0.042723,0.105666,Neutral
"BD  ( BDX )  Q4 Earnings In-Line With Estimates, Margins Contract",https://www.zacks.com/stock/news/2181912/bd-bdx-q4-earnings-in-line-with-estimates-margins-contract,2023-11-09 19:05:00,BD's (BDX) overall top line benefits from revenue growth in all its segments and both geographic regions in the fiscal fourth quarter.,ABT,0.07031,0.0,Neutral
Here's Why You Should Retain Boston Scientific  ( BSX )  Now,https://www.zacks.com/stock/news/2181886/heres-why-you-should-retain-boston-scientific-bsx-now,2023-11-09 18:18:00,"Investors are optimistic about Boston Scientific (BSX), led by growing demand for WATCHMAN FLX devices and upbeat guidance.",ABT,0.098255,0.0,Neutral
Alcon  ( ALC )  Unveils New Progress in Presbyopia Correcting IOLs,https://www.zacks.com/stock/news/2181888/alcon-alc-unveils-new-progress-in-presbyopia-correcting-iols,2023-11-09 18:17:00,Alcon's (ALC) Clareon Vivity IOL highlights proven results and high levels of patient satisfaction. It will offer a similar halo profile compared with a monofocal IOL.,ABT,0.102231,0.0,Neutral
"Surmodics  ( SRDX )  Q4 Earnings Top Estimates, Revenues Up Y/Y",https://www.zacks.com/stock/news/2181864/surmodics-srdx-q4-earnings-top-estimates-revenues-up-yy,2023-11-09 17:44:00,Surmodics (SRDX) reports a solid fiscal fourth quarter top line on the back of robust segmental revenues.,ABT,0.071251,0.0,Neutral
"Inspire Medical  ( INSP )  Q3 Earnings Top Estimates, Revenues Lag",https://www.zacks.com/stock/news/2181854/inspire-medical-insp-q3-earnings-top-estimates-revenues-lag,2023-11-09 17:41:00,Inspire Medical's (INSP) both geographic regions witness strong revenue growth in the third quarter.,ABT,0.082535,0.0,Neutral
Abbott India's Q2 profit climbs on strong sales,https://www.reuters.com/business/healthcare-pharmaceuticals/abbott-indias-q2-profit-climbs-strong-sales-2023-11-09/,2023-11-09 12:14:00,"An Abbott company logo is pictured at the reception of its office in Mumbai, India, September 8, 2015/ REUTERS/Shailesh Andrade Acquire Licensing Rights",ABT,0.182506,0.233803,Somewhat-Bullish
2 No-Brainer Stocks to Buy for Forever Dividend Growth,https://www.fool.com/investing/2023/11/09/2-stocks-to-buy-for-forever-dividend-growth/,2023-11-09 11:00:00,These companies generate billions of dollars in free cash flow every year.,ABT,0.121343,0.09891,Neutral
Corporate America weighs business impact of new weight-loss drugs,https://www.reuters.com/business/healthcare-pharmaceuticals/corporate-america-weighs-business-impact-new-weight-loss-drugs-2023-11-08/,2023-11-08 18:19:00,"[1/3] A 0.25 mg injection pen of Novo Nordisk's weight-loss drug Wegovy is shown in this photo illustration in Oslo, Norway, September 1, 2023. REUTERS/Victoria Klesty/Illustration/File Photo Acquire Licensing Rights",ABT,0.054114,0.178815,Somewhat-Bullish
"Inogen  ( INGN )  Q3 Earnings Miss Estimates, Revenues Down Y/Y",https://www.zacks.com/stock/news/2180988/inogen-ingn-q3-earnings-miss-estimates-revenues-down-yy,2023-11-08 16:09:00,"Despite higher international business-to-business sales and rental revenues, Inogen's (INGN) overall third-quarter results reflect soft performances.",ABT,0.088635,0.0,Neutral
"Accuray  ( ARAY )  Q1 Earnings In-Line With Estimates, Revenues Top",https://www.zacks.com/stock/news/2180978/accuray-aray-q1-earnings-in-line-with-estimates-revenues-top,2023-11-08 16:04:00,Accuray (ARAY) reports a solid fiscal first quarter top line on the back of robust Product revenues.,ABT,0.090474,0.0,Neutral
"Charles River's  ( CRL )  Q3 Earnings Beat, Margins Decline",https://www.zacks.com/stock/news/2180974/charles-rivers-crl-q3-earnings-beat-margins-decline,2023-11-08 15:59:00,"Charles River's (CRL) RMS organic revenue growth is primarily driven by research model services, particularly the Insourcing Solutions business.",ABT,0.090989,0.0,Neutral
"DaVita  ( DVA )  Q3 Earnings & Revenues Top Estimates, Margins Up",https://www.zacks.com/stock/news/2180975/davita-dva-q3-earnings-revenues-top-estimates-margins-up,2023-11-08 15:56:00,DaVita's (DVA) robust segmental revenues drive its third-quarter performance.,ABT,0.098255,0.0,Neutral
2 Medical Device Companies Experiencing Strong Demand Even as Weight-Loss Drugs Rise in Popularity,https://www.fool.com/investing/2023/11/08/2-medical-device-companies-experiencing-strong/,2023-11-08 14:37:00,Investors could be making a mistake by selling off these stocks this year.,ABT,0.185781,0.198329,Somewhat-Bullish
"Masimo  ( MASI )  Q3 Earnings Beat Estimates, Margins Fall",https://www.zacks.com/stock/news/2180756/masimo-masi-q3-earnings-beat-estimates-margins-fall,2023-11-08 14:08:00,Masimo's (MASI) overall third-quarter results reflect soft performance despite strength in the Hearables category.,ABT,0.096091,0.0,Neutral
"Globus Medical  ( GMED )  Q3 Earnings Top Estimates, Margins Down",https://www.zacks.com/stock/news/2180670/globus-medical-gmed-q3-earnings-top-estimates-margins-down,2023-11-08 12:59:00,Globus Medical's (GMED) legacy business continues to drive share growth across its U.S. spine and trauma portfolios in the third quarter.,ABT,0.090474,0.0,Neutral
Here's Why You Should Retain Align Technology  ( ALGN )  Stock Now,https://www.zacks.com/stock/news/2180663/heres-why-you-should-retain-align-technology-algn-stock-now,2023-11-08 12:50:00,"Investors are optimistic about Align Technology (ALGN), led by its strong global presence.",ABT,0.093108,0.0,Neutral
"Zimmer Biomet  ( ZBH )  Q3 Earnings Top Estimates, Margins Fall",https://www.zacks.com/stock/news/2180193/zimmer-biomet-zbh-q3-earnings-top-estimates-margins-fall,2023-11-07 15:49:00,Zimmer Biomet (ZBH) gains from solid strategic execution and increasing traction in innovations in the third quarter.,ABT,0.096283,0.0,Neutral
"OPKO Health  ( OPK )  Q3 Earnings Lag Estimates, Revenues Top",https://www.zacks.com/stock/news/2180185/opko-health-opk-q3-earnings-lag-estimates-revenues-top,2023-11-07 15:29:00,"Despite OPKO Health's (OPK) robust RAYALDEE sales and strength in the Pharmaceuticals segment, its overall third-quarter results reflect soft performances.",ABT,0.076358,0.0,Neutral
Myriad Genetics  ( MYGN )  Posts Narrower-Than-Estimate Loss in Q3,https://www.zacks.com/stock/news/2180152/myriad-genetics-mygn-posts-narrower-than-estimate-loss-in-q3,2023-11-07 15:09:00,"Myriad Genetics' (MYGN) third-quarter 2023 revenues increase year over year, driven by strong testing volume improvement across all its businesses.",ABT,0.093108,0.0,Neutral
"Shockwave Medical  ( SWAV )  Q3 Earnings Beat, Revenues Rise Y/Y",https://www.zacks.com/stock/news/2179942/shockwave-medical-swav-q3-earnings-beat-revenues-rise-yy,2023-11-07 13:47:00,Shockwave Medical's (SWAV) third-quarter results reflect robust revenue growth and gross margin expansion on the back of strong demand and new launches.,ABT,0.092036,0.0,Neutral
Zimmer Biomet beats quarterly profit estimates on knee procedure strength,https://www.reuters.com/business/healthcare-pharmaceuticals/zimmer-biomet-beats-quarterly-profit-estimates-knee-procedure-strength-2023-11-07/,2023-11-07 12:20:00,"The logo of medical implants maker Zimmer Biomet is seen at a plant in Winterthur, Switzerland, November 16, 2018. Picture taken November 16, 2018. REUTERS/Moritz Hager/File Photo Acquire Licensing Rights",ABT,0.175859,0.153021,Somewhat-Bullish
"Mobile health solutions market to grow at a USD 256.69 billion from 2022 to 2027 | Abbott Laboratories, AirStrip ... - PR Newswire",https://www.prnewswire.com/news-releases/mobile-health-solutions-market-to-grow-at-a-usd-256-69-billion-from-2022-to-2027--abbott-laboratories-airstrip-technologies-inc-apple-inc-and-more-among-the-key-companies-in-the-market---technavio-301978707.html,2023-11-07 01:15:00,"Mobile health solutions market to grow at a USD 256.69 billion from 2022 to 2027 | Abbott Laboratories, AirStrip ... PR ...",ABT,0.058047,0.143994,Neutral
Extracorporeal Membrane Oxygenation Machines Market to grow by USD 243.6 million from 2022 to 2027 | North ... - PR Newswire,https://www.prnewswire.com/news-releases/extracorporeal-membrane-oxygenation-machines-market-to-grow-by-usd-243-6-million-from-2022-to-2027--north-america-to-account-for-37-of-market-growth--technavio-301996790.html,2023-11-24 23:35:00,Extracorporeal Membrane Oxygenation Machines Market to grow by USD 243.6 million from 2022 to 2027 | North ... PR ...,ABT,0.145583,-0.032248,Neutral
Nutraceuticals Market to grow by USD 223.56 billion from 2022 to 2027 | The increasing cost of medical treatment to ... - PR Newswire,https://www.prnewswire.com/news-releases/nutraceuticals-market-to-grow-by-usd-223-56-billion-from-2022-to-2027--the-increasing-cost-of-medical-treatment-to-drive-market-growth---technavio-301996928.html,2023-11-24 09:15:00,Nutraceuticals Market to grow by USD 223.56 billion from 2022 to 2027 | The increasing cost of medical treatment to ... PR ...,ABT,0.05654,0.073002,Neutral
"Cell Surface Markers Market size to grow by USD 14.06 billion from 2023-2028| Abbott Laboratories, Abcam plc ... - PR Newswire",https://www.prnewswire.com/news-releases/cell-surface-markers-market-size-to-grow-by-usd-14-06-billion-from-2023-2028-abbott-laboratories-abcam-plc-agilent-technologies-inc-and-more-among-the-key-companies-in-the-market---technavio-301996069.html,2023-11-23 01:30:00,"Cell Surface Markers Market size to grow by USD 14.06 billion from 2023-2028| Abbott Laboratories, Abcam plc ... PR ...",ABT,0.064797,0.0,Neutral
Population Screening Market Is Expected To Reach $35.3 Billion By 2027 With The Rising Prevalence Of Cancer As Per The Business Research Company's Population Screening Global Market Report 2023,https://www.benzinga.com/pressreleases/23/11/g35920043/population-screening-market-is-expected-to-reach-35-3-billion-by-2027-with-the-rising-prevalence-o,2023-11-22 16:30:00,"LONDON, Nov. 22, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Population Screening Global Market Report 2023, the global population screening market is gearing up for substantial growth, set to rise from $25.04 billion in 2022 to $27.02 billion in 2023, showcasing a ...",ABT,0.058188,0.147997,Neutral
Abbott  ( ABT )  Benefits From Innovation Amid FX Headwinds,https://www.zacks.com/stock/news/2187790/abbott-abt-benefits-from-innovation-amid-fx-headwinds,2023-11-22 14:10:00,"Abbott's (ABT) mAbxience collaboration is likely to help introduce cutting-edge medicines in the areas of oncology, women's health and respiratory diseases.",ABT,0.190667,-0.104297,Neutral
Ozempic Might Be Helping Abbott Laboratories and DexCom Stock. Here's How.,https://www.fool.com/investing/2023/11/20/ozempic-helping-abbott-laboratories-dexcom-stock/,2023-11-20 11:03:00,New medicines for weight loss and diabetes stand to disrupt the competitive scene.,ABT,0.105604,0.210518,Somewhat-Bullish
Interventional Spine Devices Market to grow by USD 3.07 billion from 2023 to 2028; North America to account for 47 ... - PR Newswire,https://www.prnewswire.com/news-releases/interventional-spine-devices-market-to-grow-by-usd-3-07-billion-from-2023-to-2028-north-america-to-account-for-47-of-market-growth--technavio-301992857.html,2023-11-20 06:35:00,Interventional Spine Devices Market to grow by USD 3.07 billion from 2023 to 2028. North America to account for 47 ... PR ...,ABT,0.140485,-0.25256,Somewhat-Bearish
2 Stock Split Growth Stocks to Buy and Hold,https://www.fool.com/investing/2023/11/19/2-stock-split-growth-stocks-to-buy-and-hold/,2023-11-19 14:00:00,These companies could continue delivering excellent results long after their most recent stock splits are forgotten.,ABT,0.050254,0.050993,Neutral
Human immunodeficiency virus (HIV) rapid test kits market to grow by USD 294.96 million from 2023 to 2028; North ... - PR Newswire,https://www.prnewswire.com/news-releases/human-immunodeficiency-virus-hiv-rapid-test-kits-market-to-grow-by-usd-294-96-million-from-2023-to-2028-north-america-to-account-for-40-of-market-growth--technavio-301991616.html,2023-11-17 19:00:00,Human immunodeficiency virus ( HIV ) rapid test kits market to grow by USD 294.96 million from 2023 to 2028. North ... PR ...,ABT,0.070105,0.062237,Neutral
What's in the Cards for Medtronic  ( MDT )  in Q2 Earnings?,https://www.zacks.com/stock/news/2186123/whats-in-the-cards-for-medtronic-mdt-in-q2-earnings,2023-11-17 16:27:00,Strength in all four businesses is likely to drive Medtronic's (MDT) fiscal second-quarter performance.,ABT,0.084275,0.0,Neutral
Is DexCom the Next Big Growth Stock?,https://www.fool.com/investing/2023/11/17/is-dexcom-the-next-big-growth-stock/,2023-11-17 15:07:00,"It has significant growth drivers in play, but competitors are making inroads too.",ABT,0.054236,-0.01101,Neutral
"Syphilis Testing Market size to grow by USD 2.22 billion from 2023-2028 | Abbott Laboratories, AdvaCare Pharma ... - PR Newswire",https://www.prnewswire.com/news-releases/syphilis-testing-market-size-to-grow-by-usd-2-22-billion-from-2023-2028--abbott-laboratories-advacare-pharma-beckman-coulter-inc-and-more-among-the-key-companies-in-the-market---technavio-302006630.html,2023-12-05 23:45:00,"Syphilis Testing Market size to grow by USD 2.22 billion from 2023-2028 | Abbott Laboratories, AdvaCare Pharma ... PR ...",ABT,0.065685,0.037033,Neutral
$1000 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/23/12/36098594/1000-invested-in-abbott-laboratories-10-years-ago-would-be-worth-this-much-today,2023-12-05 18:30:14,"Abbott Laboratories ABT has outperformed the market over the past 10 years by 1.25% on an annualized basis producing an average annual return of 10.95%. Currently, Abbott Laboratories has a market capitalization of $182.13 billion.",ABT,0.980595,0.386944,Bullish
"Global Drug Discovery Market Size is Expected to Reach USD 120,809 million by 2030: Straits Research",https://www.benzinga.com/pressreleases/23/12/g36094187/global-drug-discovery-market-size-is-expected-to-reach-usd-120-809-million-by-2030-straits-researc,2023-12-05 15:10:00,"New York, United States, Dec. 05, 2023 ( GLOBE NEWSWIRE ) -- Drug discovery is the process of examining potential novel treatments, and it takes place in the domains of pharmacology, biotechnology, and medicine.",ABT,0.03853,0.0,Neutral
U.S. Clinical Nutrition Market to Reach $7.56 Billion by 2030 | Coherent Market Insights  ( CMI ) ,https://www.benzinga.com/pressreleases/23/12/g36092529/u-s-clinical-nutrition-market-to-reach-7-56-billion-by-2030-coherent-market-insights-cmi,2023-12-05 14:10:00,"Burlingame, Dec. 05, 2023 ( GLOBE NEWSWIRE ) -- According to Coherent Market Insights, The U.S. clinical nutrition market was valued at US$ 4.93 Billion in 2023 and is forecast to reach a value of US$ 7.56 Billion by 2030 at a CAGR of 6.3% between 2023 and 2030.",ABT,0.021465,-0.056222,Neutral
"Biomarkers Market size to grow by USD 56.26 billion from 2022 to 2027| Abbott Laboratories, Abcam plc, Agilent ... - PR Newswire",https://www.prnewswire.com/news-releases/biomarkers-market-size-to-grow-by-usd-56-26-billion-from-2022-to-2027-abbott-laboratories-abcam-plc-agilent-technologies-inc-and-more-among-the-key-companies-in-the-market---technavio-302004841.html,2023-12-05 01:30:00,"Biomarkers Market size to grow by USD 56.26 billion from 2022 to 2027| Abbott Laboratories, Abcam plc, Agilent ... PR ...",ABT,0.07913,-0.019424,Neutral
In-vitro Diagnostics Market to grow by USD 33.16 billion from 2021 to 2026| The rising geriatric population with chronic ... - PR Newswire,https://www.prnewswire.com/news-releases/in-vitro-diagnostics-market-to-grow-by-usd-33-16-billion--from-2021-to-2026-the-rising-geriatric-population-with-chronic-and-infectious-diseases-drives-the-market-growth--technavio-302003823.html,2023-12-04 03:20:00,In-vitro Diagnostics Market to grow by USD 33.16 billion from 2021 to 2026| The rising geriatric population with chronic ... PR ...,ABT,0.062926,0.148111,Neutral
2 Dividend Stocks to Buy and Hold Forever,https://www.fool.com/investing/2023/12/02/2-dividend-stocks-to-buy-and-hold-forever/,2023-12-02 15:00:00,These stocks offer much more than reliable dividends.,ABT,0.052226,0.152563,Somewhat-Bullish
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops,https://www.cnbc.com/2023/12/02/pfizer-weight-loss-pill-joins-list-of-obesity-drug-flops.html,2023-12-02 13:00:01,"Before successful weight loss treatments such as Wegovy and Ozempic, the pharmaceutical path to treating obesity was strewn with failures dating back decades.",ABT,0.050359,0.0,Neutral
Peering Into Abbott Laboratories's Recent Short Interest - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/short-sellers/23/12/36048995/peering-into-abbott-laboratoriess-recent-short-interest,2023-12-01 18:00:15,"Abbott Laboratories's ABT short percent of float has risen 22.81% since its last report. The company recently reported that it has 12.08 million shares sold short, which is 0.7% of all regular shares that are available for trading.",ABT,0.221819,0.155473,Somewhat-Bullish
Spotlight on Abbott Laboratories: Analyzing the Surge in Options Activity - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/markets/options/23/11/36032805/spotlight-on-abbott-laboratories-analyzing-the-surge-in-options-activity,2023-11-30 20:47:17,"Benzinga's options scanner just detected over 14 options trades for Abbott Laboratories ABT summing a total amount of $728,380. At the same time, our algo caught 5 for a total amount of 280,465.",ABT,0.68732,0.339352,Somewhat-Bullish
"In-Vitro Diagnostics Market Set to Soar, Fueled by Innovation and Rising Healthcare Needs As Per The Business Research Company's In Vitro Diagnostics Global Market Report 2023",https://www.benzinga.com/pressreleases/23/11/g36027400/in-vitro-diagnostics-market-set-to-soar-fueled-by-innovation-and-rising-healthcare-needs-as-per-th,2023-11-30 16:30:00,"LONDON, Nov. 30, 2023 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's in vitro diagnostics global market report 2023, the global in-vitro diagnostics market is on an upward trajectory, poised to expand from $95.6 billion in 2022 to $106.53 billion in 2023, reflecting a robust ...",ABT,0.055364,0.196933,Somewhat-Bullish
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/23/11/36025576/heres-how-much-you-would-have-made-owning-abbott-laboratories-stock-in-the-last-10-years,2023-11-30 15:30:46,"Abbott Laboratories ABT has outperformed the market over the past 10 years by 1.04% on an annualized basis producing an average annual return of 10.78%. Currently, Abbott Laboratories has a market capitalization of $180.50 billion.",ABT,0.980595,0.386944,Bullish
"Jim Cramer: Buy This Financial Stock, 'I Think They're High Quality' - Abbott Laboratories  ( NYSE:ABT ) ",https://www.benzinga.com/trading-ideas/long-ideas/23/11/36016776/jim-cramer-buy-this-financial-stock-i-think-theyre-high-quality,2023-11-30 14:26:54,"On CNBC's ""Mad Money Lightning Round,"" Jim Cramer said Vishay Intertechnology, Inc. VSH is ""way too cheap."" He added, ""This is one of those moments where I think you've got to buy Vishay."" Cramer also recommended buying Abbott Laboratories ABT. ""Abbot Labs has gotten way too cheap,"" he noted.",ABT,0.468029,0.318744,Somewhat-Bullish
AbbVie Should Consider a Dividend Cut -- Here's Why,https://www.fool.com/investing/2023/11/30/abbvie-should-consider-a-dividend-cut-heres-why/,2023-11-30 13:15:00,Dividend Kings with above-average yields have been badly underperforming the broader markets.,ABT,0.055751,0.104,Neutral
Should You Invest in the iShares U.S. Medical Devices ETF  ( IHI ) ?,https://www.zacks.com/stock/news/2190656/should-you-invest-in-the-ishares-us-medical-devices-etf-ihi,2023-11-29 11:20:05,Sector ETF report for IHI ...,ABT,0.129516,0.070142,Neutral
Here's Why Investors Should Retain Abbott  ( ABT )  Stock Now,https://www.zacks.com/stock/news/2189928/heres-why-investors-should-retain-abbott-abt-stock-now,2023-11-27 17:43:00,Investors are optimistic about Abbott (ABT) driven by expansion in the global market and raised guidance.,ABT,0.095138,0.021338,Neutral
"Dermatology Lasers Market to grow by USD 729.65 million from 2023-2028, North America to account for 39% of ... - PR Newswire",https://www.prnewswire.com/news-releases/dermatology-lasers-market-to-grow-by-usd-729-65-million-from-2023-2028--north-america-to-account-for-39-of-market-growth---technavio-302016307.html,2023-12-15 22:15:00,"Dermatology Lasers Market to grow by USD 729.65 million from 2023-2028, North America to account for 39% of ... PR ...",ABT,0.126119,0.155405,Somewhat-Bullish
"Meal Replacement Market to increase by USD 5.79 billion between 2023 to 2028, Powdered Products to be the major ... - PR Newswire",https://www.prnewswire.com/news-releases/meal-replacement-market-to-increase-by-usd-5-79-billion-between-2023-to-2028--powdered-products-to-be-the-major-contributing-segment---technavio-302016301.html,2023-12-15 18:30:00,"Meal Replacement Market to increase by USD 5.79 billion between 2023 to 2028, Powdered Products to be the major ... PR ...",ABT,0.043898,0.162611,Somewhat-Bullish
3 No-Brainer Healthcare Stocks to Buy Right Now,https://www.fool.com/investing/2023/12/15/3-no-brainer-healthcare-stocks-to-buy-right-now/,2023-12-15 10:00:00,These players have what it takes to boost your portfolio over time.,ABT,0.11894,0.066386,Neutral
"Neuropathy Pain Treatment Market size to grow by USD 5.84 billion from 2023 to 2028, North America accounts for 33 ... - PR Newswire",https://www.prnewswire.com/news-releases/neuropathy-pain-treatment-market-size-to-grow-by-usd-5-84-billion-from-2023-to-2028--north-america-accounts-for-33-of-market-growth--technavio-302015282.html,2023-12-14 22:15:00,"Neuropathy Pain Treatment Market size to grow by USD 5.84 billion from 2023 to 2028, North America accounts for 33 ... PR ...",ABT,0.078099,-0.22385,Somewhat-Bearish
Here's How Much You'd Have If You Invested $1000 in AbbVie a Decade Ago,https://www.zacks.com/stock/news/2197856/heres-how-much-youd-have-if-you-invested-1000-in-abbvie-a-decade-ago,2023-12-14 13:30:05,"Why investing for the long run, especially if you buy certain popular stocks, could reap huge rewards.",ABT,0.058047,0.033049,Neutral
Top Dividend Stock AbbVie Runs Hot As Market Approves Of Acquisition Spree,https://www.investors.com/research/the-income-investor/dividend-stock-abbvie-run-hot-as-market-approves-acquisition-spree/,2023-12-13 20:49:00,"Shares of biotech AbbVie ( ABBV ) are hot. The stock is nearing a buy point, having risen for 11 consecutive days - the longest streak since December 2021. The Chicago-based company - best known for its rheumatoid arthritis drug Humira - has been busy.",ABT,0.214937,0.138874,Neutral
TFF Pharmaceuticals Appoints Thomas B. King to Board of Directors,https://www.globenewswire.com/news-release/2023/12/13/2795496/0/en/TFF-Pharmaceuticals-Appoints-Thomas-B-King-to-Board-of-Directors.html,2023-12-13 13:00:00,"FORT WORTH, Texas, Dec. 13, 2023 ( GLOBE NEWSWIRE ) -- TFF Pharmaceuticals, Inc. ( NASDAQ: TFFP ) , a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing ( TFF ) technology platform, today announced ...",ABT,0.03631,-0.046551,Neutral
"Global Fertility Test Market Size is Estimated to Reach USD 1,004.2 million by 2030, Growing at a CAGR of 8.1%: Straits Research",https://www.benzinga.com/pressreleases/23/12/g36177076/global-fertility-test-market-size-is-estimated-to-reach-usd-1-004-2-million-by-2030-growing-at-a-c,2023-12-11 14:35:00,"New York, United States, Dec. 11, 2023 ( GLOBE NEWSWIRE ) -- Fertility testing determines a person's ability to have a child without artificial insemination. Getting older can affect fertility, so women and men over 35 who have been trying to conceive for at least six months but haven't been ...",ABT,0.029728,0.025451,Neutral
"Hematology Diagnostics Market Size to Reach USD 7.6 billion, With a CAGR of 5.6 % by 2031 - Report by Transparency Market Research Inc.",https://www.benzinga.com/pressreleases/23/12/g36176976/hematology-diagnostics-market-size-to-reach-usd-7-6-billion-with-a-cagr-of-5-6-by-2031-report-by-t,2023-12-11 14:30:00,"Wilmington, Delaware, United States, Dec. 11, 2023 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global hematology diagnostics market is estimated to flourish at a CAGR of 5.6% from 2023 to 2031.",ABT,0.068995,0.220325,Somewhat-Bullish
"Guitar Market size to grow by USD 1.29 billion from 2021 to 2026, North America is estimated to account for 42% of the ... - PR Newswire",https://www.prnewswire.com/news-releases/guitar-market-size-to-grow-by-usd-1-29-billion-from-2021-to-2026--north-america-is-estimated-to-account-for-42-of-the-global-market-growth---technavio-302010649.html,2023-12-11 02:15:00,"Guitar Market size to grow by USD 1.29 billion from 2021 to 2026, North America is estimated to account for 42% of the ... PR ...",ABT,0.037213,0.0,Neutral
Veterinary Software Market to grow by USD 184.07 million from 2022 to 2027|Rising awareness about disease ... - PR Newswire,https://www.prnewswire.com/news-releases/veterinary-software-market-to-grow-by-usd-184-07-million-from-2022-to-2027rising-awareness-about-disease-prevention-is-one-of-the-emerging-trends--technavio-302010647.html,2023-12-11 02:00:00,Veterinary Software Market to grow by USD 184.07 million from 2022 to 2027|Rising awareness about disease ... PR ...,ABT,0.053992,0.0,Neutral
Laboratory information management system (LIMS) market to grow by USD 897.05 million from 2022 to 2023 | Abbott ... - PR Newswire,https://www.prnewswire.com/news-releases/laboratory-information-management-system-lims-market-to-grow-by-usd-897-05-million-from-2022-to-2023--abbott-laboratories-accelerated-technology-laboratories-inc-agile-frameworks-llc-and-more-among-the-key-companies-in-the-m-302010642.html,2023-12-11 01:30:00,Laboratory information management system ( LIMS ) market to grow by USD 897.05 million from 2022 to 2023 | Abbott ... PR ...,ABT,0.061315,0.098009,Neutral
Better Dividend Stock: AbbVie vs. Medical Properties Trust,https://www.fool.com/investing/2023/12/09/better-dividend-stock-abbvie-vs-medical-properties/,2023-12-09 10:12:00,Which of these high-yield stocks has what it takes to keep raising their payouts?,ABT,0.053629,-0.026996,Neutral
2 Healthcare Stocks to Buy Hand Over Fist in December,https://www.fool.com/investing/2023/12/08/2-healthcare-stocks-to-buy-hand-over-fist-december/,2023-12-08 13:45:00,These stocks are great options now -- and most any month.,ABT,0.207127,0.142283,Neutral
3 High-Yielding Dividend Stocks That Are Near Their 52-Week Lows,https://www.fool.com/investing/2023/12/08/3-high-yielding-divdend-stocks-that-are-near-their/,2023-12-08 13:00:00,Buying these shares can provide you with some excellent recurring income while also diversifying your portfolio.,ABT,0.058615,0.106992,Neutral
Looking for Dividend Growth in the New Year? 3 Magnificent Stocks to Buy Now.,https://www.fool.com/investing/2023/12/07/for-dividend-growth-3-stocks-to-buy/,2023-12-07 10:00:00,These particular players look cheap right now.,ABT,0.052226,0.040734,Neutral
Here's How Much You Would Have Made Owning Abbott Laboratories Stock In The Last 10 Years - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/23/12/36388048/heres-how-much-you-would-have-made-owning-abbott-laboratories-stock-in-the-last-10-years,2023-12-26 17:30:21,"Abbott Laboratories ABT has outperformed the market over the past 10 years by 1.13% on an annualized basis producing an average annual return of 11.04%. Currently, Abbott Laboratories has a market capitalization of $189.58 billion.",ABT,0.980595,0.386944,Bullish
5 Top Stocks to Buy With Your End-of-the-Year Bonus,https://www.fool.com/investing/2023/12/23/5-top-stocks-to-buy-with-your-bonus/,2023-12-23 10:00:00,Your bonus could become the gift that keeps on giving.,ABT,0.077593,0.045518,Neutral
Here are the big health sector themes to watch next year,https://www.cnbc.com/2023/12/22/health-sector-themes-to-watch-in-2024.html,2023-12-22 13:41:09,"The health-care sector has seen a big rebound this month, and analysts say some beaten-down names will continue to have positive momentum in 2024.",ABT,0.025352,0.075078,Neutral
Breath Analyzers Market to grow by USD 3.36 billion from 2023 to 2028; North America to account for 28% of market ... - PR Newswire,https://www.prnewswire.com/news-releases/breath-analyzers-market-to-grow-by-usd-3-36-billion-from-2023-to-2028-north-america-to-account-for-28-of-market-growth--technavio-302018853.html,2023-12-21 22:35:00,Breath Analyzers Market to grow by USD 3.36 billion from 2023 to 2028. North America to account for 28% of market ... PR ...,ABT,0.135729,0.042815,Neutral
Better Growth Stock: AbbVie vs. Abbott Laboratories,https://www.fool.com/investing/2023/12/21/better-growth-stock-unitedhealth-group-vs-abbvie/,2023-12-21 15:23:00,Do Humira's declining sales give Abbott Laboratories the edge as the better growth stock?,ABT,0.107255,0.050859,Neutral
Abbott  ( ABT )  Gains From Global Expansion Amid Macro Woes,https://www.zacks.com/stock/news/2199328/abbott-abt-gains-from-global-expansion-amid-macro-woes,2023-12-18 14:08:00,Abbott's (ABT) EPD business continues to witness low double-digit growth. It has successfully positioned itself as one of the best-positioned large healthcare companies in emerging markets.,ABT,0.146618,0.144108,Neutral
"The Zacks Analyst Blog Highlights JPMorgan Chase, Abbott Laboratories, Qualcomm, Johnson & Johnson and BHP",https://www.zacks.com/stock/news/2199138/the-zacks-analyst-blog-highlights-jpmorgan-chase-abbott-laboratories-qualcomm-johnson-johnson-and-bhp,2023-12-18 10:09:00,"JPMorgan Chase, Abbott Laboratories, Qualcomm, Johnson & Johnson and BHP are included in this Analyst Blog.",ABT,0.186259,0.048224,Neutral
Better Income Stock: AT&T or AbbVie?,https://www.fool.com/investing/2023/12/17/better-income-stock-att-or-abbvie/,2023-12-17 20:30:00,These two blue chips are highly prized for their top-shelf dividend programs.,ABT,0.076847,0.207076,Somewhat-Bullish
Assertio  ( ASRT )  Shares Fall as Dan Peisert Steps Down as CEO,https://www.zacks.com/stock/news/2205675/assertio-asrt-shares-fall-as-dan-peisert-steps-down-as-ceo,2024-01-04 14:46:00,"Assertio (ASRT) appoints Heather Mason as its interim CEO as its current CEO, Dan Peisert, steps down from his role. Shares of the company fall on the same.",ABT,0.077845,0.0,Neutral
Ozempic and other weight-loss drugs' popularity set these stocks up for big gains,https://www.marketwatch.com/story/ozempic-and-other-weight-loss-drugs-popularity-set-these-stocks-up-for-big-gains-fa2a3f33,2024-01-04 12:10:00,Gut-punch to medical technology and processed-food stocks is temporary.,ABT,0.089019,0.002098,Neutral
Could Abbott Laboratories Stock Help You Become a Millionaire?,https://www.fool.com/investing/2024/01/03/could-abbott-laboratories-stock-help-you-become-a/,2024-01-03 14:45:00,"There is a lot going the company's way, despite recent struggles.",ABT,0.395012,0.194311,Somewhat-Bullish
"Assertio Holdings, Inc. Announces Leadership Transition",https://www.globenewswire.com/news-release/2024/01/03/2803350/0/en/Assertio-Holdings-Inc-Announces-Leadership-Transition.html,2024-01-03 13:59:00,Dan Peisert Stepping Down as CEO ...,ABT,0.055492,0.045167,Neutral
1 Concerning Trend for AbbVie Investors to Keep an Eye On,https://www.fool.com/investing/2024/01/03/1-concerning-trend-for-abbvie-investors-to-keep-an/,2024-01-03 13:30:00,Is AbbVie a good stock for dividend investors to own?,ABT,0.065866,0.061072,Neutral
XORTX Welcomes New Member to the Board of Directors,https://www.globenewswire.com/news-release/2024/01/02/2802570/0/en/XORTX-Welcomes-New-Member-to-the-Board-of-Directors.html,2024-01-02 12:00:00,"CALGARY, Alberta, Jan. 02, 2024 ( GLOBE NEWSWIRE ) -- XORTX Therapeutics Inc. ( ""XORTX"" or the ""Company"" ) ( NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU ) , a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, welcomes Mr. ...",ABT,0.052918,0.052981,Neutral
Here's How Much a $1000 Investment in AbbVie Made 10 Years Ago Would Be Worth Today,https://www.zacks.com/stock/news/2204045/heres-how-much-a-1000-investment-in-abbvie-made-10-years-ago-would-be-worth-today,2024-01-01 13:30:04,"Investing in certain stocks can pay off in the long run, especially if you hold on for a decade or more.",ABT,0.058188,0.033051,Neutral
Hypoallergenic powdered infant formula recalled over bacteria contamination,https://www.foxbusiness.com/lifestyle/hypoallergenic-powdered-infant-formula-bacteria-contamination,2023-12-31 18:22:00,"Reckitt Benckiser Group's Mead Johnson Nutrition ( MJN ) issued a voluntary recall for certain infant formula products distributed in the U.S. due to concerns that it could be contaminated with potentially dangerous bacteria, according to federal health officials.",ABT,0.080728,-0.049796,Neutral
Which Mutual Funds Are Positioned Perfectly For 2024?,https://www.investors.com/etfs-and-funds/mutual-funds/best-mutual-funds-are-positioned-perfectly-for-2024/,2023-12-29 12:00:00,Best Mutual Funds: Which Are Positioned Perfectly For 2024? Investor's Business Daily ...,ABT,0.038314,0.044768,Neutral
"Investor Michael Farr is back with his top 10 stocks he's buying for 2024, and the tilt is defensive",https://www.cnbc.com/2023/12/28/investor-michael-farr-is-back-with-his-top-10-stocks-hes-buying-for-2024-and-the-tilt-is-defensive.html,2023-12-28 19:02:55,This year's list is a bit more defensive than in years past and has a focus on earnings growth.,ABT,0.046724,0.264629,Somewhat-Bullish
"Here's a 'solid contrarian idea' for 2024, according to BTIG's Krinsky",https://www.marketwatch.com/story/heres-a-solid-contrarian-idea-for-2024-according-to-btigs-krinsky-32a86261,2023-12-28 11:34:00,Investors should consider this list of healthcare stocks for ...,ABT,0.081414,0.0,Neutral
Watch These 5 Stocks That Recently Hiked Dividends,https://www.zacks.com/stock/news/2202493/watch-these-5-stocks-that-recently-hiked-dividends,2023-12-27 13:18:00,"Investors may keep a tab on stocks like FULT, SFBS, MOS, ABT and ANDE, which have lately hiked their dividend payments.",ABT,0.384233,0.121623,Neutral
"Top Analyst Reports for AMD, Abbott Laboratories & QUALCOMM",https://www.zacks.com/research-daily/2210113/top-analyst-reports-for-amd-abbott-laboratories-qualcomm,2024-01-15 17:41:00,"Today's Research Daily features new research reports on 16 major stocks, including Advanced Micro Devices, Inc. (AMD), Abbott Laboratories (ABT) and QUALCOMM Incorporated (QCOM).",ABT,0.097457,0.113169,Neutral
Pharmaceutical Chemicals Market Size Is Expected To Grow At A CAGR Of More Than 7% Through 2024-2028 As Per The Business Research Company's Pharmaceutical Chemicals Global Market Report 2024,https://www.benzinga.com/pressreleases/24/01/g36631583/pharmaceutical-chemicals-market-size-is-expected-to-grow-at-a-cagr-of-more-than-7-through-2024-202,2024-01-15 16:30:00,"LONDON, Jan. 15, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's pharmaceutical chemicals global market report 2024, the pharmaceutical chemicals market has exhibited robust growth, escalating from $129.54 billion in 2023 to an estimated $138.71 billion in 2024, boasting a ...",ABT,0.059341,0.130056,Neutral
"Global Sulfatases Market Forecasts to 2028, with Competitor Analysis for Bayer, BASF, Yara, Compass Minerals, Sumitomo Chemicals, UPL, Israel Chemical Company, Novozymes & Syngenta Crop Protection",https://www.prnewswire.com/news-releases/global-sulfatases-market-forecasts-to-2028-with-competitor-analysis-for-bayer-basf-yara-compass-minerals-sumitomo-chemicals-upl-israel-chemical-company-novozymes--syngenta-crop-protection-302034516.html,2024-01-15 11:15:00,"Global Sulfatases Market Forecasts to 2028, with Competitor Analysis for Bayer, BASF, Yara, Compass Minerals ... PR ...",ABT,0.05749,0.121006,Neutral
Prenatal Vitamin Supplements Market to grow by USD 237.81 million from 2022 to 2027; North America to account for ... - PR Newswire,https://www.prnewswire.com/news-releases/prenatal-vitamin-supplements-market-to-grow-by-usd-237-81-million-from-2022-to-2027-north-america-to-account-for-51-of-market-growth--technavio-302034169.html,2024-01-15 06:35:00,Prenatal Vitamin Supplements Market to grow by USD 237.81 million from 2022 to 2027. North America to account for ... PR ...,ABT,0.055492,0.0,Neutral
"Uber, Abbott Laboratories, Vertex Pharmaceuticals And More On CNBC's 'Final Trades' - Abbott Laboratories  ( NYSE:ABT ) , Uber Technologies  ( NYSE:UBER ) ",https://www.benzinga.com/trading-ideas/long-ideas/24/01/36606668/uber-abbott-laboratories-vertex-pharmaceuticals-and-more-on-cnbcs-final-trades,2024-01-12 13:51:03,"On CNBC's ""Halftime Report Final Trades,"" Joshua Brown of Ritholtz Wealth Management said Uber Technologies, Inc. UBER shares hit an all-time high on Thursday above the Feb. 2021 high. He remains long on the stock and still loves it.",ABT,0.558244,0.0,Neutral
Extracorporeal Membrane Oxygenation Machines Market size to grow by 640.24 million by 2027 with a CAGR of 10.05 ... - PR Newswire,https://www.prnewswire.com/news-releases/extracorporeal-membrane-oxygenation-machines-market-size-to-grow-by-640-24-million-by-2027-with-a-cagr-of-10-05-between-2022---2027--technavio-302033129.html,2024-01-12 03:15:00,Extracorporeal Membrane Oxygenation Machines Market size to grow by 640.24 million by 2027 with a CAGR of 10.05 ... PR ...,ABT,0.048621,0.128956,Neutral
$100 Invested In Abbott Laboratories 10 Years Ago Would Be Worth This Much Today - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/24/01/36596051/100-invested-in-abbott-laboratories-10-years-ago-would-be-worth-this-much-today,2024-01-11 15:30:38,"Abbott Laboratories ABT has outperformed the market over the past 10 years by 1.21% on an annualized basis producing an average annual return of 11.09%. Currently, Abbott Laboratories has a market capitalization of $196.70 billion.",ABT,0.980595,0.386944,Bullish
2 Ultrareliable Dividend Stocks to Buy in 2024 and Hold for at Least a Decade,https://www.fool.com/investing/2024/01/11/2-ultra-reliable-dividend-stocks-to-buy-in-2024-an/,2024-01-11 10:39:00,Strong advantages over the competition could allow these businesses to keep raising their dividend payouts for at least another 10 years.,ABT,0.052685,0.124609,Neutral
Stocks Generating Improved Relative Strength: Abbott Laboratories,https://www.investors.com/ibd-data-stories/stocks-generating-improved-relative-strength-abbott-laboratories/,2024-01-11 08:00:00,"The Relative Strength ( RS ) Rating for Abbott Laboratories ( ABT ) headed into a new percentile Thursday, as it got a lift from 68 to 77. X When looking for the best stocks to buy and watch, one factor to watch closely is relative price strength.",ABT,0.76191,0.589428,Bullish
"Influenza Diagnostics Market Expected to Exceed USD 2.0 billion by 2031, at a CAGR 5.6%| Analysis by Transparency Market Research, Inc.",https://www.benzinga.com/pressreleases/24/01/g36575512/influenza-diagnostics-market-expected-to-exceed-usd-2-0-billion-by-2031-at-a-cagr-5-6-analysis-by-,2024-01-10 13:40:49,"Wilmington, Delaware, United States, Jan. 10, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. - The global influenza diagnostics market is estimated to flourish at a CAGR of 5.6% from 2023 to 2031.",ABT,0.065506,0.237603,Somewhat-Bullish
2 Top Dividend Stocks to Buy in 2024 and Hold Forever,https://www.fool.com/investing/2024/01/10/2-top-dividend-stocks-to-buy-in-2024-and-hold/,2024-01-10 12:45:00,It's hard to beat these companies' track records.,ABT,0.055621,-0.019994,Neutral
Biliary Stent Market to Cross USD 666.5 million at a CAGR of 5.2 % by 2031: Transparency Market Research Report,https://www.benzinga.com/pressreleases/24/01/g36571195/biliary-stent-market-to-cross-usd-666-5-million-at-a-cagr-of-5-2-by-2031-transparency-market-resea,2024-01-10 07:44:12,"Wilmington, Delaware, United States, Jan. 10, 2024 ( GLOBE NEWSWIRE ) -- Transparency Market Research Inc. -The global biliary stent market is estimated to flourish at a CAGR of 5.2% from 2023 to 2031.",ABT,0.036146,0.086974,Neutral
3 Simple Tricks That Every Investor Should Use  ( but Most Don't ) ,https://www.fool.com/investing/2024/01/09/3-simple-tricks-that-every-investor-should-use-but/,2024-01-09 15:15:00,Having a few tricks up your sleeve can increase your returns over time.,ABT,0.085782,0.123385,Neutral
3 Dividend Growers Suited for Income Investors,https://www.zacks.com/commentary/2207189/3-dividend-growers-suited-for-income-investors,2024-01-08 22:02:00,A company's ability to consistently pay and increase dividend payouts reflects a stable and healthy financial position. Who doesn't enjoy payday?,ABT,0.351558,0.295021,Somewhat-Bullish
Here's Why Investors Should Retain Abbott  ( ABT )  Stock Now,https://www.zacks.com/stock/news/2207160/heres-why-investors-should-retain-abbott-abt-stock-now,2024-01-08 17:41:00,Investors are optimistic about Abbott (ABT) led by solid prospects in the Diagnostic business and raised guidance.,ABT,0.098456,0.099177,Neutral
"Wearable Technology Market Gains Ground, 3 Stocks in Focus",https://www.zacks.com/stock/news/2206848/wearable-technology-market-gains-ground-3-stocks-in-focus,2024-01-08 13:45:00,"In the wearable medical devices industry, investors can keep a keen eye on stocks such as ABT, MDT and DXCM.",ABT,0.2138,0.303235,Somewhat-Bullish
World's Smallest Brain Stimulation Device For Movement Disorder: FDA Approved Abbott's Liberta RC DBS system - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/large-cap/24/01/36789135/worlds-smallest-brain-stimulation-device-for-movement-disorder-fda-approved-abbotts-liberta-rc-dbs,2024-01-25 20:19:59,"Abbott Laboratories ABT received FDA approval to launch the Liberta RC DBS system, the world's smallest rechargeable deep brain stimulation ( DBS ) device with remote programming, to treat people living with movement disorders.",ABT,0.334762,0.34956,Somewhat-Bullish
2 No-Brainer Dividend Stocks to Buy for the New Year,https://www.fool.com/investing/2024/01/25/no-brainer-dividend-stocks-to-buy-for-the-new-year/,2024-01-25 10:20:00,These companies have fantastic track records of maintaining and raising their payouts.,ABT,0.046724,0.071917,Neutral
"Leaders from Amazon, Hitachi America, Abbott Laboratories, Lendlease and More to Speak at Questex's Sensors Converge 2024",https://www.benzinga.com/pressreleases/24/01/g36765327/leaders-from-amazon-hitachi-america-abbott-laboratories-lendlease-and-more-to-speak-at-questexs-se,2024-01-24 19:00:00,"NEW YORK, Jan. 24, 2024 ( GLOBE NEWSWIRE ) -- Questex's Fierce Technology Group today announces leaders from Amazon, Hitachi America, Abbott Laboratories, Lendlease and more will speak at Sensors Converge 2024. The event will offer over 80 sessions over three days.",ABT,0.12645,-0.005835,Neutral
Why Is Abbott Stock Trading Lower Today? - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/news/earnings/24/01/36763629/abbott-laboratories-surpasses-q4-sales-expectations-despite-dip-in-covid-19-testing-demand,2024-01-24 17:34:29,"Abbott Laboratories ABT posted higher sales of $10.24 billion in the fourth quarter, despite continued soft demand for the company's Covid-19 testing equipment, beating the consensus of $10.18 billion.",ABT,0.313484,-0.060395,Neutral
"Abbott's  ( ABT )  Q4 Earnings Match Estimates, Margins Rise",https://www.zacks.com/stock/news/2215090/abbotts-abt-q4-earnings-match-estimates-margins-rise,2024-01-24 15:48:00,Abbott (ABT) delivers better-than-expected revenues and in-line earnings for the fourth quarter of 2023.,ABT,0.154951,0.155454,Somewhat-Bullish
Health Care Bellwether Skids On Light Earnings Outlook,https://www.investors.com/news/technology/abt-stock-abbott-laboratories-earnings-q3-2023/,2024-01-24 13:54:00,ABT Stock Skids On Light Earnings Outlook Despite Quarterly Sales Beat Investor's Business Daily ...,ABT,0.722944,0.311271,Somewhat-Bullish
Abbott Labs' fourth-quarter sales top estimates amid strong medical-device demand,https://www.marketwatch.com/story/abbott-labs-fourth-quarter-sales-top-estimates-amid-strong-medical-device-demand-4d68669e,2024-01-24 12:57:00,Abbott Laboratories on Wednesday reported fourth-quarter sales that topped expectations amid strength in its medical-device and nutrition segments.,ABT,0.148273,0.006598,Neutral
"Nasdaq, S&P 500 Futures Jump As Wall Street Eagerly Awaits Tesla's Q4 Earnings: Analyst Says Rally Broadening But Favors These Stocks - Invesco QQQ Trust, Series 1  ( NASDAQ:QQQ ) , SPDR S&P 500  ( ARCA:SPY ) ",https://www.benzinga.com/news/earnings/24/01/36755805/nasdaq-s-p-500-futures-jump-as-wall-street-eagerly-awaits-teslas-q4-earnings-analyst-says-rally-bro,2024-01-24 12:41:45,"U.S. stock futures indicate a positive opening on Wednesday, buoyed by strong earnings reports from Netflix, Inc. NFLX and semiconductor equipment maker ASML Holding N.V. ASML. Investors are eagerly awaiting Tesla, Inc.'s TSLA fourth-quarter results, which are expected to take center stage.",ABT,0.115787,0.0,Neutral
"S&P 500 futures point to fresh record on Netflix results, bond market calm",https://www.marketwatch.com/story/s-p-500-futures-point-to-fresh-record-on-netflix-results-bond-market-calm-bc2b7035,2024-01-24 10:25:00,"Futures showed the S&P 500 on course for another record as a batch of well-received earnings, calmer bond markets and a monetary boost in China lifted risk appetite.",ABT,0.175859,0.0,Neutral
"Investor Optimism Improves Following Earnings Reports; S&P 500 Reaches Another High - Abbott Laboratories  ( NYSE:ABT ) , IBM  ( NYSE:IBM ) ",https://www.benzinga.com/news/earnings/24/01/36752497/investor-optimism-improves-following-earnings-reports-s-p-500-reaches-another-high,2024-01-24 08:49:59,"The CNN Money Fear and Greed index showed a further increase in overall market sentiment, while the index remained in the ""Greed"" zone on Tuesday. U.S. stocks closed mixed on Tuesday, with the Dow Jones index snapping a three-day winning streak. However, the S&P 500 hit a new all-time closing ...",ABT,0.231332,0.0,Neutral
"Netflix, Tesla And 3 Stocks To Watch Heading Into Wednesday - Netflix  ( NASDAQ:NFLX ) , Tesla  ( NASDAQ:TSLA ) ",https://www.benzinga.com/news/earnings/24/01/36752351/netflix-tesla-and-3-stocks-to-watch-heading-into-wednesday,2024-01-24 07:36:40,"With U.S. stock futures trading higher this morning on Wednesday, some of the stocks that may grab investor focus today are as follows: Wall Street expects AT&T Inc. T to report quarterly earnings at 56 cents per share on revenue of $31.48 billion before the opening bell.",ABT,0.366061,0.3313,Somewhat-Bullish
"Arterial Device-Focused Inari Medical Likely Acquisition Target, Shares Are Attractively Valued: Analyst - Inari Medical  ( NASDAQ:NARI ) ",https://www.benzinga.com/analyst-ratings/analyst-color/24/01/36745475/arterial-device-focused-inari-medical-likely-acquisition-target-shares-are-attracti,2024-01-23 19:56:52,"Needham initiated coverage on Inari Medical Inc NARI, noting it as a leader in the very large and underpenetrated market for venous thrombectomy. Inari Medical projects an annual patient population of 280,000 with pulmonary embolism ( PE ) in the U.S., equating to a total available market ( TAM ) ...",ABT,0.213048,0.0,Neutral
"Protein Supplement Market Set for Robust Growth: Projected 8.7% CAGR, Reaching US$113.1 Billion by 2030, Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36742343/protein-supplement-market-set-for-robust-growth-projected-8-7-cagr-reaching-us-113-1-billion-by-20,2024-01-23 17:00:00,"New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Protein supplements play a crucial role in the health and fitness industry, aiding individuals in meeting their nutritional requirements.",ABT,0.042159,0.0,Neutral
"Cough Suppressant Market to Hit US$ 39,216.3 Million by 2030 | Updated Insights Report by Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36734013/cough-suppressant-market-to-hit-us-39-216-3-million-by-2030-updated-insights-report-by-persistence,2024-01-23 12:00:00,"New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Cough suppressants, also known as antitussives, are pharmaceutical substances engineered to alleviate cough symptoms.",ABT,0.041682,0.183297,Somewhat-Bullish
Expectorant Drugs Market Poised to Reach US$22.9 Billion by 2030 with a Steady 4.5% CAGR | Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36732382/expectorant-drugs-market-poised-to-reach-us-22-9-billion-by-2030-with-a-steady-4-5-cagr-persistenc,2024-01-23 09:30:00,"New York, Jan. 23, 2024 ( GLOBE NEWSWIRE ) -- Market Size & Overview: The global expectorant drugs market is projected to grow at a robust CAGR of 4.5%, surging from US$16.8 billion in 2023 to reach US$22.9 billion by the conclusion of 2030.",ABT,0.015226,0.306033,Somewhat-Bullish
S&P 500 ends with record high for 2nd session in row,https://www.moneycontrol.com/news/business/markets/sp-500-ends-with-record-high-for-2nd-session-in-row-12105241.html,2024-01-23 01:01:43,"Friday's finish confirmed that the SP 500 has been in a bull market since it closed at its low on Oct. 12, 2022, according to one commonly used measure.",ABT,0.087824,0.0,Neutral
Top Stocks to Watch as Earnings Approach,https://www.zacks.com/stock/news/2213851/top-stocks-to-watch-as-earnings-approach,2024-01-23 00:28:00,"Several expansive companies are expected to post stellar quarterly growth when they report Q4 results on Wednesday, January 24.",ABT,0.213988,0.219314,Somewhat-Bullish
"Rehabilitation Equipment Global Market to Showcase Growth at a CAGR of ~5% by 2028, Examines DelveInsight",https://www.prnewswire.com/news-releases/rehabilitation-equipment-global-market-to-showcase-growth-at-a-cagr-of-5-by-2028-examines-delveinsight-302040512.html,2024-01-22 22:31:00,"The increasing demand for rehabilitation equipment is driven by several factors, including a growing number of accidents, injuries, and falls.",ABT,0.02668,0.026075,Neutral
Brain Implants Market Set for Remarkable Growth: Projected to Reach $8.77 Billion by 2028 As Per The Business Research Company's Brain Implants Global Market Report 2024,https://www.benzinga.com/pressreleases/24/01/g36719319/brain-implants-market-set-for-remarkable-growth-projected-to-reach-8-77-billion-by-2028-as-per-the,2024-01-22 16:30:00,"LONDON, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Brain Implants Global Market Report 2024, the global brain implants market has been experiencing rapid growth in recent years and is poised for significant expansion in the coming years.",ABT,0.054236,0.121772,Neutral
What's in Store for Zimmer Biomet  ( ZBH )  in Q4 Earnings?,https://www.zacks.com/stock/news/2213563/whats-in-store-for-zimmer-biomet-zbh-in-q4-earnings,2024-01-22 15:42:00,Zimmer Biomet (ZBH) is expected to have gained from the uptake of Persona OsseoTi Keel Tibia for Cementless Knee Replacement in the fourth quarter.,ABT,0.175221,0.0,Neutral
Should You Buy Abbott Laboratories  ( ABT )  Ahead of Earnings?,https://www.zacks.com/stock/news/2213332/should-you-buy-abbott-laboratories-abt-ahead-of-earnings,2024-01-22 13:30:00,Abbott Laboratories (ABT) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.,ABT,0.900719,0.599723,Bullish
CVS Health  ( CVS )  to Report Q4 Earnings: What's in the Cards?,https://www.zacks.com/stock/news/2213329/cvs-health-cvs-to-report-q4-earnings-whats-in-the-cards,2024-01-22 13:24:00,CVS Health's (CVS) fourth-quarter 2023 results are likely to reflect the strength of the Pharmacy & Consumer Wellness and Health Services segments.,ABT,0.159569,0.0,Neutral
"Renal function test market forecasting a US$1.6 billion illumination by 2030, with Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36711091/renal-function-test-market-forecasting-a-us-1-6-billion-illumination-by-2030-with-persistence-mark,2024-01-22 07:00:00,"New York, Jan. 22, 2024 ( GLOBE NEWSWIRE ) -- Renal Function Test Market: A Comprehensive Analysis Renal Function Tests are a series of diagnostic tests used to assess the functioning of the kidneys.",ABT,0.014497,0.207185,Somewhat-Bullish
My 5 Top Dividend Stocks to Buy Hand Over Fist in 2024,https://www.fool.com/investing/2024/01/21/my-5-top-dividend-stocks-to-buy-in-2024/,2024-01-21 11:17:00,These stocks may help you win in 2024 -- no matter what the market does.,ABT,0.078099,0.311035,Somewhat-Bullish
$100 Invested In This Stock 10 Years Ago Would Be Worth $300 Today - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/insights/news/24/01/36700971/100-invested-in-this-stock-10-years-ago-would-be-worth-300-today,2024-01-19 20:00:27,"Abbott Laboratories ABT has outperformed the market over the past 10 years by 1.65% on an annualized basis producing an average annual return of 11.83%. Currently, Abbott Laboratories has a market capitalization of $197.62 billion.",ABT,0.980595,0.386944,Bullish
"Global Transdermal Skin Patches Market Forecast Report, 2024-2030: A $9.9B Projected Industry, Dominated by Teva Pharma, 3M Company, Nitto Denko Corporation, and Johnson & Johnson",https://www.prnewswire.com/news-releases/global-transdermal-skin-patches-market-forecast-report-2024-2030-a-9-9b-projected-industry-dominated-by-teva-pharma-3m-company-nitto-denko-corporation-and-johnson--johnson-302039341.html,2024-01-19 17:15:00,"Global Transdermal Skin Patches Market Forecast Report, 2024-2030: A $9.9B Projected Industry, Dominated by Teva ... PR ...",ABT,0.031738,0.121467,Neutral
ABT: Analyzing 2024 Gain Potential in 3 Medical Stocks,https://stocknews.com/news/abt-a-vmd-analyzing-2024-gain-potential-in-3-medical-stocks/,2024-01-19 16:27:09,"The medical industry is navigating an exciting landscape marked by unprecedented demographic shifts, widespread technological advancement, surging medical expenses, and escalating risk of chronic diseases. This dynamic landscape presents a spectrum of opportunities for the companies operating ...",ABT,0.190096,0.215581,Somewhat-Bullish
"Hepatitis C Virus Testing Market Poised to Expand at a 5.8% CAGR, Surpassing US$1,185.2 Million by 2030 | Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36691001/hepatitis-c-virus-testing-market-poised-to-expand-at-a-5-8-cagr-surpassing-us-1-185-2-million-by-2,2024-01-19 08:30:00,"New York, Jan. 19, 2024 ( GLOBE NEWSWIRE ) -- Market Overview: The Hepatitis C Virus ( HCV ) Testing Market is a dynamic and evolving sector within the healthcare industry, driven by the persistent threat posed by the Hepatitis C Virus.",ABT,0.038655,0.080127,Neutral
Continuous Glucose Monitoring Systems Market to Hit US$20.5 Billion by 2030 | Updated Insights Report by Persistence Market Research,https://www.benzinga.com/pressreleases/24/01/g36683594/continuous-glucose-monitoring-systems-market-to-hit-us-20-5-billion-by-2030-updated-insights-repor,2024-01-18 18:30:00,"New York, Jan. 19, 2024 ( GLOBE NEWSWIRE ) -- Continuous glucose monitoring ( CGM ) systems have brought significant advancements to the field of diabetes management by providing real-time data on blood glucose levels.",ABT,0.034112,0.242427,Somewhat-Bullish
"Abbott's  ( ABT )  Innovations Aid, Macroeconomic Issues Stay",https://www.zacks.com/stock/news/2211543/abbotts-abt-innovations-aid-macroeconomic-issues-stay,2024-01-17 16:01:00,"Abbott (ABT) is successfully continuing the rollout of Alinity, the company's fully integrated and automated molecular diagnostics analyzer.",ABT,0.140076,0.037643,Neutral
What's in Store for Abbott Laboratories  ( ABT )  in Q4 Earnings?,https://www.zacks.com/stock/news/2210532/whats-in-store-for-abbott-laboratories-abt-in-q4-earnings,2024-01-16 11:58:00,Abbott Laboratories' (ABT) fourth-quarter 2023 results are likely to reflect solid base business momentum.,ABT,0.145583,0.0,Neutral
"The Zacks Analyst Blog Highlights Advanced Micro Devices, Abbott Laboratories, Qualcomm, Morgan Stanley and Intuitive Surgical",https://www.zacks.com/stock/news/2210521/the-zacks-analyst-blog-highlights-advanced-micro-devices-abbott-laboratories-qualcomm-morgan-stanley-and-intuitive-surgical,2024-01-16 11:36:00,"Advanced Micro Devices, Abbott Laboratories, Qualcomm, Morgan Stanley and Intuitive Surgical are included in this Analyst Blog.",ABT,0.276648,0.110714,Neutral
Better Growth Stock: Abbott vs. AbbVie,https://www.fool.com/investing/2024/01/16/better-growth-stock-abbott-vs-abbvie/,2024-01-16 10:00:00,These healthcare giants also offer investors the promise of increasing passive income.,ABT,0.100308,0.243918,Somewhat-Bullish
2 Healthcare Dividend Kings to Buy and Hold Forever,https://www.fool.com/investing/2024/02/04/2-healthcare-dividend-kings-to-buy-and-hold-foreve/,2024-02-04 13:20:00,It's going to take a lot to interrupt these companies' streaks.,ABT,0.154455,0.085755,Neutral
Is Abbott Laboratories Stock a Buy Now?,https://www.fool.com/investing/2024/02/03/is-abbott-laboratories-stock-a-buy-now/,2024-02-03 12:45:00,Can Abbott Laboratories be a reliable income stock to hang on to now?,ABT,0.145145,0.318979,Somewhat-Bullish
Neuromodulation Market Worth $11.0 Billion | MarketsandMarkets™.,https://www.prnewswire.com/news-releases/neuromodulation-market-worth-11-0-billion--marketsandmarkets-302051831.html,2024-02-02 15:30:00,"CHICAGO, Feb. 2, 2024 /PRNewswire/ -- Neuromodulation Market in terms of revenue was estimated to be worth $6.2 billion in 2023 and is poised to reach $11.0 billion by 2028, growing at a CAGR of 12.0% from 2023 to 2028 according to a new report by MarketsandMarkets™.",ABT,0.040416,0.0,Neutral
Could Abbott Labs Be the Next Big Winner in the Billion-Dollar Weight Loss Market?,https://www.fool.com/investing/2024/02/02/could-abbott-be-big-winner-weight-loss-market/,2024-02-02 10:03:00,Abbott Labs is using its well-established strengths to make gains in the weight loss market.,ABT,0.112532,0.101063,Neutral
"Vestaron announces CEO transition, appoints Juan Estupinan as Interim CEO",https://www.benzinga.com/pressreleases/24/02/g36884636/vestaron-announces-ceo-transition-appoints-juan-estupinan-as-interim-ceo,2024-02-01 12:00:00,"Durham, North Carolina, Feb. 01, 2024 ( GLOBE NEWSWIRE ) -- The Board of Directors of Vestaron Corporation, a leading provider of innovative peptide insecticide solutions, announced today that Anna Rath has left her position as Chief Executive Officer and as a member of the Board of Directors of ...",ABT,0.067158,0.0,Neutral
Looking At Abbott Laboratories's Recent Unusual Options Activity - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/insights/options/24/01/36850241/looking-at-abbott-laboratoriess-recent-unusual-options-activity,2024-01-30 17:01:24,"Investors with a lot of money to spend have taken a bearish stance on Abbott Laboratories ABT. We noticed this today when the trades showed up on publicly available options history that we track here at Benzinga. Whether these are institutions or just wealthy individuals, we don't know.",ABT,0.723234,0.244043,Somewhat-Bullish
The Meal Replacement Market Size Is Expected To Reach $25.7 Billion By 2028 At A CAGR Of More Than 8% As Per The Business Research Company's Meal Replacement Global Market Report 2024,https://www.benzinga.com/pressreleases/24/01/g36849479/the-meal-replacement-market-size-is-expected-to-reach-25-7-billion-by-2028-at-a-cagr-of-more-than-,2024-01-30 16:30:00,"LONDON, Jan. 30, 2024 ( GLOBE NEWSWIRE ) -- As per The Business Research Company's Meal Replacement Global Market Report 2024, the meal replacement market has exhibited robust growth, escalating from $17.27 billion in 2023 to $18.54 billion in 2024, marking a Compound Annual Growth Rate ( CAGR ) ...",ABT,0.058759,0.334217,Somewhat-Bullish
"We're calling up a health care stock from our Bullpen watch list, starting a new position",https://www.cnbc.com/2024/01/29/were-calling-up-a-health-care-stock-from-our-bullpen-watch-list-starting-a-new-position.html,2024-01-29 14:03:41,"Now that expectations have cooled down, we think this pullback is one worth buying.",ABT,0.221819,0.153796,Somewhat-Bullish
Should You Invest in the iShares U.S. Medical Devices ETF  ( IHI ) ?,https://www.zacks.com/stock/news/2216843/should-you-invest-in-the-ishares-us-medical-devices-etf-ihi,2024-01-29 11:20:06,Sector ETF report for IHI ...,ABT,0.129516,0.070142,Neutral
Monthly Meeting Q&A with Jim Cramer: Everything from health care to industrials to portfolio management,https://www.cnbc.com/2024/01/28/monthly-meeting-qa-with-jim-cramer-everything-from-health-care-to-industrials.html,2024-01-28 18:01:02,"During the January Monthly Meeting, we took questions directly from Investing Club members.",ABT,0.019086,0.029932,Neutral
Looking Into Abbott Laboratories's Recent Short Interest - Abbott Laboratories  ( NYSE:ABT ) ,https://www.benzinga.com/insights/short-sellers/24/01/36806138/looking-into-abbott-laboratoriess-recent-short-interest,2024-01-26 17:45:20,"Abbott Laboratories's ABT short percent of float has fallen 11.59% since its last report. The company recently reported that it has 10.55 million shares sold short, which is 0.61% of all regular shares that are available for trading.",ABT,0.221819,0.083071,Neutral
"Stocks Rally Amid Big Earnings, Economic Data: Weekly Review",https://www.investors.com/news/stock-market-continues-to-rally-asml-netflix-tesla-intel-are-big-earnings-movers-weekly-review/,2024-01-26 17:29:00,"Stock Market Continues To Rally. ASML, Netflix, Tesla, Intel Are Big Earnings Movers: Weekly Review Investor's Business Daily ...",ABT,0.040212,0.074287,Neutral
"Thyroid Function Test Market Expansion at 4.2% CAGR to US$ 2.5 Billion, Persistence Market Research",https://www.benzinga.com/pressreleases/24/01/g36796407/thyroid-function-test-market-expansion-at-4-2-cagr-to-us-2-5-billion-persistence-market-research,2024-01-26 08:35:19,"New York, Jan. 26, 2024 ( GLOBE NEWSWIRE ) -- Thyroid Function Tests ( TFTs ) serve as diagnostic tools to assess the health and functionality of the thyroid gland, a crucial regulator of metabolism through hormone production.",ABT,0.053094,0.321943,Somewhat-Bullish
